data_1z9v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z9v _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.5 t60 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -176.96 148.86 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.23 0.612 . . . . 0.0 110.966 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -148.93 130.67 15.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 55.9 m-85 -114.68 7.57 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.985 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.4 m -84.53 115.0 22.36 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.551 HD12 ' H ' ' A' ' 7' ' ' GLU . 0.6 OUTLIER -102.92 -53.07 2.92 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' H ' HD12 ' A' ' 6' ' ' LEU . 33.1 tt0 -70.22 -13.82 62.35 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 125.155 1.382 . . . . 0.0 110.91 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -73.12 -25.05 60.71 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.237 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -32.3 63.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.68 -42.13 98.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -67.0 -17.32 64.87 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.95 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -95.19 -45.2 7.29 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.9 m -149.59 -67.34 0.21 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.933 0.396 . . . . 0.0 111.127 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.33 163.54 32.04 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.7 152.93 22.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 124.222 0.601 . . . . 0.0 109.831 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CD1' HG21 ' A' ' 54' ' ' ILE . 41.9 t80 -151.44 13.58 0.66 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.401 0.619 . . . . 0.0 110.452 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -144.59 171.06 14.91 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG21 ' HG ' ' A' ' 49' ' ' LEU . 15.5 tt -105.2 150.46 7.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -69.53 67.68 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.305 1.05 . . . . 0.0 110.973 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mmm -122.07 -101.03 0.41 Allowed 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.979 1.712 . . . . 0.0 110.242 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -159.45 124.22 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.06 141.45 39.73 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . . . -118.06 90.47 3.34 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 46' ' ' GLU . . . -107.56 76.07 0.22 Allowed Glycine 0 CA--C 1.479 -2.199 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.358 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 97.3 m-85 -70.37 -74.96 0.13 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.072 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.596 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.7 mmt180 -80.73 -33.02 35.52 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.375 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -66.29 -13.07 59.89 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' MET . 25.0 t -49.44 -37.38 25.54 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 121.501 0.667 . . . . 0.0 110.987 175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.572 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -72.68 -42.97 63.69 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 121.82 -0.55 . . . . 0.0 110.456 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' HIS . . . -60.28 -47.07 87.6 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.122 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -53.39 -39.53 64.33 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.383 0.427 . . . . 0.0 112.023 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.7 mm -62.17 -43.36 97.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.128 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HB3' HG21 ' A' ' 39' ' ' VAL . 18.5 mm-40 -79.58 -28.86 41.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.805 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -64.47 -22.95 67.12 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 123.952 0.901 . . . . 0.0 111.973 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.06 -26.61 66.83 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -59.54 2.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.07 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -141.67 -79.12 0.25 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.487 1.137 . . . . 0.0 110.01 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.499 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 14.2 ptp180 -170.49 123.19 0.65 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 33' ' ' GLU . 74.2 t -132.93 143.19 40.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.639 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.7 p -97.75 139.41 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.901 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.572 ' CE1' ' HB1' ' A' ' 29' ' ' ALA . 66.6 t60 -123.27 124.9 44.03 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.8 tt -85.65 136.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 96.4 mttt 68.1 58.32 0.73 Allowed Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 123.64 0.776 . . . . 0.0 110.93 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 Cg_endo -78.24 155.91 29.3 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 121.647 1.565 . . . . 0.0 110.29 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.596 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -152.99 39.16 0.73 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . 2.3 pm0 -105.6 175.6 5.44 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.925 0.869 . . . . 0.0 111.565 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HG2' HG23 ' A' ' 96' ' ' ILE . 4.7 tmtt? -157.44 102.67 1.92 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.38 105.95 17.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HG ' HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.26 -1.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 127.349 2.26 . . . . 0.0 114.47 175.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.75 -38.89 2.93 Favored Glycine 0 C--N 1.291 -1.946 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.79 39.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -75.79 104.07 6.17 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.5 mt -124.31 119.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 16' ' ' TYR . 62.9 mt -77.9 -33.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.932 0.77 . . . . 0.0 110.18 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.63 14.99 Favored Glycine 0 C--N 1.309 -0.933 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.58 131.25 23.19 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.79 110.43 0.67 Allowed 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.811 2.341 . . . . 0.0 111.324 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -110.58 -177.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 122.878 2.385 . . . . 0.0 112.905 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 75' ' ' THR . 59.1 t -87.23 121.17 71.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 40.22 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.042 2.495 . . . . 0.0 114.792 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.09 145.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.34 145.39 6.0 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.352 -1.404 . . . . 0.0 112.356 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.13 86.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 123.404 0.681 . . . . 0.0 109.428 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -95.07 114.96 26.82 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.29 -69.53 0.72 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -148.07 168.25 22.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -32.82 42.44 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.27 28.47 1.43 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.426 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -152.3 167.91 27.1 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.83 156.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.9 0.857 . . . . 0.0 111.383 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.604 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 ptt? -119.37 124.85 47.59 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.1 mt -107.95 87.48 3.81 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.2 Cg_exo -82.24 142.01 11.84 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.998 1.799 . . . . 0.0 112.332 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.8 49.88 1.07 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.997 1.38 . . . . 0.0 107.819 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.5 p -98.51 119.97 38.13 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 112.746 -2.024 . . . . 0.0 107.313 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -100.51 102.19 17.94 Favored Pre-proline 0 C--N 1.305 -1.345 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.002 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.3 Cg_endo -104.17 -164.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.708 0 C-N-CA 123.069 2.513 . . . . 0.0 111.18 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 74.3 m -109.8 35.39 3.38 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -141.86 -71.76 0.34 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.577 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.16 40.54 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 22.7 m -115.31 149.36 37.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 118.304 1.052 . . . . 0.0 111.214 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.07 124.68 52.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.736 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.4 t -122.33 124.83 71.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.496 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 21.8 m -125.17 145.79 31.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -147.6 118.58 7.67 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.209 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.454 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.1 tp -95.85 125.66 47.92 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 1.13 8.97 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.254 1.969 . . . . 0.0 111.164 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 68' ' ' SER . 19.5 t -100.25 164.42 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 91' ' ' GLU . 6.2 m-20 -70.23 162.21 71.01 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 118.074 0.397 . . . . 0.0 110.132 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.73 16.42 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.137 2.558 . . . . 0.0 112.207 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -70.41 -20.01 62.95 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.014 0.911 . . . . 0.0 109.115 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.491 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 7.3 tp10 -65.74 -24.29 66.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.033 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.514 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 66.5 mt -59.23 -26.96 35.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.83 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -63.59 -41.09 98.37 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 95' ' ' ARG . 2.8 mpt_? -74.82 -38.9 61.92 Favored 'General case' 0 C--O 1.193 -1.921 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 62.2 mt -58.66 -33.97 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 124.37 1.068 . . . . 0.0 111.316 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.45 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.558 0.694 . . . . 0.0 109.797 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.57 -42.55 24.77 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.011 0.91 . . . . 0.0 109.518 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.19 3.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 125.119 1.367 . . . . 0.0 111.674 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -42.19 -44.13 3.62 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 124.518 1.127 . . . . 0.0 110.751 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -160.18 98.18 1.46 Allowed Pre-proline 0 N--CA 1.401 -2.882 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.243 0.734 0 C-N-CA 123.543 2.828 . . . . 0.0 112.739 -178.022 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.446 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.566 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.468 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.486 ' N ' HD13 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.492 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HB3' HD22 ' A' ' 6' ' ' LEU . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.514 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB1' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.822 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.553 ' NE2' ' HB1' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.484 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' GLY . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.529 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.448 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.459 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.448 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.484 ' O ' HG21 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.529 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.582 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.643 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.822 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 79.9 m-70 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtt -152.49 122.26 6.94 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.641 HG22 ' SD ' ' A' ' 31' ' ' MET . 8.6 t -111.25 125.3 53.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.445 0.641 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.54 7.44 6.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.875 0.845 . . . . 0.0 109.43 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 62.5 m -94.89 96.56 9.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.769 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 7' ' ' GLU . 4.1 pp -100.29 -39.48 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.984 0.897 . . . . 0.0 110.358 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.616 ' N ' HD13 ' A' ' 6' ' ' LEU . 35.2 tt0 -77.74 -13.77 59.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.165 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.7 m -68.5 -33.56 74.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -80.33 -26.4 38.76 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.641 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' OE2' ' A' ' 15' ' ' GLU . 7.8 tt -73.55 -26.79 61.01 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.295 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 7' ' ' GLU . 79.5 mt-30 -68.89 -29.96 68.35 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -93.34 -7.0 46.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.059 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.9 m 63.85 37.85 9.39 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 122.318 1.056 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.27 55.71 0.57 Allowed Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' OE2' ' HG ' ' A' ' 10' ' ' LEU . 6.1 pm0 -100.07 174.25 6.25 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.146 0.578 . . . . 0.0 111.423 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.412 ' CD1' HG13 ' A' ' 54' ' ' ILE . 70.9 t80 -144.87 25.44 1.44 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -138.13 163.96 30.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.75 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.1 tt -115.83 165.23 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -65.84 71.87 0.06 Allowed 'General case' 0 C--N 1.362 1.15 0 CA-C-O 122.213 1.006 . . . . 0.0 109.989 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 49' ' ' LEU . 47.7 mtt -135.82 -148.4 0.3 Allowed 'General case' 0 C--N 1.259 -3.326 0 C-N-CA 126.209 1.804 . . . . 0.0 106.872 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 20' ' ' MET . 11.9 tmtt? -124.03 123.28 40.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HB3' HD22 ' A' ' 6' ' ' LEU . 8.9 ptm180 -98.89 165.8 11.59 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.78 80.68 0.94 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.492 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -96.9 82.3 0.74 Allowed Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.4 -65.9 0.87 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.3 mpt_? -85.62 -34.66 21.33 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.984 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 29.8 tt0 -79.21 -3.01 43.68 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.648 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -53.54 -41.91 66.92 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.11 94.98 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.19 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -62.32 -45.73 91.91 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.293 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.641 ' SD ' HG22 ' A' ' 3' ' ' THR . 18.4 ptm -55.98 -35.73 67.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.9 mm -59.9 -46.44 93.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 123.93 0.769 . . . . 0.0 109.927 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.4 -28.51 31.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.193 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 34.7 mtpt -57.01 -26.86 60.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.692 0.797 . . . . 0.0 110.924 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 7.0 tmtm? -62.67 -21.25 65.57 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.316 1.047 . . . . 0.0 111.26 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.86 -39.24 69.81 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 121.86 -0.525 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -176.12 -65.46 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.422 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 7.2 ptp180 -169.6 132.41 1.2 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.67 145.79 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.778 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -98.26 139.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 O-C-N 124.343 1.027 . . . . 0.0 109.996 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 37.6 t-80 -137.7 123.29 19.75 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.0 137.85 20.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.8 mttt 66.6 64.24 0.82 Allowed Pre-proline 0 C--O 1.216 -0.667 0 C-N-CA 123.133 0.573 . . . . 0.0 111.097 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.625 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 44.9 Cg_endo -95.28 148.82 1.53 Allowed 'Trans proline' 0 N--CA 1.427 -2.395 0 C-N-CA 122.126 1.884 . . . . 0.0 111.046 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -154.21 64.76 0.34 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.265 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.649 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.0 tp10 -114.38 123.24 48.98 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 124.072 0.949 . . . . 0.0 109.11 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 44.4 mtmt -106.96 72.5 0.89 Allowed 'General case' 0 CA--C 1.464 -2.339 0 CA-C-O 123.287 1.518 . . . . 0.0 107.786 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.649 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -75.43 94.73 0.98 Allowed 'Isoleucine or valine' 1 C--N 1.239 -4.229 0 CA-C-N 111.683 -2.508 . . . . 0.0 111.828 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER 64.27 -8.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.646 1.578 . . . . 0.0 113.362 175.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 92.29 -6.26 78.23 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.31 152.19 18.27 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -88.83 99.87 12.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.816 0.341 . . . . 0.0 111.77 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.34 118.02 57.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.412 HG13 ' CD1' ' A' ' 16' ' ' TYR . 3.5 mp -75.51 -43.54 41.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.403 0.62 . . . . 0.0 110.736 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.6 -9.47 77.0 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 69.3 mt -124.64 131.21 24.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.9 107.33 1.86 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.563 1.509 . . . . 0.0 109.252 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 56' ' ' ILE . 42.9 Cg_endo -103.4 -164.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 122.721 2.281 . . . . 0.0 111.485 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 75' ' ' THR . 55.7 t -75.75 116.96 60.07 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -84.1 43.93 1.46 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 122.502 2.135 . . . . 0.0 113.964 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mt -114.98 164.88 10.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.21 155.93 9.14 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.157 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.2 pt -126.22 84.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.096 0.95 . . . . 0.0 111.32 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.78 95.96 7.44 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -76.95 -56.92 4.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.769 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.13 169.88 12.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.416 ' HA ' ' HE2' ' A' ' 71' ' ' MET . 0.1 OUTLIER -88.77 -31.7 18.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.23 1.014 . . . . 0.0 108.464 -176.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 14.9 m -93.71 34.63 1.18 Allowed 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.909 1.338 . . . . 0.0 109.203 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.2 m -154.66 166.74 32.45 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.42 105.87 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 121.861 0.839 . . . . 0.0 110.968 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.416 ' HE2' ' HA ' ' A' ' 67' ' ' ARG . 21.4 ptp -86.29 123.54 31.66 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.9 mt -118.93 86.35 30.92 Favored Pre-proline 0 C--N 1.295 -1.792 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.857 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.55 ' O ' HG21 ' A' ' 81' ' ' THR . 4.3 Cg_exo -75.14 149.96 36.89 Favored 'Trans proline' 0 N--CA 1.422 -2.689 0 N-CA-C 108.353 -1.441 . . . . 0.0 108.353 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.08 41.4 2.11 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 44.5 p -95.07 102.85 14.68 Favored 'General case' 0 N--CA 1.398 -3.054 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -102.05 102.38 23.75 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.743 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.8 Cg_endo -102.45 -159.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.311 0 C-N-CA 123.253 2.635 . . . . 0.0 110.136 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -93.86 25.46 3.62 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.121 0.962 . . . . 0.0 110.172 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -128.09 -74.91 0.57 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.829 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 157.66 -174.78 35.07 Favored Glycine 0 N--CA 1.416 -2.655 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.55 HG21 ' O ' ' A' ' 73' ' ' PRO . 5.0 m -121.48 152.12 39.5 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 117.406 0.603 . . . . 0.0 109.627 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . . . -105.15 111.83 24.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.7 t -102.24 90.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.625 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 26.9 m -104.64 135.47 42.42 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 O-C-N 121.457 -0.777 . . . . 0.0 111.473 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.17 115.88 16.95 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.529 0.68 . . . . 0.0 109.277 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 68' ' ' SER . 26.8 tp -99.49 125.03 42.39 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.2 8.45 4.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.348 2.032 . . . . 0.0 111.785 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.15 157.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.42 152.71 94.23 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.89 -7.51 18.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.625 2.883 . . . . 0.0 112.398 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.64 -24.56 63.97 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.61 -27.71 69.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.573 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 78.2 mt -59.17 -41.0 82.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 C-N-CA 122.168 0.187 . . . . 0.0 110.988 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.92 -47.33 86.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.973 0.892 . . . . 0.0 109.66 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -68.32 -41.78 80.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.174 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.92 -28.56 44.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 C-N-CA 124.128 0.971 . . . . 0.0 113.188 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.36 -37.09 84.5 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.212 0.53 . . . . 0.0 110.343 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.22 -37.06 46.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.219 1.009 . . . . 0.0 108.996 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 99' ' ' VAL . 57.8 t -91.07 17.25 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.287 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.534 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.65 -48.33 69.5 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.23 -48.31 0.6 Allowed Pre-proline 0 C--N 1.293 -1.887 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.392 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 C--N 1.389 2.675 0 C-N-CA 123.687 2.925 . . . . 0.0 115.25 177.804 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 64.6 t60 . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -130.07 139.56 50.95 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 t -107.6 123.53 48.6 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.525 0.679 . . . . 0.0 111.706 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -129.99 -0.48 4.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.419 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p -87.22 101.36 13.44 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.652 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -97.34 -44.85 6.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.457 ' N ' HD22 ' A' ' 6' ' ' LEU . 34.9 tt0 -81.42 -4.8 56.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.316 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -71.04 -24.77 62.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.883 0.849 . . . . 0.0 109.559 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 79' ' ' TYR . 38.5 t80 -78.39 -21.84 48.74 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.828 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.06 -35.29 79.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.89 -14.01 62.31 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -91.95 -46.24 7.93 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.7 m -163.39 -67.69 0.04 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.47 0.653 . . . . 0.0 109.428 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.11 -179.87 20.11 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -97.1 177.51 5.57 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 118.243 1.022 . . . . 0.0 108.777 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.419 ' HA ' HG21 ' A' ' 54' ' ' ILE . 18.1 t80 -129.15 14.41 6.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.655 1.217 . . . . 0.0 108.549 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 49' ' ' LEU . 5.0 mp0 -132.3 -168.01 1.98 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.489 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG21 ' HG ' ' A' ' 49' ' ' LEU . 10.9 tt -122.39 45.59 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.375 1.084 . . . . 0.0 110.793 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 56.73 31.07 18.73 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.793 1.237 . . . . 0.0 111.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.413 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 91.1 mmm -121.86 -168.37 1.69 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 45.1 mmtm -89.25 138.16 31.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.782 1.628 . . . . 0.0 111.478 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 48' ' ' ILE . 11.9 ptm180 -107.45 140.63 40.1 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.55 88.79 2.57 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.397 0.618 . . . . 0.0 111.146 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -108.88 78.87 0.24 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.678 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -71.19 -56.83 5.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.781 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 3.2 mmp_? -94.39 -33.17 13.26 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.63 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 25.9 tt0 -82.32 -0.43 45.63 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.975 -177.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 31' ' ' MET . 50.7 t -57.36 -38.15 73.73 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . . . -67.73 -41.78 82.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.427 0.632 . . . . 0.0 109.335 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.37 98.78 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.272 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.629 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 9.9 ptt? -54.52 -35.11 62.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.257 0.348 . . . . 0.0 111.749 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.687 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 44.9 mm -62.72 -39.44 84.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.421 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.77 -27.27 21.25 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.586 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 38.0 mtpt -59.6 -18.24 39.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.048 0.939 . . . . 0.0 112.126 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -68.6 -14.31 62.93 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.14 -55.55 5.34 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 111.213 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -167.62 -64.38 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 40.5 ptt180 -163.16 124.68 2.47 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.0 t -133.52 151.89 34.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.4 p -102.06 148.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 123.873 0.733 . . . . 0.0 110.215 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 29' ' ' ALA . 78.5 t60 -144.47 143.98 31.14 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.21 146.16 9.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.612 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 49.1 mtmt 65.22 48.51 0.66 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 110.723 -176.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 6.0 Cg_exo -89.1 161.77 5.81 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.62 2.214 . . . . 0.0 111.096 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -171.75 75.19 0.1 OUTLIER Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.171 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' CB ' ' HB3' ' A' ' 27' ' ' GLU . 26.7 tt0 -120.94 123.83 43.43 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.709 0.766 . . . . 0.0 110.244 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 50' ' ' GLY . 2.4 tmtm? -124.03 104.13 8.71 Favored 'General case' 0 N--CA 1.394 -3.273 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -106.6 130.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.795 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 55.32 15.95 1.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.038 2.135 . . . . 0.0 112.843 176.181 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.558 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . 81.68 -25.08 4.08 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.043 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' O ' HD11 ' A' ' 53' ' ' ILE . . . -143.44 145.1 32.34 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -74.57 89.14 2.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 117.754 0.252 . . . . 0.0 111.141 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 55' ' ' GLY . 4.7 mp -116.72 127.92 74.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 16' ' ' TYR . 55.2 mt -91.84 -17.23 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 122.096 0.95 . . . . 0.0 108.653 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 87.43 -17.68 42.22 Favored Glycine 0 CA--C 1.499 -0.923 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.1 mt -119.74 105.27 43.51 Favored Pre-proline 0 N--CA 1.413 -2.32 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.16 110.31 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.667 2.912 . . . . 0.0 112.462 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -95.85 175.29 0.9 Allowed 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.747 2.298 . . . . 0.0 111.741 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.9 t -85.12 106.5 9.05 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.3 100.76 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.373 2.049 . . . . 0.0 113.651 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.8 mt -134.54 86.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . -136.32 151.33 20.76 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.48 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.05 104.07 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 123.645 0.778 . . . . 0.0 108.931 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.13 99.06 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -76.36 -69.82 0.48 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.522 0.677 . . . . 0.0 109.821 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -163.91 168.4 19.47 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HG3' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -81.69 -31.09 32.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.189 0.995 . . . . 0.0 108.432 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.535 ' OG ' ' HD3' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -92.17 28.41 1.9 Allowed 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.408 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 m -152.46 166.6 31.45 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.6 m -76.95 103.59 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 118.979 0.809 . . . . 0.0 110.958 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.642 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 23.5 ptt? -83.43 119.26 24.44 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -108.58 88.48 5.2 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 71' ' ' MET . 12.6 Cg_endo -96.07 167.5 1.24 Allowed 'Trans proline' 0 N--CA 1.403 -3.807 0 C-N-CA 121.973 1.782 . . . . 0.0 111.097 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -140.34 113.01 8.05 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.7 p -128.06 139.79 52.33 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -112.31 88.88 11.34 Favored Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.636 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 75' ' ' THR . 73.5 Cg_endo -106.1 -151.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 123.923 3.082 . . . . 0.0 109.808 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.0 t -100.74 13.35 35.2 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.55 ' HD2' ' CE2' ' A' ' 9' ' ' TYR . 48.3 t80 -124.84 -81.55 0.63 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.562 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -174.0 40.63 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 10.2 m -118.75 158.06 26.31 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.33 0.565 . . . . 0.0 110.218 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . . . -114.91 125.43 53.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.4 t -107.34 108.0 24.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.547 ' HB ' ' HG2' ' A' ' 44' ' ' PRO . 29.3 m -114.32 141.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.446 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -134.56 108.57 8.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.0 tp -95.23 129.09 36.29 Favored Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.5 13.51 2.63 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.429 2.086 . . . . 0.0 110.839 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.88 159.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.66 146.12 99.0 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 11.3 Cg_endo -54.34 -13.74 5.68 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.84 3.027 . . . . 0.0 113.879 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.4 -20.69 63.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 92' ' ' GLU . 4.4 tp10 -64.3 -30.53 71.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.52 HG13 ' HG3' ' A' ' 67' ' ' ARG . 48.8 mm -70.04 -31.58 48.21 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.954 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.96 -39.47 94.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -64.97 -48.67 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.463 1.125 . . . . 0.0 108.172 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.1 mt -68.96 -19.58 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.088 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 65.5 tp -77.18 -26.58 53.07 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.019 0.928 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.69 -37.53 59.46 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 56.5 t -62.36 -65.56 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . 59.2 -57.67 0.05 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.732 2.013 . . . . 0.0 114.969 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 32.5 mt-10 -128.06 -69.66 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.134 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.558 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 73.1 Cg_endo . . . . . 0 N--CA 1.437 -1.829 0 CA-C-N 120.681 1.279 . . . . 0.0 112.565 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.604 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 67.1 mtm -152.79 128.54 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m -106.74 111.45 23.98 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.2 m-85 -128.69 10.43 6.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.169 0.509 . . . . 0.0 111.141 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.4 m -131.69 106.93 8.46 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.49 HD11 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -80.92 -37.47 29.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.121 0.962 . . . . 0.0 111.419 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.41 ' H ' HD13 ' A' ' 6' ' ' LEU . 8.3 tp10 -71.38 -19.24 62.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.278 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.538 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.3 m -73.01 -31.96 64.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -70.47 -30.13 66.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.126 0.489 . . . . 0.0 110.092 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.6 -43.64 98.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.81 -11.7 59.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.388 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 8' ' ' THR . 52.5 mt-30 -89.67 -32.83 16.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.6 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -164.5 -67.07 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.47 166.01 38.66 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.85 141.29 56.49 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.716 0.769 . . . . 0.0 111.732 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -139.7 8.38 2.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 54.7 mt-10 -152.86 148.98 27.8 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.34 -1.754 . . . . 0.0 106.741 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.503 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 12.4 tt -89.31 159.93 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -72.11 70.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.794 1.283 . . . . 0.0 109.972 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 mmt -136.69 -175.5 4.04 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.901 -1.954 . . . . 0.0 106.139 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 51.4 mttp -84.52 118.19 24.16 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 119.485 1.039 . . . . 0.0 110.997 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' CZ ' HD11 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -108.37 136.62 47.69 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.411 -177.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -143.36 96.18 2.87 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -114.48 85.12 0.38 Allowed Glycine 0 N--CA 1.423 -2.176 0 C-N-CA 120.302 -0.951 . . . . 0.0 114.476 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -69.28 -81.03 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 117.105 0.452 . . . . 0.0 112.108 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 20.9 mtp-105 -73.13 -32.95 65.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.547 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 13.1 tp10 -70.05 -13.85 62.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.743 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 43.4 t -60.63 -31.9 71.07 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -69.1 -46.13 68.5 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.455 0.645 . . . . 0.0 110.204 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.586 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.51 -44.87 81.38 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.379 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.443 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 22.4 ptp -56.32 -31.14 63.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 28' ' ' CYS . 46.7 mm -60.96 -40.74 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.663 0.744 . . . . 0.0 109.531 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -80.45 -34.25 36.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.281 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 74.3 mttt -68.26 -13.54 62.33 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -64.23 -30.55 71.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.484 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.71 -47.06 27.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.626 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.58 -74.3 0.06 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 120.756 0.313 . . . . 0.0 110.595 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 ttp180 -165.82 124.63 1.61 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.471 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 58.8 t -136.39 165.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.6 p -112.51 149.35 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.437 0.695 . . . . 0.0 109.901 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.586 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 46.2 t60 -140.74 128.84 22.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.4 mp -98.09 136.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 97.0 mttt 71.78 55.97 0.38 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.868 1.267 . . . . 0.0 110.432 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 85.4 Cg_endo -74.16 135.38 20.71 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.997 1.131 . . . . 0.0 109.716 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.94 46.58 1.08 Allowed Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 4.4 pm0 -112.99 153.21 28.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-O 121.643 0.735 . . . . 0.0 110.696 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -140.97 61.76 1.49 Allowed 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.454 ' C ' HD21 ' A' ' 49' ' ' LEU . 33.7 pt -64.29 105.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.576 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.3 OUTLIER 70.49 -10.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.965 2.106 . . . . 0.0 113.792 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.84 -1.16 88.03 Favored Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.59 120.79 3.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.721 1.608 . . . . 0.0 107.069 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.93 87.5 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.321 0.582 . . . . 0.0 112.275 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -116.54 130.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.1 mm -71.88 -40.87 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.498 0.666 . . . . 0.0 109.597 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.0 0.24 63.87 Favored Glycine 0 C--N 1.308 -0.996 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mt -130.52 129.38 22.75 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.64 107.08 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.333 2.022 . . . . 0.0 110.07 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 36.0 Cg_endo -103.97 -167.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.272 0 C-N-CA 122.566 2.177 . . . . 0.0 111.319 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 75' ' ' THR . 41.3 t -99.16 100.67 10.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 10.3 Cg_endo -87.66 102.59 0.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.721 2.28 . . . . 0.0 113.541 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.53 164.52 34.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 133.13 -175.09 20.3 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.556 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.72 107.04 4.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -99.51 108.62 21.1 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -85.34 -55.93 3.78 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -171.94 166.8 6.29 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -35.48 74.58 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.531 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 16.0 m -96.37 31.4 2.24 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.608 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -151.43 161.65 42.33 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG13 ' OE2' ' A' ' 85' ' ' GLU . 9.5 m -77.35 112.77 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.979 0.895 . . . . 0.0 109.865 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.587 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -90.84 123.05 34.08 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.72 89.27 12.85 Favored Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.138 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 71' ' ' MET . 4.9 Cg_exo -85.04 155.94 11.29 Favored 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 121.872 1.714 . . . . 0.0 110.029 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -125.22 75.73 1.48 Allowed 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.536 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 p -106.51 134.62 49.36 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.455 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -110.79 88.81 8.42 Favored Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.875 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 75' ' ' THR . 44.3 Cg_endo -103.38 -159.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.658 2.905 . . . . 0.0 109.797 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 10.1 t -94.58 5.31 52.21 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.448 0.642 . . . . 0.0 109.302 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -120.68 -84.42 0.66 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.152 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -168.8 39.63 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 27.7 m -116.96 147.76 41.99 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.313 0.578 . . . . 0.0 110.08 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -120.12 121.59 39.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 82.9 t -104.38 104.91 17.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -103.22 133.78 46.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.439 ' OE2' HG13 ' A' ' 70' ' ' VAL . 36.2 tt0 -132.69 115.21 15.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.324 0.583 . . . . 0.0 109.696 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.507 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 21.9 tp -99.37 132.99 22.33 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.38 -3.4 10.8 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.311 2.007 . . . . 0.0 111.834 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.507 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.5 t -96.0 164.32 2.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.0 t70 -68.61 146.89 97.93 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 123.208 0.603 . . . . 0.0 110.755 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.04 -10.92 1.24 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 124.134 3.223 . . . . 0.0 114.749 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.1 pt-20 -55.63 -22.61 23.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.279 0.632 . . . . 0.0 110.814 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -58.88 -23.19 60.65 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.864 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 27.2 mm -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -65.15 -37.55 87.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.09 -51.01 66.07 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' A' ' 47' ' ' LYS . 3.0 mt -58.42 -29.58 38.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.451 0 C-N-CA 125.74 1.616 . . . . 0.0 113.028 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.48 -36.68 79.3 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.237 0.542 . . . . 0.0 110.685 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.43 -45.1 10.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.215 1.007 . . . . 0.0 109.878 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.67 13.81 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 125.771 1.628 . . . . 0.0 111.095 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . . . -63.84 -36.31 83.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.417 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 29.2 mt-10 -88.73 -52.54 0.37 Allowed Pre-proline 0 N--CA 1.412 -2.361 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.657 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 32.5 Cg_endo . . . . . 0 N--CA 1.426 -2.491 0 C-N-CA 122.079 1.853 . . . . 0.0 112.353 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 CA--C 1.499 -0.987 0 CA-C-O 120.995 0.426 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.455 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 70.9 mtm -152.0 123.83 7.99 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.3 m -100.61 118.53 36.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 120.4 0.143 . . . . 0.0 111.085 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.8 m-85 -134.74 14.48 3.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.411 0.624 . . . . 0.0 109.535 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.0 m -135.05 102.43 5.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD11 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.04 -33.3 59.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.387 1.089 . . . . 0.0 111.542 -175.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.479 ' OE1' HD12 ' A' ' 10' ' ' LEU . 10.6 tp10 -73.7 -22.16 60.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.77 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -68.61 -30.87 69.69 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.14 -29.18 61.69 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.102 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' OE1' ' A' ' 7' ' ' GLU . 8.4 tt -61.9 -45.24 94.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.413 ' NE2' ' HG3' ' A' ' 7' ' ' GLU . 67.8 mt-30 -68.34 -35.34 77.63 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.162 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.46 ' C ' ' HG ' ' A' ' 13' ' ' SER . 48.1 mt-30 -66.27 -46.58 76.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.661 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.46 ' HG ' ' C ' ' A' ' 12' ' ' GLN . 28.3 m -155.33 -67.82 0.12 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.244 0.545 . . . . 0.0 110.647 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.25 166.84 37.27 Favored Glycine 0 N--CA 1.413 -2.865 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.52 143.57 56.09 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-O 121.499 0.666 . . . . 0.0 111.767 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.13 3.85 3.44 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 48.6 mt-10 -151.49 155.54 38.75 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -94.88 166.89 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -75.66 72.43 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.406 1.098 . . . . 0.0 109.787 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 mmt -137.89 -176.37 4.41 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.899 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -78.04 111.31 13.8 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 118.784 0.72 . . . . 0.0 109.997 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' OE2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -103.72 132.19 50.21 Favored 'General case' 0 N--CA 1.406 -2.632 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.64 98.56 3.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -120.89 86.9 0.4 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.207 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.442 ' CE1' ' HZ ' ' A' ' 4' ' ' PHE . 98.2 m-85 -71.78 -75.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.249 0.547 . . . . 0.0 110.51 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.617 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.2 mmp_? -70.08 -38.24 75.65 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.501 ' OE1' ' HB1' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -74.91 -8.74 57.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.987 -176.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.8 t -58.21 -35.14 71.22 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.132 0.491 . . . . 0.0 109.686 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -68.19 -42.66 79.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.512 0.673 . . . . 0.0 110.219 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB1' ' OE1' ' A' ' 27' ' ' GLU . . . -63.67 -49.1 74.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.122 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.5 ptp -57.14 -33.12 67.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 28' ' ' CYS . 47.5 mm -65.15 -39.25 84.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.715 0.769 . . . . 0.0 109.63 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.35 -31.78 43.1 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.62 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.479 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.0 mttt -66.4 -21.29 66.22 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -60.98 -25.61 66.97 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.66 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.71 -49.68 24.5 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -166.38 -71.38 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.911 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 52.2 ttp180 -164.15 111.56 1.11 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.89 150.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.168 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -103.23 148.0 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.625 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.49 ' CE1' ' HB1' ' A' ' 29' ' ' ALA . 42.2 t60 -133.43 111.96 11.17 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.5 mp -82.77 138.32 19.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.415 ' HA ' HD13 ' A' ' 86' ' ' LEU . 96.1 mttt 69.99 59.23 0.53 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.522 1.129 . . . . 0.0 110.782 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.95 166.0 23.66 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.059 1.839 . . . . 0.0 111.051 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -162.06 52.41 0.32 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 4.9 pm0 -116.32 151.98 34.78 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.053 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -138.34 60.43 1.61 Allowed 'General case' 0 CA--C 1.468 -2.203 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 175.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' C ' ' H ' ' A' ' 50' ' ' GLY . 40.1 pt -69.27 112.2 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.129 0 CA-C-N 112.187 -2.278 . . . . 0.0 110.407 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 75.64 -19.33 0.41 Allowed 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.723 2.009 . . . . 0.0 113.139 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 99.71 -9.9 60.56 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.15 115.82 2.07 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -67.74 123.3 20.14 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -136.8 128.35 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.84 -37.15 60.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.22 -35.65 4.65 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.44 HG23 ' H ' ' A' ' 78' ' ' CYS . 59.0 mt -93.24 120.71 66.53 Favored Pre-proline 0 N--CA 1.417 -2.093 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.49 111.42 2.32 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.176 1.917 . . . . 0.0 110.004 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -101.76 -176.04 0.12 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.556 2.17 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 75' ' ' THR . 52.2 t -79.86 113.96 42.24 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.96 52.93 2.3 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.13 2.553 . . . . 0.0 115.272 -173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.4 mt -111.93 154.35 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 150.35 173.6 20.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 119.238 -1.458 . . . . 0.0 113.436 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -122.32 90.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.53 101.22 13.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.52 -70.43 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.626 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -162.62 170.98 17.63 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.416 ' HE ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.1 -29.7 64.35 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.473 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 17.6 m -99.35 27.63 5.08 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.179 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 m -149.02 159.03 44.59 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.3 114.79 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 122.026 0.917 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.614 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -92.88 96.69 10.28 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.64 98.51 9.68 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 71' ' ' MET . 25.0 Cg_endo -92.19 171.19 2.6 Favored 'Trans proline' 1 N--CA 1.398 -4.104 0 C-N-CA 121.671 1.581 . . . . 0.0 112.08 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -124.18 48.05 1.98 Allowed 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.6 p -97.94 111.29 23.65 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-N 113.078 -1.873 . . . . 0.0 108.122 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -103.53 103.64 37.1 Favored Pre-proline 0 C--N 1.29 -2.0 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.858 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 75' ' ' THR . 19.6 Cg_endo -97.31 -164.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.768 0 C-N-CA 122.202 1.934 . . . . 0.0 108.249 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.44 ' H ' HG23 ' A' ' 56' ' ' ILE . 42.6 t -98.6 13.84 30.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.191 0.996 . . . . 0.0 109.065 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -115.02 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.962 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -179.2 164.14 32.14 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 38' ' ' ARG . 8.4 m -91.29 152.48 20.46 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.07 135.52 53.62 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 t -127.65 131.79 69.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.45 147.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 40.6 tt0 -149.88 116.82 5.93 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.367 0.417 . . . . 0.0 110.24 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.3 tp -96.45 129.88 32.15 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.35 -8.27 17.28 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.748 1.632 . . . . 0.0 111.588 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 11.6 t -100.46 156.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.54 151.72 87.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 O-C-N 123.197 0.31 . . . . 0.0 111.699 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.16 -14.35 33.27 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.726 2.951 . . . . 0.0 113.263 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.65 -25.61 62.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.318 0.647 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 95' ' ' ARG . 49.8 mm-40 -75.04 -28.87 60.6 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.257 0.551 . . . . 0.0 110.017 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.416 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 48.9 mm -77.42 -27.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.931 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -65.91 -37.01 84.96 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 38.2 ttt180 -65.48 -47.25 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.992 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.66 -21.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.1 -27.08 60.71 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -27.16 61.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 99' ' ' VAL . 43.2 t -102.79 22.46 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.136 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -58.21 -49.58 76.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.46 -42.13 0.41 Allowed Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 C--N 1.386 2.521 0 C-N-CA 123.752 2.968 . . . . 0.0 115.722 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -172.85 136.18 0.68 Allowed 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.977 0.911 . . . . 0.0 109.675 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.5 m -148.62 129.48 14.28 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -116.22 0.73 12.98 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.82 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.2 m -82.31 111.8 18.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.857 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 7' ' ' GLU . 4.5 pp -106.37 -44.73 4.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.766 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.672 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 42.5 tt0 -68.42 -10.77 57.47 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.048 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 p -70.96 -28.36 64.42 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -75.89 -30.33 58.79 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.5 tp -57.67 -43.39 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.974 0.893 . . . . 0.0 109.325 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -74.04 -12.76 60.71 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.381 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.39 -32.82 10.97 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.055 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -155.43 -66.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 109.844 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.02 162.89 36.68 Favored Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.672 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 9.5 tp10 -83.62 147.99 27.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 117.709 0.755 . . . . 0.0 109.318 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 54' ' ' ILE . 66.9 t80 -131.27 18.12 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.055 0.931 . . . . 0.0 109.586 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -147.26 170.52 17.11 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.425 HG21 ' HG ' ' A' ' 49' ' ' LEU . 16.9 tt -102.69 158.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -75.06 69.87 2.0 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 123.34 1.543 . . . . 0.0 112.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 29.9 mmm -128.62 -155.86 0.72 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.55 2.74 . . . . 0.0 106.037 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.24 123.19 47.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.886 0.766 . . . . 0.0 109.314 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -93.92 135.14 35.56 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.16 92.68 3.83 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -111.78 79.01 0.25 Allowed Glycine 0 C--N 1.291 -1.957 0 C-N-CA 118.818 -1.658 . . . . 0.0 112.47 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 95.3 m-85 -73.12 -69.6 0.41 Allowed 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 117.459 0.629 . . . . 0.0 109.311 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.693 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 25.9 mmt180 -80.5 -36.78 32.82 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.288 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 34' ' ' LYS . 3.5 tm-20 -66.0 -13.05 59.18 Favored 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 31' ' ' MET . 27.2 t -48.68 -40.13 26.98 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.82 0.819 . . . . 0.0 110.287 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -71.71 -42.43 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.728 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.422 ' HB3' ' CB ' ' A' ' 41' ' ' HIS . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.236 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 27.3 ptt? -51.58 -40.38 59.67 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.799 0.687 . . . . 0.0 111.863 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.3 mm -60.25 -45.02 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.467 ' HB3' HG23 ' A' ' 39' ' ' VAL . 19.8 mm-40 -80.8 -30.45 35.91 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.175 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 81' ' ' THR . 28.6 mtpt -61.29 -26.97 68.14 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.348 1.059 . . . . 0.0 112.288 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -66.27 -22.56 66.31 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 123.837 0.71 . . . . 0.0 110.694 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.97 -60.12 2.41 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -144.37 -76.85 0.22 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.106 0.955 . . . . 0.0 109.974 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.486 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 17.2 ptp180 -168.7 124.79 0.96 Allowed 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 33' ' ' GLU . 73.4 t -134.43 145.66 32.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.291 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.4 p -98.5 142.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 O-C-N 124.398 1.061 . . . . 0.0 108.566 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.501 ' CE1' ' HB1' ' A' ' 29' ' ' ALA . 84.5 t60 -133.49 120.29 20.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.1 tt -81.33 147.73 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 62.07 56.52 2.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.528 0.731 . . . . 0.0 111.473 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 84.4 Cg_endo -77.37 156.37 32.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.033 1.822 . . . . 0.0 111.152 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.693 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -160.75 56.49 0.32 Allowed Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.507 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 2.3 pm0 -115.98 174.38 6.07 Favored 'General case' 0 C--N 1.26 -3.314 0 CA-C-N 113.919 -1.14 . . . . 0.0 110.555 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.1 mmtt -154.85 89.45 1.24 Allowed 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 126.309 1.844 . . . . 0.0 106.09 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.431 ' C ' HD21 ' A' ' 49' ' ' LEU . 28.8 pt -85.34 100.39 8.45 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.269 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.431 HD21 ' C ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER 58.52 16.59 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.063 1.745 . . . . 0.0 111.967 176.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 -51.74 4.04 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.23 142.68 50.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -70.21 103.4 2.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -123.06 114.59 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 16' ' ' TYR . 69.3 mt -77.43 -44.45 30.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 122.229 1.014 . . . . 0.0 109.057 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.91 -29.96 9.75 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.9 mm -86.59 125.64 66.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.58 106.82 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.478 2.119 . . . . 0.0 110.521 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -107.79 -161.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.234 0 C-N-CA 123.002 2.468 . . . . 0.0 111.396 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 75' ' ' THR . 46.8 t -96.35 113.05 61.74 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.34 50.12 1.86 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.524 2.816 . . . . 0.0 114.63 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.58 149.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.37 167.66 36.55 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.747 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -135.4 82.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.22 94.53 9.23 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -72.19 -62.49 1.41 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.548 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.8 179.13 9.5 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -90.98 -33.37 15.58 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.12 40.08 1.01 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.679 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 t -165.19 -178.74 5.24 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.58 105.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.553 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 22.8 ptm -89.53 100.87 13.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.9 mt -101.29 100.81 14.49 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.709 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.7 Cg_exo -82.09 148.62 15.21 Favored 'Trans proline' 0 N--CA 1.436 -1.907 0 C-N-CA 122.071 1.847 . . . . 0.0 110.405 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.49 60.39 0.73 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.602 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.1 p -106.39 119.81 40.23 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.145 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.13 101.64 13.19 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 75' ' ' THR . 87.1 Cg_endo -105.07 -156.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 123.198 2.599 . . . . 0.0 111.191 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -109.24 29.13 7.81 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.061 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -144.07 -80.36 0.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.195 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.81 -176.54 46.75 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.486 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 51.0 m -118.31 146.95 43.96 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.052 0.926 . . . . 0.0 110.873 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.26 38.5 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 123.372 0.669 . . . . 0.0 111.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 42.6 t -117.97 112.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.1 m -115.01 142.53 27.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 O-C-N 121.486 -0.759 . . . . 0.0 109.247 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 tt0 -139.12 113.79 9.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.284 0.564 . . . . 0.0 110.421 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.3 tp -93.44 130.09 36.62 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.06 19.63 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.624 2.216 . . . . 0.0 111.277 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.579 ' O ' ' HB3' ' A' ' 68' ' ' SER . 36.5 t -122.34 156.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.01 162.14 41.22 Favored Pre-proline 0 C--N 1.307 -1.255 0 O-C-N 123.487 0.492 . . . . 0.0 111.258 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.2 2.41 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.406 2.737 . . . . 0.0 113.219 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.95 -30.62 70.34 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.834 0.854 . . . . 0.0 109.708 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -66.66 -23.49 66.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.252 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.67 -30.17 41.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.66 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.84 -39.73 94.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -76.93 -37.77 54.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.76 -29.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.0 -33.69 76.11 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.6 0.76 . . . . 0.0 109.851 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.61 -24.9 38.78 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.429 1.109 . . . . 0.0 109.049 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 99' ' ' VAL . 86.8 t -92.61 15.25 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.075 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.96 -49.8 8.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.542 1.137 . . . . 0.0 113.198 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.05 93.38 3.42 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.355 2.704 . . . . 0.0 112.405 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 . . . . . 0 C--O 1.219 -0.519 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.7 mtt 69.95 112.26 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.075 0.95 . . . . 0.0 109.853 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.408 HG23 ' SD ' ' A' ' 31' ' ' MET . 90.4 m -113.37 128.17 56.37 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.533 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -129.85 21.45 5.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 30.9 m -89.16 87.42 7.16 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.6 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' H ' HD12 ' A' ' 6' ' ' LEU 0.295 0.0 OUTLIER -84.28 -43.7 14.58 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.43 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 28.3 tt0 -69.75 -4.83 21.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 123.031 1.396 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 29.6 m -76.62 -19.96 57.25 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.617 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.664 ' CD1' ' HA ' ' A' ' 15' ' ' GLU . 2.7 p90 -64.8 -33.11 75.22 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' CE1' ' A' ' 9' ' ' TYR . 10.0 mt -71.41 -35.63 71.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.891 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -76.57 -26.66 55.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.271 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 8' ' ' THR . 45.8 mt-30 -83.38 -14.0 53.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 m 71.25 33.96 1.87 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.495 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.27 90.57 0.2 Allowed Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.879 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.664 ' HA ' ' CD1' ' A' ' 9' ' ' TYR . 3.0 pm0 -59.55 124.35 19.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.984 0.897 . . . . 0.0 111.781 177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -147.15 9.76 0.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.488 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 44.9 mt-10 -147.34 179.76 7.42 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.485 -175.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG21 ' HG ' ' A' ' 49' ' ' LEU 0.288 13.0 tt -109.49 18.43 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-O 121.91 0.862 . . . . 0.0 111.376 178.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.37 36.33 25.41 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.769 1.271 . . . . 0.0 109.701 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.2 mmt -98.46 -96.54 0.22 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.684 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.76 126.9 9.12 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . 10.7 ptm180 -113.7 154.07 27.92 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -134.98 89.39 2.52 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . -106.72 82.0 0.31 Allowed Glycine 0 CA--C 1.486 -1.76 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.335 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -70.95 -70.14 0.33 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.651 0.263 . . . . 0.0 111.339 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 51.1 mtt180 -87.61 -30.54 20.39 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.322 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 10.5 mt-10 -75.22 -3.75 34.93 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 28.0 p -53.14 -37.15 61.55 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 121.419 0.628 . . . . 0.0 110.455 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.59 -41.09 63.33 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.149 0.5 . . . . 0.0 110.443 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.65 68.6 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.063 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.408 ' SD ' HG23 ' A' ' 3' ' ' THR . 26.2 ptm -51.8 -38.49 55.88 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.763 0.664 . . . . 0.0 112.619 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 28' ' ' CYS . 76.7 mt -57.51 -49.52 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 123.923 0.764 . . . . 0.0 110.567 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -82.79 -26.96 31.3 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.888 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 81' ' ' THR . 14.2 mtpp -58.58 -21.64 53.67 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 123.965 0.906 . . . . 0.0 112.29 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -58.44 -22.76 55.5 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.858 0.724 . . . . 0.0 111.398 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.62 1.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -166.24 -59.64 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -155.31 121.03 5.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.5 t -128.61 145.13 36.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 2.7 p -96.73 137.59 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 O-C-N 123.858 0.723 . . . . 0.0 110.053 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -139.84 129.43 24.36 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.1 tt -90.26 145.04 7.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 53.0 mtmt 67.54 61.97 0.77 Allowed Pre-proline 0 C--O 1.217 -0.636 0 C-N-CA 123.351 0.66 . . . . 0.0 110.992 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 69.6 Cg_endo -81.14 173.03 12.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.584 2.189 . . . . 0.0 112.19 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.8 55.86 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.134 -1.031 . . . . 0.0 112.258 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 29.5 tt0 -121.98 137.56 54.75 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.626 0.727 . . . . 0.0 111.856 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 6.1 mmtt -126.51 111.03 13.92 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' ' 22' ' ' ARG . 29.2 pt -100.2 122.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.553 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.445 ' HG ' HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 54.51 16.42 1.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.014 2.126 . . . . 0.0 113.74 175.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 100' ' ' ALA . . . 83.81 -44.89 3.38 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.006 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.84 125.2 42.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HG3' HD11 ' A' ' 48' ' ' ILE . 55.8 ttp180 -67.56 98.82 0.7 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 123.639 0.587 . . . . 0.0 111.173 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.69 123.5 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mm -83.35 -37.68 13.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.894 0.854 . . . . 0.0 109.207 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.43 -7.96 66.41 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.562 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.2 mm -135.3 132.47 20.03 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.78 109.45 0.42 Allowed 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 123.204 2.603 . . . . 0.0 112.175 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -87.67 161.27 7.82 Favored 'Trans proline' 0 N--CA 1.427 -2.404 0 C-N-CA 122.388 2.059 . . . . 0.0 110.938 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.71 139.17 95.38 Favored Pre-proline 0 C--N 1.301 -1.505 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.095 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.79 34.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.523 3.262 1 C-N-CA 127.349 5.366 . . . . 0.0 119.656 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.435 HG23 ' CG2' ' A' ' 75' ' ' THR 0.27 2.8 pt 67.78 -171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 127.676 2.39 . . . . 0.0 112.602 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' H ' ' A' ' 74' ' ' TYR . . . -143.63 -113.2 0.9 Allowed Glycine 1 N--CA 1.388 -4.525 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.296 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.38 122.94 64.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -130.27 125.43 34.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -100.54 -63.72 1.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.1 tp10 -165.33 168.58 16.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -31.7 67.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.466 ' C ' ' HG1' ' A' ' 69' ' ' THR . 8.5 p -93.34 30.88 1.59 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.323 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 68' ' ' SER . 31.4 m -156.99 161.0 39.57 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 m -71.08 145.02 12.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.29 0.567 . . . . 0.0 110.216 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.439 ' O ' HG13 ' A' ' 83' ' ' VAL . 25.2 ptt? -134.73 139.2 45.01 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.87 80.32 25.26 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.456 ' O ' HG23 ' A' ' 81' ' ' THR . 1.3 Cg_endo -81.86 132.06 7.35 Favored 'Trans proline' 0 N--CA 1.414 -3.198 0 C-N-CA 121.587 1.525 . . . . 0.0 109.981 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' H ' ' N ' ' A' ' 62' ' ' GLY . 79.2 m-85 -91.9 57.89 3.27 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-O 122.268 1.033 . . . . 0.0 108.705 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 36.7 p -103.92 102.66 12.46 Favored 'General case' 1 N--CA 1.376 -4.157 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -95.29 106.9 28.97 Favored Pre-proline 0 C--N 1.277 -2.587 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.249 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 75' ' ' THR . 22.6 Cg_endo -95.26 -165.53 0.11 Allowed 'Trans proline' 0 N--CA 1.431 -2.167 0 C-N-CA 122.704 2.27 . . . . 0.0 110.471 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.3 t -95.77 15.7 19.48 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.637 0.732 . . . . 0.0 109.131 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -135.56 -62.95 0.68 Allowed 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 166.28 148.27 5.5 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.186 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -84.61 158.3 20.92 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 124.879 1.272 . . . . 0.0 108.678 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.542 ' HB3' ' HZ1' ' A' ' 34' ' ' LYS . . . -122.36 120.68 34.72 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.879 -0.513 . . . . 0.0 111.063 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 95.4 t -103.31 84.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 44' ' ' PRO . 12.4 m -108.45 124.71 65.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -118.43 120.75 38.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.126 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.4 tp -96.65 130.77 29.58 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.09 -4.13 11.81 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.214 1.943 . . . . 0.0 111.142 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 12.0 t -97.64 161.66 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 91' ' ' GLU . 11.7 m-20 -72.44 163.66 65.88 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 118.096 0.407 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.79 6.2 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 89' ' ' ASP . 11.2 pt-20 -67.38 -27.17 66.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.813 0.845 . . . . 0.0 109.016 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.418 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.4 mm-40 -64.2 -29.27 70.39 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.083 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 mt -64.35 -28.45 44.91 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.661 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.62 -47.29 70.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.365 0.602 . . . . 0.0 109.602 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -66.78 -32.04 73.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.411 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 92' ' ' GLU . 69.1 mt -86.28 -5.63 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-O 121.879 0.847 . . . . 0.0 110.107 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.78 -33.49 30.85 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.03 -32.79 71.11 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.785 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' VAL . 18.9 t -107.03 28.35 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.448 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.581 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.419 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -59.67 -31.29 69.41 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -157.27 -57.78 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.58 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 N--CA 1.442 -1.557 0 C-N-CA 120.942 1.095 . . . . 0.0 113.228 -176.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 . . . . . 0 CA--C 1.505 -0.788 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -174.95 126.74 0.28 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.875 1.27 . . . . 0.0 109.146 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.53 HG22 ' SD ' ' A' ' 31' ' ' MET . 11.9 t -124.47 134.45 53.05 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.73 0.776 . . . . 0.0 110.855 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.08 26.11 4.57 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.916 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 65.3 m -126.51 101.1 6.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.689 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -84.96 -46.03 11.63 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.969 0.89 . . . . 0.0 113.031 -176.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' N ' HD21 ' A' ' 6' ' ' LEU . 42.0 tt0 -73.18 -12.29 60.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.118 0.961 . . . . 0.0 110.95 -175.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 24.2 m -73.58 -26.2 60.71 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.986 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -72.64 -32.96 66.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.99 -41.7 99.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -67.78 -27.7 66.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.13 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 8' ' ' THR . 28.1 mt-30 -78.41 -45.86 21.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.659 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.414 ' OG ' ' HD2' ' A' ' 35' ' ' LYS . 45.1 m -158.68 -68.29 0.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.899 0.38 . . . . 0.0 111.367 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.04 174.33 31.06 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.358 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.02 146.16 24.56 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 124.295 0.644 . . . . 0.0 109.725 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -139.59 21.48 2.53 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.56 ' HB3' HD21 ' A' ' 49' ' ' LEU . 38.7 mp0 -140.97 175.84 9.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.091 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.513 ' H ' HD21 ' A' ' 49' ' ' LEU . 7.0 tt -109.47 7.04 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.047 -1.033 . . . . 0.0 109.079 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 65.2 t-80 74.7 73.97 0.11 Allowed 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.829 1.651 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.46 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.0 179.49 9.17 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -61.46 111.06 1.64 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.967 0.889 . . . . 0.0 109.883 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.697 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.2 119.24 38.58 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.389 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.3 85.99 2.49 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.76 81.66 0.48 Allowed Glycine 0 CA--C 1.469 -2.803 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.289 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -69.89 -78.73 0.07 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 117.119 0.459 . . . . 0.0 110.314 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -84.04 -21.04 31.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.958 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -81.51 -10.72 59.41 Favored 'General case' 0 C--O 1.205 -1.263 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.48 -177.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 53.7 t -51.97 -38.15 55.59 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.569 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.01 -44.59 69.0 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.179 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB1' ' OE2' ' A' ' 27' ' ' GLU . . . -58.85 -52.44 65.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.965 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.53 ' SD ' HG22 ' A' ' 3' ' ' THR . 21.6 ptp -54.07 -38.2 65.04 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.864 0.728 . . . . 0.0 112.779 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 28' ' ' CYS . 80.3 mt -58.96 -45.02 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.682 0.753 . . . . 0.0 109.524 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.401 ' HB3' HG21 ' A' ' 39' ' ' VAL . 61.7 mm-40 -79.85 -32.2 40.49 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.617 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 84.1 mttt -58.42 -28.5 65.31 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 122.924 0.49 . . . . 0.0 111.165 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 8.1 ttpp -64.66 -13.39 53.82 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.049 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -65.52 0.92 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -142.85 -75.22 0.27 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.721 0.772 . . . . 0.0 109.687 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 36.3 ptt180 -156.3 128.15 7.35 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 33' ' ' GLU . 69.6 t -140.08 141.64 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.526 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.5 p -106.94 147.06 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 19.8 t-80 -135.56 134.21 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.7 tt -90.48 143.65 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 67.41 64.01 0.72 Allowed Pre-proline 0 C--N 1.32 -0.714 0 C-N-CA 123.822 0.849 . . . . 0.0 110.642 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.38 172.12 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.205 1.27 . . . . 0.0 110.233 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.21 54.43 0.13 Allowed Glycine 0 CA--C 1.464 -3.152 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.551 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 1.6 pm0 -112.35 157.84 20.52 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 122.366 1.079 . . . . 0.0 112.414 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -143.86 72.4 1.35 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 113.479 -1.692 . . . . 0.0 107.577 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 72.0 mt -91.58 108.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 66.01 16.93 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.96 1.304 . . . . 0.0 109.381 177.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.19 4.5 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -175.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.18 118.3 25.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -64.32 104.39 0.76 Allowed 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.131 0.894 . . . . 0.0 112.716 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.461 ' H ' HD13 ' A' ' 49' ' ' LEU . 49.6 mm -114.66 135.13 55.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.49 -35.36 32.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-O 121.233 0.539 . . . . 0.0 110.0 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.51 -21.73 20.34 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.25 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.62 120.26 56.42 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.42 112.55 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.968 2.445 . . . . 0.0 111.327 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -101.39 -176.61 0.13 Allowed 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 122.615 2.21 . . . . 0.0 111.081 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.3 t -67.57 121.02 77.35 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.05 56.02 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 114.745 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.4 147.66 32.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 155.5 148.15 4.94 Favored Glycine 0 CA--C 1.483 -1.933 0 C-N-CA 118.539 -1.791 . . . . 0.0 113.52 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.3 pt -129.12 153.19 38.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.02 115.29 20.31 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.99 -71.97 0.44 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.242 0.544 . . . . 0.0 111.902 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 31.0 tt0 -148.36 166.12 29.02 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 5.7 tpp180 -83.22 -35.43 25.41 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.058 0.933 . . . . 0.0 110.551 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.7 p -88.66 29.96 0.96 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.775 1.274 . . . . 0.0 111.514 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 66' ' ' GLU . 87.5 m -154.72 170.72 20.91 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.93 161.01 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.202 1.001 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.531 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 26.8 ptt? -118.4 131.38 56.29 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.11 88.35 14.71 Favored Pre-proline 0 C--N 1.291 -1.961 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.343 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 71' ' ' MET . 6.4 Cg_endo -90.53 144.28 3.81 Favored 'Trans proline' 0 N--CA 1.408 -3.534 0 C-N-CA 121.545 1.496 . . . . 0.0 109.966 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -110.87 46.32 1.07 Allowed 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 123.298 1.523 . . . . 0.0 107.405 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 39.6 p -93.26 105.57 17.63 Favored 'General case' 0 N--CA 1.389 -3.498 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.163 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -105.78 96.61 12.85 Favored Pre-proline 0 C--N 1.275 -2.634 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 75' ' ' THR . 23.7 Cg_endo -99.0 -164.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.365 2.71 . . . . 0.0 111.166 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.5 t -88.72 -6.16 57.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.362 0.601 . . . . 0.0 110.058 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -96.32 -74.22 0.57 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 171.26 172.08 37.07 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.472 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 28.0 m -94.5 141.73 28.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.63 125.58 52.74 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.29 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 41.7 t -126.47 124.69 65.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.2 m -126.71 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -134.31 123.12 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 68' ' ' SER . 28.4 tp -103.05 128.18 28.22 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.84 1.78 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.69 1.593 . . . . 0.0 110.698 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.451 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -103.59 158.27 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.98 151.13 81.22 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 123.203 0.314 . . . . 0.0 110.671 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.443 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 11.6 Cg_endo -56.13 -22.03 37.92 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.686 2.924 . . . . 0.0 112.997 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.84 -23.11 60.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.681 0.792 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.404 ' OE1' ' HD2' ' A' ' 95' ' ' ARG . 8.4 tp10 -69.18 -43.59 73.91 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.409 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 58.4 mt -71.17 -27.0 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.73 -37.64 76.59 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -67.98 -36.36 79.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.631 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 37.3 mm -72.65 -17.82 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.961 177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.72 -20.86 58.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.106 0.955 . . . . 0.0 108.715 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.19 -25.96 42.68 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.02 14.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.406 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.21 49.77 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.74 -50.65 0.15 Allowed Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.432 -2.114 0 C-N-CA 121.087 1.191 . . . . 0.0 112.664 -178.648 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 85.2 m-70 . . . . . 0 C--O 1.215 -0.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -139.59 129.63 25.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -121.61 117.09 25.85 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -126.08 2.26 7.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.571 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.418 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 61.0 m -86.48 92.19 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.571 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.528 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -85.6 -34.65 21.37 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -81.12 -16.92 51.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.942 0.877 . . . . 0.0 110.931 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.3 m -69.79 -22.29 63.34 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -78.33 -20.12 52.09 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.651 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.1 tt -72.91 -37.87 67.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.79 -30.43 69.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.366 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -94.18 -5.49 46.94 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.926 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m 60.33 43.29 13.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.125 0.964 . . . . 0.0 110.305 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.48 49.97 0.65 Allowed Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.532 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.26 138.83 54.26 Favored 'General case' 0 C--O 1.248 1.007 0 O-C-N 124.61 0.829 . . . . 0.0 110.783 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -143.55 20.35 1.86 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 19' ' ' HIS . 0.5 OUTLIER -154.97 179.75 8.83 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.806 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.534 ' H ' HD21 ' A' ' 49' ' ' LEU 0.329 13.5 tt -107.31 29.48 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.973 178.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.651 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 43.5 m80 61.99 17.84 9.36 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.6 mmm -85.57 -110.79 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.015 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.6 tttp -129.09 115.0 17.06 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -109.15 162.32 14.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.377 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -156.71 87.69 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -103.82 81.01 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 115.154 0.821 . . . . 0.0 115.154 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -77.47 -39.35 46.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.562 0.696 . . . . 0.0 111.177 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 38.2 mmt180 -107.78 -41.05 5.1 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.712 0.768 . . . . 0.0 111.241 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB2' ' H ' ' A' ' 45' ' ' GLY . 26.3 tt0 -78.88 -0.04 29.17 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.103 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 39.4 t -52.58 -47.16 67.05 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 109.728 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -68.88 -38.8 79.9 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.754 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -58.78 -44.74 90.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.701 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.7 ptm -65.02 -33.26 75.61 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.554 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.1 -38.61 82.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 34.8 mt-10 -77.7 -38.25 47.77 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.667 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.463 ' HZ3' ' CG1' ' A' ' 84' ' ' VAL . 78.7 mttt -63.51 -20.01 65.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.462 0.705 . . . . 0.0 111.771 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -67.4 -20.42 65.53 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.504 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.57 -62.17 1.67 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 2.2 mmp_? -159.82 -67.14 0.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.577 1.151 . . . . 0.0 109.824 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.571 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 19.0 ptt180 -155.12 122.19 5.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.75 145.11 28.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.5 p -108.89 142.38 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.414 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 19.4 t60 -135.06 130.8 36.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.6 tt -82.82 144.17 10.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 94.8 mttt 63.82 63.11 1.48 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.148 0.579 . . . . 0.0 110.717 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 63.4 Cg_endo -80.32 170.7 15.82 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.969 1.78 . . . . 0.0 111.767 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.503 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -175.06 54.0 0.13 Allowed Glycine 0 N--CA 1.409 -3.102 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.441 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.506 ' CD ' HG21 ' A' ' 48' ' ' ILE . 7.6 tp10 -110.44 118.39 36.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.507 1.146 . . . . 0.0 108.841 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 34.0 mtmt -110.17 71.44 0.76 Allowed 'General case' 0 N--CA 1.393 -3.309 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.136 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.506 HG21 ' CD ' ' A' ' 46' ' ' GLU . 5.0 pt -70.92 102.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.25 -3.74 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.923 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD21 ' H ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 69.72 -26.12 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 126.823 2.049 . . . . 0.0 113.621 175.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.91 -3.36 48.62 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.71 116.18 11.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -69.73 88.17 0.52 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 mm -123.73 127.38 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -76.39 -28.86 18.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.548 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.43 17.59 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.3 mt -99.88 121.67 53.45 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.65 107.65 0.91 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.773 2.315 . . . . 0.0 110.92 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -104.8 179.92 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 122.68 2.253 . . . . 0.0 111.752 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 75' ' ' THR . 51.3 t -84.87 106.73 9.35 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.41 98.78 0.74 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.234 1.956 . . . . 0.0 114.554 -170.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.49 158.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 130.12 167.18 11.99 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 118.577 -1.773 . . . . 0.0 113.769 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.2 mp -142.63 124.35 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.43 101.76 12.27 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.74 -55.65 16.16 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.55 171.41 7.61 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HA ' HH11 ' A' ' 67' ' ' ARG . 3.4 tpp180 -85.68 -35.99 20.54 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 118.881 0.764 . . . . 0.0 112.113 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 9.4 t -91.03 28.32 1.62 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 122.96 1.362 . . . . 0.0 108.569 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 67' ' ' ARG . 24.8 m -143.21 163.93 31.59 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 17.1 m -72.88 124.01 28.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.332 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.9 ptt? -85.32 132.19 34.29 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.4 tp -116.02 80.92 9.53 Favored Pre-proline 0 C--N 1.293 -1.884 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.667 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 71' ' ' MET . 9.5 Cg_endo -89.58 104.8 0.37 Allowed 'Trans proline' 0 N--CA 1.409 -3.456 0 C-N-CA 121.971 1.781 . . . . 0.0 108.707 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.26 57.28 4.39 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.114 1.435 . . . . 0.0 107.374 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.631 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.2 p -91.17 127.86 36.77 Favored 'General case' 1 N--CA 1.378 -4.064 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.58 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -99.49 95.97 4.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.631 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.4 Cg_endo -105.29 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.787 0 C-N-CA 122.974 2.449 . . . . 0.0 111.281 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.6 t -95.87 12.08 31.47 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -117.74 -80.83 0.61 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.068 -0.395 . . . . 0.0 110.339 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.72 176.35 47.99 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 29.2 m -94.7 135.14 36.53 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.447 0.641 . . . . 0.0 109.401 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.52 112.38 23.89 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.949 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 33.9 t -115.34 134.61 57.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.463 ' CG1' ' HZ3' ' A' ' 34' ' ' LYS . 15.8 m -136.26 151.08 28.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -142.13 122.12 13.67 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.4 tp -104.13 139.05 19.73 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -86.14 2.1 7.56 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 122.616 2.211 . . . . 0.0 111.69 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.485 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 9.9 t -103.14 150.84 6.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.44 144.32 92.28 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 124.14 0.9 . . . . 0.0 110.163 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.4 -18.67 3.84 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.61 3.54 . . . . 0.0 114.385 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.51 -18.38 51.52 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.629 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 25.6 tp10 -60.24 -28.03 67.7 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 124.187 0.995 . . . . 0.0 109.575 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.75 -38.37 75.65 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.121 0 C-N-CA 122.155 0.182 . . . . 0.0 111.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.46 -33.64 75.54 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.406 0.622 . . . . 0.0 110.768 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.629 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 63.4 ttt180 -71.49 -45.58 62.1 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.8 mm -65.64 -22.5 30.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.189 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.0 tp -74.21 -30.07 62.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.154 0.502 . . . . 0.0 109.792 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.21 -41.74 27.62 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.65 15.66 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.996 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -67.14 -33.53 75.63 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.25 98.06 21.56 Favored Pre-proline 0 N--CA 1.416 -2.136 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.555 2.837 . . . . 0.0 111.269 177.716 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 CA--C 1.498 -1.04 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 4' ' ' PHE . 26.0 ptt? -179.97 133.22 0.1 Allowed 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.238 1.415 . . . . 0.0 108.762 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.4 m -132.16 122.82 25.93 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HE2' ' SD ' ' A' ' 2' ' ' MET . 88.6 m-85 -116.85 -8.99 11.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.976 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 76.5 m -80.0 100.8 8.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.807 0.813 . . . . 0.0 110.793 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.542 HD23 ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -88.32 -38.13 15.41 Favored 'General case' 0 C--O 1.182 -2.461 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.542 ' N ' HD23 ' A' ' 6' ' ' LEU . 30.3 tt0 -68.82 -9.45 51.24 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.817 0.818 . . . . 0.0 111.871 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.4 m -75.38 -15.17 60.49 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.104 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.661 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.71 -28.4 67.29 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.409 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.661 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 6.1 tt -70.23 -39.05 75.31 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.055 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -76.36 -1.79 28.58 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.714 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.97 -28.71 5.47 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -163.58 -54.13 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.442 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.32 -153.91 24.71 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB2' HG12 ' A' ' 56' ' ' ILE . 2.2 mp0 -80.63 137.33 36.34 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 118.994 1.397 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -142.31 3.28 1.52 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.591 0.71 . . . . 0.0 110.097 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -150.69 176.94 10.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.446 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tt -110.35 157.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 6.5 t60 -71.53 71.9 0.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.472 1.13 . . . . 0.0 108.987 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.4 mmt -138.68 -167.41 2.19 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.089 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.72 113.28 22.44 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -100.75 130.31 46.76 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -124.08 85.17 2.37 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.513 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -99.58 75.92 0.48 Allowed Glycine 0 C--N 1.282 -2.442 0 C-N-CA 119.399 -1.382 . . . . 0.0 111.013 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.85 -79.87 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 121.35 0.595 . . . . 0.0 110.629 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.505 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 5.6 mpt_? -75.7 -35.83 60.19 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.006 0.432 . . . . 0.0 111.688 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 18.0 tp10 -66.28 -11.37 50.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.002 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 36.3 t -51.01 -41.75 59.99 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.477 0.656 . . . . 0.0 110.274 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.03 -43.1 75.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.075 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.643 ' HB1' ' CG ' ' A' ' 41' ' ' HIS . . . -66.28 -45.64 79.77 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.1 ptp -56.64 -33.11 66.0 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.519 0.512 . . . . 0.0 111.726 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.2 mm -62.97 -36.34 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.434 0.635 . . . . 0.0 110.023 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -78.35 -33.63 48.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.557 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 60.7 mttt -67.42 -9.49 42.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.719 1.208 . . . . 0.0 113.391 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -69.49 -22.93 63.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.35 -65.01 0.75 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -152.45 -67.7 0.16 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.1 ttp180 -165.82 115.43 1.0 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.468 0.707 . . . . 0.0 109.413 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.526 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 44.3 t -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -112.68 149.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.643 ' CG ' ' HB1' ' A' ' 30' ' ' ALA . 32.5 t-80 -138.28 119.5 14.62 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.4 tt -83.31 147.44 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.61 51.59 0.49 Allowed Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.699 0.799 . . . . 0.0 112.039 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 96.4 Cg_endo -90.18 159.58 4.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.418 2.079 . . . . 0.0 110.608 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.505 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -151.66 44.9 0.64 Allowed Glycine 0 CA--C 1.467 -2.951 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 4.2 pm0 -97.76 156.86 16.37 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-O 122.627 1.204 . . . . 0.0 113.304 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 0.5 OUTLIER -145.19 86.85 1.79 Allowed 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.363 175.176 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.413 ' C ' HD22 ' A' ' 49' ' ' LEU . 2.6 pt -87.24 99.9 9.18 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 113.471 -1.695 . . . . 0.0 112.313 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER 66.88 4.5 3.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.976 2.11 . . . . 0.0 114.098 175.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.56 -21.42 5.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.142 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.74 30.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' CZ ' HD11 ' A' ' 48' ' ' ILE . 21.8 tpt180 -86.58 105.93 17.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.63 136.91 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 45.4 mm -99.1 -40.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.531 0.681 . . . . 0.0 109.588 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.83 -26.37 22.61 Favored Glycine 0 C--N 1.312 -0.756 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG12 ' HB2' ' A' ' 15' ' ' GLU . 36.6 mm -111.69 109.79 55.35 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.89 109.25 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.995 2.463 . . . . 0.0 111.723 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -101.95 -163.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.415 2.743 . . . . 0.0 109.919 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 75' ' ' THR . 86.6 t -73.47 118.95 73.15 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.13 40.86 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.118 2.545 . . . . 0.0 114.541 -172.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.31 149.52 18.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.5 138.35 2.42 Favored Glycine 0 C--N 1.305 -1.186 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.894 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.51 114.14 41.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 122.706 0.402 . . . . 0.0 110.661 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.43 106.2 18.24 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.73 -64.24 1.04 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -166.94 179.94 5.0 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.437 HH22 ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.04 -40.09 14.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 119.045 0.839 . . . . 0.0 109.437 -176.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.6 t -89.39 26.76 1.59 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.695 1.236 . . . . 0.0 109.511 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 67' ' ' ARG . 26.9 m -144.28 160.93 40.16 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.72 144.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 122.676 0.39 . . . . 0.0 110.335 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.612 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 27.1 ptt? -99.93 136.7 39.45 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.9 mm -109.05 89.19 6.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 71' ' ' MET . 2.5 Cg_endo -88.1 146.9 6.59 Favored 'Trans proline' 0 N--CA 1.427 -2.439 0 C-N-CA 122.126 1.884 . . . . 0.0 111.737 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -123.25 44.27 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.578 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 41.4 p -100.86 111.41 23.62 Favored 'General case' 0 N--CA 1.4 -2.961 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.103 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -100.74 97.2 6.37 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 75' ' ' THR . 97.2 Cg_endo -103.98 -165.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.04 2.493 . . . . 0.0 111.593 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.6 t -74.04 -21.57 59.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.504 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -95.84 -84.7 0.34 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.734 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.97 -179.67 45.7 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 9.8 m -106.4 145.58 31.56 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.485 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -119.34 121.88 40.56 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -175.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 56.3 t -110.02 120.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.416 HG11 ' OE1' ' A' ' 27' ' ' GLU . 35.4 m -113.49 143.77 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.9 tt0 -148.65 115.78 6.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.216 0.462 . . . . 0.0 110.224 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 68' ' ' SER . 29.5 tp -94.84 143.33 25.98 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -93.39 -2.55 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.621 1.547 . . . . 0.0 110.971 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.524 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 23.7 t -91.49 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.19 149.3 75.96 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 124.166 0.916 . . . . 0.0 112.792 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.69 -6.17 4.21 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.838 3.025 . . . . 0.0 113.351 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.56 -27.3 66.11 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.274 0.559 . . . . 0.0 109.504 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -60.07 -26.82 66.47 Favored 'General case' 0 C--O 1.204 -1.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.163 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.3 mt -56.87 -40.12 69.45 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.809 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.633 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.46 -47.67 85.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.645 0.736 . . . . 0.0 109.795 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -64.95 -44.13 90.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 73.7 mt -69.6 -28.29 37.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.613 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.1 tp -70.77 -29.6 65.86 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 123.313 0.645 . . . . 0.0 110.173 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -32.25 51.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.7 15.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.355 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.69 -47.89 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.747 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -135.6 87.93 25.28 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 C--O 1.257 1.432 0 C-N-CA 123.262 2.641 . . . . 0.0 112.347 -178.318 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.594 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 65.7 mtm -156.11 124.7 5.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -102.04 113.59 26.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 64.9 m-85 -127.96 12.5 6.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.799 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.66 102.68 4.36 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -77.23 -36.45 54.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 111.419 -175.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.09 -25.56 62.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.691 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -77.99 -24.34 48.03 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -24.17 60.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 110.232 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.51 -43.63 98.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -69.42 -35.76 76.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.226 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.31 -35.42 66.08 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.435 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -161.81 -54.92 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.243 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.7 173.47 37.22 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.3 141.22 38.64 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.489 0.662 . . . . 0.0 111.73 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.446 ' CE2' ' HE2' ' A' ' 31' ' ' MET . 88.5 t80 -137.66 4.86 2.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 44.7 mt-10 -149.79 146.33 27.11 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 15.3 tt -85.1 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.561 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -68.59 77.17 0.28 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 122.724 1.25 . . . . 0.0 110.483 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.43 ' HA ' ' HE3' ' A' ' 20' ' ' MET . 2.0 mmt -146.15 -174.39 4.42 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.39 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -88.5 114.72 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.164 0.893 . . . . 0.0 110.874 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.558 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -102.98 152.53 21.21 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.124 -175.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.08 77.75 1.32 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -97.68 82.35 0.68 Allowed Glycine 0 C--N 1.294 -1.789 0 C-N-CA 121.02 -0.609 . . . . 0.0 114.052 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -70.18 -82.52 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 117.352 0.576 . . . . 0.0 111.652 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 2.5 mmp_? -70.39 -36.72 74.25 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' OE2' HG11 ' A' ' 84' ' ' VAL . 2.7 tp10 -69.35 -12.64 61.83 Favored 'General case' 0 C--O 1.217 -0.647 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.219 -177.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 44.4 t -60.9 -34.19 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-O 121.218 0.532 . . . . 0.0 110.009 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -70.53 -41.64 72.27 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.788 0.804 . . . . 0.0 109.398 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -64.23 -47.73 78.56 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.106 -1.407 . . . . 0.0 113.077 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.5 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 ptp -56.12 -31.64 63.47 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.577 0.548 . . . . 0.0 112.272 -176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 28' ' ' CYS . 48.6 mm -59.65 -42.84 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 122.08 0.943 . . . . 0.0 109.078 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.87 -34.34 30.12 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.547 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 31' ' ' MET . 72.2 mttt -65.92 -12.91 58.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.702 0.801 . . . . 0.0 111.927 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.11 -24.83 62.37 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.816 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.67 -53.14 36.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.107 0.48 . . . . 0.0 110.718 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -166.9 -69.97 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -162.12 123.63 2.71 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.4 t -134.66 159.95 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.7 p -105.96 143.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.488 0.715 . . . . 0.0 109.596 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 62.3 t60 -135.01 123.34 23.14 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 2.6 mp -89.7 142.42 12.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.481 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 99.2 mttt 71.62 43.35 0.2 Allowed Pre-proline 0 C--O 1.21 -1.019 0 C-N-CA 124.11 0.964 . . . . 0.0 112.545 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 9.8 Cg_endo -75.42 143.04 27.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 CA-C-N 120.786 1.316 . . . . 0.0 110.783 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.533 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -144.03 54.29 0.58 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 10.0 pm0 -101.1 129.48 46.99 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.19 0.995 . . . . 0.0 110.125 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.513 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 43.1 mtmt -118.84 69.99 0.82 Allowed 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.417 ' C ' HD23 ' A' ' 49' ' ' LEU . 39.1 pt -86.57 109.7 19.25 Favored 'Isoleucine or valine' 1 C--N 1.222 -4.936 0 CA-C-N 111.317 -2.674 . . . . 0.0 112.329 -175.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER 65.7 -3.1 0.76 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.936 2.095 . . . . 0.0 113.863 175.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.04 -25.66 13.53 Favored Glycine 0 C--N 1.293 -1.82 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.23 19.33 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -71.39 103.05 2.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.735 0.779 . . . . 0.0 111.646 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 55.9 mt -128.0 132.17 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 mm -73.45 -27.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.99 0.9 . . . . 0.0 108.888 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.23 -28.1 15.51 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.4 mt -105.54 114.99 62.56 Favored Pre-proline 0 N--CA 1.416 -2.159 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.85 107.27 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.605 2.203 . . . . 0.0 110.518 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -95.96 -174.99 0.29 Allowed 'Trans proline' 0 N--CA 1.426 -2.441 0 C-N-CA 122.671 2.247 . . . . 0.0 111.663 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.7 t -68.86 116.48 41.65 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.81 70.52 7.38 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.002 1.801 . . . . 0.0 113.293 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -130.71 145.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 156.94 153.67 6.75 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 118.98 -1.581 . . . . 0.0 113.67 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.75 103.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.65 108.97 20.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.2 -69.8 0.53 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.418 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -153.21 164.92 37.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -80.76 -31.69 35.81 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.022 0.915 . . . . 0.0 108.602 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.484 ' OG ' ' HD3' ' A' ' 90' ' ' PRO . 11.1 p -94.86 38.48 1.12 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.4 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 70' ' ' VAL . 54.4 m -161.75 171.22 18.21 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.409 ' N ' HG23 ' A' ' 69' ' ' THR . 28.9 m -76.44 161.21 4.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.69 0.757 . . . . 0.0 109.714 177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.637 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 16.1 ptp -140.09 118.0 11.78 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -106.65 94.59 10.46 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-O 121.137 0.494 . . . . 0.0 109.913 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.637 ' HD3' ' O ' ' A' ' 71' ' ' MET . 9.6 Cg_endo -92.2 164.99 3.08 Favored 'Trans proline' 0 N--CA 1.412 -3.296 0 C-N-CA 122.103 1.869 . . . . 0.0 110.8 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -129.1 58.81 1.59 Allowed 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.55 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 27.2 p -100.42 110.11 22.29 Favored 'General case' 0 N--CA 1.386 -3.644 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.149 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -105.19 100.65 26.27 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.8 Cg_endo -104.74 -159.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 123.092 2.528 . . . . 0.0 108.41 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 50.3 t -83.02 -9.04 59.47 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.062 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.34 -79.59 0.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.796 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 176.45 -172.23 45.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.8 m -112.7 149.18 33.27 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 117.452 0.626 . . . . 0.0 109.422 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.84 47.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 59.0 t -109.82 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.523 HG11 ' OE2' ' A' ' 27' ' ' GLU . 2.6 m -102.2 155.27 4.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -155.0 108.83 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.1 tp -97.61 128.97 32.7 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.15 22.55 0.94 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.542 2.161 . . . . 0.0 111.412 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.6 t -130.5 151.7 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.84 152.55 82.39 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.484 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 38.4 Cg_endo -65.41 -4.19 8.97 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.736 2.957 . . . . 0.0 112.656 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.64 -29.91 70.37 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -66.1 -25.16 66.88 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.056 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.37 -35.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 O-C-N 123.074 0.234 . . . . 0.0 110.681 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.81 -43.77 97.93 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -43.5 83.55 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.629 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.88 -21.88 24.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 123.397 0.679 . . . . 0.0 111.099 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -74.06 -27.29 60.85 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.259 0.552 . . . . 0.0 109.808 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.5 -41.61 14.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.989 0.9 . . . . 0.0 108.63 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.6 t -82.45 7.86 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.987 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.513 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -52.91 -60.59 3.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.497 1.119 . . . . 0.0 113.813 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.01 -47.91 0.33 Allowed Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.426 -2.451 0 C-N-CA 121.583 1.522 . . . . 0.0 112.507 177.802 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 p80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -174.01 135.6 0.49 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.3 m -134.14 124.16 25.6 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -121.55 3.32 10.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.83 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.2 m -95.75 101.74 13.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.306 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 7' ' ' GLU . 1.6 pp -92.3 -29.71 16.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.797 0.808 . . . . 0.0 112.263 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.515 ' N ' HD13 ' A' ' 6' ' ' LEU . 35.2 tt0 -68.97 -24.51 64.26 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.158 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.8 m -66.44 -32.48 73.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.022 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.74 -28.95 60.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.889 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tt -69.52 -35.13 75.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -66.8 -38.06 85.76 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.624 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -73.72 -3.12 26.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.056 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m 67.48 13.5 9.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.107 1.363 . . . . 0.0 111.783 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.84 59.74 0.36 Allowed Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.67 127.49 31.53 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.244 -0.978 . . . . 0.0 110.613 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -145.77 10.73 1.22 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 27.8 mt-10 -148.0 176.65 10.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.809 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.477 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.6 tt -127.33 161.02 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -67.31 73.36 0.13 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.359 1.076 . . . . 0.0 111.111 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 81.9 mtp -130.1 -121.79 0.22 Allowed 'General case' 0 C--N 1.266 -3.055 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.169 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 101' ' ' GLU . 11.0 tmtt? -147.18 122.89 10.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HD2' ' OE1' ' A' ' 17' ' ' GLU . 14.1 ptm180 -104.11 167.33 9.83 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.668 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -152.58 79.25 1.22 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -109.32 82.84 0.31 Allowed Glycine 0 CA--C 1.471 -2.714 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -72.22 -63.45 1.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.939 0.876 . . . . 0.0 109.251 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.61 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 29.2 mmt180 -84.12 -38.81 20.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.906 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.501 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 29.2 mt-10 -74.84 -1.86 24.14 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 31' ' ' MET . 41.5 t -51.21 -45.15 61.78 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.08 -41.22 74.39 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.59 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.4 -47.19 87.15 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 124.165 0.986 . . . . 0.0 113.152 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -56.83 -38.67 72.95 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.414 0.446 . . . . 0.0 111.345 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.65 -39.05 80.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.747 0.784 . . . . 0.0 109.604 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -75.11 -42.74 55.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.63 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.5 mttt -63.58 -20.03 65.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.543 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -67.28 -26.52 66.58 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.552 0.533 . . . . 0.0 110.306 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -53.15 32.34 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.866 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -162.43 -70.84 0.05 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.559 0.695 . . . . 0.0 110.052 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.458 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.3 ttt180 -163.28 117.67 1.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -137.15 144.03 33.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.593 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -97.22 145.81 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.439 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 74.0 t60 -138.93 121.45 16.19 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 61.6 mt -79.42 138.06 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 64.6 mttm 74.68 65.88 0.27 Allowed Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.692 1.245 . . . . 0.0 109.22 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -88.38 166.17 6.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.224 1.949 . . . . 0.0 111.767 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.447 ' H ' ' HG3' ' A' ' 27' ' ' GLU . . . -179.79 55.61 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.794 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 7.1 tp10 -122.12 145.22 48.38 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.66 0.784 . . . . 0.0 109.958 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -140.46 80.98 1.78 Allowed 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 50' ' ' GLY . 23.8 pt -71.75 105.14 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.323 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.477 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 68.52 -23.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.756 2.022 . . . . 0.0 113.996 175.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.16 -30.43 10.4 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -176.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.01 142.98 50.25 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.25 97.7 9.72 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.389 -1.325 . . . . 0.0 113.386 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.02 117.83 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.28 -37.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 120.968 0.413 . . . . 0.0 111.344 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.98 -0.97 70.01 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.28 130.45 16.04 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -53.89 107.46 0.21 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.366 2.711 . . . . 0.0 112.903 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -114.33 -169.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 123.324 2.682 . . . . 0.0 112.63 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.11 107.95 51.23 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 75' ' ' THR . 32.5 Cg_exo -61.26 118.42 5.29 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.23 2.62 . . . . 0.0 111.964 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.6 mm -128.54 100.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . -118.18 81.1 0.32 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.51 112.97 38.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 4.8 p-10 -126.03 127.28 45.61 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.12 -48.21 10.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.8 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.491 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 21.7 tt0 -170.16 167.17 8.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.511 ' HA ' ' HE1' ' A' ' 71' ' ' MET . 6.7 tpt85 -76.58 -29.66 56.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.801 0.334 . . . . 0.0 111.059 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' A' ' 66' ' ' GLU . 33.1 t -99.24 33.74 2.34 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.897 1.332 . . . . 0.0 108.558 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -148.75 162.53 39.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.93 124.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 122.137 0.97 . . . . 0.0 112.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.511 ' HE1' ' HA ' ' A' ' 67' ' ' ARG . 16.7 ptp -134.72 152.05 51.46 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.407 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.65 90.47 48.15 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 42.2 Cg_endo -105.02 44.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.052 2.501 . . . . 0.0 113.437 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.74 -103.4 0.14 Allowed 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 121.526 0.679 . . . . 0.0 112.012 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 60' ' ' PRO . 3.0 p -162.18 179.66 7.75 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.973 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.71 85.02 43.87 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -103.59 -167.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 123.086 2.524 . . . . 0.0 113.896 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.67 -22.12 60.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.008 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -75.59 -68.79 0.53 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.578 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 170.4 163.72 24.91 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 38' ' ' ARG . 6.5 m -91.73 151.18 20.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.408 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -127.23 126.08 42.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 t -118.21 129.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 HG11 ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -122.72 142.37 39.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.7 tt0 -142.83 122.17 13.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 25.0 tp -99.78 137.06 20.12 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.54 -5.74 7.16 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.153 1.902 . . . . 0.0 111.53 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.561 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.0 t -99.01 163.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.45 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.9 t70 -65.32 144.91 99.11 Favored Pre-proline 0 C--N 1.304 -1.396 0 C-N-CA 123.153 0.581 . . . . 0.0 110.214 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.72 -9.58 0.15 Allowed 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 124.034 3.156 . . . . 0.0 115.404 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 9.9 pt-20 -59.43 -18.7 41.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.12 0.568 . . . . 0.0 111.411 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -61.27 -19.91 62.26 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.24 -36.96 77.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.564 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.89 -39.22 88.46 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 109.609 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -69.37 -47.01 65.57 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.445 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.3 mm -73.34 -10.13 13.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.824 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.65 -31.4 32.36 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.45 -34.28 54.49 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.3 t -100.72 29.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.574 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.61 -20.71 64.51 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.659 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.6 mt-10 -139.89 -59.47 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 52.5 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 C-N-CA 121.415 1.41 . . . . 0.0 113.858 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.413 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.8 ptp -171.44 130.8 0.72 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.315 0.646 . . . . 0.0 110.016 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -120.96 126.54 50.21 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.597 0.713 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 23' ' ' ALA . 91.7 m-85 -133.25 22.05 4.06 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.63 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 7.7 p -103.44 78.46 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.089 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 18' ' ' ILE . 5.2 tt -70.68 -54.28 12.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.085 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -75.96 3.95 9.23 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.7 1.238 . . . . 0.0 111.802 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 5' ' ' CYS . 9.0 m -87.44 -2.24 58.48 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.543 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -64.68 -17.92 64.52 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.111 176.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.543 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 4.8 tt -76.12 -35.55 59.24 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.45 -30.47 68.39 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 108.073 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 9' ' ' TYR . 45.5 mt-30 -78.39 -14.63 59.31 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.575 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.7 t 67.03 30.75 7.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.22 1.008 . . . . 0.0 109.833 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.79 88.66 0.11 Allowed Glycine 0 N--CA 1.417 -2.608 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.186 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.47 132.67 54.63 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.46 ' HA ' HG23 ' A' ' 54' ' ' ILE . 48.2 t80 -139.44 12.06 2.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.509 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' OE2' ' HA ' ' A' ' 6' ' ' LEU . 41.4 mt-10 -146.46 176.21 9.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.491 ' O ' HD11 ' A' ' 6' ' ' LEU . 11.2 tp -118.9 154.5 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -69.71 74.55 0.42 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.968 1.366 . . . . 0.0 111.387 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.3 mmm -132.51 -145.8 0.27 Allowed 'General case' 0 C--N 1.269 -2.897 0 C-N-CA 127.235 2.214 . . . . 0.0 107.371 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -119.45 129.54 54.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 119.202 0.91 . . . . 0.0 110.471 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.8 175.18 5.58 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -163.59 76.89 0.39 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.822 0.701 . . . . 0.0 111.901 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -90.9 74.46 1.69 Allowed Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.674 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.1 -68.19 0.58 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.559 0.695 . . . . 0.0 110.357 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.616 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 32.3 mmt180 -75.33 -44.18 46.68 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.896 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 24.8 mt-10 -77.62 2.59 16.11 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.2 t -50.41 -44.34 55.06 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.89 -34.07 57.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.464 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.429 ' C ' ' HD3' ' A' ' 34' ' ' LYS . . . -61.4 -48.79 79.62 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.474 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.9 ptp -59.89 -33.85 72.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.907 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.728 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 81.3 mt -62.94 -34.24 65.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.51 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.04 -31.78 21.79 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.042 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.533 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.7 mtpt -59.09 -16.8 21.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.893 0.877 . . . . 0.0 111.877 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.728 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 22.3 ptmt -77.4 -16.0 59.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.455 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.4 72.31 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.347 -0.221 . . . . 0.0 111.524 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 177.17 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' THR . 41.5 ttp180 -156.78 116.87 3.55 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -133.1 146.06 33.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.664 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.789 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -93.4 137.81 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 124.119 0.887 . . . . 0.0 109.017 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -139.1 125.79 20.74 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.82 140.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 62.5 mttp 69.23 65.67 0.5 Allowed Pre-proline 0 C--O 1.22 -0.467 0 C-N-CA 124.24 1.016 . . . . 0.0 110.2 -175.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.466 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 44.3 Cg_endo -88.35 161.48 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.802 2.335 . . . . 0.0 112.91 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.58 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 177.69 62.64 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.615 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 16.1 tt0 -118.21 101.29 8.1 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 124.147 0.979 . . . . 0.0 108.667 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 20.2 mmtt -95.43 91.39 6.18 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.002 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 22' ' ' ARG . 42.1 pt -92.13 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.246 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER 68.32 -1.99 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.139 1.776 . . . . 0.0 112.818 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.95 -33.16 4.32 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.27 122.41 37.68 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HD3' HD13 ' A' ' 48' ' ' ILE . 19.1 tpp180 -64.65 100.2 0.37 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.795 0.684 . . . . 0.0 110.409 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 60.2 mt -121.47 131.1 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 16' ' ' TYR . 57.9 mt -99.15 -31.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.666 0.746 . . . . 0.0 109.822 -177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.48 15.48 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.34 117.04 43.66 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.19 112.11 3.24 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.806 2.338 . . . . 0.0 113.514 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 3.1 Cg_endo -91.92 -171.35 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.924 2.416 . . . . 0.0 108.838 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.575 ' HB ' ' CB ' ' A' ' 75' ' ' THR . 80.9 t -82.2 132.85 52.05 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.6 70.59 7.23 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.557 1.504 . . . . 0.0 113.827 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.14 91.67 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.94 103.25 3.02 Favored Glycine 0 N--CA 1.414 -2.827 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.815 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.8 mt -102.35 76.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -110.94 118.83 37.17 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.164 0.507 . . . . 0.0 110.081 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -90.18 -57.15 2.95 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.373 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -162.54 167.61 23.11 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.436 ' HA ' ' HE1' ' A' ' 71' ' ' MET . 0.3 OUTLIER -81.63 -27.41 34.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.546 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 20.8 t -94.09 30.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 123.058 1.409 . . . . 0.0 108.952 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 68' ' ' SER . 26.7 m -153.85 162.93 40.82 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -63.64 131.25 29.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.765 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.436 ' HE1' ' HA ' ' A' ' 67' ' ' ARG . 14.4 ptp -126.99 124.33 39.17 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.7 mt -114.1 96.79 43.32 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.24 148.89 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.851 1.7 . . . . 0.0 113.04 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 58' ' ' PRO . 73.4 m-85 75.57 -155.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 125.088 1.355 . . . . 0.0 110.681 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.575 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 97.4 m -145.61 -75.51 0.22 Allowed 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -129.53 90.87 42.68 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.433 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -85.85 -171.03 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.671 2.247 . . . . 0.0 110.837 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 41.2 t -81.53 -34.45 31.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.473 0.654 . . . . 0.0 110.465 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -89.3 -68.55 0.77 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -177.1 169.93 42.41 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.9 m -98.42 152.52 19.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.94 149.9 42.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.789 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.5 t -134.43 98.67 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 44' ' ' PRO . 19.9 m -113.48 135.96 51.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.32 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -135.82 124.94 24.42 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.979 0.418 . . . . 0.0 110.184 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.0 tp -101.34 125.83 36.52 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.93 13.41 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.484 2.122 . . . . 0.0 111.05 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 18.3 t -113.71 151.91 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.428 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 25.7 m-20 -61.95 154.85 66.32 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 124.08 0.952 . . . . 0.0 111.309 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.29 -17.09 24.85 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.723 2.949 . . . . 0.0 113.367 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.8 pt-20 -63.41 -16.79 61.56 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.516 0.726 . . . . 0.0 111.222 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.14 -19.78 63.2 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.3 mm -66.42 -28.31 43.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.308 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.48 -42.66 92.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.326 0.584 . . . . 0.0 109.749 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.51 -50.24 70.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.654 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -68.14 -20.06 25.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.452 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 tp -70.91 -28.67 64.7 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.285 0.634 . . . . 0.0 110.0 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.95 -32.25 61.69 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.3 t -83.58 -3.07 7.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.67 -35.17 60.76 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.272 0.629 . . . . 0.0 112.534 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -149.39 93.94 4.0 Favored Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' CG ' ' HB3' ' A' ' 23' ' ' ALA . 23.1 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 123.25 2.634 . . . . 0.0 112.422 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 m80 . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.764 0.316 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.544 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 72.0 mtm -147.53 123.18 10.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.9 m -98.77 114.43 26.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.794 0.33 . . . . 0.0 111.04 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.9 m-85 -129.28 14.41 6.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.455 0.645 . . . . 0.0 109.306 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.5 m -135.53 102.85 5.25 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -78.56 -33.95 47.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.079 0.942 . . . . 0.0 111.956 -175.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.84 -20.99 60.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.88 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 14.6 m -70.68 -35.15 72.67 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -70.29 -27.3 64.3 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.454 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.14 -51.12 70.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.85 -27.85 66.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.01 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 8' ' ' THR . 53.2 mt-30 -77.35 -44.74 28.37 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.662 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -148.37 -50.76 0.17 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.289 0.566 . . . . 0.0 110.904 -176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.43 163.28 19.8 Favored Glycine 0 N--CA 1.422 -2.26 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.24 139.2 58.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.389 0.614 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -132.22 2.94 3.95 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -149.95 143.68 25.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 13.8 tt -81.63 163.74 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.0 72.32 1.63 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.635 1.207 . . . . 0.0 109.646 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.9 mmt -140.51 -176.06 4.5 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.246 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -81.11 116.67 21.14 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 119.284 0.947 . . . . 0.0 111.243 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.505 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -106.94 134.75 49.62 Favored 'General case' 0 N--CA 1.4 -2.95 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.39 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.41 79.88 1.79 Allowed 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.24 80.81 0.49 Allowed Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.859 -175.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -68.94 -79.44 0.06 Allowed 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 117.045 0.422 . . . . 0.0 111.585 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.509 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 19.9 mtp-105 -75.33 -31.24 60.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.917 -1.113 . . . . 0.0 113.435 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' CD ' ' HZ3' ' A' ' 34' ' ' LYS . 9.0 tp10 -70.9 -12.64 61.66 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 109.665 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.3 t -60.73 -32.24 71.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -69.04 -45.49 70.3 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.435 0.635 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.544 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -67.55 -42.53 82.52 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.872 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -57.26 -32.34 66.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.584 0.23 . . . . 0.0 111.38 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 28' ' ' CYS . 50.0 mm -62.31 -40.3 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.52 -36.77 52.15 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.733 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 72.4 mttt -65.04 -15.22 62.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.755 0.822 . . . . 0.0 112.533 -178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -67.95 -23.98 65.12 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.636 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.15 -39.76 68.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.334 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 178.35 -68.76 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.761 0.824 . . . . 0.0 109.413 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.0 ttp180 -163.51 124.01 2.25 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.5 t -138.29 157.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -107.76 149.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.472 0.709 . . . . 0.0 109.991 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.544 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 51.6 t60 -135.62 128.02 30.37 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -96.8 136.54 27.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 98.9 mttt 70.48 53.89 0.42 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.58 1.152 . . . . 0.0 111.294 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 65.3 Cg_endo -70.58 144.55 49.96 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 121.161 1.241 . . . . 0.0 109.981 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.29 47.7 0.97 Allowed Glycine 0 CA--C 1.474 -2.489 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 10.2 pm0 -105.98 148.47 27.66 Favored 'General case' 0 N--CA 1.396 -3.159 0 CA-C-O 121.945 0.879 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 51.4 mtmt -134.75 80.85 1.87 Allowed 'General case' 0 CA--C 1.454 -2.742 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.443 ' C ' HD21 ' A' ' 49' ' ' LEU . 34.6 pt -95.89 104.35 15.74 Favored 'Isoleucine or valine' 1 C--N 1.221 -4.98 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.148 -175.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 59.03 6.01 0.61 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 126.733 2.013 . . . . 0.0 113.728 175.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.5 -3.46 67.89 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.84 131.83 4.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -76.86 86.33 3.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.39 127.17 64.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.24 -39.28 64.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.82 9.57 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.8 mt -102.96 120.83 51.19 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.85 107.39 0.17 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 123.257 2.638 . . . . 0.0 112.74 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -97.26 137.02 0.44 Allowed 'Trans proline' 0 N--CA 1.424 -2.587 0 C-N-CA 122.573 2.182 . . . . 0.0 111.693 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -67.63 114.03 17.5 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.24 88.01 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.397 2.065 . . . . 0.0 114.418 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 74' ' ' TYR . 73.0 mt -122.89 146.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 142.47 -174.84 23.21 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.829 -2.129 . . . . 0.0 114.547 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.16 102.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.17 105.38 17.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.82 -69.91 0.55 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.523 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.74 167.78 12.93 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -34.23 77.36 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 124.785 1.234 . . . . 0.0 107.844 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -99.46 32.16 2.89 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.385 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -151.72 160.46 43.59 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.424 HG13 ' OE2' ' A' ' 85' ' ' GLU . 5.3 m -77.8 119.79 27.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.893 0.854 . . . . 0.0 110.735 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.664 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.0 ptp -98.49 111.59 23.9 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.72 92.55 7.46 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.664 ' HD3' ' O ' ' A' ' 71' ' ' MET . 30.4 Cg_endo -100.9 178.04 0.23 Allowed 'Trans proline' 0 N--CA 1.406 -3.63 0 C-N-CA 121.799 1.666 . . . . 0.0 112.489 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 43.0 t80 -135.42 81.7 1.91 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.564 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 22.5 p -97.24 139.24 33.51 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.871 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -111.56 88.1 8.86 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.448 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 75' ' ' THR . 58.0 Cg_endo -107.68 -153.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 123.914 3.076 . . . . 0.0 108.454 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 21.7 t -110.65 11.01 22.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -118.1 -82.26 0.63 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.951 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.87 -174.55 45.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 37.1 m -109.78 148.26 31.78 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.77 135.53 55.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.9 t -121.43 108.65 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.2 m -108.24 129.65 62.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.424 ' OE2' HG13 ' A' ' 70' ' ' VAL . 39.8 tt0 -132.6 117.67 18.23 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.598 0.636 . . . . 0.0 110.821 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 19.8 tp -99.75 134.76 20.81 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.18 -3.1 9.53 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.328 2.019 . . . . 0.0 111.734 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.447 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -94.76 157.95 3.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 18.0 t70 -65.07 146.29 98.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 122.476 0.31 . . . . 0.0 111.512 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -50.98 -10.93 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.215 3.277 . . . . 0.0 114.788 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 7.9 pt-20 -57.29 -23.13 46.45 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 120.964 0.411 . . . . 0.0 110.438 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -59.74 -26.85 66.0 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.494 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.0 mm -67.89 -33.71 63.03 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 C-N-CA 121.398 -0.121 . . . . 0.0 110.796 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.33 -43.16 99.47 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -64.74 -51.02 64.58 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.719 -1.582 . . . . 0.0 109.01 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.8 mt -64.59 -25.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 124.003 0.921 . . . . 0.0 112.453 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.67 -39.89 94.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.174 0.511 . . . . 0.0 109.797 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -86.63 -41.31 14.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.942 0.877 . . . . 0.0 110.09 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.42 2.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.445 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -47.74 -48.67 29.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.65 -47.15 0.48 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 N--CA 1.434 -2.025 0 CA-C-N 120.224 1.116 . . . . 0.0 112.019 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.476 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.3 mpp? -151.77 132.57 14.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -127.77 115.39 18.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 84.2 m-85 -125.39 -5.0 7.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 48.0 m -77.69 90.07 3.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.212 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 20' ' ' MET 0.251 0.0 OUTLIER -79.17 -50.35 11.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.685 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 6' ' ' LEU . 1.2 tt0 -76.75 -8.5 57.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.755 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 65.6 m -69.61 -26.36 64.4 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 54.2 m-85 -75.38 -23.21 57.07 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 4.4 tt -70.11 -40.05 75.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -68.3 -23.72 64.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.966 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.58 5.62 45.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.012 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m 60.9 31.4 19.99 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.523 0.729 . . . . 0.0 111.937 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . -145.72 67.61 0.41 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.67 145.47 53.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.255 0.55 . . . . 0.0 111.337 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -145.66 27.79 1.2 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -155.99 171.77 19.53 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.406 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.431 HG21 ' HG ' ' A' ' 49' ' ' LEU . 8.7 tt -105.5 16.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.758 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.41 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 71.7 m80 65.31 69.09 0.48 Allowed 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 122.522 1.153 . . . . 0.0 110.471 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.707 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.7 tmm? -148.97 -168.69 3.17 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 63.5 tttp -75.76 112.36 12.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 119.66 1.118 . . . . 0.0 110.986 -177.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -106.8 161.07 15.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB1' ' NZ ' ' A' ' 47' ' ' LYS . . . -160.24 91.09 0.92 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.23 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.41 89.59 0.59 Allowed Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.94 -67.36 0.71 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.155 0.979 . . . . 0.0 109.279 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.8 mmt180 -81.42 -34.76 31.34 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.023 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 21.1 tt0 -80.31 -5.01 55.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.097 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 12.4 t -49.42 -46.28 47.43 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.274 0.559 . . . . 0.0 109.553 174.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.16 75.72 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.556 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.408 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -60.7 -47.32 86.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.02 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.455 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.0 ptm -61.02 -35.25 76.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.23 -42.87 91.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.338 0.589 . . . . 0.0 109.923 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -77.73 -35.13 52.26 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.898 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HZ1' ' CG1' ' A' ' 84' ' ' VAL . 82.1 mttt -57.9 -24.8 59.33 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 0.0 112.39 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.34 -21.78 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.331 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.59 77.77 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.644 0.259 . . . . 0.0 110.596 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -175.36 -69.44 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.336 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.4 ptt180 -151.15 123.58 8.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.0 t -138.07 141.43 38.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.78 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.6 p -108.82 143.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 52.0 t60 -133.81 130.49 38.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 15.7 tt -83.87 141.49 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.5 mttt 68.14 64.62 0.63 Allowed Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 0.0 110.781 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.47 171.1 16.37 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.927 1.751 . . . . 0.0 111.483 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -174.5 50.35 0.14 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.957 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.8 tp10 -119.09 144.47 46.59 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.545 ' HZ1' ' HB2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -139.68 81.6 1.83 Allowed 'General case' 0 CA--C 1.444 -3.118 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.521 HG23 ' CD ' ' A' ' 46' ' ' GLU . 9.6 pt -72.72 110.05 5.48 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.444 0 CA-C-N 111.677 -2.511 . . . . 0.0 109.903 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 62.11 14.74 6.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 125.84 1.656 . . . . 0.0 112.398 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 -41.07 2.6 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.53 121.41 41.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' HG13 ' A' ' 48' ' ' ILE . 56.7 ttp180 -62.52 92.48 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 124.506 1.122 . . . . 0.0 113.011 -177.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.5 mm -124.26 132.73 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.3 mt -79.99 -29.36 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.504 0.668 . . . . 0.0 109.851 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 17' ' ' GLU . . . 82.6 5.72 89.22 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.943 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.6 mt -126.72 122.14 23.44 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -65.18 107.87 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.192 1.928 . . . . 0.0 109.783 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -110.26 -172.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.132 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.0 t -73.67 116.85 55.77 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.26 39.19 0.52 Allowed 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 123.583 2.855 . . . . 0.0 115.6 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.73 141.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 165.09 129.65 1.06 Allowed Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 117.979 -2.058 . . . . 0.0 113.635 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 146.96 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -121.76 93.58 4.04 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.69 -64.34 0.88 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.265 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 1.5 tm-20 -159.78 169.92 22.6 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 69' ' ' THR . 5.0 tpp180 -87.1 -38.6 16.33 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.279 0.561 . . . . 0.0 112.351 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 18.5 t -91.23 29.9 1.35 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 122.994 1.378 . . . . 0.0 107.924 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 67' ' ' ARG . 16.9 m -145.65 170.02 17.3 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.58 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.444 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.3 ptt? -115.78 142.96 46.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.4 tp -114.34 80.44 5.89 Favored Pre-proline 0 C--N 1.292 -1.905 0 C-N-CA 119.655 -0.818 . . . . 0.0 113.12 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 3.0 Cg_exo -84.82 98.64 0.7 Allowed 'Trans proline' 0 N--CA 1.425 -2.503 0 C-N-CA 121.932 1.754 . . . . 0.0 107.72 176.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -88.92 67.65 8.24 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 123.046 1.403 . . . . 0.0 108.865 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.507 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 18.8 p -104.59 138.94 40.19 Favored 'General case' 1 N--CA 1.366 -4.665 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.618 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.17 92.52 9.61 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.564 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.3 Cg_endo -101.76 -165.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 122.93 2.42 . . . . 0.0 110.828 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.1 t -93.24 0.74 57.16 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -108.29 -78.48 0.59 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.256 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.21 178.35 46.83 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 71.3 m -93.1 131.61 37.98 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.54 116.85 32.74 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.871 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 39.0 t -120.85 133.31 67.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.466 ' CG1' ' HZ1' ' A' ' 34' ' ' LYS . 15.9 m -134.49 144.29 35.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 38.7 tt0 -137.73 125.82 22.91 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 68' ' ' SER . 26.3 tp -101.16 138.24 19.91 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.76 -3.95 11.32 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 121.82 1.68 . . . . 0.0 111.568 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.461 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 40.1 t -103.63 159.06 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.59 158.68 57.67 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 123.637 0.585 . . . . 0.0 110.909 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.33 -9.87 7.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.895 3.063 . . . . 0.0 113.636 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.57 -25.64 52.94 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 110.487 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.2 tp10 -63.82 -31.51 72.72 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 67' ' ' ARG . 65.5 mt -60.12 -42.58 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.44 0.296 . . . . 0.0 110.8 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.17 -36.9 85.68 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.313 0.578 . . . . 0.0 110.397 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.426 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 43.2 ttt180 -71.71 -42.3 67.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.256 1.027 . . . . 0.0 108.257 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.2 mm -65.46 -17.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 125.347 1.459 . . . . 0.0 110.908 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -78.38 -28.39 47.01 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -82.14 -43.92 17.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.35 11.61 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.702 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.98 -50.94 67.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.779 0.832 . . . . 0.0 110.23 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.52 92.51 47.75 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.861 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 123.753 2.969 . . . . 0.0 110.849 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.446 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.566 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.468 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.486 ' N ' HD13 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.492 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HB3' HD22 ' A' ' 6' ' ' LEU . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.514 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB1' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.822 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.553 ' NE2' ' HB1' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.484 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' GLY . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.529 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.448 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.459 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.448 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.484 ' O ' HG21 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.529 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.582 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.643 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.822 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.459 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' HD23 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.687 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.687 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.686 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.537 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.537 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.604 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.604 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.458 HD23 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' HG12 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.421 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.529 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -170.92 130.4 0.79 Allowed 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 125.712 1.605 . . . . 0.0 107.77 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.428 HG21 ' SD ' ' A' ' 31' ' ' MET . 9.9 t -114.57 129.01 56.63 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.94 0.876 . . . . 0.0 112.124 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -130.87 25.39 4.99 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.669 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 82.4 m -129.89 99.99 5.3 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -80.63 -45.17 17.7 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.401 ' N ' HD21 ' A' ' 6' ' ' LEU . 41.8 tt0 -74.55 -2.84 27.65 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.155 0.979 . . . . 0.0 111.863 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.489 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 49.9 m -76.84 -26.64 54.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.85 -24.15 58.54 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.26 -20.12 62.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.102 0.953 . . . . 0.0 108.924 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -91.14 9.53 30.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.857 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' C ' ' HG ' ' A' ' 13' ' ' SER . 22.4 mt-30 -128.97 -46.45 1.25 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.597 0.713 . . . . 0.0 109.349 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 12' ' ' GLN . 45.8 m -153.67 -155.66 0.61 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.56 166.01 53.24 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -81.35 147.25 29.94 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.411 ' HA ' HG21 ' A' ' 54' ' ' ILE . 61.1 t80 -126.88 22.63 6.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 122.652 1.215 . . . . 0.0 108.348 -176.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HB3' HD22 ' A' ' 49' ' ' LEU . 7.5 mp0 -142.36 167.9 21.0 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.337 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.508 ' H ' ' CD1' ' A' ' 49' ' ' LEU . 3.1 tt -100.59 -1.54 9.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 -176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 79.98 79.25 0.05 OUTLIER 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 126.716 2.007 . . . . 0.0 106.581 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.407 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -158.7 -179.08 7.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -176.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.71 101.99 3.22 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.918 1.342 . . . . 0.0 111.292 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.627 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -93.8 121.68 35.5 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.697 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.88 79.06 1.68 Allowed 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -95.85 88.39 1.05 Allowed Glycine 0 CA--C 1.472 -2.645 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.529 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.34 -64.6 1.13 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.543 0.687 . . . . 0.0 110.13 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.655 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 6.1 mmp_? -84.38 -40.96 17.21 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -67.34 -11.98 59.02 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.952 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 48.8 t -55.48 -41.92 73.67 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.88 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.551 ' HB1' ' NE2' ' A' ' 41' ' ' HIS . . . -70.81 -32.11 69.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.027 0.442 . . . . 0.0 110.625 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 41' ' ' HIS . . . -75.49 -41.36 55.64 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.443 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.3 ptp -61.62 -33.06 73.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.993 0.425 . . . . 0.0 111.672 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.19 -28.41 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.798 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 29' ' ' ALA . 15.4 mm-40 -92.73 -37.24 12.48 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.559 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 73.2 mttt -58.8 -24.94 62.64 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 124.772 1.229 . . . . 0.0 111.246 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -60.47 -26.83 67.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 O-C-N 124.331 1.019 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.26 -62.7 1.3 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.198 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -152.11 -70.01 0.16 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.862 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.538 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 28.2 ptt180 -158.48 123.76 4.36 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.0 t -140.74 154.73 21.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.901 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.7 p -115.03 144.15 23.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.169 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.551 ' NE2' ' HB1' ' A' ' 29' ' ' ALA . 4.0 t-80 -113.45 126.34 55.22 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 19.3 tt -86.33 134.57 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.458 ' HA ' HD11 ' A' ' 86' ' ' LEU . 65.3 mttp 66.7 60.1 0.94 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.861 0.865 . . . . 0.0 109.906 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 86' ' ' LEU . 57.5 Cg_endo -69.25 168.24 21.45 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.771 1.647 . . . . 0.0 110.639 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.655 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 179.47 56.8 0.08 OUTLIER Glycine 1 CA--C 1.448 -4.103 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -177.148 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -116.35 147.27 41.76 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 114.163 -1.019 . . . . 0.0 109.857 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.571 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 7.8 mmtm -136.64 76.56 1.6 Allowed 'General case' 0 C--N 1.263 -3.193 0 CA-C-O 123.801 1.762 . . . . 0.0 107.907 174.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 79.9 mt -88.39 107.55 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.698 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.364 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 17' ' ' GLU . 2.4 mt 70.57 -3.77 1.82 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.492 1.117 . . . . 0.0 111.251 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.8 -37.73 3.66 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.27 131.12 27.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -71.93 103.84 3.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.904 0.859 . . . . 0.0 109.216 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 50.8 mm -120.01 134.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' A' ' 16' ' ' TYR . 69.5 mt -84.61 -41.38 15.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.752 0.787 . . . . 0.0 109.229 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.69 -18.51 34.03 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 mm -101.02 108.78 56.07 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -53.05 109.32 0.34 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.477 2.785 . . . . 0.0 112.577 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -97.37 -179.66 0.38 Allowed 'Trans proline' 0 N--CA 1.432 -2.12 0 C-N-CA 122.713 2.275 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 75' ' ' THR . 77.6 t -67.37 112.33 9.82 Favored Pre-proline 0 C--O 1.213 -0.835 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.27 75.09 5.14 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.86 1.707 . . . . 0.0 115.455 -170.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.0 mt -136.64 142.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.634 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 138.11 156.74 7.24 Favored Glycine 0 N--CA 1.403 -3.535 0 C-N-CA 118.981 -1.58 . . . . 0.0 114.13 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.1 pt -150.87 160.84 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 123.423 0.689 . . . . 0.0 111.3 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.93 136.48 42.68 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.44 -61.87 1.66 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.737 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -155.83 166.22 34.16 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 3.0 tpp180 -77.09 -33.62 56.96 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.793 0.806 . . . . 0.0 110.468 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.613 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.49 31.54 1.02 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 122.782 1.277 . . . . 0.0 110.288 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.476 ' C ' ' HG3' ' A' ' 85' ' ' GLU . 64.4 m -154.61 173.49 16.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -79.19 166.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-O 122.473 1.13 . . . . 0.0 110.228 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.525 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.4 ptt? -120.77 122.25 39.96 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 174.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.8 90.29 15.01 Favored Pre-proline 0 C--N 1.293 -1.867 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.174 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.634 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 71.7 Cg_endo -103.21 171.09 0.21 Allowed 'Trans proline' 1 N--CA 1.385 -4.898 0 C-N-CA 120.8 1.0 . . . . 0.0 111.449 176.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -126.05 32.53 5.23 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 122.213 1.006 . . . . 0.0 110.304 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 37.0 p -80.6 104.38 11.09 Favored 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.511 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -103.88 102.23 29.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.688 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 75' ' ' THR . 64.3 Cg_endo -98.46 -156.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.736 2.957 . . . . 0.0 112.072 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.2 t -95.95 28.56 3.08 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.369 1.08 . . . . 0.0 108.092 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -136.81 -85.28 0.33 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.68 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -172.77 173.81 45.59 Favored Glycine 0 C--N 1.315 -0.589 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 25.1 m -89.28 135.7 33.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB1' ' HZ2' ' A' ' 34' ' ' LYS . . . -109.91 126.93 54.39 Favored 'General case' 0 N--CA 1.397 -3.119 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 54.2 t -133.02 138.85 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -140.06 140.52 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.476 ' HG3' ' C ' ' A' ' 69' ' ' THR . 42.5 tt0 -138.71 118.67 13.34 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 43' ' ' LYS . 13.2 tp -97.17 143.9 26.94 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.27 12.67 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.907 1.738 . . . . 0.0 112.34 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.613 ' O ' ' HB3' ' A' ' 68' ' ' SER . 26.1 t -117.79 156.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.459 ' CB ' ' HG2' ' A' ' 91' ' ' GLU . 1.8 m-20 -51.81 157.51 1.97 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 124.201 0.938 . . . . 0.0 111.871 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.28 -11.37 31.11 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.586 2.191 . . . . 0.0 110.539 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.459 ' HG2' ' CB ' ' A' ' 89' ' ' ASP . 12.8 pt-20 -66.61 -16.87 64.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.226 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 96' ' ' ILE . 7.3 tp10 -59.52 -26.49 65.36 Favored 'General case' 0 C--N 1.375 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -56.38 -36.16 45.98 Favored 'Isoleucine or valine' 0 C--O 1.167 -3.242 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -56.04 -40.94 74.23 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.93 0.871 . . . . 0.0 110.796 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -39.03 42.29 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.208 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 92' ' ' GLU . 43.2 mm -75.29 -18.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.317 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.9 tp -82.14 -27.89 32.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.731 0.777 . . . . 0.0 109.018 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -100.74 7.88 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.669 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -55.13 -61.8 2.08 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -177.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.54 -43.93 0.22 Allowed Pre-proline 0 C--N 1.258 -3.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.911 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.423 -2.638 0 C-N-CA 121.163 1.242 . . . . 0.0 112.347 179.129 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' HIS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.459 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' HD23 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.687 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.687 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.686 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.537 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.537 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.604 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.604 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.458 HD23 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' HG12 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.421 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.529 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.5 t60 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -176.96 148.86 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.23 0.612 . . . . 0.0 110.966 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -148.93 130.67 15.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 55.9 m-85 -114.68 7.57 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.985 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.4 m -84.53 115.0 22.36 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.551 HD12 ' H ' ' A' ' 7' ' ' GLU . 0.6 OUTLIER -102.92 -53.07 2.92 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' H ' HD12 ' A' ' 6' ' ' LEU . 33.1 tt0 -70.22 -13.82 62.35 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 125.155 1.382 . . . . 0.0 110.91 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -73.12 -25.05 60.71 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.237 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -32.3 63.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.68 -42.13 98.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -67.0 -17.32 64.87 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.95 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -95.19 -45.2 7.29 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.9 m -149.59 -67.34 0.21 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.933 0.396 . . . . 0.0 111.127 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.33 163.54 32.04 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.7 152.93 22.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 124.222 0.601 . . . . 0.0 109.831 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CD1' HG21 ' A' ' 54' ' ' ILE . 41.9 t80 -151.44 13.58 0.66 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.401 0.619 . . . . 0.0 110.452 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -144.59 171.06 14.91 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG21 ' HG ' ' A' ' 49' ' ' LEU . 15.5 tt -105.2 150.46 7.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -69.53 67.68 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.305 1.05 . . . . 0.0 110.973 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mmm -122.07 -101.03 0.41 Allowed 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.979 1.712 . . . . 0.0 110.242 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -159.45 124.22 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.06 141.45 39.73 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . . . -118.06 90.47 3.34 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 46' ' ' GLU . . . -107.56 76.07 0.22 Allowed Glycine 0 CA--C 1.479 -2.199 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.358 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 97.3 m-85 -70.37 -74.96 0.13 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.072 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.596 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.7 mmt180 -80.73 -33.02 35.52 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.375 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -66.29 -13.07 59.89 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' MET . 25.0 t -49.44 -37.38 25.54 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 121.501 0.667 . . . . 0.0 110.987 175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.572 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -72.68 -42.97 63.69 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 121.82 -0.55 . . . . 0.0 110.456 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' HIS . . . -60.28 -47.07 87.6 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.122 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -53.39 -39.53 64.33 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.383 0.427 . . . . 0.0 112.023 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.7 mm -62.17 -43.36 97.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.128 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HB3' HG21 ' A' ' 39' ' ' VAL . 18.5 mm-40 -79.58 -28.86 41.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.805 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -64.47 -22.95 67.12 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 123.952 0.901 . . . . 0.0 111.973 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.06 -26.61 66.83 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -59.54 2.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.07 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -141.67 -79.12 0.25 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.487 1.137 . . . . 0.0 110.01 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.499 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 14.2 ptp180 -170.49 123.19 0.65 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 33' ' ' GLU . 74.2 t -132.93 143.19 40.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.639 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.7 p -97.75 139.41 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.901 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.572 ' CE1' ' HB1' ' A' ' 29' ' ' ALA . 66.6 t60 -123.27 124.9 44.03 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.8 tt -85.65 136.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 96.4 mttt 68.1 58.32 0.73 Allowed Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 123.64 0.776 . . . . 0.0 110.93 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 Cg_endo -78.24 155.91 29.3 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 121.647 1.565 . . . . 0.0 110.29 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.596 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -152.99 39.16 0.73 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . 2.3 pm0 -105.6 175.6 5.44 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.925 0.869 . . . . 0.0 111.565 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HG2' HG23 ' A' ' 96' ' ' ILE . 4.7 tmtt? -157.44 102.67 1.92 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.38 105.95 17.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HG ' HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.26 -1.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 127.349 2.26 . . . . 0.0 114.47 175.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.75 -38.89 2.93 Favored Glycine 0 C--N 1.291 -1.946 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.79 39.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -75.79 104.07 6.17 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.5 mt -124.31 119.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 16' ' ' TYR . 62.9 mt -77.9 -33.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.932 0.77 . . . . 0.0 110.18 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.63 14.99 Favored Glycine 0 C--N 1.309 -0.933 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.58 131.25 23.19 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.79 110.43 0.67 Allowed 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.811 2.341 . . . . 0.0 111.324 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -110.58 -177.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 122.878 2.385 . . . . 0.0 112.905 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 75' ' ' THR . 59.1 t -87.23 121.17 71.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 40.22 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.042 2.495 . . . . 0.0 114.792 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.09 145.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.34 145.39 6.0 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.352 -1.404 . . . . 0.0 112.356 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.13 86.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 123.404 0.681 . . . . 0.0 109.428 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -95.07 114.96 26.82 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.29 -69.53 0.72 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -148.07 168.25 22.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -32.82 42.44 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.27 28.47 1.43 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.426 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -152.3 167.91 27.1 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.83 156.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.9 0.857 . . . . 0.0 111.383 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.604 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 ptt? -119.37 124.85 47.59 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.1 mt -107.95 87.48 3.81 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.2 Cg_exo -82.24 142.01 11.84 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.998 1.799 . . . . 0.0 112.332 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.8 49.88 1.07 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.997 1.38 . . . . 0.0 107.819 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.5 p -98.51 119.97 38.13 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 112.746 -2.024 . . . . 0.0 107.313 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -100.51 102.19 17.94 Favored Pre-proline 0 C--N 1.305 -1.345 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.002 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.3 Cg_endo -104.17 -164.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.708 0 C-N-CA 123.069 2.513 . . . . 0.0 111.18 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 74.3 m -109.8 35.39 3.38 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -141.86 -71.76 0.34 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.577 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.16 40.54 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 22.7 m -115.31 149.36 37.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 118.304 1.052 . . . . 0.0 111.214 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.07 124.68 52.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.736 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.4 t -122.33 124.83 71.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.496 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 21.8 m -125.17 145.79 31.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -147.6 118.58 7.67 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.209 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.454 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.1 tp -95.85 125.66 47.92 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 1.13 8.97 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.254 1.969 . . . . 0.0 111.164 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 68' ' ' SER . 19.5 t -100.25 164.42 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 91' ' ' GLU . 6.2 m-20 -70.23 162.21 71.01 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 118.074 0.397 . . . . 0.0 110.132 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.73 16.42 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.137 2.558 . . . . 0.0 112.207 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -70.41 -20.01 62.95 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.014 0.911 . . . . 0.0 109.115 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.491 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 7.3 tp10 -65.74 -24.29 66.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.033 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.514 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 66.5 mt -59.23 -26.96 35.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.83 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -63.59 -41.09 98.37 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 95' ' ' ARG . 2.8 mpt_? -74.82 -38.9 61.92 Favored 'General case' 0 C--O 1.193 -1.921 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 62.2 mt -58.66 -33.97 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 124.37 1.068 . . . . 0.0 111.316 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.45 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.558 0.694 . . . . 0.0 109.797 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.57 -42.55 24.77 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.011 0.91 . . . . 0.0 109.518 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.19 3.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 125.119 1.367 . . . . 0.0 111.674 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -42.19 -44.13 3.62 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 124.518 1.127 . . . . 0.0 110.751 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -160.18 98.18 1.46 Allowed Pre-proline 0 N--CA 1.401 -2.882 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.243 0.734 0 C-N-CA 123.543 2.828 . . . . 0.0 112.739 -178.022 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.446 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.566 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.468 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.486 ' N ' HD13 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.492 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HB3' HD22 ' A' ' 6' ' ' LEU . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.514 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB1' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.822 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.553 ' NE2' ' HB1' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.484 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' GLY . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.529 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.448 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.459 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.448 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' O ' HG21 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.529 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.582 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.643 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.822 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 79.9 m-70 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtt -152.49 122.26 6.94 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.641 HG22 ' SD ' ' A' ' 31' ' ' MET . 8.6 t -111.25 125.3 53.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.445 0.641 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.54 7.44 6.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.875 0.845 . . . . 0.0 109.43 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 62.5 m -94.89 96.56 9.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.769 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 7' ' ' GLU . 4.1 pp -100.29 -39.48 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.984 0.897 . . . . 0.0 110.358 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.616 ' N ' HD13 ' A' ' 6' ' ' LEU . 35.2 tt0 -77.74 -13.77 59.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.165 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.7 m -68.5 -33.56 74.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -80.33 -26.4 38.76 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.641 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' OE2' ' A' ' 15' ' ' GLU . 7.8 tt -73.55 -26.79 61.01 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.295 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 7' ' ' GLU . 79.5 mt-30 -68.89 -29.96 68.35 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -93.34 -7.0 46.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.059 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.9 m 63.85 37.85 9.39 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 122.318 1.056 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.27 55.71 0.57 Allowed Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' OE2' ' HG ' ' A' ' 10' ' ' LEU . 6.1 pm0 -100.07 174.25 6.25 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.146 0.578 . . . . 0.0 111.423 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.412 ' CD1' HG13 ' A' ' 54' ' ' ILE . 70.9 t80 -144.87 25.44 1.44 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -138.13 163.96 30.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.75 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.1 tt -115.83 165.23 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -65.84 71.87 0.06 Allowed 'General case' 0 C--N 1.362 1.15 0 CA-C-O 122.213 1.006 . . . . 0.0 109.989 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 49' ' ' LEU . 47.7 mtt -135.82 -148.4 0.3 Allowed 'General case' 0 C--N 1.259 -3.326 0 C-N-CA 126.209 1.804 . . . . 0.0 106.872 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 20' ' ' MET . 11.9 tmtt? -124.03 123.28 40.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HB3' HD22 ' A' ' 6' ' ' LEU . 8.9 ptm180 -98.89 165.8 11.59 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.78 80.68 0.94 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.492 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -96.9 82.3 0.74 Allowed Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.4 -65.9 0.87 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.3 mpt_? -85.62 -34.66 21.33 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.984 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 29.8 tt0 -79.21 -3.01 43.68 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.648 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -53.54 -41.91 66.92 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.11 94.98 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.19 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -62.32 -45.73 91.91 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.293 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.641 ' SD ' HG22 ' A' ' 3' ' ' THR . 18.4 ptm -55.98 -35.73 67.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.9 mm -59.9 -46.44 93.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 123.93 0.769 . . . . 0.0 109.927 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.4 -28.51 31.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.193 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 34.7 mtpt -57.01 -26.86 60.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.692 0.797 . . . . 0.0 110.924 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 7.0 tmtm? -62.67 -21.25 65.57 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.316 1.047 . . . . 0.0 111.26 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.86 -39.24 69.81 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 121.86 -0.525 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -176.12 -65.46 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.422 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 7.2 ptp180 -169.6 132.41 1.2 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.67 145.79 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.778 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -98.26 139.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 O-C-N 124.343 1.027 . . . . 0.0 109.996 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 37.6 t-80 -137.7 123.29 19.75 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.0 137.85 20.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.8 mttt 66.6 64.24 0.82 Allowed Pre-proline 0 C--O 1.216 -0.667 0 C-N-CA 123.133 0.573 . . . . 0.0 111.097 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.625 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 44.9 Cg_endo -95.28 148.82 1.53 Allowed 'Trans proline' 0 N--CA 1.427 -2.395 0 C-N-CA 122.126 1.884 . . . . 0.0 111.046 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -154.21 64.76 0.34 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.265 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.649 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.0 tp10 -114.38 123.24 48.98 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 124.072 0.949 . . . . 0.0 109.11 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 44.4 mtmt -106.96 72.5 0.89 Allowed 'General case' 0 CA--C 1.464 -2.339 0 CA-C-O 123.287 1.518 . . . . 0.0 107.786 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.649 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -75.43 94.73 0.98 Allowed 'Isoleucine or valine' 1 C--N 1.239 -4.229 0 CA-C-N 111.683 -2.508 . . . . 0.0 111.828 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER 64.27 -8.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.646 1.578 . . . . 0.0 113.362 175.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 92.29 -6.26 78.23 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.31 152.19 18.27 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -88.83 99.87 12.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.816 0.341 . . . . 0.0 111.77 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.34 118.02 57.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.412 HG13 ' CD1' ' A' ' 16' ' ' TYR . 3.5 mp -75.51 -43.54 41.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.403 0.62 . . . . 0.0 110.736 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.6 -9.47 77.0 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 69.3 mt -124.64 131.21 24.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.9 107.33 1.86 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.563 1.509 . . . . 0.0 109.252 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 56' ' ' ILE . 42.9 Cg_endo -103.4 -164.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 122.721 2.281 . . . . 0.0 111.485 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 75' ' ' THR . 55.7 t -75.75 116.96 60.07 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -84.1 43.93 1.46 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 122.502 2.135 . . . . 0.0 113.964 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mt -114.98 164.88 10.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.21 155.93 9.14 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.157 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.2 pt -126.22 84.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.096 0.95 . . . . 0.0 111.32 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.78 95.96 7.44 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -76.95 -56.92 4.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.769 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.13 169.88 12.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.416 ' HA ' ' HE2' ' A' ' 71' ' ' MET . 0.1 OUTLIER -88.77 -31.7 18.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.23 1.014 . . . . 0.0 108.464 -176.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 14.9 m -93.71 34.63 1.18 Allowed 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.909 1.338 . . . . 0.0 109.203 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.2 m -154.66 166.74 32.45 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.42 105.87 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 121.861 0.839 . . . . 0.0 110.968 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.416 ' HE2' ' HA ' ' A' ' 67' ' ' ARG . 21.4 ptp -86.29 123.54 31.66 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.9 mt -118.93 86.35 30.92 Favored Pre-proline 0 C--N 1.295 -1.792 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.857 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.55 ' O ' HG21 ' A' ' 81' ' ' THR . 4.3 Cg_exo -75.14 149.96 36.89 Favored 'Trans proline' 0 N--CA 1.422 -2.689 0 N-CA-C 108.353 -1.441 . . . . 0.0 108.353 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.08 41.4 2.11 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 44.5 p -95.07 102.85 14.68 Favored 'General case' 0 N--CA 1.398 -3.054 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -102.05 102.38 23.75 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.743 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.8 Cg_endo -102.45 -159.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.311 0 C-N-CA 123.253 2.635 . . . . 0.0 110.136 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -93.86 25.46 3.62 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.121 0.962 . . . . 0.0 110.172 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -128.09 -74.91 0.57 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.829 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 157.66 -174.78 35.07 Favored Glycine 0 N--CA 1.416 -2.655 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.55 HG21 ' O ' ' A' ' 73' ' ' PRO . 5.0 m -121.48 152.12 39.5 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 117.406 0.603 . . . . 0.0 109.627 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . . . -105.15 111.83 24.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.7 t -102.24 90.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.625 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 26.9 m -104.64 135.47 42.42 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 O-C-N 121.457 -0.777 . . . . 0.0 111.473 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.17 115.88 16.95 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.529 0.68 . . . . 0.0 109.277 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 68' ' ' SER . 26.8 tp -99.49 125.03 42.39 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.2 8.45 4.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.348 2.032 . . . . 0.0 111.785 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.15 157.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.42 152.71 94.23 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.89 -7.51 18.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.625 2.883 . . . . 0.0 112.398 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.64 -24.56 63.97 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.61 -27.71 69.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.573 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 78.2 mt -59.17 -41.0 82.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 C-N-CA 122.168 0.187 . . . . 0.0 110.988 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.92 -47.33 86.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.973 0.892 . . . . 0.0 109.66 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -68.32 -41.78 80.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.174 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.92 -28.56 44.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 C-N-CA 124.128 0.971 . . . . 0.0 113.188 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.36 -37.09 84.5 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.212 0.53 . . . . 0.0 110.343 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.22 -37.06 46.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.219 1.009 . . . . 0.0 108.996 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 99' ' ' VAL . 57.8 t -91.07 17.25 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.287 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.534 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.65 -48.33 69.5 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.23 -48.31 0.6 Allowed Pre-proline 0 C--N 1.293 -1.887 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.392 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 C--N 1.389 2.675 0 C-N-CA 123.687 2.925 . . . . 0.0 115.25 177.804 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 64.6 t60 . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -130.07 139.56 50.95 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 t -107.6 123.53 48.6 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.525 0.679 . . . . 0.0 111.706 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -129.99 -0.48 4.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.419 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p -87.22 101.36 13.44 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.652 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -97.34 -44.85 6.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.457 ' N ' HD22 ' A' ' 6' ' ' LEU . 34.9 tt0 -81.42 -4.8 56.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.316 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -71.04 -24.77 62.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.883 0.849 . . . . 0.0 109.559 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 79' ' ' TYR . 38.5 t80 -78.39 -21.84 48.74 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.828 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.06 -35.29 79.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.89 -14.01 62.31 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -91.95 -46.24 7.93 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.7 m -163.39 -67.69 0.04 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.47 0.653 . . . . 0.0 109.428 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.11 -179.87 20.11 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -97.1 177.51 5.57 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 118.243 1.022 . . . . 0.0 108.777 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.419 ' HA ' HG21 ' A' ' 54' ' ' ILE . 18.1 t80 -129.15 14.41 6.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.655 1.217 . . . . 0.0 108.549 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 49' ' ' LEU . 5.0 mp0 -132.3 -168.01 1.98 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.489 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG21 ' HG ' ' A' ' 49' ' ' LEU . 10.9 tt -122.39 45.59 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.375 1.084 . . . . 0.0 110.793 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 56.73 31.07 18.73 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.793 1.237 . . . . 0.0 111.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.413 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 91.1 mmm -121.86 -168.37 1.69 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 45.1 mmtm -89.25 138.16 31.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.782 1.628 . . . . 0.0 111.478 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 48' ' ' ILE . 11.9 ptm180 -107.45 140.63 40.1 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.55 88.79 2.57 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.397 0.618 . . . . 0.0 111.146 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -108.88 78.87 0.24 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.678 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -71.19 -56.83 5.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.781 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 3.2 mmp_? -94.39 -33.17 13.26 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.63 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 25.9 tt0 -82.32 -0.43 45.63 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.975 -177.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 31' ' ' MET . 50.7 t -57.36 -38.15 73.73 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . . . -67.73 -41.78 82.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.427 0.632 . . . . 0.0 109.335 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.37 98.78 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.272 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.629 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 9.9 ptt? -54.52 -35.11 62.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.257 0.348 . . . . 0.0 111.749 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.687 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 44.9 mm -62.72 -39.44 84.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.421 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.77 -27.27 21.25 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.586 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 38.0 mtpt -59.6 -18.24 39.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.048 0.939 . . . . 0.0 112.126 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -68.6 -14.31 62.93 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.14 -55.55 5.34 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 111.213 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -167.62 -64.38 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 40.5 ptt180 -163.16 124.68 2.47 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.0 t -133.52 151.89 34.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.4 p -102.06 148.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 123.873 0.733 . . . . 0.0 110.215 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 29' ' ' ALA . 78.5 t60 -144.47 143.98 31.14 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.21 146.16 9.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.612 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 49.1 mtmt 65.22 48.51 0.66 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 110.723 -176.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 6.0 Cg_exo -89.1 161.77 5.81 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.62 2.214 . . . . 0.0 111.096 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -171.75 75.19 0.1 OUTLIER Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.171 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' CB ' ' HB3' ' A' ' 27' ' ' GLU . 26.7 tt0 -120.94 123.83 43.43 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.709 0.766 . . . . 0.0 110.244 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 50' ' ' GLY . 2.4 tmtm? -124.03 104.13 8.71 Favored 'General case' 0 N--CA 1.394 -3.273 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -106.6 130.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.795 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 55.32 15.95 1.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.038 2.135 . . . . 0.0 112.843 176.181 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.558 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . 81.68 -25.08 4.08 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.043 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' O ' HD11 ' A' ' 53' ' ' ILE . . . -143.44 145.1 32.34 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -74.57 89.14 2.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 117.754 0.252 . . . . 0.0 111.141 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 55' ' ' GLY . 4.7 mp -116.72 127.92 74.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 16' ' ' TYR . 55.2 mt -91.84 -17.23 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 122.096 0.95 . . . . 0.0 108.653 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 87.43 -17.68 42.22 Favored Glycine 0 CA--C 1.499 -0.923 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.1 mt -119.74 105.27 43.51 Favored Pre-proline 0 N--CA 1.413 -2.32 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.16 110.31 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.667 2.912 . . . . 0.0 112.462 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -95.85 175.29 0.9 Allowed 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.747 2.298 . . . . 0.0 111.741 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.9 t -85.12 106.5 9.05 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.3 100.76 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.373 2.049 . . . . 0.0 113.651 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.8 mt -134.54 86.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . -136.32 151.33 20.76 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.48 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.05 104.07 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 123.645 0.778 . . . . 0.0 108.931 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.13 99.06 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -76.36 -69.82 0.48 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.522 0.677 . . . . 0.0 109.821 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -163.91 168.4 19.47 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HG3' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -81.69 -31.09 32.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.189 0.995 . . . . 0.0 108.432 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.535 ' OG ' ' HD3' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -92.17 28.41 1.9 Allowed 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.408 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 m -152.46 166.6 31.45 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.6 m -76.95 103.59 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 118.979 0.809 . . . . 0.0 110.958 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.642 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 23.5 ptt? -83.43 119.26 24.44 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -108.58 88.48 5.2 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 71' ' ' MET . 12.6 Cg_endo -96.07 167.5 1.24 Allowed 'Trans proline' 0 N--CA 1.403 -3.807 0 C-N-CA 121.973 1.782 . . . . 0.0 111.097 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -140.34 113.01 8.05 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.7 p -128.06 139.79 52.33 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -112.31 88.88 11.34 Favored Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.636 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 75' ' ' THR . 73.5 Cg_endo -106.1 -151.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 123.923 3.082 . . . . 0.0 109.808 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.0 t -100.74 13.35 35.2 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.55 ' HD2' ' CE2' ' A' ' 9' ' ' TYR . 48.3 t80 -124.84 -81.55 0.63 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.562 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -174.0 40.63 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 10.2 m -118.75 158.06 26.31 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.33 0.565 . . . . 0.0 110.218 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . . . -114.91 125.43 53.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.4 t -107.34 108.0 24.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.547 ' HB ' ' HG2' ' A' ' 44' ' ' PRO . 29.3 m -114.32 141.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.446 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -134.56 108.57 8.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.0 tp -95.23 129.09 36.29 Favored Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.5 13.51 2.63 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.429 2.086 . . . . 0.0 110.839 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.88 159.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.66 146.12 99.0 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 11.3 Cg_endo -54.34 -13.74 5.68 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.84 3.027 . . . . 0.0 113.879 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.4 -20.69 63.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 92' ' ' GLU . 4.4 tp10 -64.3 -30.53 71.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.52 HG13 ' HG3' ' A' ' 67' ' ' ARG . 48.8 mm -70.04 -31.58 48.21 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.954 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.96 -39.47 94.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -64.97 -48.67 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.463 1.125 . . . . 0.0 108.172 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.1 mt -68.96 -19.58 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.088 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 65.5 tp -77.18 -26.58 53.07 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.019 0.928 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.69 -37.53 59.46 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 56.5 t -62.36 -65.56 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . 59.2 -57.67 0.05 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.732 2.013 . . . . 0.0 114.969 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 32.5 mt-10 -128.06 -69.66 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.134 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.558 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 73.1 Cg_endo . . . . . 0 N--CA 1.437 -1.829 0 CA-C-N 120.681 1.279 . . . . 0.0 112.565 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.604 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 67.1 mtm -152.79 128.54 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m -106.74 111.45 23.98 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.2 m-85 -128.69 10.43 6.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.169 0.509 . . . . 0.0 111.141 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.4 m -131.69 106.93 8.46 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.49 HD11 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -80.92 -37.47 29.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.121 0.962 . . . . 0.0 111.419 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.41 ' H ' HD13 ' A' ' 6' ' ' LEU . 8.3 tp10 -71.38 -19.24 62.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.278 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.538 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.3 m -73.01 -31.96 64.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -70.47 -30.13 66.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.126 0.489 . . . . 0.0 110.092 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.6 -43.64 98.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.81 -11.7 59.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.388 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 8' ' ' THR . 52.5 mt-30 -89.67 -32.83 16.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.6 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -164.5 -67.07 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.47 166.01 38.66 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.85 141.29 56.49 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.716 0.769 . . . . 0.0 111.732 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -139.7 8.38 2.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 54.7 mt-10 -152.86 148.98 27.8 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.34 -1.754 . . . . 0.0 106.741 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.503 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 12.4 tt -89.31 159.93 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -72.11 70.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.794 1.283 . . . . 0.0 109.972 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 mmt -136.69 -175.5 4.04 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.901 -1.954 . . . . 0.0 106.139 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 51.4 mttp -84.52 118.19 24.16 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 119.485 1.039 . . . . 0.0 110.997 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' CZ ' HD11 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -108.37 136.62 47.69 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.411 -177.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -143.36 96.18 2.87 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -114.48 85.12 0.38 Allowed Glycine 0 N--CA 1.423 -2.176 0 C-N-CA 120.302 -0.951 . . . . 0.0 114.476 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -69.28 -81.03 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 117.105 0.452 . . . . 0.0 112.108 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 20.9 mtp-105 -73.13 -32.95 65.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.547 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 13.1 tp10 -70.05 -13.85 62.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.743 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 43.4 t -60.63 -31.9 71.07 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -69.1 -46.13 68.5 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.455 0.645 . . . . 0.0 110.204 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.586 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.51 -44.87 81.38 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.379 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.443 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 22.4 ptp -56.32 -31.14 63.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 28' ' ' CYS . 46.7 mm -60.96 -40.74 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.663 0.744 . . . . 0.0 109.531 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -80.45 -34.25 36.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.281 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 74.3 mttt -68.26 -13.54 62.33 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -64.23 -30.55 71.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.484 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.71 -47.06 27.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.626 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.58 -74.3 0.06 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 120.756 0.313 . . . . 0.0 110.595 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 ttp180 -165.82 124.63 1.61 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.471 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 58.8 t -136.39 165.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.6 p -112.51 149.35 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.437 0.695 . . . . 0.0 109.901 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.586 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 46.2 t60 -140.74 128.84 22.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.4 mp -98.09 136.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 97.0 mttt 71.78 55.97 0.38 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.868 1.267 . . . . 0.0 110.432 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 85.4 Cg_endo -74.16 135.38 20.71 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.997 1.131 . . . . 0.0 109.716 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.94 46.58 1.08 Allowed Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 4.4 pm0 -112.99 153.21 28.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-O 121.643 0.735 . . . . 0.0 110.696 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -140.97 61.76 1.49 Allowed 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.454 ' C ' HD21 ' A' ' 49' ' ' LEU . 33.7 pt -64.29 105.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.576 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.3 OUTLIER 70.49 -10.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.965 2.106 . . . . 0.0 113.792 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.84 -1.16 88.03 Favored Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.59 120.79 3.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.721 1.608 . . . . 0.0 107.069 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.93 87.5 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.321 0.582 . . . . 0.0 112.275 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -116.54 130.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.1 mm -71.88 -40.87 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.498 0.666 . . . . 0.0 109.597 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.0 0.24 63.87 Favored Glycine 0 C--N 1.308 -0.996 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mt -130.52 129.38 22.75 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.64 107.08 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.333 2.022 . . . . 0.0 110.07 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 36.0 Cg_endo -103.97 -167.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.272 0 C-N-CA 122.566 2.177 . . . . 0.0 111.319 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 75' ' ' THR . 41.3 t -99.16 100.67 10.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 10.3 Cg_endo -87.66 102.59 0.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.721 2.28 . . . . 0.0 113.541 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.53 164.52 34.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 133.13 -175.09 20.3 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.556 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.72 107.04 4.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -99.51 108.62 21.1 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -85.34 -55.93 3.78 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -171.94 166.8 6.29 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -35.48 74.58 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.531 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 16.0 m -96.37 31.4 2.24 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.608 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -151.43 161.65 42.33 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG13 ' OE2' ' A' ' 85' ' ' GLU . 9.5 m -77.35 112.77 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.979 0.895 . . . . 0.0 109.865 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.587 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -90.84 123.05 34.08 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.72 89.27 12.85 Favored Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.138 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 71' ' ' MET . 4.9 Cg_exo -85.04 155.94 11.29 Favored 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 121.872 1.714 . . . . 0.0 110.029 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -125.22 75.73 1.48 Allowed 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.536 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 p -106.51 134.62 49.36 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.455 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -110.79 88.81 8.42 Favored Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.875 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 75' ' ' THR . 44.3 Cg_endo -103.38 -159.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.658 2.905 . . . . 0.0 109.797 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 10.1 t -94.58 5.31 52.21 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.448 0.642 . . . . 0.0 109.302 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -120.68 -84.42 0.66 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.152 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -168.8 39.63 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 27.7 m -116.96 147.76 41.99 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.313 0.578 . . . . 0.0 110.08 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -120.12 121.59 39.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 82.9 t -104.38 104.91 17.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -103.22 133.78 46.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.439 ' OE2' HG13 ' A' ' 70' ' ' VAL . 36.2 tt0 -132.69 115.21 15.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.324 0.583 . . . . 0.0 109.696 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.507 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 21.9 tp -99.37 132.99 22.33 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.38 -3.4 10.8 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.311 2.007 . . . . 0.0 111.834 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.507 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.5 t -96.0 164.32 2.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.0 t70 -68.61 146.89 97.93 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 123.208 0.603 . . . . 0.0 110.755 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.04 -10.92 1.24 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 124.134 3.223 . . . . 0.0 114.749 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.1 pt-20 -55.63 -22.61 23.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.279 0.632 . . . . 0.0 110.814 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -58.88 -23.19 60.65 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.864 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 27.2 mm -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -65.15 -37.55 87.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.09 -51.01 66.07 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' A' ' 47' ' ' LYS . 3.0 mt -58.42 -29.58 38.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.451 0 C-N-CA 125.74 1.616 . . . . 0.0 113.028 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.48 -36.68 79.3 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.237 0.542 . . . . 0.0 110.685 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.43 -45.1 10.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.215 1.007 . . . . 0.0 109.878 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.67 13.81 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 125.771 1.628 . . . . 0.0 111.095 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . . . -63.84 -36.31 83.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.417 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 29.2 mt-10 -88.73 -52.54 0.37 Allowed Pre-proline 0 N--CA 1.412 -2.361 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.657 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 32.5 Cg_endo . . . . . 0 N--CA 1.426 -2.491 0 C-N-CA 122.079 1.853 . . . . 0.0 112.353 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 CA--C 1.499 -0.987 0 CA-C-O 120.995 0.426 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.455 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 70.9 mtm -152.0 123.83 7.99 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.3 m -100.61 118.53 36.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 120.4 0.143 . . . . 0.0 111.085 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.8 m-85 -134.74 14.48 3.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.411 0.624 . . . . 0.0 109.535 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.0 m -135.05 102.43 5.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD11 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.04 -33.3 59.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.387 1.089 . . . . 0.0 111.542 -175.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.479 ' OE1' HD12 ' A' ' 10' ' ' LEU . 10.6 tp10 -73.7 -22.16 60.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.77 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -68.61 -30.87 69.69 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.14 -29.18 61.69 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.102 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' OE1' ' A' ' 7' ' ' GLU . 8.4 tt -61.9 -45.24 94.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.413 ' NE2' ' HG3' ' A' ' 7' ' ' GLU . 67.8 mt-30 -68.34 -35.34 77.63 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.162 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.46 ' C ' ' HG ' ' A' ' 13' ' ' SER . 48.1 mt-30 -66.27 -46.58 76.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.661 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.46 ' HG ' ' C ' ' A' ' 12' ' ' GLN . 28.3 m -155.33 -67.82 0.12 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.244 0.545 . . . . 0.0 110.647 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.25 166.84 37.27 Favored Glycine 0 N--CA 1.413 -2.865 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.52 143.57 56.09 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-O 121.499 0.666 . . . . 0.0 111.767 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.13 3.85 3.44 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 48.6 mt-10 -151.49 155.54 38.75 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -94.88 166.89 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -75.66 72.43 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.406 1.098 . . . . 0.0 109.787 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 mmt -137.89 -176.37 4.41 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.899 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -78.04 111.31 13.8 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 118.784 0.72 . . . . 0.0 109.997 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' OE2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -103.72 132.19 50.21 Favored 'General case' 0 N--CA 1.406 -2.632 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.64 98.56 3.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -120.89 86.9 0.4 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.207 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' CE1' ' HZ ' ' A' ' 4' ' ' PHE . 98.2 m-85 -71.78 -75.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.249 0.547 . . . . 0.0 110.51 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.617 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.2 mmp_? -70.08 -38.24 75.65 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.501 ' OE1' ' HB1' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -74.91 -8.74 57.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.987 -176.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.8 t -58.21 -35.14 71.22 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.132 0.491 . . . . 0.0 109.686 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -68.19 -42.66 79.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.512 0.673 . . . . 0.0 110.219 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB1' ' OE1' ' A' ' 27' ' ' GLU . . . -63.67 -49.1 74.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.122 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.5 ptp -57.14 -33.12 67.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 28' ' ' CYS . 47.5 mm -65.15 -39.25 84.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.715 0.769 . . . . 0.0 109.63 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.35 -31.78 43.1 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.62 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.0 mttt -66.4 -21.29 66.22 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -60.98 -25.61 66.97 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.66 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.71 -49.68 24.5 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -166.38 -71.38 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.911 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 52.2 ttp180 -164.15 111.56 1.11 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.89 150.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.168 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -103.23 148.0 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.625 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.49 ' CE1' ' HB1' ' A' ' 29' ' ' ALA . 42.2 t60 -133.43 111.96 11.17 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.5 mp -82.77 138.32 19.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' HA ' HD13 ' A' ' 86' ' ' LEU . 96.1 mttt 69.99 59.23 0.53 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.522 1.129 . . . . 0.0 110.782 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.95 166.0 23.66 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.059 1.839 . . . . 0.0 111.051 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.617 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -162.06 52.41 0.32 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 4.9 pm0 -116.32 151.98 34.78 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.053 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -138.34 60.43 1.61 Allowed 'General case' 0 CA--C 1.468 -2.203 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 175.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' C ' ' H ' ' A' ' 50' ' ' GLY . 40.1 pt -69.27 112.2 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.129 0 CA-C-N 112.187 -2.278 . . . . 0.0 110.407 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 75.64 -19.33 0.41 Allowed 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.723 2.009 . . . . 0.0 113.139 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 99.71 -9.9 60.56 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.15 115.82 2.07 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -67.74 123.3 20.14 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -136.8 128.35 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.84 -37.15 60.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.22 -35.65 4.65 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.44 HG23 ' H ' ' A' ' 78' ' ' CYS . 59.0 mt -93.24 120.71 66.53 Favored Pre-proline 0 N--CA 1.417 -2.093 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.49 111.42 2.32 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.176 1.917 . . . . 0.0 110.004 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -101.76 -176.04 0.12 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.556 2.17 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 75' ' ' THR . 52.2 t -79.86 113.96 42.24 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.96 52.93 2.3 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.13 2.553 . . . . 0.0 115.272 -173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.4 mt -111.93 154.35 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 150.35 173.6 20.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 119.238 -1.458 . . . . 0.0 113.436 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -122.32 90.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.53 101.22 13.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.52 -70.43 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.626 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -162.62 170.98 17.63 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.416 ' HE ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.1 -29.7 64.35 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.473 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 17.6 m -99.35 27.63 5.08 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.179 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 m -149.02 159.03 44.59 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.3 114.79 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 122.026 0.917 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.614 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -92.88 96.69 10.28 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.64 98.51 9.68 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 71' ' ' MET . 25.0 Cg_endo -92.19 171.19 2.6 Favored 'Trans proline' 1 N--CA 1.398 -4.104 0 C-N-CA 121.671 1.581 . . . . 0.0 112.08 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -124.18 48.05 1.98 Allowed 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.6 p -97.94 111.29 23.65 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-N 113.078 -1.873 . . . . 0.0 108.122 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -103.53 103.64 37.1 Favored Pre-proline 0 C--N 1.29 -2.0 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.858 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 75' ' ' THR . 19.6 Cg_endo -97.31 -164.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.768 0 C-N-CA 122.202 1.934 . . . . 0.0 108.249 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.44 ' H ' HG23 ' A' ' 56' ' ' ILE . 42.6 t -98.6 13.84 30.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.191 0.996 . . . . 0.0 109.065 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -115.02 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.962 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -179.2 164.14 32.14 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 38' ' ' ARG . 8.4 m -91.29 152.48 20.46 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.07 135.52 53.62 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 t -127.65 131.79 69.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.45 147.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 40.6 tt0 -149.88 116.82 5.93 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.367 0.417 . . . . 0.0 110.24 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.3 tp -96.45 129.88 32.15 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.35 -8.27 17.28 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.748 1.632 . . . . 0.0 111.588 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 11.6 t -100.46 156.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.54 151.72 87.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 O-C-N 123.197 0.31 . . . . 0.0 111.699 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.16 -14.35 33.27 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.726 2.951 . . . . 0.0 113.263 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.65 -25.61 62.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.318 0.647 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 95' ' ' ARG . 49.8 mm-40 -75.04 -28.87 60.6 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.257 0.551 . . . . 0.0 110.017 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.416 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 48.9 mm -77.42 -27.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.931 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -65.91 -37.01 84.96 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 38.2 ttt180 -65.48 -47.25 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.992 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.66 -21.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.1 -27.08 60.71 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -27.16 61.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 99' ' ' VAL . 43.2 t -102.79 22.46 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.136 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -58.21 -49.58 76.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.46 -42.13 0.41 Allowed Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 C--N 1.386 2.521 0 C-N-CA 123.752 2.968 . . . . 0.0 115.722 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -172.85 136.18 0.68 Allowed 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.977 0.911 . . . . 0.0 109.675 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.5 m -148.62 129.48 14.28 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -116.22 0.73 12.98 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.82 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.2 m -82.31 111.8 18.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.857 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 7' ' ' GLU . 4.5 pp -106.37 -44.73 4.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.766 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.672 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 42.5 tt0 -68.42 -10.77 57.47 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.048 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 p -70.96 -28.36 64.42 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -75.89 -30.33 58.79 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.5 tp -57.67 -43.39 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.974 0.893 . . . . 0.0 109.325 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -74.04 -12.76 60.71 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.381 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.39 -32.82 10.97 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.055 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -155.43 -66.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 109.844 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.02 162.89 36.68 Favored Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.672 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 9.5 tp10 -83.62 147.99 27.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 117.709 0.755 . . . . 0.0 109.318 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 54' ' ' ILE . 66.9 t80 -131.27 18.12 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.055 0.931 . . . . 0.0 109.586 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -147.26 170.52 17.11 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.425 HG21 ' HG ' ' A' ' 49' ' ' LEU . 16.9 tt -102.69 158.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -75.06 69.87 2.0 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 123.34 1.543 . . . . 0.0 112.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 29.9 mmm -128.62 -155.86 0.72 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.55 2.74 . . . . 0.0 106.037 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.24 123.19 47.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.886 0.766 . . . . 0.0 109.314 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -93.92 135.14 35.56 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.16 92.68 3.83 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -111.78 79.01 0.25 Allowed Glycine 0 C--N 1.291 -1.957 0 C-N-CA 118.818 -1.658 . . . . 0.0 112.47 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 95.3 m-85 -73.12 -69.6 0.41 Allowed 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 117.459 0.629 . . . . 0.0 109.311 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.693 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 25.9 mmt180 -80.5 -36.78 32.82 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.288 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 34' ' ' LYS . 3.5 tm-20 -66.0 -13.05 59.18 Favored 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 31' ' ' MET . 27.2 t -48.68 -40.13 26.98 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.82 0.819 . . . . 0.0 110.287 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -71.71 -42.43 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.728 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.422 ' HB3' ' CB ' ' A' ' 41' ' ' HIS . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.236 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 27.3 ptt? -51.58 -40.38 59.67 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.799 0.687 . . . . 0.0 111.863 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.3 mm -60.25 -45.02 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.467 ' HB3' HG23 ' A' ' 39' ' ' VAL . 19.8 mm-40 -80.8 -30.45 35.91 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.175 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 81' ' ' THR . 28.6 mtpt -61.29 -26.97 68.14 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.348 1.059 . . . . 0.0 112.288 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -66.27 -22.56 66.31 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 123.837 0.71 . . . . 0.0 110.694 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.97 -60.12 2.41 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -144.37 -76.85 0.22 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.106 0.955 . . . . 0.0 109.974 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.486 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 17.2 ptp180 -168.7 124.79 0.96 Allowed 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 33' ' ' GLU . 73.4 t -134.43 145.66 32.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.291 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.4 p -98.5 142.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 O-C-N 124.398 1.061 . . . . 0.0 108.566 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.501 ' CE1' ' HB1' ' A' ' 29' ' ' ALA . 84.5 t60 -133.49 120.29 20.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.1 tt -81.33 147.73 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 62.07 56.52 2.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.528 0.731 . . . . 0.0 111.473 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 84.4 Cg_endo -77.37 156.37 32.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.033 1.822 . . . . 0.0 111.152 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.693 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -160.75 56.49 0.32 Allowed Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 2.3 pm0 -115.98 174.38 6.07 Favored 'General case' 0 C--N 1.26 -3.314 0 CA-C-N 113.919 -1.14 . . . . 0.0 110.555 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.1 mmtt -154.85 89.45 1.24 Allowed 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 126.309 1.844 . . . . 0.0 106.09 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.431 ' C ' HD21 ' A' ' 49' ' ' LEU . 28.8 pt -85.34 100.39 8.45 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.269 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.431 HD21 ' C ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER 58.52 16.59 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.063 1.745 . . . . 0.0 111.967 176.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 -51.74 4.04 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.23 142.68 50.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -70.21 103.4 2.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -123.06 114.59 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 16' ' ' TYR . 69.3 mt -77.43 -44.45 30.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 122.229 1.014 . . . . 0.0 109.057 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.91 -29.96 9.75 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.9 mm -86.59 125.64 66.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.58 106.82 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.478 2.119 . . . . 0.0 110.521 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -107.79 -161.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.234 0 C-N-CA 123.002 2.468 . . . . 0.0 111.396 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 75' ' ' THR . 46.8 t -96.35 113.05 61.74 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.34 50.12 1.86 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.524 2.816 . . . . 0.0 114.63 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.58 149.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.37 167.66 36.55 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.747 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -135.4 82.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.22 94.53 9.23 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -72.19 -62.49 1.41 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.548 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.8 179.13 9.5 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -90.98 -33.37 15.58 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.12 40.08 1.01 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.679 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 t -165.19 -178.74 5.24 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.58 105.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.553 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 22.8 ptm -89.53 100.87 13.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.9 mt -101.29 100.81 14.49 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.709 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.7 Cg_exo -82.09 148.62 15.21 Favored 'Trans proline' 0 N--CA 1.436 -1.907 0 C-N-CA 122.071 1.847 . . . . 0.0 110.405 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.49 60.39 0.73 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.602 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.1 p -106.39 119.81 40.23 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.145 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.13 101.64 13.19 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 75' ' ' THR . 87.1 Cg_endo -105.07 -156.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 123.198 2.599 . . . . 0.0 111.191 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -109.24 29.13 7.81 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.061 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -144.07 -80.36 0.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.195 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.81 -176.54 46.75 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.486 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 51.0 m -118.31 146.95 43.96 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.052 0.926 . . . . 0.0 110.873 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.26 38.5 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 123.372 0.669 . . . . 0.0 111.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 42.6 t -117.97 112.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.1 m -115.01 142.53 27.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 O-C-N 121.486 -0.759 . . . . 0.0 109.247 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 tt0 -139.12 113.79 9.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.284 0.564 . . . . 0.0 110.421 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.3 tp -93.44 130.09 36.62 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.06 19.63 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.624 2.216 . . . . 0.0 111.277 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.579 ' O ' ' HB3' ' A' ' 68' ' ' SER . 36.5 t -122.34 156.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.01 162.14 41.22 Favored Pre-proline 0 C--N 1.307 -1.255 0 O-C-N 123.487 0.492 . . . . 0.0 111.258 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.2 2.41 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.406 2.737 . . . . 0.0 113.219 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.95 -30.62 70.34 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.834 0.854 . . . . 0.0 109.708 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -66.66 -23.49 66.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.252 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.67 -30.17 41.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.66 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.84 -39.73 94.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -76.93 -37.77 54.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.76 -29.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.0 -33.69 76.11 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.6 0.76 . . . . 0.0 109.851 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.61 -24.9 38.78 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.429 1.109 . . . . 0.0 109.049 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 99' ' ' VAL . 86.8 t -92.61 15.25 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.075 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.96 -49.8 8.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.542 1.137 . . . . 0.0 113.198 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.05 93.38 3.42 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.355 2.704 . . . . 0.0 112.405 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 . . . . . 0 C--O 1.219 -0.519 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.7 mtt 69.95 112.26 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.075 0.95 . . . . 0.0 109.853 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.408 HG23 ' SD ' ' A' ' 31' ' ' MET . 90.4 m -113.37 128.17 56.37 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.533 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -129.85 21.45 5.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 30.9 m -89.16 87.42 7.16 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.6 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' H ' HD12 ' A' ' 6' ' ' LEU 0.295 0.0 OUTLIER -84.28 -43.7 14.58 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.43 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 28.3 tt0 -69.75 -4.83 21.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 123.031 1.396 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 29.6 m -76.62 -19.96 57.25 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.617 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.664 ' CD1' ' HA ' ' A' ' 15' ' ' GLU . 2.7 p90 -64.8 -33.11 75.22 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' CE1' ' A' ' 9' ' ' TYR . 10.0 mt -71.41 -35.63 71.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.891 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -76.57 -26.66 55.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.271 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 8' ' ' THR . 45.8 mt-30 -83.38 -14.0 53.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 m 71.25 33.96 1.87 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.495 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.27 90.57 0.2 Allowed Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.879 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.664 ' HA ' ' CD1' ' A' ' 9' ' ' TYR . 3.0 pm0 -59.55 124.35 19.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.984 0.897 . . . . 0.0 111.781 177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -147.15 9.76 0.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.488 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 44.9 mt-10 -147.34 179.76 7.42 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.485 -175.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG21 ' HG ' ' A' ' 49' ' ' LEU 0.288 13.0 tt -109.49 18.43 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-O 121.91 0.862 . . . . 0.0 111.376 178.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.37 36.33 25.41 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.769 1.271 . . . . 0.0 109.701 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.2 mmt -98.46 -96.54 0.22 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.684 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.76 126.9 9.12 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . 10.7 ptm180 -113.7 154.07 27.92 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -134.98 89.39 2.52 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . -106.72 82.0 0.31 Allowed Glycine 0 CA--C 1.486 -1.76 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.335 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -70.95 -70.14 0.33 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.651 0.263 . . . . 0.0 111.339 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 51.1 mtt180 -87.61 -30.54 20.39 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.322 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 10.5 mt-10 -75.22 -3.75 34.93 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 28.0 p -53.14 -37.15 61.55 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 121.419 0.628 . . . . 0.0 110.455 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.59 -41.09 63.33 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.149 0.5 . . . . 0.0 110.443 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.65 68.6 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.063 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.408 ' SD ' HG23 ' A' ' 3' ' ' THR . 26.2 ptm -51.8 -38.49 55.88 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.763 0.664 . . . . 0.0 112.619 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 28' ' ' CYS . 76.7 mt -57.51 -49.52 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 123.923 0.764 . . . . 0.0 110.567 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -82.79 -26.96 31.3 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.888 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 81' ' ' THR . 14.2 mtpp -58.58 -21.64 53.67 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 123.965 0.906 . . . . 0.0 112.29 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -58.44 -22.76 55.5 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.858 0.724 . . . . 0.0 111.398 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.62 1.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -166.24 -59.64 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -155.31 121.03 5.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.5 t -128.61 145.13 36.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 2.7 p -96.73 137.59 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 O-C-N 123.858 0.723 . . . . 0.0 110.053 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -139.84 129.43 24.36 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.1 tt -90.26 145.04 7.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 53.0 mtmt 67.54 61.97 0.77 Allowed Pre-proline 0 C--O 1.217 -0.636 0 C-N-CA 123.351 0.66 . . . . 0.0 110.992 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 69.6 Cg_endo -81.14 173.03 12.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.584 2.189 . . . . 0.0 112.19 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.8 55.86 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.134 -1.031 . . . . 0.0 112.258 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 29.5 tt0 -121.98 137.56 54.75 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.626 0.727 . . . . 0.0 111.856 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 6.1 mmtt -126.51 111.03 13.92 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.441 HG21 ' HB2' ' A' ' 22' ' ' ARG . 29.2 pt -100.2 122.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.553 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.445 ' HG ' HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 54.51 16.42 1.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.014 2.126 . . . . 0.0 113.74 175.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 100' ' ' ALA . . . 83.81 -44.89 3.38 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.006 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.84 125.2 42.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HG3' HD11 ' A' ' 48' ' ' ILE . 55.8 ttp180 -67.56 98.82 0.7 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 123.639 0.587 . . . . 0.0 111.173 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.69 123.5 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mm -83.35 -37.68 13.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.894 0.854 . . . . 0.0 109.207 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.43 -7.96 66.41 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.562 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.2 mm -135.3 132.47 20.03 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.78 109.45 0.42 Allowed 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 123.204 2.603 . . . . 0.0 112.175 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -87.67 161.27 7.82 Favored 'Trans proline' 0 N--CA 1.427 -2.404 0 C-N-CA 122.388 2.059 . . . . 0.0 110.938 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.71 139.17 95.38 Favored Pre-proline 0 C--N 1.301 -1.505 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.095 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.79 34.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.523 3.262 1 C-N-CA 127.349 5.366 . . . . 0.0 119.656 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.435 HG23 ' CG2' ' A' ' 75' ' ' THR 0.27 2.8 pt 67.78 -171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 127.676 2.39 . . . . 0.0 112.602 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' H ' ' A' ' 74' ' ' TYR . . . -143.63 -113.2 0.9 Allowed Glycine 1 N--CA 1.388 -4.525 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.296 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.38 122.94 64.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -130.27 125.43 34.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -100.54 -63.72 1.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.1 tp10 -165.33 168.58 16.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -31.7 67.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.466 ' C ' ' HG1' ' A' ' 69' ' ' THR . 8.5 p -93.34 30.88 1.59 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.323 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 68' ' ' SER . 31.4 m -156.99 161.0 39.57 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 m -71.08 145.02 12.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.29 0.567 . . . . 0.0 110.216 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.439 ' O ' HG13 ' A' ' 83' ' ' VAL . 25.2 ptt? -134.73 139.2 45.01 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.87 80.32 25.26 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' O ' HG23 ' A' ' 81' ' ' THR . 1.3 Cg_endo -81.86 132.06 7.35 Favored 'Trans proline' 0 N--CA 1.414 -3.198 0 C-N-CA 121.587 1.525 . . . . 0.0 109.981 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' H ' ' N ' ' A' ' 62' ' ' GLY . 79.2 m-85 -91.9 57.89 3.27 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-O 122.268 1.033 . . . . 0.0 108.705 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 36.7 p -103.92 102.66 12.46 Favored 'General case' 1 N--CA 1.376 -4.157 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -95.29 106.9 28.97 Favored Pre-proline 0 C--N 1.277 -2.587 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.249 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 75' ' ' THR . 22.6 Cg_endo -95.26 -165.53 0.11 Allowed 'Trans proline' 0 N--CA 1.431 -2.167 0 C-N-CA 122.704 2.27 . . . . 0.0 110.471 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.3 t -95.77 15.7 19.48 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.637 0.732 . . . . 0.0 109.131 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -135.56 -62.95 0.68 Allowed 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 166.28 148.27 5.5 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.186 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -84.61 158.3 20.92 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 124.879 1.272 . . . . 0.0 108.678 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.542 ' HB3' ' HZ1' ' A' ' 34' ' ' LYS . . . -122.36 120.68 34.72 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.879 -0.513 . . . . 0.0 111.063 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 95.4 t -103.31 84.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 44' ' ' PRO . 12.4 m -108.45 124.71 65.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -118.43 120.75 38.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.126 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.4 tp -96.65 130.77 29.58 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.09 -4.13 11.81 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.214 1.943 . . . . 0.0 111.142 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 12.0 t -97.64 161.66 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 91' ' ' GLU . 11.7 m-20 -72.44 163.66 65.88 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 118.096 0.407 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.79 6.2 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 89' ' ' ASP . 11.2 pt-20 -67.38 -27.17 66.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.813 0.845 . . . . 0.0 109.016 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.418 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.4 mm-40 -64.2 -29.27 70.39 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.083 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 mt -64.35 -28.45 44.91 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.661 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.62 -47.29 70.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.365 0.602 . . . . 0.0 109.602 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -66.78 -32.04 73.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.411 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 92' ' ' GLU . 69.1 mt -86.28 -5.63 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-O 121.879 0.847 . . . . 0.0 110.107 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.78 -33.49 30.85 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.03 -32.79 71.11 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.785 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' VAL . 18.9 t -107.03 28.35 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.448 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.581 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.419 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -59.67 -31.29 69.41 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -157.27 -57.78 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.58 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 N--CA 1.442 -1.557 0 C-N-CA 120.942 1.095 . . . . 0.0 113.228 -176.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 . . . . . 0 CA--C 1.505 -0.788 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -174.95 126.74 0.28 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.875 1.27 . . . . 0.0 109.146 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.53 HG22 ' SD ' ' A' ' 31' ' ' MET . 11.9 t -124.47 134.45 53.05 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.73 0.776 . . . . 0.0 110.855 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.08 26.11 4.57 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.916 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 65.3 m -126.51 101.1 6.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.689 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -84.96 -46.03 11.63 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.969 0.89 . . . . 0.0 113.031 -176.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' N ' HD21 ' A' ' 6' ' ' LEU . 42.0 tt0 -73.18 -12.29 60.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.118 0.961 . . . . 0.0 110.95 -175.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 24.2 m -73.58 -26.2 60.71 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.986 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -72.64 -32.96 66.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.99 -41.7 99.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -67.78 -27.7 66.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.13 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 8' ' ' THR . 28.1 mt-30 -78.41 -45.86 21.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.659 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.414 ' OG ' ' HD2' ' A' ' 35' ' ' LYS . 45.1 m -158.68 -68.29 0.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.899 0.38 . . . . 0.0 111.367 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.04 174.33 31.06 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.358 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.02 146.16 24.56 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 124.295 0.644 . . . . 0.0 109.725 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -139.59 21.48 2.53 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.56 ' HB3' HD21 ' A' ' 49' ' ' LEU . 38.7 mp0 -140.97 175.84 9.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.091 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.513 ' H ' HD21 ' A' ' 49' ' ' LEU . 7.0 tt -109.47 7.04 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.047 -1.033 . . . . 0.0 109.079 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 65.2 t-80 74.7 73.97 0.11 Allowed 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.829 1.651 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.46 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.0 179.49 9.17 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -61.46 111.06 1.64 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.967 0.889 . . . . 0.0 109.883 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.697 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.2 119.24 38.58 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.389 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.3 85.99 2.49 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.76 81.66 0.48 Allowed Glycine 0 CA--C 1.469 -2.803 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.289 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -69.89 -78.73 0.07 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 117.119 0.459 . . . . 0.0 110.314 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -84.04 -21.04 31.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.958 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -81.51 -10.72 59.41 Favored 'General case' 0 C--O 1.205 -1.263 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.48 -177.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 53.7 t -51.97 -38.15 55.59 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.569 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.01 -44.59 69.0 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.179 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB1' ' OE2' ' A' ' 27' ' ' GLU . . . -58.85 -52.44 65.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.965 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.53 ' SD ' HG22 ' A' ' 3' ' ' THR . 21.6 ptp -54.07 -38.2 65.04 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.864 0.728 . . . . 0.0 112.779 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 28' ' ' CYS . 80.3 mt -58.96 -45.02 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.682 0.753 . . . . 0.0 109.524 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.401 ' HB3' HG21 ' A' ' 39' ' ' VAL . 61.7 mm-40 -79.85 -32.2 40.49 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.617 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 84.1 mttt -58.42 -28.5 65.31 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 122.924 0.49 . . . . 0.0 111.165 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 8.1 ttpp -64.66 -13.39 53.82 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.049 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -65.52 0.92 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -142.85 -75.22 0.27 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.721 0.772 . . . . 0.0 109.687 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 36.3 ptt180 -156.3 128.15 7.35 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 33' ' ' GLU . 69.6 t -140.08 141.64 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.526 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.5 p -106.94 147.06 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 19.8 t-80 -135.56 134.21 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.7 tt -90.48 143.65 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 67.41 64.01 0.72 Allowed Pre-proline 0 C--N 1.32 -0.714 0 C-N-CA 123.822 0.849 . . . . 0.0 110.642 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.38 172.12 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.205 1.27 . . . . 0.0 110.233 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.21 54.43 0.13 Allowed Glycine 0 CA--C 1.464 -3.152 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.551 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 1.6 pm0 -112.35 157.84 20.52 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 122.366 1.079 . . . . 0.0 112.414 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -143.86 72.4 1.35 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 113.479 -1.692 . . . . 0.0 107.577 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 72.0 mt -91.58 108.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 66.01 16.93 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.96 1.304 . . . . 0.0 109.381 177.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.19 4.5 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -175.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.18 118.3 25.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -64.32 104.39 0.76 Allowed 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.131 0.894 . . . . 0.0 112.716 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.461 ' H ' HD13 ' A' ' 49' ' ' LEU . 49.6 mm -114.66 135.13 55.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.49 -35.36 32.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-O 121.233 0.539 . . . . 0.0 110.0 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.51 -21.73 20.34 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.25 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.62 120.26 56.42 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.42 112.55 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.968 2.445 . . . . 0.0 111.327 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -101.39 -176.61 0.13 Allowed 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 122.615 2.21 . . . . 0.0 111.081 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.3 t -67.57 121.02 77.35 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.05 56.02 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 114.745 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.4 147.66 32.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 155.5 148.15 4.94 Favored Glycine 0 CA--C 1.483 -1.933 0 C-N-CA 118.539 -1.791 . . . . 0.0 113.52 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.3 pt -129.12 153.19 38.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.02 115.29 20.31 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.99 -71.97 0.44 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.242 0.544 . . . . 0.0 111.902 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 31.0 tt0 -148.36 166.12 29.02 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 5.7 tpp180 -83.22 -35.43 25.41 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.058 0.933 . . . . 0.0 110.551 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.7 p -88.66 29.96 0.96 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.775 1.274 . . . . 0.0 111.514 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 66' ' ' GLU . 87.5 m -154.72 170.72 20.91 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.93 161.01 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.202 1.001 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.531 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 26.8 ptt? -118.4 131.38 56.29 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.11 88.35 14.71 Favored Pre-proline 0 C--N 1.291 -1.961 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.343 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 71' ' ' MET . 6.4 Cg_endo -90.53 144.28 3.81 Favored 'Trans proline' 0 N--CA 1.408 -3.534 0 C-N-CA 121.545 1.496 . . . . 0.0 109.966 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -110.87 46.32 1.07 Allowed 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 123.298 1.523 . . . . 0.0 107.405 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 39.6 p -93.26 105.57 17.63 Favored 'General case' 0 N--CA 1.389 -3.498 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.163 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -105.78 96.61 12.85 Favored Pre-proline 0 C--N 1.275 -2.634 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 75' ' ' THR . 23.7 Cg_endo -99.0 -164.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.365 2.71 . . . . 0.0 111.166 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.5 t -88.72 -6.16 57.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.362 0.601 . . . . 0.0 110.058 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -96.32 -74.22 0.57 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 171.26 172.08 37.07 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.472 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 28.0 m -94.5 141.73 28.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.63 125.58 52.74 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.29 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 41.7 t -126.47 124.69 65.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.2 m -126.71 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -134.31 123.12 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 68' ' ' SER . 28.4 tp -103.05 128.18 28.22 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.84 1.78 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.69 1.593 . . . . 0.0 110.698 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.451 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -103.59 158.27 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.98 151.13 81.22 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 123.203 0.314 . . . . 0.0 110.671 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.443 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 11.6 Cg_endo -56.13 -22.03 37.92 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.686 2.924 . . . . 0.0 112.997 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.84 -23.11 60.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.681 0.792 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.404 ' OE1' ' HD2' ' A' ' 95' ' ' ARG . 8.4 tp10 -69.18 -43.59 73.91 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.409 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 58.4 mt -71.17 -27.0 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.73 -37.64 76.59 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -67.98 -36.36 79.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.631 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 37.3 mm -72.65 -17.82 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.961 177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.72 -20.86 58.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.106 0.955 . . . . 0.0 108.715 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.19 -25.96 42.68 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.02 14.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.406 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.21 49.77 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.74 -50.65 0.15 Allowed Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.432 -2.114 0 C-N-CA 121.087 1.191 . . . . 0.0 112.664 -178.648 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 85.2 m-70 . . . . . 0 C--O 1.215 -0.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -139.59 129.63 25.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -121.61 117.09 25.85 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -126.08 2.26 7.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.571 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.418 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 61.0 m -86.48 92.19 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.571 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.528 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -85.6 -34.65 21.37 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -81.12 -16.92 51.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.942 0.877 . . . . 0.0 110.931 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.3 m -69.79 -22.29 63.34 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -78.33 -20.12 52.09 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.651 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.1 tt -72.91 -37.87 67.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.79 -30.43 69.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.366 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -94.18 -5.49 46.94 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.926 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m 60.33 43.29 13.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.125 0.964 . . . . 0.0 110.305 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.48 49.97 0.65 Allowed Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.532 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.26 138.83 54.26 Favored 'General case' 0 C--O 1.248 1.007 0 O-C-N 124.61 0.829 . . . . 0.0 110.783 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -143.55 20.35 1.86 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 19' ' ' HIS . 0.5 OUTLIER -154.97 179.75 8.83 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.806 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.534 ' H ' HD21 ' A' ' 49' ' ' LEU 0.329 13.5 tt -107.31 29.48 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.973 178.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.651 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 43.5 m80 61.99 17.84 9.36 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.6 mmm -85.57 -110.79 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.015 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.6 tttp -129.09 115.0 17.06 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -109.15 162.32 14.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.377 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -156.71 87.69 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -103.82 81.01 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 115.154 0.821 . . . . 0.0 115.154 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -77.47 -39.35 46.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.562 0.696 . . . . 0.0 111.177 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 38.2 mmt180 -107.78 -41.05 5.1 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.712 0.768 . . . . 0.0 111.241 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB2' ' H ' ' A' ' 45' ' ' GLY . 26.3 tt0 -78.88 -0.04 29.17 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.103 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 39.4 t -52.58 -47.16 67.05 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 109.728 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -68.88 -38.8 79.9 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.754 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -58.78 -44.74 90.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.701 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.7 ptm -65.02 -33.26 75.61 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.554 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.1 -38.61 82.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 34.8 mt-10 -77.7 -38.25 47.77 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.667 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.463 ' HZ3' ' CG1' ' A' ' 84' ' ' VAL . 78.7 mttt -63.51 -20.01 65.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.462 0.705 . . . . 0.0 111.771 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -67.4 -20.42 65.53 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.504 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.57 -62.17 1.67 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 2.2 mmp_? -159.82 -67.14 0.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.577 1.151 . . . . 0.0 109.824 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.571 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 19.0 ptt180 -155.12 122.19 5.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.75 145.11 28.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.5 p -108.89 142.38 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.414 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 19.4 t60 -135.06 130.8 36.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.6 tt -82.82 144.17 10.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 94.8 mttt 63.82 63.11 1.48 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.148 0.579 . . . . 0.0 110.717 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 63.4 Cg_endo -80.32 170.7 15.82 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.969 1.78 . . . . 0.0 111.767 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.503 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -175.06 54.0 0.13 Allowed Glycine 0 N--CA 1.409 -3.102 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.441 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.506 ' CD ' HG21 ' A' ' 48' ' ' ILE . 7.6 tp10 -110.44 118.39 36.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.507 1.146 . . . . 0.0 108.841 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 34.0 mtmt -110.17 71.44 0.76 Allowed 'General case' 0 N--CA 1.393 -3.309 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.136 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.506 HG21 ' CD ' ' A' ' 46' ' ' GLU . 5.0 pt -70.92 102.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.25 -3.74 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.923 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD21 ' H ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 69.72 -26.12 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 126.823 2.049 . . . . 0.0 113.621 175.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.91 -3.36 48.62 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.71 116.18 11.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -69.73 88.17 0.52 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 mm -123.73 127.38 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -76.39 -28.86 18.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.548 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.43 17.59 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.3 mt -99.88 121.67 53.45 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.65 107.65 0.91 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.773 2.315 . . . . 0.0 110.92 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -104.8 179.92 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 122.68 2.253 . . . . 0.0 111.752 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 75' ' ' THR . 51.3 t -84.87 106.73 9.35 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.41 98.78 0.74 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.234 1.956 . . . . 0.0 114.554 -170.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.49 158.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 130.12 167.18 11.99 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 118.577 -1.773 . . . . 0.0 113.769 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.2 mp -142.63 124.35 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.43 101.76 12.27 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.74 -55.65 16.16 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.55 171.41 7.61 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HA ' HH11 ' A' ' 67' ' ' ARG . 3.4 tpp180 -85.68 -35.99 20.54 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 118.881 0.764 . . . . 0.0 112.113 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 9.4 t -91.03 28.32 1.62 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 122.96 1.362 . . . . 0.0 108.569 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 67' ' ' ARG . 24.8 m -143.21 163.93 31.59 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 17.1 m -72.88 124.01 28.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.332 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.9 ptt? -85.32 132.19 34.29 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.4 tp -116.02 80.92 9.53 Favored Pre-proline 0 C--N 1.293 -1.884 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.667 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 71' ' ' MET . 9.5 Cg_endo -89.58 104.8 0.37 Allowed 'Trans proline' 0 N--CA 1.409 -3.456 0 C-N-CA 121.971 1.781 . . . . 0.0 108.707 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.26 57.28 4.39 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.114 1.435 . . . . 0.0 107.374 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.631 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.2 p -91.17 127.86 36.77 Favored 'General case' 1 N--CA 1.378 -4.064 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.58 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -99.49 95.97 4.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.631 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.4 Cg_endo -105.29 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.787 0 C-N-CA 122.974 2.449 . . . . 0.0 111.281 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.6 t -95.87 12.08 31.47 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -117.74 -80.83 0.61 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.068 -0.395 . . . . 0.0 110.339 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.72 176.35 47.99 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 29.2 m -94.7 135.14 36.53 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.447 0.641 . . . . 0.0 109.401 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.52 112.38 23.89 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.949 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 33.9 t -115.34 134.61 57.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.463 ' CG1' ' HZ3' ' A' ' 34' ' ' LYS . 15.8 m -136.26 151.08 28.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -142.13 122.12 13.67 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.4 tp -104.13 139.05 19.73 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -86.14 2.1 7.56 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 122.616 2.211 . . . . 0.0 111.69 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.485 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 9.9 t -103.14 150.84 6.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.44 144.32 92.28 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 124.14 0.9 . . . . 0.0 110.163 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.4 -18.67 3.84 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.61 3.54 . . . . 0.0 114.385 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.51 -18.38 51.52 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.629 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 25.6 tp10 -60.24 -28.03 67.7 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 124.187 0.995 . . . . 0.0 109.575 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.75 -38.37 75.65 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.121 0 C-N-CA 122.155 0.182 . . . . 0.0 111.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.46 -33.64 75.54 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.406 0.622 . . . . 0.0 110.768 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.629 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 63.4 ttt180 -71.49 -45.58 62.1 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.8 mm -65.64 -22.5 30.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.189 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.0 tp -74.21 -30.07 62.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.154 0.502 . . . . 0.0 109.792 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.21 -41.74 27.62 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.65 15.66 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.996 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -67.14 -33.53 75.63 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.25 98.06 21.56 Favored Pre-proline 0 N--CA 1.416 -2.136 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.555 2.837 . . . . 0.0 111.269 177.716 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 CA--C 1.498 -1.04 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 4' ' ' PHE . 26.0 ptt? -179.97 133.22 0.1 Allowed 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.238 1.415 . . . . 0.0 108.762 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.4 m -132.16 122.82 25.93 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HE2' ' SD ' ' A' ' 2' ' ' MET . 88.6 m-85 -116.85 -8.99 11.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.976 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 76.5 m -80.0 100.8 8.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.807 0.813 . . . . 0.0 110.793 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.542 HD23 ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -88.32 -38.13 15.41 Favored 'General case' 0 C--O 1.182 -2.461 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.542 ' N ' HD23 ' A' ' 6' ' ' LEU . 30.3 tt0 -68.82 -9.45 51.24 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.817 0.818 . . . . 0.0 111.871 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.4 m -75.38 -15.17 60.49 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.104 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.661 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.71 -28.4 67.29 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.409 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.661 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 6.1 tt -70.23 -39.05 75.31 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.055 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -76.36 -1.79 28.58 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.714 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.97 -28.71 5.47 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -163.58 -54.13 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.442 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.32 -153.91 24.71 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB2' HG12 ' A' ' 56' ' ' ILE . 2.2 mp0 -80.63 137.33 36.34 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 118.994 1.397 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -142.31 3.28 1.52 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.591 0.71 . . . . 0.0 110.097 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -150.69 176.94 10.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tt -110.35 157.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 6.5 t60 -71.53 71.9 0.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.472 1.13 . . . . 0.0 108.987 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.4 mmt -138.68 -167.41 2.19 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.089 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.72 113.28 22.44 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -100.75 130.31 46.76 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -124.08 85.17 2.37 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.513 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -99.58 75.92 0.48 Allowed Glycine 0 C--N 1.282 -2.442 0 C-N-CA 119.399 -1.382 . . . . 0.0 111.013 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.85 -79.87 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 121.35 0.595 . . . . 0.0 110.629 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.505 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 5.6 mpt_? -75.7 -35.83 60.19 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.006 0.432 . . . . 0.0 111.688 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 18.0 tp10 -66.28 -11.37 50.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.002 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 36.3 t -51.01 -41.75 59.99 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.477 0.656 . . . . 0.0 110.274 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.03 -43.1 75.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.075 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.643 ' HB1' ' CG ' ' A' ' 41' ' ' HIS . . . -66.28 -45.64 79.77 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.1 ptp -56.64 -33.11 66.0 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.519 0.512 . . . . 0.0 111.726 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.2 mm -62.97 -36.34 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.434 0.635 . . . . 0.0 110.023 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -78.35 -33.63 48.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.557 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 60.7 mttt -67.42 -9.49 42.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.719 1.208 . . . . 0.0 113.391 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -69.49 -22.93 63.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.35 -65.01 0.75 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -152.45 -67.7 0.16 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.1 ttp180 -165.82 115.43 1.0 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.468 0.707 . . . . 0.0 109.413 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 44.3 t -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -112.68 149.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.643 ' CG ' ' HB1' ' A' ' 30' ' ' ALA . 32.5 t-80 -138.28 119.5 14.62 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.4 tt -83.31 147.44 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.61 51.59 0.49 Allowed Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.699 0.799 . . . . 0.0 112.039 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 96.4 Cg_endo -90.18 159.58 4.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.418 2.079 . . . . 0.0 110.608 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.505 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -151.66 44.9 0.64 Allowed Glycine 0 CA--C 1.467 -2.951 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 4.2 pm0 -97.76 156.86 16.37 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-O 122.627 1.204 . . . . 0.0 113.304 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 0.5 OUTLIER -145.19 86.85 1.79 Allowed 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.363 175.176 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.413 ' C ' HD22 ' A' ' 49' ' ' LEU . 2.6 pt -87.24 99.9 9.18 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 113.471 -1.695 . . . . 0.0 112.313 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER 66.88 4.5 3.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.976 2.11 . . . . 0.0 114.098 175.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.56 -21.42 5.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.142 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.74 30.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' CZ ' HD11 ' A' ' 48' ' ' ILE . 21.8 tpt180 -86.58 105.93 17.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.63 136.91 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 45.4 mm -99.1 -40.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.531 0.681 . . . . 0.0 109.588 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.83 -26.37 22.61 Favored Glycine 0 C--N 1.312 -0.756 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG12 ' HB2' ' A' ' 15' ' ' GLU . 36.6 mm -111.69 109.79 55.35 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.89 109.25 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.995 2.463 . . . . 0.0 111.723 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -101.95 -163.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.415 2.743 . . . . 0.0 109.919 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 75' ' ' THR . 86.6 t -73.47 118.95 73.15 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.13 40.86 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.118 2.545 . . . . 0.0 114.541 -172.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.31 149.52 18.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.5 138.35 2.42 Favored Glycine 0 C--N 1.305 -1.186 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.894 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.51 114.14 41.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 122.706 0.402 . . . . 0.0 110.661 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.43 106.2 18.24 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.73 -64.24 1.04 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -166.94 179.94 5.0 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.437 HH22 ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.04 -40.09 14.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 119.045 0.839 . . . . 0.0 109.437 -176.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.6 t -89.39 26.76 1.59 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.695 1.236 . . . . 0.0 109.511 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 67' ' ' ARG . 26.9 m -144.28 160.93 40.16 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.72 144.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 122.676 0.39 . . . . 0.0 110.335 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.612 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 27.1 ptt? -99.93 136.7 39.45 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.9 mm -109.05 89.19 6.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 71' ' ' MET . 2.5 Cg_endo -88.1 146.9 6.59 Favored 'Trans proline' 0 N--CA 1.427 -2.439 0 C-N-CA 122.126 1.884 . . . . 0.0 111.737 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -123.25 44.27 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.578 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 41.4 p -100.86 111.41 23.62 Favored 'General case' 0 N--CA 1.4 -2.961 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.103 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -100.74 97.2 6.37 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 75' ' ' THR . 97.2 Cg_endo -103.98 -165.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.04 2.493 . . . . 0.0 111.593 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.6 t -74.04 -21.57 59.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.504 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -95.84 -84.7 0.34 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.734 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.97 -179.67 45.7 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 9.8 m -106.4 145.58 31.56 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.485 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -119.34 121.88 40.56 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -175.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 56.3 t -110.02 120.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.416 HG11 ' OE1' ' A' ' 27' ' ' GLU . 35.4 m -113.49 143.77 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.9 tt0 -148.65 115.78 6.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.216 0.462 . . . . 0.0 110.224 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 68' ' ' SER . 29.5 tp -94.84 143.33 25.98 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -93.39 -2.55 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.621 1.547 . . . . 0.0 110.971 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.524 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 23.7 t -91.49 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.19 149.3 75.96 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 124.166 0.916 . . . . 0.0 112.792 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.69 -6.17 4.21 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.838 3.025 . . . . 0.0 113.351 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.56 -27.3 66.11 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.274 0.559 . . . . 0.0 109.504 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -60.07 -26.82 66.47 Favored 'General case' 0 C--O 1.204 -1.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.163 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.3 mt -56.87 -40.12 69.45 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.809 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.633 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.46 -47.67 85.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.645 0.736 . . . . 0.0 109.795 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -64.95 -44.13 90.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 73.7 mt -69.6 -28.29 37.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.613 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.1 tp -70.77 -29.6 65.86 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 123.313 0.645 . . . . 0.0 110.173 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -32.25 51.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.7 15.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.355 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.69 -47.89 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.747 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -135.6 87.93 25.28 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 C--O 1.257 1.432 0 C-N-CA 123.262 2.641 . . . . 0.0 112.347 -178.318 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.594 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 65.7 mtm -156.11 124.7 5.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -102.04 113.59 26.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 64.9 m-85 -127.96 12.5 6.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.799 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.66 102.68 4.36 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -77.23 -36.45 54.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 111.419 -175.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.09 -25.56 62.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.691 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -77.99 -24.34 48.03 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -24.17 60.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 110.232 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.51 -43.63 98.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -69.42 -35.76 76.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.226 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.31 -35.42 66.08 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.435 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -161.81 -54.92 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.243 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.7 173.47 37.22 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.3 141.22 38.64 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.489 0.662 . . . . 0.0 111.73 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.446 ' CE2' ' HE2' ' A' ' 31' ' ' MET . 88.5 t80 -137.66 4.86 2.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 44.7 mt-10 -149.79 146.33 27.11 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 15.3 tt -85.1 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.561 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -68.59 77.17 0.28 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 122.724 1.25 . . . . 0.0 110.483 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.43 ' HA ' ' HE3' ' A' ' 20' ' ' MET . 2.0 mmt -146.15 -174.39 4.42 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.39 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -88.5 114.72 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.164 0.893 . . . . 0.0 110.874 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.558 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -102.98 152.53 21.21 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.124 -175.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.08 77.75 1.32 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -97.68 82.35 0.68 Allowed Glycine 0 C--N 1.294 -1.789 0 C-N-CA 121.02 -0.609 . . . . 0.0 114.052 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -70.18 -82.52 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 117.352 0.576 . . . . 0.0 111.652 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 2.5 mmp_? -70.39 -36.72 74.25 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' OE2' HG11 ' A' ' 84' ' ' VAL . 2.7 tp10 -69.35 -12.64 61.83 Favored 'General case' 0 C--O 1.217 -0.647 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.219 -177.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 44.4 t -60.9 -34.19 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-O 121.218 0.532 . . . . 0.0 110.009 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -70.53 -41.64 72.27 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.788 0.804 . . . . 0.0 109.398 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -64.23 -47.73 78.56 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.106 -1.407 . . . . 0.0 113.077 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.5 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 ptp -56.12 -31.64 63.47 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.577 0.548 . . . . 0.0 112.272 -176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 28' ' ' CYS . 48.6 mm -59.65 -42.84 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 122.08 0.943 . . . . 0.0 109.078 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.87 -34.34 30.12 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.547 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 31' ' ' MET . 72.2 mttt -65.92 -12.91 58.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.702 0.801 . . . . 0.0 111.927 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.11 -24.83 62.37 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.816 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.67 -53.14 36.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.107 0.48 . . . . 0.0 110.718 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -166.9 -69.97 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -162.12 123.63 2.71 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.4 t -134.66 159.95 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.7 p -105.96 143.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.488 0.715 . . . . 0.0 109.596 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 62.3 t60 -135.01 123.34 23.14 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 2.6 mp -89.7 142.42 12.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.481 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 99.2 mttt 71.62 43.35 0.2 Allowed Pre-proline 0 C--O 1.21 -1.019 0 C-N-CA 124.11 0.964 . . . . 0.0 112.545 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 9.8 Cg_endo -75.42 143.04 27.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 CA-C-N 120.786 1.316 . . . . 0.0 110.783 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.533 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -144.03 54.29 0.58 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 10.0 pm0 -101.1 129.48 46.99 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.19 0.995 . . . . 0.0 110.125 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.513 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 43.1 mtmt -118.84 69.99 0.82 Allowed 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.417 ' C ' HD23 ' A' ' 49' ' ' LEU . 39.1 pt -86.57 109.7 19.25 Favored 'Isoleucine or valine' 1 C--N 1.222 -4.936 0 CA-C-N 111.317 -2.674 . . . . 0.0 112.329 -175.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER 65.7 -3.1 0.76 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.936 2.095 . . . . 0.0 113.863 175.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.04 -25.66 13.53 Favored Glycine 0 C--N 1.293 -1.82 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.23 19.33 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -71.39 103.05 2.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.735 0.779 . . . . 0.0 111.646 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 55.9 mt -128.0 132.17 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 mm -73.45 -27.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.99 0.9 . . . . 0.0 108.888 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.23 -28.1 15.51 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.4 mt -105.54 114.99 62.56 Favored Pre-proline 0 N--CA 1.416 -2.159 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.85 107.27 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.605 2.203 . . . . 0.0 110.518 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -95.96 -174.99 0.29 Allowed 'Trans proline' 0 N--CA 1.426 -2.441 0 C-N-CA 122.671 2.247 . . . . 0.0 111.663 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.7 t -68.86 116.48 41.65 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.81 70.52 7.38 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.002 1.801 . . . . 0.0 113.293 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -130.71 145.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 156.94 153.67 6.75 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 118.98 -1.581 . . . . 0.0 113.67 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.75 103.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.65 108.97 20.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.2 -69.8 0.53 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.418 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -153.21 164.92 37.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -80.76 -31.69 35.81 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.022 0.915 . . . . 0.0 108.602 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.484 ' OG ' ' HD3' ' A' ' 90' ' ' PRO . 11.1 p -94.86 38.48 1.12 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.4 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 70' ' ' VAL . 54.4 m -161.75 171.22 18.21 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.409 ' N ' HG23 ' A' ' 69' ' ' THR . 28.9 m -76.44 161.21 4.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.69 0.757 . . . . 0.0 109.714 177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.637 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 16.1 ptp -140.09 118.0 11.78 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -106.65 94.59 10.46 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-O 121.137 0.494 . . . . 0.0 109.913 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.637 ' HD3' ' O ' ' A' ' 71' ' ' MET . 9.6 Cg_endo -92.2 164.99 3.08 Favored 'Trans proline' 0 N--CA 1.412 -3.296 0 C-N-CA 122.103 1.869 . . . . 0.0 110.8 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -129.1 58.81 1.59 Allowed 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.55 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 27.2 p -100.42 110.11 22.29 Favored 'General case' 0 N--CA 1.386 -3.644 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.149 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -105.19 100.65 26.27 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.8 Cg_endo -104.74 -159.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 123.092 2.528 . . . . 0.0 108.41 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 50.3 t -83.02 -9.04 59.47 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.062 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.34 -79.59 0.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.796 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 176.45 -172.23 45.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.8 m -112.7 149.18 33.27 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 117.452 0.626 . . . . 0.0 109.422 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.84 47.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 59.0 t -109.82 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.523 HG11 ' OE2' ' A' ' 27' ' ' GLU . 2.6 m -102.2 155.27 4.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -155.0 108.83 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.1 tp -97.61 128.97 32.7 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.15 22.55 0.94 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.542 2.161 . . . . 0.0 111.412 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.6 t -130.5 151.7 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.84 152.55 82.39 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.484 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 38.4 Cg_endo -65.41 -4.19 8.97 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.736 2.957 . . . . 0.0 112.656 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.64 -29.91 70.37 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -66.1 -25.16 66.88 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.056 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.37 -35.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 O-C-N 123.074 0.234 . . . . 0.0 110.681 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.81 -43.77 97.93 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -43.5 83.55 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.629 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.88 -21.88 24.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 123.397 0.679 . . . . 0.0 111.099 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -74.06 -27.29 60.85 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.259 0.552 . . . . 0.0 109.808 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.5 -41.61 14.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.989 0.9 . . . . 0.0 108.63 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.6 t -82.45 7.86 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.987 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.513 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -52.91 -60.59 3.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.497 1.119 . . . . 0.0 113.813 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.01 -47.91 0.33 Allowed Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.426 -2.451 0 C-N-CA 121.583 1.522 . . . . 0.0 112.507 177.802 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 p80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -174.01 135.6 0.49 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.3 m -134.14 124.16 25.6 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -121.55 3.32 10.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.83 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.2 m -95.75 101.74 13.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.306 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 7' ' ' GLU . 1.6 pp -92.3 -29.71 16.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.797 0.808 . . . . 0.0 112.263 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' N ' HD13 ' A' ' 6' ' ' LEU . 35.2 tt0 -68.97 -24.51 64.26 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.158 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.8 m -66.44 -32.48 73.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.022 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.74 -28.95 60.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.889 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tt -69.52 -35.13 75.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -66.8 -38.06 85.76 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.624 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -73.72 -3.12 26.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.056 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m 67.48 13.5 9.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.107 1.363 . . . . 0.0 111.783 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.84 59.74 0.36 Allowed Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.67 127.49 31.53 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.244 -0.978 . . . . 0.0 110.613 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -145.77 10.73 1.22 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 27.8 mt-10 -148.0 176.65 10.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.809 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.477 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.6 tt -127.33 161.02 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -67.31 73.36 0.13 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.359 1.076 . . . . 0.0 111.111 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 81.9 mtp -130.1 -121.79 0.22 Allowed 'General case' 0 C--N 1.266 -3.055 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.169 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 101' ' ' GLU . 11.0 tmtt? -147.18 122.89 10.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HD2' ' OE1' ' A' ' 17' ' ' GLU . 14.1 ptm180 -104.11 167.33 9.83 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.668 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -152.58 79.25 1.22 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -109.32 82.84 0.31 Allowed Glycine 0 CA--C 1.471 -2.714 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -72.22 -63.45 1.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.939 0.876 . . . . 0.0 109.251 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.61 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 29.2 mmt180 -84.12 -38.81 20.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.906 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.501 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 29.2 mt-10 -74.84 -1.86 24.14 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 31' ' ' MET . 41.5 t -51.21 -45.15 61.78 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.08 -41.22 74.39 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.59 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.4 -47.19 87.15 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 124.165 0.986 . . . . 0.0 113.152 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -56.83 -38.67 72.95 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.414 0.446 . . . . 0.0 111.345 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.65 -39.05 80.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.747 0.784 . . . . 0.0 109.604 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -75.11 -42.74 55.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.63 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.5 mttt -63.58 -20.03 65.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.543 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -67.28 -26.52 66.58 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.552 0.533 . . . . 0.0 110.306 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -53.15 32.34 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.866 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -162.43 -70.84 0.05 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.559 0.695 . . . . 0.0 110.052 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.458 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.3 ttt180 -163.28 117.67 1.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -137.15 144.03 33.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.593 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -97.22 145.81 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.439 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 74.0 t60 -138.93 121.45 16.19 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 61.6 mt -79.42 138.06 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 64.6 mttm 74.68 65.88 0.27 Allowed Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.692 1.245 . . . . 0.0 109.22 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -88.38 166.17 6.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.224 1.949 . . . . 0.0 111.767 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.447 ' H ' ' HG3' ' A' ' 27' ' ' GLU . . . -179.79 55.61 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.794 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 7.1 tp10 -122.12 145.22 48.38 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.66 0.784 . . . . 0.0 109.958 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -140.46 80.98 1.78 Allowed 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 50' ' ' GLY . 23.8 pt -71.75 105.14 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.323 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.477 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 68.52 -23.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.756 2.022 . . . . 0.0 113.996 175.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.16 -30.43 10.4 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -176.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.01 142.98 50.25 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.25 97.7 9.72 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.389 -1.325 . . . . 0.0 113.386 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.02 117.83 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.28 -37.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 120.968 0.413 . . . . 0.0 111.344 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.98 -0.97 70.01 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.28 130.45 16.04 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -53.89 107.46 0.21 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.366 2.711 . . . . 0.0 112.903 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -114.33 -169.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 123.324 2.682 . . . . 0.0 112.63 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.11 107.95 51.23 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 75' ' ' THR . 32.5 Cg_exo -61.26 118.42 5.29 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.23 2.62 . . . . 0.0 111.964 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.6 mm -128.54 100.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . -118.18 81.1 0.32 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.51 112.97 38.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 4.8 p-10 -126.03 127.28 45.61 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.12 -48.21 10.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.8 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.491 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 21.7 tt0 -170.16 167.17 8.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.511 ' HA ' ' HE1' ' A' ' 71' ' ' MET . 6.7 tpt85 -76.58 -29.66 56.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.801 0.334 . . . . 0.0 111.059 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' A' ' 66' ' ' GLU . 33.1 t -99.24 33.74 2.34 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.897 1.332 . . . . 0.0 108.558 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -148.75 162.53 39.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.93 124.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 122.137 0.97 . . . . 0.0 112.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.511 ' HE1' ' HA ' ' A' ' 67' ' ' ARG . 16.7 ptp -134.72 152.05 51.46 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.407 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.65 90.47 48.15 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 42.2 Cg_endo -105.02 44.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.052 2.501 . . . . 0.0 113.437 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.74 -103.4 0.14 Allowed 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 121.526 0.679 . . . . 0.0 112.012 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 60' ' ' PRO . 3.0 p -162.18 179.66 7.75 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.973 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.71 85.02 43.87 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -103.59 -167.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 123.086 2.524 . . . . 0.0 113.896 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.67 -22.12 60.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.008 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -75.59 -68.79 0.53 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.578 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 170.4 163.72 24.91 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 38' ' ' ARG . 6.5 m -91.73 151.18 20.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.408 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -127.23 126.08 42.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 t -118.21 129.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 HG11 ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -122.72 142.37 39.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.7 tt0 -142.83 122.17 13.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 25.0 tp -99.78 137.06 20.12 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.54 -5.74 7.16 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.153 1.902 . . . . 0.0 111.53 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.561 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.0 t -99.01 163.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.9 t70 -65.32 144.91 99.11 Favored Pre-proline 0 C--N 1.304 -1.396 0 C-N-CA 123.153 0.581 . . . . 0.0 110.214 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.72 -9.58 0.15 Allowed 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 124.034 3.156 . . . . 0.0 115.404 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 9.9 pt-20 -59.43 -18.7 41.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.12 0.568 . . . . 0.0 111.411 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -61.27 -19.91 62.26 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.24 -36.96 77.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.564 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.89 -39.22 88.46 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 109.609 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -69.37 -47.01 65.57 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.445 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.3 mm -73.34 -10.13 13.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.824 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.65 -31.4 32.36 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.45 -34.28 54.49 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.3 t -100.72 29.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.574 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.61 -20.71 64.51 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.659 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.6 mt-10 -139.89 -59.47 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 52.5 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 C-N-CA 121.415 1.41 . . . . 0.0 113.858 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.413 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.8 ptp -171.44 130.8 0.72 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.315 0.646 . . . . 0.0 110.016 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -120.96 126.54 50.21 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.597 0.713 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 23' ' ' ALA . 91.7 m-85 -133.25 22.05 4.06 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.63 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 7.7 p -103.44 78.46 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.089 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 18' ' ' ILE . 5.2 tt -70.68 -54.28 12.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.085 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -75.96 3.95 9.23 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.7 1.238 . . . . 0.0 111.802 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 5' ' ' CYS . 9.0 m -87.44 -2.24 58.48 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.543 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -64.68 -17.92 64.52 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.111 176.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.543 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 4.8 tt -76.12 -35.55 59.24 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.45 -30.47 68.39 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 108.073 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 9' ' ' TYR . 45.5 mt-30 -78.39 -14.63 59.31 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.575 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.7 t 67.03 30.75 7.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.22 1.008 . . . . 0.0 109.833 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.79 88.66 0.11 Allowed Glycine 0 N--CA 1.417 -2.608 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.186 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.47 132.67 54.63 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.46 ' HA ' HG23 ' A' ' 54' ' ' ILE . 48.2 t80 -139.44 12.06 2.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.509 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' OE2' ' HA ' ' A' ' 6' ' ' LEU . 41.4 mt-10 -146.46 176.21 9.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.491 ' O ' HD11 ' A' ' 6' ' ' LEU . 11.2 tp -118.9 154.5 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -69.71 74.55 0.42 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.968 1.366 . . . . 0.0 111.387 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.3 mmm -132.51 -145.8 0.27 Allowed 'General case' 0 C--N 1.269 -2.897 0 C-N-CA 127.235 2.214 . . . . 0.0 107.371 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -119.45 129.54 54.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 119.202 0.91 . . . . 0.0 110.471 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.8 175.18 5.58 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -163.59 76.89 0.39 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.822 0.701 . . . . 0.0 111.901 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -90.9 74.46 1.69 Allowed Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.674 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.1 -68.19 0.58 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.559 0.695 . . . . 0.0 110.357 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.616 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 32.3 mmt180 -75.33 -44.18 46.68 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.896 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 24.8 mt-10 -77.62 2.59 16.11 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.2 t -50.41 -44.34 55.06 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.89 -34.07 57.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.464 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.429 ' C ' ' HD3' ' A' ' 34' ' ' LYS . . . -61.4 -48.79 79.62 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.474 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.9 ptp -59.89 -33.85 72.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.907 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.728 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 81.3 mt -62.94 -34.24 65.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.51 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.04 -31.78 21.79 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.042 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.7 mtpt -59.09 -16.8 21.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.893 0.877 . . . . 0.0 111.877 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.728 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 22.3 ptmt -77.4 -16.0 59.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.455 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.4 72.31 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.347 -0.221 . . . . 0.0 111.524 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 177.17 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' THR . 41.5 ttp180 -156.78 116.87 3.55 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -133.1 146.06 33.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.664 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.789 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -93.4 137.81 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 124.119 0.887 . . . . 0.0 109.017 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -139.1 125.79 20.74 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.82 140.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 62.5 mttp 69.23 65.67 0.5 Allowed Pre-proline 0 C--O 1.22 -0.467 0 C-N-CA 124.24 1.016 . . . . 0.0 110.2 -175.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.466 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 44.3 Cg_endo -88.35 161.48 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.802 2.335 . . . . 0.0 112.91 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.58 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 177.69 62.64 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.615 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 16.1 tt0 -118.21 101.29 8.1 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 124.147 0.979 . . . . 0.0 108.667 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 20.2 mmtt -95.43 91.39 6.18 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.002 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 22' ' ' ARG . 42.1 pt -92.13 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.246 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER 68.32 -1.99 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.139 1.776 . . . . 0.0 112.818 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.95 -33.16 4.32 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.27 122.41 37.68 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HD3' HD13 ' A' ' 48' ' ' ILE . 19.1 tpp180 -64.65 100.2 0.37 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.795 0.684 . . . . 0.0 110.409 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 60.2 mt -121.47 131.1 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 16' ' ' TYR . 57.9 mt -99.15 -31.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.666 0.746 . . . . 0.0 109.822 -177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.48 15.48 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.34 117.04 43.66 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.19 112.11 3.24 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.806 2.338 . . . . 0.0 113.514 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 3.1 Cg_endo -91.92 -171.35 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.924 2.416 . . . . 0.0 108.838 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.575 ' HB ' ' CB ' ' A' ' 75' ' ' THR . 80.9 t -82.2 132.85 52.05 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.6 70.59 7.23 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.557 1.504 . . . . 0.0 113.827 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.14 91.67 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.94 103.25 3.02 Favored Glycine 0 N--CA 1.414 -2.827 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.815 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.8 mt -102.35 76.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -110.94 118.83 37.17 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.164 0.507 . . . . 0.0 110.081 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -90.18 -57.15 2.95 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.373 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -162.54 167.61 23.11 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.436 ' HA ' ' HE1' ' A' ' 71' ' ' MET . 0.3 OUTLIER -81.63 -27.41 34.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.546 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 20.8 t -94.09 30.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 123.058 1.409 . . . . 0.0 108.952 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 68' ' ' SER . 26.7 m -153.85 162.93 40.82 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -63.64 131.25 29.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.765 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.436 ' HE1' ' HA ' ' A' ' 67' ' ' ARG . 14.4 ptp -126.99 124.33 39.17 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.7 mt -114.1 96.79 43.32 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.24 148.89 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.851 1.7 . . . . 0.0 113.04 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 58' ' ' PRO . 73.4 m-85 75.57 -155.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 125.088 1.355 . . . . 0.0 110.681 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.575 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 97.4 m -145.61 -75.51 0.22 Allowed 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -129.53 90.87 42.68 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.433 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -85.85 -171.03 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.671 2.247 . . . . 0.0 110.837 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 41.2 t -81.53 -34.45 31.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.473 0.654 . . . . 0.0 110.465 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -89.3 -68.55 0.77 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -177.1 169.93 42.41 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.9 m -98.42 152.52 19.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.94 149.9 42.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.789 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.5 t -134.43 98.67 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 44' ' ' PRO . 19.9 m -113.48 135.96 51.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.32 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -135.82 124.94 24.42 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.979 0.418 . . . . 0.0 110.184 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.0 tp -101.34 125.83 36.52 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.93 13.41 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.484 2.122 . . . . 0.0 111.05 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 18.3 t -113.71 151.91 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.428 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 25.7 m-20 -61.95 154.85 66.32 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 124.08 0.952 . . . . 0.0 111.309 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.29 -17.09 24.85 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.723 2.949 . . . . 0.0 113.367 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.8 pt-20 -63.41 -16.79 61.56 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.516 0.726 . . . . 0.0 111.222 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.14 -19.78 63.2 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.3 mm -66.42 -28.31 43.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.308 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.48 -42.66 92.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.326 0.584 . . . . 0.0 109.749 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.51 -50.24 70.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.654 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -68.14 -20.06 25.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.452 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 tp -70.91 -28.67 64.7 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.285 0.634 . . . . 0.0 110.0 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.95 -32.25 61.69 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.3 t -83.58 -3.07 7.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.67 -35.17 60.76 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.272 0.629 . . . . 0.0 112.534 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -149.39 93.94 4.0 Favored Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' CG ' ' HB3' ' A' ' 23' ' ' ALA . 23.1 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 123.25 2.634 . . . . 0.0 112.422 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 m80 . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.764 0.316 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.544 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 72.0 mtm -147.53 123.18 10.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.9 m -98.77 114.43 26.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.794 0.33 . . . . 0.0 111.04 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.9 m-85 -129.28 14.41 6.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.455 0.645 . . . . 0.0 109.306 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.5 m -135.53 102.85 5.25 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -78.56 -33.95 47.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.079 0.942 . . . . 0.0 111.956 -175.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.84 -20.99 60.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.88 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 14.6 m -70.68 -35.15 72.67 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -70.29 -27.3 64.3 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.454 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.14 -51.12 70.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.85 -27.85 66.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.01 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 8' ' ' THR . 53.2 mt-30 -77.35 -44.74 28.37 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.662 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -148.37 -50.76 0.17 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.289 0.566 . . . . 0.0 110.904 -176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.43 163.28 19.8 Favored Glycine 0 N--CA 1.422 -2.26 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.24 139.2 58.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.389 0.614 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -132.22 2.94 3.95 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -149.95 143.68 25.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 13.8 tt -81.63 163.74 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.0 72.32 1.63 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.635 1.207 . . . . 0.0 109.646 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.9 mmt -140.51 -176.06 4.5 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.246 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -81.11 116.67 21.14 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 119.284 0.947 . . . . 0.0 111.243 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -106.94 134.75 49.62 Favored 'General case' 0 N--CA 1.4 -2.95 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.39 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.41 79.88 1.79 Allowed 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.24 80.81 0.49 Allowed Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.859 -175.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -68.94 -79.44 0.06 Allowed 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 117.045 0.422 . . . . 0.0 111.585 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.509 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 19.9 mtp-105 -75.33 -31.24 60.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.917 -1.113 . . . . 0.0 113.435 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' CD ' ' HZ3' ' A' ' 34' ' ' LYS . 9.0 tp10 -70.9 -12.64 61.66 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 109.665 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.3 t -60.73 -32.24 71.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 41' ' ' HIS . . . -69.04 -45.49 70.3 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.435 0.635 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.544 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -67.55 -42.53 82.52 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.872 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -57.26 -32.34 66.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.584 0.23 . . . . 0.0 111.38 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 28' ' ' CYS . 50.0 mm -62.31 -40.3 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.52 -36.77 52.15 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.733 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 72.4 mttt -65.04 -15.22 62.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.755 0.822 . . . . 0.0 112.533 -178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -67.95 -23.98 65.12 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.636 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.15 -39.76 68.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.334 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 178.35 -68.76 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.761 0.824 . . . . 0.0 109.413 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.0 ttp180 -163.51 124.01 2.25 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.5 t -138.29 157.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -107.76 149.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.472 0.709 . . . . 0.0 109.991 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.544 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 51.6 t60 -135.62 128.02 30.37 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -96.8 136.54 27.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 98.9 mttt 70.48 53.89 0.42 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.58 1.152 . . . . 0.0 111.294 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 65.3 Cg_endo -70.58 144.55 49.96 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 121.161 1.241 . . . . 0.0 109.981 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.29 47.7 0.97 Allowed Glycine 0 CA--C 1.474 -2.489 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 10.2 pm0 -105.98 148.47 27.66 Favored 'General case' 0 N--CA 1.396 -3.159 0 CA-C-O 121.945 0.879 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 51.4 mtmt -134.75 80.85 1.87 Allowed 'General case' 0 CA--C 1.454 -2.742 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.443 ' C ' HD21 ' A' ' 49' ' ' LEU . 34.6 pt -95.89 104.35 15.74 Favored 'Isoleucine or valine' 1 C--N 1.221 -4.98 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.148 -175.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 59.03 6.01 0.61 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 126.733 2.013 . . . . 0.0 113.728 175.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.5 -3.46 67.89 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.84 131.83 4.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -76.86 86.33 3.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.39 127.17 64.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.24 -39.28 64.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.82 9.57 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.8 mt -102.96 120.83 51.19 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.85 107.39 0.17 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 123.257 2.638 . . . . 0.0 112.74 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -97.26 137.02 0.44 Allowed 'Trans proline' 0 N--CA 1.424 -2.587 0 C-N-CA 122.573 2.182 . . . . 0.0 111.693 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -67.63 114.03 17.5 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.24 88.01 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.397 2.065 . . . . 0.0 114.418 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 74' ' ' TYR . 73.0 mt -122.89 146.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 142.47 -174.84 23.21 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.829 -2.129 . . . . 0.0 114.547 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.16 102.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.17 105.38 17.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.82 -69.91 0.55 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.523 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.74 167.78 12.93 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -34.23 77.36 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 124.785 1.234 . . . . 0.0 107.844 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -99.46 32.16 2.89 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.385 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -151.72 160.46 43.59 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.424 HG13 ' OE2' ' A' ' 85' ' ' GLU . 5.3 m -77.8 119.79 27.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.893 0.854 . . . . 0.0 110.735 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.664 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.0 ptp -98.49 111.59 23.9 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.72 92.55 7.46 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.664 ' HD3' ' O ' ' A' ' 71' ' ' MET . 30.4 Cg_endo -100.9 178.04 0.23 Allowed 'Trans proline' 0 N--CA 1.406 -3.63 0 C-N-CA 121.799 1.666 . . . . 0.0 112.489 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 43.0 t80 -135.42 81.7 1.91 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.564 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 22.5 p -97.24 139.24 33.51 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.871 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -111.56 88.1 8.86 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.448 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 75' ' ' THR . 58.0 Cg_endo -107.68 -153.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 123.914 3.076 . . . . 0.0 108.454 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 21.7 t -110.65 11.01 22.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -118.1 -82.26 0.63 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.951 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.87 -174.55 45.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 37.1 m -109.78 148.26 31.78 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.77 135.53 55.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.9 t -121.43 108.65 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.2 m -108.24 129.65 62.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.424 ' OE2' HG13 ' A' ' 70' ' ' VAL . 39.8 tt0 -132.6 117.67 18.23 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.598 0.636 . . . . 0.0 110.821 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 19.8 tp -99.75 134.76 20.81 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.18 -3.1 9.53 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.328 2.019 . . . . 0.0 111.734 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.447 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -94.76 157.95 3.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 18.0 t70 -65.07 146.29 98.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 122.476 0.31 . . . . 0.0 111.512 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -50.98 -10.93 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.215 3.277 . . . . 0.0 114.788 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 7.9 pt-20 -57.29 -23.13 46.45 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 120.964 0.411 . . . . 0.0 110.438 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -59.74 -26.85 66.0 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.494 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.0 mm -67.89 -33.71 63.03 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 C-N-CA 121.398 -0.121 . . . . 0.0 110.796 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.33 -43.16 99.47 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -64.74 -51.02 64.58 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.719 -1.582 . . . . 0.0 109.01 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.8 mt -64.59 -25.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 124.003 0.921 . . . . 0.0 112.453 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.67 -39.89 94.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.174 0.511 . . . . 0.0 109.797 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -86.63 -41.31 14.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.942 0.877 . . . . 0.0 110.09 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.42 2.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.445 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -47.74 -48.67 29.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.65 -47.15 0.48 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 N--CA 1.434 -2.025 0 CA-C-N 120.224 1.116 . . . . 0.0 112.019 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.476 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.3 mpp? -151.77 132.57 14.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -127.77 115.39 18.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 84.2 m-85 -125.39 -5.0 7.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 48.0 m -77.69 90.07 3.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.212 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 20' ' ' MET 0.251 0.0 OUTLIER -79.17 -50.35 11.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.685 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 6' ' ' LEU . 1.2 tt0 -76.75 -8.5 57.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.755 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 65.6 m -69.61 -26.36 64.4 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 54.2 m-85 -75.38 -23.21 57.07 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 4.4 tt -70.11 -40.05 75.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -68.3 -23.72 64.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.966 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.58 5.62 45.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.012 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m 60.9 31.4 19.99 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.523 0.729 . . . . 0.0 111.937 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . -145.72 67.61 0.41 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.67 145.47 53.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.255 0.55 . . . . 0.0 111.337 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -145.66 27.79 1.2 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -155.99 171.77 19.53 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.406 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.431 HG21 ' HG ' ' A' ' 49' ' ' LEU . 8.7 tt -105.5 16.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.758 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.41 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 71.7 m80 65.31 69.09 0.48 Allowed 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 122.522 1.153 . . . . 0.0 110.471 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.707 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.7 tmm? -148.97 -168.69 3.17 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 63.5 tttp -75.76 112.36 12.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 119.66 1.118 . . . . 0.0 110.986 -177.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -106.8 161.07 15.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB1' ' NZ ' ' A' ' 47' ' ' LYS . . . -160.24 91.09 0.92 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.23 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.41 89.59 0.59 Allowed Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.94 -67.36 0.71 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.155 0.979 . . . . 0.0 109.279 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.8 mmt180 -81.42 -34.76 31.34 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.023 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 21.1 tt0 -80.31 -5.01 55.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.097 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 12.4 t -49.42 -46.28 47.43 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.274 0.559 . . . . 0.0 109.553 174.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.16 75.72 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.556 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.408 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -60.7 -47.32 86.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.02 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.455 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.0 ptm -61.02 -35.25 76.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.23 -42.87 91.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.338 0.589 . . . . 0.0 109.923 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -77.73 -35.13 52.26 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.898 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HZ1' ' CG1' ' A' ' 84' ' ' VAL . 82.1 mttt -57.9 -24.8 59.33 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 0.0 112.39 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.34 -21.78 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.331 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.59 77.77 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.644 0.259 . . . . 0.0 110.596 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -175.36 -69.44 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.336 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.4 ptt180 -151.15 123.58 8.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.0 t -138.07 141.43 38.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.78 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.6 p -108.82 143.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 52.0 t60 -133.81 130.49 38.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 15.7 tt -83.87 141.49 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.5 mttt 68.14 64.62 0.63 Allowed Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 0.0 110.781 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.47 171.1 16.37 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.927 1.751 . . . . 0.0 111.483 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -174.5 50.35 0.14 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.957 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.8 tp10 -119.09 144.47 46.59 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.545 ' HZ1' ' HB2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -139.68 81.6 1.83 Allowed 'General case' 0 CA--C 1.444 -3.118 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.521 HG23 ' CD ' ' A' ' 46' ' ' GLU . 9.6 pt -72.72 110.05 5.48 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.444 0 CA-C-N 111.677 -2.511 . . . . 0.0 109.903 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 62.11 14.74 6.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 125.84 1.656 . . . . 0.0 112.398 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 -41.07 2.6 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.53 121.41 41.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' HG13 ' A' ' 48' ' ' ILE . 56.7 ttp180 -62.52 92.48 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 124.506 1.122 . . . . 0.0 113.011 -177.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.5 mm -124.26 132.73 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.3 mt -79.99 -29.36 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.504 0.668 . . . . 0.0 109.851 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 17' ' ' GLU . . . 82.6 5.72 89.22 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.943 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.6 mt -126.72 122.14 23.44 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -65.18 107.87 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.192 1.928 . . . . 0.0 109.783 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -110.26 -172.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.132 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.0 t -73.67 116.85 55.77 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.26 39.19 0.52 Allowed 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 123.583 2.855 . . . . 0.0 115.6 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.73 141.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 165.09 129.65 1.06 Allowed Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 117.979 -2.058 . . . . 0.0 113.635 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 146.96 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -121.76 93.58 4.04 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.69 -64.34 0.88 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.265 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 1.5 tm-20 -159.78 169.92 22.6 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 69' ' ' THR . 5.0 tpp180 -87.1 -38.6 16.33 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.279 0.561 . . . . 0.0 112.351 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 18.5 t -91.23 29.9 1.35 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 122.994 1.378 . . . . 0.0 107.924 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 67' ' ' ARG . 16.9 m -145.65 170.02 17.3 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.58 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.444 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.3 ptt? -115.78 142.96 46.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.4 tp -114.34 80.44 5.89 Favored Pre-proline 0 C--N 1.292 -1.905 0 C-N-CA 119.655 -0.818 . . . . 0.0 113.12 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 3.0 Cg_exo -84.82 98.64 0.7 Allowed 'Trans proline' 0 N--CA 1.425 -2.503 0 C-N-CA 121.932 1.754 . . . . 0.0 107.72 176.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -88.92 67.65 8.24 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 123.046 1.403 . . . . 0.0 108.865 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.507 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 18.8 p -104.59 138.94 40.19 Favored 'General case' 1 N--CA 1.366 -4.665 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.618 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.17 92.52 9.61 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.564 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.3 Cg_endo -101.76 -165.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 122.93 2.42 . . . . 0.0 110.828 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.1 t -93.24 0.74 57.16 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -108.29 -78.48 0.59 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.256 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.21 178.35 46.83 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 71.3 m -93.1 131.61 37.98 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.54 116.85 32.74 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.871 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 39.0 t -120.85 133.31 67.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.466 ' CG1' ' HZ1' ' A' ' 34' ' ' LYS . 15.9 m -134.49 144.29 35.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 38.7 tt0 -137.73 125.82 22.91 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 68' ' ' SER . 26.3 tp -101.16 138.24 19.91 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.76 -3.95 11.32 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 121.82 1.68 . . . . 0.0 111.568 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.461 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 40.1 t -103.63 159.06 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.59 158.68 57.67 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 123.637 0.585 . . . . 0.0 110.909 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.33 -9.87 7.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.895 3.063 . . . . 0.0 113.636 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.57 -25.64 52.94 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 110.487 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.2 tp10 -63.82 -31.51 72.72 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 67' ' ' ARG . 65.5 mt -60.12 -42.58 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.44 0.296 . . . . 0.0 110.8 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.17 -36.9 85.68 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.313 0.578 . . . . 0.0 110.397 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.426 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 43.2 ttt180 -71.71 -42.3 67.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.256 1.027 . . . . 0.0 108.257 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.2 mm -65.46 -17.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 125.347 1.459 . . . . 0.0 110.908 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -78.38 -28.39 47.01 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -82.14 -43.92 17.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.35 11.61 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.702 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.98 -50.94 67.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.779 0.832 . . . . 0.0 110.23 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.52 92.51 47.75 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.861 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 123.753 2.969 . . . . 0.0 110.849 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.446 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.566 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.468 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.486 ' N ' HD13 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.492 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HB3' HD22 ' A' ' 6' ' ' LEU . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.514 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB1' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.822 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.553 ' NE2' ' HB1' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.484 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' GLY . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.529 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.448 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.459 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.448 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' O ' HG21 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.529 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.582 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.643 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.822 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.459 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' HD23 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.687 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.687 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.686 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.537 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.537 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.604 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.604 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.458 HD23 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' HG12 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.421 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.529 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -170.92 130.4 0.79 Allowed 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 125.712 1.605 . . . . 0.0 107.77 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.428 HG21 ' SD ' ' A' ' 31' ' ' MET . 9.9 t -114.57 129.01 56.63 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.94 0.876 . . . . 0.0 112.124 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -130.87 25.39 4.99 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.669 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 82.4 m -129.89 99.99 5.3 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -80.63 -45.17 17.7 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.401 ' N ' HD21 ' A' ' 6' ' ' LEU . 41.8 tt0 -74.55 -2.84 27.65 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.155 0.979 . . . . 0.0 111.863 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.489 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 49.9 m -76.84 -26.64 54.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.85 -24.15 58.54 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.26 -20.12 62.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.102 0.953 . . . . 0.0 108.924 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -91.14 9.53 30.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.857 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' C ' ' HG ' ' A' ' 13' ' ' SER . 22.4 mt-30 -128.97 -46.45 1.25 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.597 0.713 . . . . 0.0 109.349 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 12' ' ' GLN . 45.8 m -153.67 -155.66 0.61 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.56 166.01 53.24 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -81.35 147.25 29.94 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.411 ' HA ' HG21 ' A' ' 54' ' ' ILE . 61.1 t80 -126.88 22.63 6.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 122.652 1.215 . . . . 0.0 108.348 -176.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HB3' HD22 ' A' ' 49' ' ' LEU . 7.5 mp0 -142.36 167.9 21.0 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.337 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.508 ' H ' ' CD1' ' A' ' 49' ' ' LEU . 3.1 tt -100.59 -1.54 9.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 -176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 79.98 79.25 0.05 OUTLIER 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 126.716 2.007 . . . . 0.0 106.581 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.407 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -158.7 -179.08 7.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -176.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.71 101.99 3.22 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.918 1.342 . . . . 0.0 111.292 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.627 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -93.8 121.68 35.5 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.697 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.88 79.06 1.68 Allowed 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -95.85 88.39 1.05 Allowed Glycine 0 CA--C 1.472 -2.645 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.529 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.34 -64.6 1.13 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.543 0.687 . . . . 0.0 110.13 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.655 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 6.1 mmp_? -84.38 -40.96 17.21 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -67.34 -11.98 59.02 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.952 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 48.8 t -55.48 -41.92 73.67 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.88 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.551 ' HB1' ' NE2' ' A' ' 41' ' ' HIS . . . -70.81 -32.11 69.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.027 0.442 . . . . 0.0 110.625 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 41' ' ' HIS . . . -75.49 -41.36 55.64 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.443 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.3 ptp -61.62 -33.06 73.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.993 0.425 . . . . 0.0 111.672 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.19 -28.41 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.798 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 29' ' ' ALA . 15.4 mm-40 -92.73 -37.24 12.48 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.559 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 73.2 mttt -58.8 -24.94 62.64 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 124.772 1.229 . . . . 0.0 111.246 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -60.47 -26.83 67.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 O-C-N 124.331 1.019 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.26 -62.7 1.3 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.198 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -152.11 -70.01 0.16 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.862 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.538 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 28.2 ptt180 -158.48 123.76 4.36 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.0 t -140.74 154.73 21.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.901 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.7 p -115.03 144.15 23.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.169 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' NE2' ' HB1' ' A' ' 29' ' ' ALA . 4.0 t-80 -113.45 126.34 55.22 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 19.3 tt -86.33 134.57 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.458 ' HA ' HD11 ' A' ' 86' ' ' LEU . 65.3 mttp 66.7 60.1 0.94 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.861 0.865 . . . . 0.0 109.906 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 86' ' ' LEU . 57.5 Cg_endo -69.25 168.24 21.45 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.771 1.647 . . . . 0.0 110.639 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.655 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 179.47 56.8 0.08 OUTLIER Glycine 1 CA--C 1.448 -4.103 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -177.148 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -116.35 147.27 41.76 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 114.163 -1.019 . . . . 0.0 109.857 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.571 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 7.8 mmtm -136.64 76.56 1.6 Allowed 'General case' 0 C--N 1.263 -3.193 0 CA-C-O 123.801 1.762 . . . . 0.0 107.907 174.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 79.9 mt -88.39 107.55 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.698 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.364 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 17' ' ' GLU . 2.4 mt 70.57 -3.77 1.82 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.492 1.117 . . . . 0.0 111.251 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.8 -37.73 3.66 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.27 131.12 27.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -71.93 103.84 3.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.904 0.859 . . . . 0.0 109.216 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 50.8 mm -120.01 134.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' A' ' 16' ' ' TYR . 69.5 mt -84.61 -41.38 15.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.752 0.787 . . . . 0.0 109.229 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.69 -18.51 34.03 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 mm -101.02 108.78 56.07 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -53.05 109.32 0.34 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.477 2.785 . . . . 0.0 112.577 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -97.37 -179.66 0.38 Allowed 'Trans proline' 0 N--CA 1.432 -2.12 0 C-N-CA 122.713 2.275 . . . . 0.0 111.487 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 75' ' ' THR . 77.6 t -67.37 112.33 9.82 Favored Pre-proline 0 C--O 1.213 -0.835 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.27 75.09 5.14 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.86 1.707 . . . . 0.0 115.455 -170.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.0 mt -136.64 142.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.634 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 138.11 156.74 7.24 Favored Glycine 0 N--CA 1.403 -3.535 0 C-N-CA 118.981 -1.58 . . . . 0.0 114.13 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.1 pt -150.87 160.84 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 123.423 0.689 . . . . 0.0 111.3 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.93 136.48 42.68 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.44 -61.87 1.66 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.737 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -155.83 166.22 34.16 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 3.0 tpp180 -77.09 -33.62 56.96 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.793 0.806 . . . . 0.0 110.468 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.613 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.49 31.54 1.02 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 122.782 1.277 . . . . 0.0 110.288 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.476 ' C ' ' HG3' ' A' ' 85' ' ' GLU . 64.4 m -154.61 173.49 16.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -79.19 166.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-O 122.473 1.13 . . . . 0.0 110.228 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.525 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.4 ptt? -120.77 122.25 39.96 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 174.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.8 90.29 15.01 Favored Pre-proline 0 C--N 1.293 -1.867 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.174 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.634 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 71.7 Cg_endo -103.21 171.09 0.21 Allowed 'Trans proline' 1 N--CA 1.385 -4.898 0 C-N-CA 120.8 1.0 . . . . 0.0 111.449 176.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -126.05 32.53 5.23 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 122.213 1.006 . . . . 0.0 110.304 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 37.0 p -80.6 104.38 11.09 Favored 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.511 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -103.88 102.23 29.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.688 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 75' ' ' THR . 64.3 Cg_endo -98.46 -156.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.736 2.957 . . . . 0.0 112.072 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.2 t -95.95 28.56 3.08 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.369 1.08 . . . . 0.0 108.092 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -136.81 -85.28 0.33 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.68 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -172.77 173.81 45.59 Favored Glycine 0 C--N 1.315 -0.589 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 25.1 m -89.28 135.7 33.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB1' ' HZ2' ' A' ' 34' ' ' LYS . . . -109.91 126.93 54.39 Favored 'General case' 0 N--CA 1.397 -3.119 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 54.2 t -133.02 138.85 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -140.06 140.52 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.476 ' HG3' ' C ' ' A' ' 69' ' ' THR . 42.5 tt0 -138.71 118.67 13.34 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 43' ' ' LYS . 13.2 tp -97.17 143.9 26.94 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.27 12.67 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.907 1.738 . . . . 0.0 112.34 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.613 ' O ' ' HB3' ' A' ' 68' ' ' SER . 26.1 t -117.79 156.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' CB ' ' HG2' ' A' ' 91' ' ' GLU . 1.8 m-20 -51.81 157.51 1.97 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 124.201 0.938 . . . . 0.0 111.871 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.28 -11.37 31.11 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.586 2.191 . . . . 0.0 110.539 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.459 ' HG2' ' CB ' ' A' ' 89' ' ' ASP . 12.8 pt-20 -66.61 -16.87 64.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.226 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' O ' HG12 ' A' ' 96' ' ' ILE . 7.3 tp10 -59.52 -26.49 65.36 Favored 'General case' 0 C--N 1.375 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -56.38 -36.16 45.98 Favored 'Isoleucine or valine' 0 C--O 1.167 -3.242 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -56.04 -40.94 74.23 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.93 0.871 . . . . 0.0 110.796 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -39.03 42.29 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.208 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 92' ' ' GLU . 43.2 mm -75.29 -18.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.317 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.9 tp -82.14 -27.89 32.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.731 0.777 . . . . 0.0 109.018 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -100.74 7.88 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.669 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -55.13 -61.8 2.08 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -177.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.54 -43.93 0.22 Allowed Pre-proline 0 C--N 1.258 -3.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.911 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.423 -2.638 0 C-N-CA 121.163 1.242 . . . . 0.0 112.347 179.129 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.459 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' HD23 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.687 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.687 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.686 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.537 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB3' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.537 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.604 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.604 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.458 HD23 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.493 ' O ' HG12 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.421 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.529 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.5 t60 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -176.96 148.86 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.23 0.612 . . . . 0.0 110.966 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -148.93 130.67 15.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 55.9 m-85 -114.68 7.57 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.985 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.4 m -84.53 115.0 22.36 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 7' ' ' GLU . 0.6 OUTLIER -102.92 -53.07 2.92 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.759 ' H ' HD12 ' A' ' 6' ' ' LEU . 33.1 tt0 -70.22 -13.82 62.35 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 125.155 1.382 . . . . 0.0 110.91 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -73.12 -25.05 60.71 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.237 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -32.3 63.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.68 -42.13 98.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -67.0 -17.32 64.87 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.95 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -95.19 -45.2 7.29 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.9 m -149.59 -67.34 0.21 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.933 0.396 . . . . 0.0 111.127 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.33 163.54 32.04 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.7 152.93 22.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 124.222 0.601 . . . . 0.0 109.831 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.518 ' HA ' HG23 ' A' ' 54' ' ' ILE . 41.9 t80 -151.44 13.58 0.66 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.401 0.619 . . . . 0.0 110.452 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -144.59 171.06 14.91 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.699 HG22 ' HG ' ' A' ' 49' ' ' LEU . 15.5 tt -105.2 150.46 7.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -69.53 67.68 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.305 1.05 . . . . 0.0 110.973 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mmm -122.07 -101.03 0.41 Allowed 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.979 1.712 . . . . 0.0 110.242 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 37.6 ttmt -159.45 124.22 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.413 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -108.06 141.45 39.73 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . . . -118.06 90.47 3.34 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.56 76.07 0.22 Allowed Glycine 0 CA--C 1.479 -2.199 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.358 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 97.3 m-85 -70.37 -74.96 0.13 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.072 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.601 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.7 mmt180 -80.73 -33.02 35.52 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.375 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -66.29 -13.07 59.89 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' MET . 25.0 t -49.44 -37.38 25.54 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 121.501 0.667 . . . . 0.0 110.987 175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.68 -42.97 63.69 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 121.82 -0.55 . . . . 0.0 110.456 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -60.28 -47.07 87.6 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.122 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -53.39 -39.53 64.33 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.383 0.427 . . . . 0.0 112.023 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.7 mm -62.17 -43.36 97.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.128 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.608 ' HB3' HG21 ' A' ' 39' ' ' VAL . 18.5 mm-40 -79.58 -28.86 41.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.805 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -64.47 -22.95 67.12 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 123.952 0.901 . . . . 0.0 111.973 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.06 -26.61 66.83 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -59.54 2.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.07 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -141.67 -79.12 0.25 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.487 1.137 . . . . 0.0 110.01 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.499 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 14.2 ptp180 -170.49 123.19 0.65 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 33' ' ' GLU . 74.2 t -132.93 143.19 40.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.639 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.7 p -97.75 139.41 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.901 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.633 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 57.6 t-80 -123.27 124.9 44.03 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.8 tt -85.65 136.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 96.4 mttt 68.1 58.32 0.73 Allowed Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 123.64 0.776 . . . . 0.0 110.93 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 Cg_endo -78.24 155.91 29.3 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 121.647 1.565 . . . . 0.0 110.29 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -152.99 39.16 0.73 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.3 pm0 -105.6 175.6 5.44 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.925 0.869 . . . . 0.0 111.565 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.609 ' HG2' HG23 ' A' ' 96' ' ' ILE . 4.7 tmtt? -157.44 102.67 1.92 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.38 105.95 17.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.699 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.26 -1.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 127.349 2.26 . . . . 0.0 114.47 175.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.75 -38.89 2.93 Favored Glycine 0 C--N 1.291 -1.946 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.79 39.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -75.79 104.07 6.17 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.466 HD12 HG21 ' A' ' 18' ' ' ILE . 48.5 mt -124.31 119.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 16' ' ' TYR . 62.9 mt -77.9 -33.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.932 0.77 . . . . 0.0 110.18 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.63 14.99 Favored Glycine 0 C--N 1.309 -0.933 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.58 131.25 23.19 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 48.2 Cg_exo -58.79 110.43 0.67 Allowed 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.811 2.341 . . . . 0.0 111.324 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 30.0 Cg_endo -110.58 -177.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 122.878 2.385 . . . . 0.0 112.905 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 75' ' ' THR . 59.1 t -87.23 121.17 71.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 40.22 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.042 2.495 . . . . 0.0 114.792 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.09 145.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.34 145.39 6.0 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.352 -1.404 . . . . 0.0 112.356 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.13 86.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 123.404 0.681 . . . . 0.0 109.428 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -95.07 114.96 26.82 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.29 -69.53 0.72 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -148.07 168.25 22.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -32.82 42.44 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.27 28.47 1.43 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.426 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -152.3 167.91 27.1 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 85' ' ' GLU . 29.9 m -78.83 156.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.9 0.857 . . . . 0.0 111.383 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.614 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 ptt? -119.37 124.85 47.59 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.1 mt -107.95 87.48 3.81 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.2 Cg_exo -82.24 142.01 11.84 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.998 1.799 . . . . 0.0 112.332 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.8 49.88 1.07 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.997 1.38 . . . . 0.0 107.819 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.5 p -98.51 119.97 38.13 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 112.746 -2.024 . . . . 0.0 107.313 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -100.51 102.19 17.94 Favored Pre-proline 0 C--N 1.305 -1.345 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.002 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.3 Cg_endo -104.17 -164.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.708 0 C-N-CA 123.069 2.513 . . . . 0.0 111.18 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 74.3 m -109.8 35.39 3.38 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -141.86 -71.76 0.34 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.577 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.16 40.54 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 22.7 m -115.31 149.36 37.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 118.304 1.052 . . . . 0.0 111.214 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.07 124.68 52.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.4 t -122.33 124.83 71.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.517 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 21.8 m -125.17 145.79 31.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.432 ' HB2' HG12 ' A' ' 70' ' ' VAL . 44.2 tt0 -147.6 118.58 7.67 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.209 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.1 tp -95.85 125.66 47.92 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 1.13 8.97 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.254 1.969 . . . . 0.0 111.164 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.55 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 19.5 t -100.25 164.42 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 91' ' ' GLU . 6.2 m-20 -70.23 162.21 71.01 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 118.074 0.397 . . . . 0.0 110.132 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.73 16.42 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.137 2.558 . . . . 0.0 112.207 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -70.41 -20.01 62.95 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.014 0.911 . . . . 0.0 109.115 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.504 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 7.3 tp10 -65.74 -24.29 66.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.033 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.559 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 66.5 mt -59.23 -26.96 35.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.83 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -63.59 -41.09 98.37 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HD2' ' H ' ' A' ' 95' ' ' ARG . 2.8 mpt_? -74.82 -38.9 61.92 Favored 'General case' 0 C--O 1.193 -1.921 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.609 HG23 ' HG2' ' A' ' 47' ' ' LYS . 62.2 mt -58.66 -33.97 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 124.37 1.068 . . . . 0.0 111.316 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.45 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.558 0.694 . . . . 0.0 109.797 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.57 -42.55 24.77 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.011 0.91 . . . . 0.0 109.518 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.19 3.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 125.119 1.367 . . . . 0.0 111.674 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -42.19 -44.13 3.62 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 124.518 1.127 . . . . 0.0 110.751 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -160.18 98.18 1.46 Allowed Pre-proline 0 N--CA 1.401 -2.882 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.243 0.734 0 C-N-CA 123.543 2.828 . . . . 0.0 112.739 -178.022 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.572 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HD11 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.527 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.632 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 20' ' ' MET . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' ILE . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.528 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.825 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 96' ' ' ILE . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG22 ' HB2' ' A' ' 22' ' ' ARG . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' HB2' ' A' ' 20' ' ' MET . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.61 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.657 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 67' ' ' ARG . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.491 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 79.9 m-70 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtt -152.49 122.26 6.94 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.649 HG21 ' SD ' ' A' ' 31' ' ' MET . 8.6 t -111.25 125.3 53.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.445 0.641 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.54 7.44 6.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.875 0.845 . . . . 0.0 109.43 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 62.5 m -94.89 96.56 9.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.769 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 7' ' ' GLU . 4.1 pp -100.29 -39.48 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.984 0.897 . . . . 0.0 110.358 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.625 ' N ' HD12 ' A' ' 6' ' ' LEU . 35.2 tt0 -77.74 -13.77 59.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.165 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.7 m -68.5 -33.56 74.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -80.33 -26.4 38.76 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.641 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HG ' ' OE2' ' A' ' 15' ' ' GLU . 7.8 tt -73.55 -26.79 61.01 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.295 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 7' ' ' GLU . 79.5 mt-30 -68.89 -29.96 68.35 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -93.34 -7.0 46.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.059 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.9 m 63.85 37.85 9.39 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 122.318 1.056 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.27 55.71 0.57 Allowed Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.475 ' OE2' ' HG ' ' A' ' 10' ' ' LEU . 6.1 pm0 -100.07 174.25 6.25 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.146 0.578 . . . . 0.0 111.423 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.431 ' CD1' HG13 ' A' ' 54' ' ' ILE . 70.9 t80 -144.87 25.44 1.44 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -138.13 163.96 30.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.75 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.477 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.1 tt -115.83 165.23 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.404 ' N ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-70 -65.84 71.87 0.06 Allowed 'General case' 0 C--N 1.362 1.15 0 CA-C-O 122.213 1.006 . . . . 0.0 109.989 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.641 ' SD ' ' HB3' ' A' ' 49' ' ' LEU . 47.7 mtt -135.82 -148.4 0.3 Allowed 'General case' 0 C--N 1.259 -3.326 0 C-N-CA 126.209 1.804 . . . . 0.0 106.872 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 20' ' ' MET . 11.9 tmtt? -124.03 123.28 40.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HB3' HD23 ' A' ' 6' ' ' LEU . 8.9 ptm180 -98.89 165.8 11.59 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.78 80.68 0.94 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.492 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -96.9 82.3 0.74 Allowed Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.4 -65.9 0.87 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.3 mpt_? -85.62 -34.66 21.33 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.984 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 29.8 tt0 -79.21 -3.01 43.68 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.648 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -53.54 -41.91 66.92 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.11 94.98 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.19 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.32 -45.73 91.91 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.293 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.649 ' SD ' HG21 ' A' ' 3' ' ' THR . 18.4 ptm -55.98 -35.73 67.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.9 mm -59.9 -46.44 93.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 123.93 0.769 . . . . 0.0 109.927 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.4 -28.51 31.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.193 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 34.7 mtpt -57.01 -26.86 60.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.692 0.797 . . . . 0.0 110.924 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 7.0 tmtm? -62.67 -21.25 65.57 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.316 1.047 . . . . 0.0 111.26 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.86 -39.24 69.81 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 121.86 -0.525 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -176.12 -65.46 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 7.2 ptp180 -169.6 132.41 1.2 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.67 145.79 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -98.26 139.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 O-C-N 124.343 1.027 . . . . 0.0 109.996 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 37.6 t-80 -137.7 123.29 19.75 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.0 137.85 20.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.8 mttt 66.6 64.24 0.82 Allowed Pre-proline 0 C--O 1.216 -0.667 0 C-N-CA 123.133 0.573 . . . . 0.0 111.097 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.635 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 44.9 Cg_endo -95.28 148.82 1.53 Allowed 'Trans proline' 0 N--CA 1.427 -2.395 0 C-N-CA 122.126 1.884 . . . . 0.0 111.046 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.457 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -154.21 64.76 0.34 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.265 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.658 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.0 tp10 -114.38 123.24 48.98 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 124.072 0.949 . . . . 0.0 109.11 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 44.4 mtmt -106.96 72.5 0.89 Allowed 'General case' 0 CA--C 1.464 -2.339 0 CA-C-O 123.287 1.518 . . . . 0.0 107.786 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.658 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -75.43 94.73 0.98 Allowed 'Isoleucine or valine' 1 C--N 1.239 -4.229 0 CA-C-N 111.683 -2.508 . . . . 0.0 111.828 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.641 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER 64.27 -8.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.646 1.578 . . . . 0.0 113.362 175.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.29 -6.26 78.23 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.31 152.19 18.27 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -88.83 99.87 12.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.816 0.341 . . . . 0.0 111.77 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.34 118.02 57.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 77' ' ' PRO . 3.5 mp -75.51 -43.54 41.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.403 0.62 . . . . 0.0 110.736 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.6 -9.47 77.0 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.3 mt -124.64 131.21 24.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.9 107.33 1.86 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.563 1.509 . . . . 0.0 109.252 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -103.4 -164.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 122.721 2.281 . . . . 0.0 111.485 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 75' ' ' THR . 55.7 t -75.75 116.96 60.07 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -84.1 43.93 1.46 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 122.502 2.135 . . . . 0.0 113.964 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 51.1 mt -114.98 164.88 10.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.21 155.93 9.14 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.157 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.2 pt -126.22 84.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.096 0.95 . . . . 0.0 111.32 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.78 95.96 7.44 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -76.95 -56.92 4.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.769 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.13 169.88 12.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 0.1 OUTLIER -88.77 -31.7 18.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.23 1.014 . . . . 0.0 108.464 -176.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 14.9 m -93.71 34.63 1.18 Allowed 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.909 1.338 . . . . 0.0 109.203 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.2 m -154.66 166.74 32.45 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.42 105.87 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 121.861 0.839 . . . . 0.0 110.968 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.47 ' HE3' ' HA ' ' A' ' 67' ' ' ARG . 21.4 ptp -86.29 123.54 31.66 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.9 mt -118.93 86.35 30.92 Favored Pre-proline 0 C--N 1.295 -1.792 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.857 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.555 ' O ' HG21 ' A' ' 81' ' ' THR . 4.3 Cg_exo -75.14 149.96 36.89 Favored 'Trans proline' 0 N--CA 1.422 -2.689 0 N-CA-C 108.353 -1.441 . . . . 0.0 108.353 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 72.4 m-85 -113.08 41.4 2.11 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 44.5 p -95.07 102.85 14.68 Favored 'General case' 0 N--CA 1.398 -3.054 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -102.05 102.38 23.75 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.743 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.8 Cg_endo -102.45 -159.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.311 0 C-N-CA 123.253 2.635 . . . . 0.0 110.136 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -93.86 25.46 3.62 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.121 0.962 . . . . 0.0 110.172 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -128.09 -74.91 0.57 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.829 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 157.66 -174.78 35.07 Favored Glycine 0 N--CA 1.416 -2.655 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 73' ' ' PRO . 5.0 m -121.48 152.12 39.5 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 117.406 0.603 . . . . 0.0 109.627 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -105.15 111.83 24.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.7 t -102.24 90.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.635 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 26.9 m -104.64 135.47 42.42 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 O-C-N 121.457 -0.777 . . . . 0.0 111.473 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.17 115.88 16.95 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.529 0.68 . . . . 0.0 109.277 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 68' ' ' SER . 26.8 tp -99.49 125.03 42.39 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.2 8.45 4.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.348 2.032 . . . . 0.0 111.785 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.509 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.8 t -104.15 157.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.42 152.71 94.23 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.89 -7.51 18.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.625 2.883 . . . . 0.0 112.398 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.64 -24.56 63.97 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.61 -27.71 69.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.573 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 67' ' ' ARG . 78.2 mt -59.17 -41.0 82.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 C-N-CA 122.168 0.187 . . . . 0.0 110.988 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.92 -47.33 86.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.973 0.892 . . . . 0.0 109.66 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -68.32 -41.78 80.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.174 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.455 HG23 ' HG2' ' A' ' 47' ' ' LYS . 4.1 mt -65.92 -28.56 44.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 C-N-CA 124.128 0.971 . . . . 0.0 113.188 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.36 -37.09 84.5 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.212 0.53 . . . . 0.0 110.343 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.22 -37.06 46.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.219 1.009 . . . . 0.0 108.996 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 99' ' ' VAL . 57.8 t -91.07 17.25 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.287 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.524 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.65 -48.33 69.5 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.23 -48.31 0.6 Allowed Pre-proline 0 C--N 1.293 -1.887 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.392 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 C--N 1.389 2.675 0 C-N-CA 123.687 2.925 . . . . 0.0 115.25 177.804 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 64.6 t60 . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -130.07 139.56 50.95 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 t -107.6 123.53 48.6 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.525 0.679 . . . . 0.0 111.706 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -129.99 -0.48 4.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.419 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p -87.22 101.36 13.44 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.652 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.554 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -97.34 -44.85 6.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' N ' HD22 ' A' ' 6' ' ' LEU . 34.9 tt0 -81.42 -4.8 56.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.316 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -71.04 -24.77 62.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.883 0.849 . . . . 0.0 109.559 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 79' ' ' TYR . 38.5 t80 -78.39 -21.84 48.74 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.828 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.06 -35.29 79.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.89 -14.01 62.31 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -91.95 -46.24 7.93 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.7 m -163.39 -67.69 0.04 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.47 0.653 . . . . 0.0 109.428 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.11 -179.87 20.11 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 16' ' ' TYR . 29.8 tt0 -97.1 177.51 5.57 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 118.243 1.022 . . . . 0.0 108.777 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.563 ' HA ' HG23 ' A' ' 54' ' ' ILE . 18.1 t80 -129.15 14.41 6.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.655 1.217 . . . . 0.0 108.549 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HA ' HD21 ' A' ' 49' ' ' LEU . 5.0 mp0 -132.3 -168.01 1.98 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.489 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.625 HG22 ' HG ' ' A' ' 49' ' ' LEU . 10.9 tt -122.39 45.59 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.375 1.084 . . . . 0.0 110.793 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 56.73 31.07 18.73 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.793 1.237 . . . . 0.0 111.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.505 ' HB2' HD12 ' A' ' 49' ' ' LEU . 91.1 mmm -121.86 -168.37 1.69 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 45.1 mmtm -89.25 138.16 31.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.782 1.628 . . . . 0.0 111.478 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.73 ' HB2' HG22 ' A' ' 48' ' ' ILE . 11.9 ptm180 -107.45 140.63 40.1 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.55 88.79 2.57 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.397 0.618 . . . . 0.0 111.146 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -108.88 78.87 0.24 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.678 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -71.19 -56.83 5.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.781 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 3.2 mmp_? -94.39 -33.17 13.26 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.63 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 25.9 tt0 -82.32 -0.43 45.63 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.975 -177.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 31' ' ' MET . 50.7 t -57.36 -38.15 73.73 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.73 -41.78 82.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.427 0.632 . . . . 0.0 109.335 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -62.5 -41.37 98.78 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.272 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 9.9 ptt? -54.52 -35.11 62.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.257 0.348 . . . . 0.0 111.749 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.697 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 44.9 mm -62.72 -39.44 84.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.421 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.77 -27.27 21.25 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.586 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 38.0 mtpt -59.6 -18.24 39.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.048 0.939 . . . . 0.0 112.126 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -68.6 -14.31 62.93 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.14 -55.55 5.34 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 111.213 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -167.62 -64.38 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 40.5 ptt180 -163.16 124.68 2.47 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.0 t -133.52 151.89 34.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.738 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.4 p -102.06 148.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 123.873 0.733 . . . . 0.0 110.215 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.458 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 78.5 t60 -144.47 143.98 31.14 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.21 146.16 9.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.594 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 49.1 mtmt 65.22 48.51 0.66 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 110.723 -176.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 6.0 Cg_exo -89.1 161.77 5.81 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.62 2.214 . . . . 0.0 111.096 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.519 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -171.75 75.19 0.1 OUTLIER Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.171 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 26.7 tt0 -120.94 123.83 43.43 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.709 0.766 . . . . 0.0 110.244 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 50' ' ' GLY . 2.4 tmtm? -124.03 104.13 8.71 Favored 'General case' 0 N--CA 1.394 -3.273 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.73 HG22 ' HB2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -106.6 130.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.795 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 55.32 15.95 1.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.038 2.135 . . . . 0.0 112.843 176.181 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.564 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . 81.68 -25.08 4.08 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.043 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.415 ' O ' HD12 ' A' ' 53' ' ' ILE . . . -143.44 145.1 32.34 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -74.57 89.14 2.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 117.754 0.252 . . . . 0.0 111.141 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 55' ' ' GLY . 4.7 mp -116.72 127.92 74.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 16' ' ' TYR . 55.2 mt -91.84 -17.23 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 122.096 0.95 . . . . 0.0 108.653 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 87.43 -17.68 42.22 Favored Glycine 0 CA--C 1.499 -0.923 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.1 mt -119.74 105.27 43.51 Favored Pre-proline 0 N--CA 1.413 -2.32 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 51.7 Cg_exo -53.16 110.31 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.667 2.912 . . . . 0.0 112.462 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 52.7 Cg_endo -95.85 175.29 0.9 Allowed 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.747 2.298 . . . . 0.0 111.741 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.9 t -85.12 106.5 9.05 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.3 100.76 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.373 2.049 . . . . 0.0 113.651 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.8 mt -134.54 86.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.6 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . -136.32 151.33 20.76 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.48 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.05 104.07 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 123.645 0.778 . . . . 0.0 108.931 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.13 99.06 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -76.36 -69.82 0.48 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.522 0.677 . . . . 0.0 109.821 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -163.91 168.4 19.47 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG3' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -81.69 -31.09 32.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.189 0.995 . . . . 0.0 108.432 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' HD3' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -92.17 28.41 1.9 Allowed 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.408 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 m -152.46 166.6 31.45 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 85' ' ' GLU . 18.6 m -76.95 103.59 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 118.979 0.809 . . . . 0.0 110.958 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.65 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 23.5 ptt? -83.43 119.26 24.44 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -108.58 88.48 5.2 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 71' ' ' MET . 12.6 Cg_endo -96.07 167.5 1.24 Allowed 'Trans proline' 0 N--CA 1.403 -3.807 0 C-N-CA 121.973 1.782 . . . . 0.0 111.097 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 73.4 t80 -140.34 113.01 8.05 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.7 p -128.06 139.79 52.33 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -112.31 88.88 11.34 Favored Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.636 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 75' ' ' THR . 73.5 Cg_endo -106.1 -151.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 123.923 3.082 . . . . 0.0 109.808 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.0 t -100.74 13.35 35.2 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.55 ' HD2' ' CE2' ' A' ' 9' ' ' TYR . 48.3 t80 -124.84 -81.55 0.63 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.562 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -174.0 40.63 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 10.2 m -118.75 158.06 26.31 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.33 0.565 . . . . 0.0 110.218 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -114.91 125.43 53.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.4 t -107.34 108.0 24.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 44' ' ' PRO . 29.3 m -114.32 141.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.446 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.484 ' HB2' HG12 ' A' ' 70' ' ' VAL . 38.7 tt0 -134.56 108.57 8.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.0 tp -95.23 129.09 36.29 Favored Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.5 13.51 2.63 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.429 2.086 . . . . 0.0 110.839 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.514 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 21.4 t -115.88 159.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 9.7 t70 -65.66 146.12 99.0 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.542 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 11.3 Cg_endo -54.34 -13.74 5.68 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.84 3.027 . . . . 0.0 113.879 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.4 pt-20 -61.4 -20.69 63.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 4.4 tp10 -64.3 -30.53 71.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HG3' ' A' ' 67' ' ' ARG . 48.8 mm -70.04 -31.58 48.21 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.954 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.96 -39.47 94.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -64.97 -48.67 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.463 1.125 . . . . 0.0 108.172 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.1 mt -68.96 -19.58 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.088 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 65.5 tp -77.18 -26.58 53.07 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.019 0.928 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.69 -37.53 59.46 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 56.5 t -62.36 -65.56 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . 59.2 -57.67 0.05 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.732 2.013 . . . . 0.0 114.969 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 32.5 mt-10 -128.06 -69.66 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.134 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.558 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 73.1 Cg_endo . . . . . 0 N--CA 1.437 -1.829 0 CA-C-N 120.681 1.279 . . . . 0.0 112.565 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.622 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 67.1 mtm -152.79 128.54 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m -106.74 111.45 23.98 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.2 m-85 -128.69 10.43 6.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.169 0.509 . . . . 0.0 111.141 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.4 m -131.69 106.93 8.46 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -80.92 -37.47 29.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.121 0.962 . . . . 0.0 111.419 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' H ' HD13 ' A' ' 6' ' ' LEU . 8.3 tp10 -71.38 -19.24 62.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.278 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.535 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.3 m -73.01 -31.96 64.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -70.47 -30.13 66.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.126 0.489 . . . . 0.0 110.092 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.6 -43.64 98.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.81 -11.7 59.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.388 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 8' ' ' THR . 52.5 mt-30 -89.67 -32.83 16.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.6 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -164.5 -67.07 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.47 166.01 38.66 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.85 141.29 56.49 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.716 0.769 . . . . 0.0 111.732 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -139.7 8.38 2.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 54.7 mt-10 -152.86 148.98 27.8 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.34 -1.754 . . . . 0.0 106.741 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.54 HG22 ' HG ' ' A' ' 49' ' ' LEU . 12.4 tt -89.31 159.93 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -72.11 70.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.794 1.283 . . . . 0.0 109.972 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 mmt -136.69 -175.5 4.04 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.901 -1.954 . . . . 0.0 106.139 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 51.4 mttp -84.52 118.19 24.16 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 119.485 1.039 . . . . 0.0 110.997 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.502 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -108.37 136.62 47.69 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.411 -177.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . . . -143.36 96.18 2.87 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -114.48 85.12 0.38 Allowed Glycine 0 N--CA 1.423 -2.176 0 C-N-CA 120.302 -0.951 . . . . 0.0 114.476 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -69.28 -81.03 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 117.105 0.452 . . . . 0.0 112.108 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 20.9 mtp-105 -73.13 -32.95 65.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 13.1 tp10 -70.05 -13.85 62.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.743 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 43.4 t -60.63 -31.9 71.07 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.13 68.5 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.455 0.645 . . . . 0.0 110.204 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.63 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.51 -44.87 81.38 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.379 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.465 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 22.4 ptp -56.32 -31.14 63.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 28' ' ' CYS . 46.7 mm -60.96 -40.74 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.663 0.744 . . . . 0.0 109.531 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HB3' HG21 ' A' ' 39' ' ' VAL . 8.5 mm-40 -80.45 -34.25 36.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.281 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.503 ' HE2' ' O ' ' A' ' 39' ' ' VAL . 74.3 mttt -68.26 -13.54 62.33 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -64.23 -30.55 71.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.484 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.71 -47.06 27.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.626 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.58 -74.3 0.06 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 120.756 0.313 . . . . 0.0 110.595 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 ttp180 -165.82 124.63 1.61 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 58.8 t -136.39 165.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.6 p -112.51 149.35 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.437 0.695 . . . . 0.0 109.901 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.63 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 46.2 t60 -140.74 128.84 22.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.4 mp -98.09 136.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 97.0 mttt 71.78 55.97 0.38 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.868 1.267 . . . . 0.0 110.432 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 85.4 Cg_endo -74.16 135.38 20.71 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.997 1.131 . . . . 0.0 109.716 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.94 46.58 1.08 Allowed Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 4.4 pm0 -112.99 153.21 28.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-O 121.643 0.735 . . . . 0.0 110.696 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -140.97 61.76 1.49 Allowed 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.446 ' C ' HD22 ' A' ' 49' ' ' LEU . 33.7 pt -64.29 105.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.576 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.54 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 70.49 -10.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.965 2.106 . . . . 0.0 113.792 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.84 -1.16 88.03 Favored Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.59 120.79 3.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.721 1.608 . . . . 0.0 107.069 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.93 87.5 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.321 0.582 . . . . 0.0 112.275 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.493 HD12 HG21 ' A' ' 18' ' ' ILE . 61.5 mt -116.54 130.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.1 mm -71.88 -40.87 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.498 0.666 . . . . 0.0 109.597 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.0 0.24 63.87 Favored Glycine 0 C--N 1.308 -0.996 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mt -130.52 129.38 22.75 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.64 107.08 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.333 2.022 . . . . 0.0 110.07 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 36.0 Cg_endo -103.97 -167.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.272 0 C-N-CA 122.566 2.177 . . . . 0.0 111.319 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 75' ' ' THR . 41.3 t -99.16 100.67 10.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 10.3 Cg_endo -87.66 102.59 0.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.721 2.28 . . . . 0.0 113.541 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.53 164.52 34.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 133.13 -175.09 20.3 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.556 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.72 107.04 4.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -99.51 108.62 21.1 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -85.34 -55.93 3.78 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.597 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -171.94 166.8 6.29 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -35.48 74.58 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.597 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 16.0 m -96.37 31.4 2.24 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.608 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -151.43 161.65 42.33 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.448 HG13 ' OE2' ' A' ' 85' ' ' GLU . 9.5 m -77.35 112.77 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.979 0.895 . . . . 0.0 109.865 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.603 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -90.84 123.05 34.08 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.72 89.27 12.85 Favored Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.138 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 71' ' ' MET . 4.9 Cg_exo -85.04 155.94 11.29 Favored 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 121.872 1.714 . . . . 0.0 110.029 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -125.22 75.73 1.48 Allowed 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.553 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 p -106.51 134.62 49.36 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.455 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -110.79 88.81 8.42 Favored Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.875 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 75' ' ' THR . 44.3 Cg_endo -103.38 -159.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.658 2.905 . . . . 0.0 109.797 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 10.1 t -94.58 5.31 52.21 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.448 0.642 . . . . 0.0 109.302 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -120.68 -84.42 0.66 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.152 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -168.8 39.63 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 27.7 m -116.96 147.76 41.99 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.313 0.578 . . . . 0.0 110.08 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.471 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -120.12 121.59 39.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 82.9 t -104.38 104.91 17.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -103.22 133.78 46.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.448 ' OE2' HG13 ' A' ' 70' ' ' VAL . 36.2 tt0 -132.69 115.21 15.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.324 0.583 . . . . 0.0 109.696 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 21.9 tp -99.37 132.99 22.33 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.38 -3.4 10.8 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.311 2.007 . . . . 0.0 111.834 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.602 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.5 t -96.0 164.32 2.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.0 t70 -68.61 146.89 97.93 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 123.208 0.603 . . . . 0.0 110.755 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.04 -10.92 1.24 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 124.134 3.223 . . . . 0.0 114.749 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.1 pt-20 -55.63 -22.61 23.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.279 0.632 . . . . 0.0 110.814 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -58.88 -23.19 60.65 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.864 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 27.2 mm -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -65.15 -37.55 87.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.09 -51.01 66.07 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' A' ' 47' ' ' LYS . 3.0 mt -58.42 -29.58 38.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.451 0 C-N-CA 125.74 1.616 . . . . 0.0 113.028 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.48 -36.68 79.3 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.237 0.542 . . . . 0.0 110.685 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.43 -45.1 10.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.215 1.007 . . . . 0.0 109.878 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.67 13.81 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 125.771 1.628 . . . . 0.0 111.095 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.713 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . . . -63.84 -36.31 83.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 29.2 mt-10 -88.73 -52.54 0.37 Allowed Pre-proline 0 N--CA 1.412 -2.361 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.657 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 32.5 Cg_endo . . . . . 0 N--CA 1.426 -2.491 0 C-N-CA 122.079 1.853 . . . . 0.0 112.353 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 CA--C 1.499 -0.987 0 CA-C-O 120.995 0.426 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.474 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 70.9 mtm -152.0 123.83 7.99 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.3 m -100.61 118.53 36.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 120.4 0.143 . . . . 0.0 111.085 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.8 m-85 -134.74 14.48 3.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.411 0.624 . . . . 0.0 109.535 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.0 m -135.05 102.43 5.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -76.04 -33.3 59.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.387 1.089 . . . . 0.0 111.542 -175.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' OE1' HD13 ' A' ' 10' ' ' LEU . 10.6 tp10 -73.7 -22.16 60.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.77 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -68.61 -30.87 69.69 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.14 -29.18 61.69 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.102 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.49 HD13 ' OE1' ' A' ' 7' ' ' GLU . 8.4 tt -61.9 -45.24 94.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' A' ' 7' ' ' GLU . 67.8 mt-30 -68.34 -35.34 77.63 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.162 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.27 -46.58 76.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.661 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 m -155.33 -67.82 0.12 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.244 0.545 . . . . 0.0 110.647 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.25 166.84 37.27 Favored Glycine 0 N--CA 1.413 -2.865 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.52 143.57 56.09 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-O 121.499 0.666 . . . . 0.0 111.767 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.13 3.85 3.44 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 48.6 mt-10 -151.49 155.54 38.75 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.643 HG22 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -94.88 166.89 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -75.66 72.43 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.406 1.098 . . . . 0.0 109.787 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 mmt -137.89 -176.37 4.41 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.899 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -78.04 111.31 13.8 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 118.784 0.72 . . . . 0.0 109.997 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HB2' ' OE2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -103.72 132.19 50.21 Favored 'General case' 0 N--CA 1.406 -2.632 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.64 98.56 3.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -120.89 86.9 0.4 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.207 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.442 ' CE1' ' HZ ' ' A' ' 4' ' ' PHE . 98.2 m-85 -71.78 -75.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.249 0.547 . . . . 0.0 110.51 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.632 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.2 mmp_? -70.08 -38.24 75.65 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -74.91 -8.74 57.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.987 -176.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.8 t -58.21 -35.14 71.22 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.132 0.491 . . . . 0.0 109.686 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.19 -42.66 79.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.512 0.673 . . . . 0.0 110.219 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -63.67 -49.1 74.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.122 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.5 ptp -57.14 -33.12 67.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 28' ' ' CYS . 47.5 mm -65.15 -39.25 84.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.715 0.769 . . . . 0.0 109.63 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.35 -31.78 43.1 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.62 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.0 mttt -66.4 -21.29 66.22 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -60.98 -25.61 66.97 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.66 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.71 -49.68 24.5 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -166.38 -71.38 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.911 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' THR . 52.2 ttp180 -164.15 111.56 1.11 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.89 150.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.168 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -103.23 148.0 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.625 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 49.3 t-80 -133.43 111.96 11.17 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.5 mp -82.77 138.32 19.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.431 ' HA ' HD12 ' A' ' 86' ' ' LEU . 96.1 mttt 69.99 59.23 0.53 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.522 1.129 . . . . 0.0 110.782 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 96.6 Cg_endo -78.95 166.0 23.66 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.059 1.839 . . . . 0.0 111.051 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -162.06 52.41 0.32 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 4.9 pm0 -116.32 151.98 34.78 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.053 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -138.34 60.43 1.61 Allowed 'General case' 0 CA--C 1.468 -2.203 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 175.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.406 ' C ' HD22 ' A' ' 49' ' ' LEU . 40.1 pt -69.27 112.2 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.129 0 CA-C-N 112.187 -2.278 . . . . 0.0 110.407 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.643 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 75.64 -19.33 0.41 Allowed 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.723 2.009 . . . . 0.0 113.139 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.71 -9.9 60.56 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.15 115.82 2.07 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -67.74 123.3 20.14 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -136.8 128.35 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.84 -37.15 60.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.22 -35.65 4.65 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 78' ' ' CYS . 59.0 mt -93.24 120.71 66.53 Favored Pre-proline 0 N--CA 1.417 -2.093 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.49 111.42 2.32 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.176 1.917 . . . . 0.0 110.004 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -101.76 -176.04 0.12 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.556 2.17 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 75' ' ' THR . 52.2 t -79.86 113.96 42.24 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 8.1 Cg_exo -72.96 52.93 2.3 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.13 2.553 . . . . 0.0 115.272 -173.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.4 mt -111.93 154.35 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 150.35 173.6 20.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 119.238 -1.458 . . . . 0.0 113.436 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -122.32 90.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.53 101.22 13.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.52 -70.43 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.626 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -162.62 170.98 17.63 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.1 -29.7 64.35 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.524 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 17.6 m -99.35 27.63 5.08 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.179 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 m -149.02 159.03 44.59 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.3 114.79 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 122.026 0.917 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.615 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -92.88 96.69 10.28 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.64 98.51 9.68 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 71' ' ' MET . 25.0 Cg_endo -92.19 171.19 2.6 Favored 'Trans proline' 1 N--CA 1.398 -4.104 0 C-N-CA 121.671 1.581 . . . . 0.0 112.08 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -124.18 48.05 1.98 Allowed 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.6 p -97.94 111.29 23.65 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-N 113.078 -1.873 . . . . 0.0 108.122 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -103.53 103.64 37.1 Favored Pre-proline 0 C--N 1.29 -2.0 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.858 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 75' ' ' THR . 19.6 Cg_endo -97.31 -164.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.768 0 C-N-CA 122.202 1.934 . . . . 0.0 108.249 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.483 ' H ' HG21 ' A' ' 56' ' ' ILE . 42.6 t -98.6 13.84 30.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.191 0.996 . . . . 0.0 109.065 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -115.02 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.962 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -179.2 164.14 32.14 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 8.4 m -91.29 152.48 20.46 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.07 135.52 53.62 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 t -127.65 131.79 69.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.42 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.3 m -131.45 147.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 40.6 tt0 -149.88 116.82 5.93 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.367 0.417 . . . . 0.0 110.24 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.3 tp -96.45 129.88 32.15 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.35 -8.27 17.28 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.748 1.632 . . . . 0.0 111.588 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.51 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 11.6 t -100.46 156.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.54 151.72 87.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 O-C-N 123.197 0.31 . . . . 0.0 111.699 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.16 -14.35 33.27 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.726 2.951 . . . . 0.0 113.263 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.65 -25.61 62.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.318 0.647 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' ARG . 49.8 mm-40 -75.04 -28.87 60.6 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.257 0.551 . . . . 0.0 110.017 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 48.9 mm -77.42 -27.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.931 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -65.91 -37.01 84.96 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 38.2 ttt180 -65.48 -47.25 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.992 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.66 -21.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.1 -27.08 60.71 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -27.16 61.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 99' ' ' VAL . 43.2 t -102.79 22.46 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.136 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . . . -58.21 -49.58 76.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.46 -42.13 0.41 Allowed Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 C--N 1.386 2.521 0 C-N-CA 123.752 2.968 . . . . 0.0 115.722 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -172.85 136.18 0.68 Allowed 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.977 0.911 . . . . 0.0 109.675 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.5 m -148.62 129.48 14.28 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 61.2 m-85 -116.22 0.73 12.98 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.82 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.2 m -82.31 111.8 18.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.857 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 22' ' ' ARG . 4.5 pp -106.37 -44.73 4.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.766 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.665 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 42.5 tt0 -68.42 -10.77 57.47 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.048 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 p -70.96 -28.36 64.42 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -75.89 -30.33 58.79 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 15' ' ' GLU . 36.5 tp -57.67 -43.39 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.974 0.893 . . . . 0.0 109.325 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -74.04 -12.76 60.71 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.381 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.39 -32.82 10.97 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.055 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -155.43 -66.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 109.844 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.02 162.89 36.68 Favored Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.665 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 9.5 tp10 -83.62 147.99 27.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 117.709 0.755 . . . . 0.0 109.318 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' HG23 ' A' ' 54' ' ' ILE . 66.9 t80 -131.27 18.12 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.055 0.931 . . . . 0.0 109.586 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 19.4 mm-40 -147.26 170.52 17.11 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.606 HG22 ' HG ' ' A' ' 49' ' ' LEU . 16.9 tt -102.69 158.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -75.06 69.87 2.0 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 123.34 1.543 . . . . 0.0 112.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.426 ' O ' HD21 ' A' ' 6' ' ' LEU . 29.9 mmm -128.62 -155.86 0.72 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.55 2.74 . . . . 0.0 106.037 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.24 123.19 47.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.886 0.766 . . . . 0.0 109.314 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -93.92 135.14 35.56 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.16 92.68 3.83 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -111.78 79.01 0.25 Allowed Glycine 0 C--N 1.291 -1.957 0 C-N-CA 118.818 -1.658 . . . . 0.0 112.47 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 95.3 m-85 -73.12 -69.6 0.41 Allowed 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 117.459 0.629 . . . . 0.0 109.311 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.698 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 25.9 mmt180 -80.5 -36.78 32.82 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.288 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 3.5 tm-20 -66.0 -13.05 59.18 Favored 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 31' ' ' MET . 27.2 t -48.68 -40.13 26.98 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.82 0.819 . . . . 0.0 110.287 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.71 -42.43 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.728 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.236 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.566 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 27.3 ptt? -51.58 -40.38 59.67 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.799 0.687 . . . . 0.0 111.863 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.3 mm -60.25 -45.02 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 39' ' ' VAL . 19.8 mm-40 -80.8 -30.45 35.91 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.175 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 81' ' ' THR . 28.6 mtpt -61.29 -26.97 68.14 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.348 1.059 . . . . 0.0 112.288 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -66.27 -22.56 66.31 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 123.837 0.71 . . . . 0.0 110.694 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.97 -60.12 2.41 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -144.37 -76.85 0.22 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.106 0.955 . . . . 0.0 109.974 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.2 ptp180 -168.7 124.79 0.96 Allowed 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 33' ' ' GLU . 73.4 t -134.43 145.66 32.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.291 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.4 p -98.5 142.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 O-C-N 124.398 1.061 . . . . 0.0 108.566 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.51 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 51.9 t-80 -133.49 120.29 20.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.1 tt -81.33 147.73 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 62.07 56.52 2.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.528 0.731 . . . . 0.0 111.473 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 84.4 Cg_endo -77.37 156.37 32.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.033 1.822 . . . . 0.0 111.152 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.698 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -160.75 56.49 0.32 Allowed Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 2.3 pm0 -115.98 174.38 6.07 Favored 'General case' 0 C--N 1.26 -3.314 0 CA-C-N 113.919 -1.14 . . . . 0.0 110.555 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.514 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.1 mmtt -154.85 89.45 1.24 Allowed 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 126.309 1.844 . . . . 0.0 106.09 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.418 ' C ' HD22 ' A' ' 49' ' ' LEU . 28.8 pt -85.34 100.39 8.45 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.269 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.606 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 58.52 16.59 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.063 1.745 . . . . 0.0 111.967 176.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 -51.74 4.04 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.23 142.68 50.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -70.21 103.4 2.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 18' ' ' ILE . 61.5 mt -123.06 114.59 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.444 HG23 ' CD1' ' A' ' 16' ' ' TYR . 69.3 mt -77.43 -44.45 30.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 122.229 1.014 . . . . 0.0 109.057 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.91 -29.96 9.75 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.427 ' H ' HG22 ' A' ' 54' ' ' ILE . 31.9 mm -86.59 125.64 66.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.58 106.82 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.478 2.119 . . . . 0.0 110.521 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -107.79 -161.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.234 0 C-N-CA 123.002 2.468 . . . . 0.0 111.396 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 75' ' ' THR . 46.8 t -96.35 113.05 61.74 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.34 50.12 1.86 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.524 2.816 . . . . 0.0 114.63 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.58 149.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.37 167.66 36.55 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.747 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -135.4 82.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.22 94.53 9.23 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 8.2 mm-40 -72.19 -62.49 1.41 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.548 -177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.8 179.13 9.5 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -90.98 -33.37 15.58 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.12 40.08 1.01 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.679 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.4 t -165.19 -178.74 5.24 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.58 105.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.555 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 22.8 ptm -89.53 100.87 13.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.9 mt -101.29 100.81 14.49 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.709 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.7 Cg_exo -82.09 148.62 15.21 Favored 'Trans proline' 0 N--CA 1.436 -1.907 0 C-N-CA 122.071 1.847 . . . . 0.0 110.405 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.49 60.39 0.73 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.604 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.1 p -106.39 119.81 40.23 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.145 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.13 101.64 13.19 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 75' ' ' THR . 87.1 Cg_endo -105.07 -156.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 123.198 2.599 . . . . 0.0 111.191 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -109.24 29.13 7.81 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.061 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -144.07 -80.36 0.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.195 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.81 -176.54 46.75 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 51.0 m -118.31 146.95 43.96 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.052 0.926 . . . . 0.0 110.873 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.26 38.5 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 123.372 0.669 . . . . 0.0 111.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 42.6 t -117.97 112.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.1 m -115.01 142.53 27.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 O-C-N 121.486 -0.759 . . . . 0.0 109.247 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 tt0 -139.12 113.79 9.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.284 0.564 . . . . 0.0 110.421 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.3 tp -93.44 130.09 36.62 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.06 19.63 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.624 2.216 . . . . 0.0 111.277 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' SER . 36.5 t -122.34 156.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.01 162.14 41.22 Favored Pre-proline 0 C--N 1.307 -1.255 0 O-C-N 123.487 0.492 . . . . 0.0 111.258 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.2 2.41 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.406 2.737 . . . . 0.0 113.219 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.95 -30.62 70.34 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.834 0.854 . . . . 0.0 109.708 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -66.66 -23.49 66.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.252 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.67 -30.17 41.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.66 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.84 -39.73 94.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.635 ' HD2' ' H ' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -76.93 -37.77 54.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.76 -29.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.0 -33.69 76.11 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.6 0.76 . . . . 0.0 109.851 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.61 -24.9 38.78 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.429 1.109 . . . . 0.0 109.049 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -92.61 15.25 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.075 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.514 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.96 -49.8 8.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.542 1.137 . . . . 0.0 113.198 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.05 93.38 3.42 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.355 2.704 . . . . 0.0 112.405 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 . . . . . 0 C--O 1.219 -0.519 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.7 mtt 69.95 112.26 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.075 0.95 . . . . 0.0 109.853 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.42 HG21 ' SD ' ' A' ' 31' ' ' MET . 90.4 m -113.37 128.17 56.37 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.533 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -129.85 21.45 5.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 30.9 m -89.16 87.42 7.16 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.6 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.621 HD13 ' H ' ' A' ' 6' ' ' LEU 0.295 0.0 OUTLIER -84.28 -43.7 14.58 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.43 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 28.3 tt0 -69.75 -4.83 21.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 123.031 1.396 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 29.6 m -76.62 -19.96 57.25 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.617 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.686 ' CD1' ' HA ' ' A' ' 15' ' ' GLU . 2.7 p90 -64.8 -33.11 75.22 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' CE1' ' A' ' 9' ' ' TYR . 10.0 mt -71.41 -35.63 71.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.891 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -76.57 -26.66 55.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.271 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 8' ' ' THR . 45.8 mt-30 -83.38 -14.0 53.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 m 71.25 33.96 1.87 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.495 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.27 90.57 0.2 Allowed Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.879 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.686 ' HA ' ' CD1' ' A' ' 9' ' ' TYR . 3.0 pm0 -59.55 124.35 19.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.984 0.897 . . . . 0.0 111.781 177.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -147.15 9.76 0.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.488 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.575 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 44.9 mt-10 -147.34 179.76 7.42 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.485 -175.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.655 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.288 13.0 tt -109.49 18.43 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-O 121.91 0.862 . . . . 0.0 111.376 178.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.37 36.33 25.41 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.769 1.271 . . . . 0.0 109.701 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.2 mmt -98.46 -96.54 0.22 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.684 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.76 126.9 9.12 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.575 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . 10.7 ptm180 -113.7 154.07 27.92 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -134.98 89.39 2.52 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . -106.72 82.0 0.31 Allowed Glycine 0 CA--C 1.486 -1.76 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.335 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -70.95 -70.14 0.33 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.651 0.263 . . . . 0.0 111.339 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 51.1 mtt180 -87.61 -30.54 20.39 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.322 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 10.5 mt-10 -75.22 -3.75 34.93 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 28.0 p -53.14 -37.15 61.55 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 121.419 0.628 . . . . 0.0 110.455 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.59 -41.09 63.33 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.149 0.5 . . . . 0.0 110.443 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.65 68.6 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.063 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.42 ' SD ' HG21 ' A' ' 3' ' ' THR . 26.2 ptm -51.8 -38.49 55.88 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.763 0.664 . . . . 0.0 112.619 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 28' ' ' CYS . 76.7 mt -57.51 -49.52 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 123.923 0.764 . . . . 0.0 110.567 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 39' ' ' VAL . 38.7 mt-10 -82.79 -26.96 31.3 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.888 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 81' ' ' THR . 14.2 mtpp -58.58 -21.64 53.67 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 123.965 0.906 . . . . 0.0 112.29 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -58.44 -22.76 55.5 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.858 0.724 . . . . 0.0 111.398 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.62 1.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -166.24 -59.64 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -155.31 121.03 5.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 33' ' ' GLU . 77.5 t -128.61 145.13 36.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 2.7 p -96.73 137.59 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 O-C-N 123.858 0.723 . . . . 0.0 110.053 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -139.84 129.43 24.36 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.1 tt -90.26 145.04 7.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 53.0 mtmt 67.54 61.97 0.77 Allowed Pre-proline 0 C--O 1.217 -0.636 0 C-N-CA 123.351 0.66 . . . . 0.0 110.992 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 69.6 Cg_endo -81.14 173.03 12.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.584 2.189 . . . . 0.0 112.19 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.8 55.86 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.134 -1.031 . . . . 0.0 112.258 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 29.5 tt0 -121.98 137.56 54.75 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.626 0.727 . . . . 0.0 111.856 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 6.1 mmtt -126.51 111.03 13.92 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.604 ' HB ' HD22 ' A' ' 49' ' ' LEU . 29.2 pt -100.2 122.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.553 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.655 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 54.51 16.42 1.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.014 2.126 . . . . 0.0 113.74 175.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 100' ' ' ALA . . . 83.81 -44.89 3.38 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.006 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.84 125.2 42.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG3' HD11 ' A' ' 48' ' ' ILE . 55.8 ttp180 -67.56 98.82 0.7 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 123.639 0.587 . . . . 0.0 111.173 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.69 123.5 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mm -83.35 -37.68 13.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.894 0.854 . . . . 0.0 109.207 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.43 -7.96 66.41 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.562 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.2 mm -135.3 132.47 20.03 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 51.5 Cg_exo -55.78 109.45 0.42 Allowed 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 123.204 2.603 . . . . 0.0 112.175 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 6.9 Cg_endo -87.67 161.27 7.82 Favored 'Trans proline' 0 N--CA 1.427 -2.404 0 C-N-CA 122.388 2.059 . . . . 0.0 110.938 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.71 139.17 95.38 Favored Pre-proline 0 C--N 1.301 -1.505 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.095 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.79 34.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.523 3.262 1 C-N-CA 127.349 5.366 . . . . 0.0 119.656 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' HA ' HG23 ' A' ' 75' ' ' THR 0.27 2.8 pt 67.78 -171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 127.676 2.39 . . . . 0.0 112.602 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' H ' ' A' ' 74' ' ' TYR . . . -143.63 -113.2 0.9 Allowed Glycine 1 N--CA 1.388 -4.525 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.296 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.38 122.94 64.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 71' ' ' MET . 4.0 p-10 -130.27 125.43 34.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -100.54 -63.72 1.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.1 tp10 -165.33 168.58 16.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -31.7 67.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 8.5 p -93.34 30.88 1.59 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.323 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.416 ' CA ' ' HG3' ' A' ' 85' ' ' GLU . 31.4 m -156.99 161.0 39.57 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 m -71.08 145.02 12.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.29 0.567 . . . . 0.0 110.216 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 83' ' ' VAL . 25.2 ptt? -134.73 139.2 45.01 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.87 80.32 25.26 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.464 ' O ' HG21 ' A' ' 81' ' ' THR . 1.3 Cg_endo -81.86 132.06 7.35 Favored 'Trans proline' 0 N--CA 1.414 -3.198 0 C-N-CA 121.587 1.525 . . . . 0.0 109.981 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.514 ' H ' ' N ' ' A' ' 62' ' ' GLY . 79.2 m-85 -91.9 57.89 3.27 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-O 122.268 1.033 . . . . 0.0 108.705 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 61' ' ' ILE . 36.7 p -103.92 102.66 12.46 Favored 'General case' 1 N--CA 1.376 -4.157 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -95.29 106.9 28.97 Favored Pre-proline 0 C--N 1.277 -2.587 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.249 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 75' ' ' THR . 22.6 Cg_endo -95.26 -165.53 0.11 Allowed 'Trans proline' 0 N--CA 1.431 -2.167 0 C-N-CA 122.704 2.27 . . . . 0.0 110.471 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.3 t -95.77 15.7 19.48 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.637 0.732 . . . . 0.0 109.131 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -135.56 -62.95 0.68 Allowed 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 166.28 148.27 5.5 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.186 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.634 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -84.61 158.3 20.92 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 124.879 1.272 . . . . 0.0 108.678 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . . . -122.36 120.68 34.72 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.879 -0.513 . . . . 0.0 111.063 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 95.4 t -103.31 84.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 44' ' ' PRO . 12.4 m -108.45 124.71 65.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.416 ' HG3' ' CA ' ' A' ' 69' ' ' THR . 43.4 tt0 -118.43 120.75 38.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.126 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.4 tp -96.65 130.77 29.58 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.09 -4.13 11.81 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.214 1.943 . . . . 0.0 111.142 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.537 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 12.0 t -97.64 161.66 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 91' ' ' GLU . 11.7 m-20 -72.44 163.66 65.88 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 118.096 0.407 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.79 6.2 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 89' ' ' ASP . 11.2 pt-20 -67.38 -27.17 66.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.813 0.845 . . . . 0.0 109.016 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.4 mm-40 -64.2 -29.27 70.39 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.083 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 mt -64.35 -28.45 44.91 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.661 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.62 -47.29 70.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.365 0.602 . . . . 0.0 109.602 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -66.78 -32.04 73.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.411 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 92' ' ' GLU . 69.1 mt -86.28 -5.63 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-O 121.879 0.847 . . . . 0.0 110.107 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.78 -33.49 30.85 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.03 -32.79 71.11 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.785 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' VAL . 18.9 t -107.03 28.35 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.448 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.581 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.588 ' HB1' ' HA2' ' A' ' 50' ' ' GLY . . . -59.67 -31.29 69.41 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.446 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 37.0 tt0 -157.27 -57.78 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.58 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 92.8 Cg_endo . . . . . 0 N--CA 1.442 -1.557 0 C-N-CA 120.942 1.095 . . . . 0.0 113.228 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.402 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 63.6 m-70 . . . . . 0 CA--C 1.505 -0.788 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -174.95 126.74 0.28 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.875 1.27 . . . . 0.0 109.146 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.534 HG21 ' SD ' ' A' ' 31' ' ' MET . 11.9 t -124.47 134.45 53.05 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.73 0.776 . . . . 0.0 110.855 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.08 26.11 4.57 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.916 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.477 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 65.3 m -126.51 101.1 6.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.689 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.567 ' CD2' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -84.96 -46.03 11.63 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.969 0.89 . . . . 0.0 113.031 -176.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' H ' HD13 ' A' ' 6' ' ' LEU . 42.0 tt0 -73.18 -12.29 60.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.118 0.961 . . . . 0.0 110.95 -175.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 24.2 m -73.58 -26.2 60.71 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.986 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -72.64 -32.96 66.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.99 -41.7 99.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 11' ' ' GLN . 11.3 mm-40 -67.78 -27.7 66.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.13 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 8' ' ' THR . 28.1 mt-30 -78.41 -45.86 21.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.659 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.431 ' OG ' ' HD2' ' A' ' 35' ' ' LYS . 45.1 m -158.68 -68.29 0.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.899 0.38 . . . . 0.0 111.367 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.04 174.33 31.06 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.358 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.02 146.16 24.56 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 124.295 0.644 . . . . 0.0 109.725 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.425 ' HA ' HG23 ' A' ' 54' ' ' ILE . 40.8 t80 -139.59 21.48 2.53 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.635 ' HB3' HD21 ' A' ' 49' ' ' LEU . 38.7 mp0 -140.97 175.84 9.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.091 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.702 HG22 HD22 ' A' ' 49' ' ' LEU . 7.0 tt -109.47 7.04 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.047 -1.033 . . . . 0.0 109.079 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 65.2 t-80 74.7 73.97 0.11 Allowed 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.829 1.651 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.522 ' HB3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.0 179.49 9.17 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' N ' ' SD ' ' A' ' 20' ' ' MET . 86.2 mttt -61.46 111.06 1.64 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.967 0.889 . . . . 0.0 109.883 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.762 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.2 119.24 38.58 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.389 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.3 85.99 2.49 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.676 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.76 81.66 0.48 Allowed Glycine 0 CA--C 1.469 -2.803 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.289 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -69.89 -78.73 0.07 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 117.119 0.459 . . . . 0.0 110.314 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -84.04 -21.04 31.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.958 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.619 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -81.51 -10.72 59.41 Favored 'General case' 0 C--O 1.205 -1.263 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.48 -177.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 53.7 t -51.97 -38.15 55.59 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.569 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.01 -44.59 69.0 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.179 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -58.85 -52.44 65.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.965 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 3' ' ' THR . 21.6 ptp -54.07 -38.2 65.04 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.864 0.728 . . . . 0.0 112.779 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 28' ' ' CYS . 80.3 mt -58.96 -45.02 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.682 0.753 . . . . 0.0 109.524 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 39' ' ' VAL . 61.7 mm-40 -79.85 -32.2 40.49 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.617 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 84.1 mttt -58.42 -28.5 65.31 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 122.924 0.49 . . . . 0.0 111.165 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 8.1 ttpp -64.66 -13.39 53.82 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.049 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -65.52 0.92 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -142.85 -75.22 0.27 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.721 0.772 . . . . 0.0 109.687 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.48 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 36.3 ptt180 -156.3 128.15 7.35 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 33' ' ' GLU . 69.6 t -140.08 141.64 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.526 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.5 p -106.94 147.06 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 19.8 t-80 -135.56 134.21 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 20.7 tt -90.48 143.65 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 86' ' ' LEU . 61.7 mttp 67.41 64.01 0.72 Allowed Pre-proline 0 C--N 1.32 -0.714 0 C-N-CA 123.822 0.849 . . . . 0.0 110.642 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.38 172.12 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.205 1.27 . . . . 0.0 110.233 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.21 54.43 0.13 Allowed Glycine 0 CA--C 1.464 -3.152 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.619 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 1.6 pm0 -112.35 157.84 20.52 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 122.366 1.079 . . . . 0.0 112.414 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -143.86 72.4 1.35 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 113.479 -1.692 . . . . 0.0 107.577 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.618 HG22 ' HG ' ' A' ' 49' ' ' LEU . 72.0 mt -91.58 108.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.702 HD22 HG22 ' A' ' 18' ' ' ILE . 0.9 OUTLIER 66.01 16.93 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.96 1.304 . . . . 0.0 109.381 177.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.19 4.5 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -175.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.18 118.3 25.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -64.32 104.39 0.76 Allowed 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.131 0.894 . . . . 0.0 112.716 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 49' ' ' LEU . 49.6 mm -114.66 135.13 55.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.425 HG23 ' HA ' ' A' ' 16' ' ' TYR . 60.2 mt -75.49 -35.36 32.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-O 121.233 0.539 . . . . 0.0 110.0 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.51 -21.73 20.34 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.25 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.62 120.26 56.42 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.42 112.55 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.968 2.445 . . . . 0.0 111.327 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -101.39 -176.61 0.13 Allowed 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 122.615 2.21 . . . . 0.0 111.081 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.3 t -67.57 121.02 77.35 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.05 56.02 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 114.745 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.4 147.66 32.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 155.5 148.15 4.94 Favored Glycine 0 CA--C 1.483 -1.933 0 C-N-CA 118.539 -1.791 . . . . 0.0 113.52 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.3 pt -129.12 153.19 38.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.02 115.29 20.31 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.99 -71.97 0.44 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.242 0.544 . . . . 0.0 111.902 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 31.0 tt0 -148.36 166.12 29.02 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 5.7 tpp180 -83.22 -35.43 25.41 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.058 0.933 . . . . 0.0 110.551 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.7 p -88.66 29.96 0.96 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.775 1.274 . . . . 0.0 111.514 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 66' ' ' GLU . 87.5 m -154.72 170.72 20.91 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 85' ' ' GLU . 27.1 m -78.93 161.01 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.202 1.001 . . . . 0.0 111.117 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.547 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 26.8 ptt? -118.4 131.38 56.29 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.11 88.35 14.71 Favored Pre-proline 0 C--N 1.291 -1.961 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.343 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 71' ' ' MET . 6.4 Cg_endo -90.53 144.28 3.81 Favored 'Trans proline' 0 N--CA 1.408 -3.534 0 C-N-CA 121.545 1.496 . . . . 0.0 109.966 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -110.87 46.32 1.07 Allowed 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 123.298 1.523 . . . . 0.0 107.405 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 39.6 p -93.26 105.57 17.63 Favored 'General case' 0 N--CA 1.389 -3.498 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.163 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -105.78 96.61 12.85 Favored Pre-proline 0 C--N 1.275 -2.634 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 75' ' ' THR . 23.7 Cg_endo -99.0 -164.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.365 2.71 . . . . 0.0 111.166 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.5 t -88.72 -6.16 57.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.362 0.601 . . . . 0.0 110.058 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -96.32 -74.22 0.57 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 171.26 172.08 37.07 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 28.0 m -94.5 141.73 28.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.63 125.58 52.74 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.29 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 41.7 t -126.47 124.69 65.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.2 m -126.71 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.442 ' HB2' HG12 ' A' ' 70' ' ' VAL . 52.5 tt0 -134.31 123.12 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' SER . 28.4 tp -103.05 128.18 28.22 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.84 1.78 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.69 1.593 . . . . 0.0 110.698 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.548 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -103.59 158.27 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.98 151.13 81.22 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 123.203 0.314 . . . . 0.0 110.671 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 11.6 Cg_endo -56.13 -22.03 37.92 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.686 2.924 . . . . 0.0 112.997 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.84 -23.11 60.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.681 0.792 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 96' ' ' ILE . 8.4 tp10 -69.18 -43.59 73.91 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.42 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 58.4 mt -71.17 -27.0 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.73 -37.64 76.59 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -67.98 -36.36 79.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.631 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 92' ' ' GLU . 37.3 mm -72.65 -17.82 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.961 177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.72 -20.86 58.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.106 0.955 . . . . 0.0 108.715 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.19 -25.96 42.68 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.02 14.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.406 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.21 49.77 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.74 -50.65 0.15 Allowed Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.432 -2.114 0 C-N-CA 121.087 1.191 . . . . 0.0 112.664 -178.648 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 85.2 m-70 . . . . . 0 C--O 1.215 -0.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -139.59 129.63 25.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -121.61 117.09 25.85 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -126.08 2.26 7.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.571 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.428 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 61.0 m -86.48 92.19 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.571 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.661 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -85.6 -34.65 21.37 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -81.12 -16.92 51.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.942 0.877 . . . . 0.0 110.931 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.3 m -69.79 -22.29 63.34 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -78.33 -20.12 52.09 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.661 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.1 tt -72.91 -37.87 67.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.79 -30.43 69.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.366 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -94.18 -5.49 46.94 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.926 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m 60.33 43.29 13.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.125 0.964 . . . . 0.0 110.305 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.48 49.97 0.65 Allowed Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.532 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.26 138.83 54.26 Favored 'General case' 0 C--O 1.248 1.007 0 O-C-N 124.61 0.829 . . . . 0.0 110.783 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -143.55 20.35 1.86 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -154.97 179.75 8.83 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.806 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.622 ' H ' HD21 ' A' ' 49' ' ' LEU 0.329 13.5 tt -107.31 29.48 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.973 178.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.661 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 43.5 m80 61.99 17.84 9.36 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.423 ' HB2' HD12 ' A' ' 49' ' ' LEU . 60.6 mmm -85.57 -110.79 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.015 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.6 tttp -129.09 115.0 17.06 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -109.15 162.32 14.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.377 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -156.71 87.69 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -103.82 81.01 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 115.154 0.821 . . . . 0.0 115.154 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -77.47 -39.35 46.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.562 0.696 . . . . 0.0 111.177 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.518 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 38.2 mmt180 -107.78 -41.05 5.1 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.712 0.768 . . . . 0.0 111.241 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 26.3 tt0 -78.88 -0.04 29.17 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.103 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 39.4 t -52.58 -47.16 67.05 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 109.728 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -68.88 -38.8 79.9 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.754 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -58.78 -44.74 90.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.701 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.7 ptm -65.02 -33.26 75.61 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.554 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.1 -38.61 82.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 34.8 mt-10 -77.7 -38.25 47.77 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.667 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 31' ' ' MET . 78.7 mttt -63.51 -20.01 65.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.462 0.705 . . . . 0.0 111.771 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -67.4 -20.42 65.53 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.504 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.57 -62.17 1.67 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.62 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 2.2 mmp_? -159.82 -67.14 0.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.577 1.151 . . . . 0.0 109.824 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.591 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 19.0 ptt180 -155.12 122.19 5.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.75 145.11 28.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.5 p -108.89 142.38 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 19.4 t60 -135.06 130.8 36.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.6 tt -82.82 144.17 10.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 94.8 mttt 63.82 63.11 1.48 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.148 0.579 . . . . 0.0 110.717 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 63.4 Cg_endo -80.32 170.7 15.82 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.969 1.78 . . . . 0.0 111.767 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -175.06 54.0 0.13 Allowed Glycine 0 N--CA 1.409 -3.102 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.441 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 7.6 tp10 -110.44 118.39 36.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.507 1.146 . . . . 0.0 108.841 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 34.0 mtmt -110.17 71.44 0.76 Allowed 'General case' 0 N--CA 1.393 -3.309 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.136 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.541 ' HB ' HD22 ' A' ' 49' ' ' LEU . 5.0 pt -70.92 102.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.25 -3.74 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.923 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.622 HD21 ' H ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 69.72 -26.12 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 126.823 2.049 . . . . 0.0 113.621 175.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.91 -3.36 48.62 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.71 116.18 11.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -69.73 88.17 0.52 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 mm -123.73 127.38 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -76.39 -28.86 18.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.548 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.43 17.59 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.3 mt -99.88 121.67 53.45 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.65 107.65 0.91 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.773 2.315 . . . . 0.0 110.92 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -104.8 179.92 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 122.68 2.253 . . . . 0.0 111.752 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' THR . 51.3 t -84.87 106.73 9.35 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 75' ' ' THR . 89.9 Cg_endo -84.41 98.78 0.74 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.234 1.956 . . . . 0.0 114.554 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.49 158.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 130.12 167.18 11.99 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 118.577 -1.773 . . . . 0.0 113.769 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.2 mp -142.63 124.35 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.43 101.76 12.27 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.74 -55.65 16.16 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.55 171.41 7.61 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HA ' HH11 ' A' ' 67' ' ' ARG . 3.4 tpp180 -85.68 -35.99 20.54 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 118.881 0.764 . . . . 0.0 112.113 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 9.4 t -91.03 28.32 1.62 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 122.96 1.362 . . . . 0.0 108.569 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' ARG . 24.8 m -143.21 163.93 31.59 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 17.1 m -72.88 124.01 28.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.332 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.509 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.9 ptt? -85.32 132.19 34.29 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.4 tp -116.02 80.92 9.53 Favored Pre-proline 0 C--N 1.293 -1.884 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.667 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 9.5 Cg_endo -89.58 104.8 0.37 Allowed 'Trans proline' 0 N--CA 1.409 -3.456 0 C-N-CA 121.971 1.781 . . . . 0.0 108.707 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.26 57.28 4.39 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.114 1.435 . . . . 0.0 107.374 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.634 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.2 p -91.17 127.86 36.77 Favored 'General case' 1 N--CA 1.378 -4.064 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.58 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -99.49 95.97 4.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.4 Cg_endo -105.29 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.787 0 C-N-CA 122.974 2.449 . . . . 0.0 111.281 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.6 t -95.87 12.08 31.47 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -117.74 -80.83 0.61 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.068 -0.395 . . . . 0.0 110.339 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.72 176.35 47.99 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.591 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 29.2 m -94.7 135.14 36.53 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.447 0.641 . . . . 0.0 109.401 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.52 112.38 23.89 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.949 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 33.9 t -115.34 134.61 57.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.453 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 15.8 m -136.26 151.08 28.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -142.13 122.12 13.67 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.4 tp -104.13 139.05 19.73 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 5.7 Cg_exo -86.14 2.1 7.56 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 122.616 2.211 . . . . 0.0 111.69 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.59 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 9.9 t -103.14 150.84 6.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.44 144.32 92.28 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 124.14 0.9 . . . . 0.0 110.163 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.4 -18.67 3.84 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.61 3.54 . . . . 0.0 114.385 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.51 -18.38 51.52 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.642 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 25.6 tp10 -60.24 -28.03 67.7 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 124.187 0.995 . . . . 0.0 109.575 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.75 -38.37 75.65 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.121 0 C-N-CA 122.155 0.182 . . . . 0.0 111.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.46 -33.64 75.54 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.406 0.622 . . . . 0.0 110.768 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 63.4 ttt180 -71.49 -45.58 62.1 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 ' HG2' ' A' ' 47' ' ' LYS . 14.8 mm -65.64 -22.5 30.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.189 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.0 tp -74.21 -30.07 62.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.154 0.502 . . . . 0.0 109.792 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.21 -41.74 27.62 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.65 15.66 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.996 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -67.14 -33.53 75.63 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.25 98.06 21.56 Favored Pre-proline 0 N--CA 1.416 -2.136 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.555 2.837 . . . . 0.0 111.269 177.716 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 CA--C 1.498 -1.04 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.41 ' SD ' ' HE2' ' A' ' 4' ' ' PHE . 26.0 ptt? -179.97 133.22 0.1 Allowed 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.238 1.415 . . . . 0.0 108.762 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.4 m -132.16 122.82 25.93 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HE2' ' SD ' ' A' ' 2' ' ' MET . 88.6 m-85 -116.85 -8.99 11.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.976 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 76.5 m -80.0 100.8 8.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.807 0.813 . . . . 0.0 110.793 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.668 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -88.32 -38.13 15.41 Favored 'General case' 0 C--O 1.182 -2.461 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 30.3 tt0 -68.82 -9.45 51.24 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.817 0.818 . . . . 0.0 111.871 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.487 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.4 m -75.38 -15.17 60.49 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.104 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.661 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.71 -28.4 67.29 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.409 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.661 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 6.1 tt -70.23 -39.05 75.31 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.055 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -76.36 -1.79 28.58 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.714 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.97 -28.71 5.47 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -163.58 -54.13 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.442 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.32 -153.91 24.71 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HB2' HG12 ' A' ' 56' ' ' ILE . 2.2 mp0 -80.63 137.33 36.34 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 118.994 1.397 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.471 ' HA ' HG23 ' A' ' 54' ' ' ILE . 34.9 t80 -142.31 3.28 1.52 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.591 0.71 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB3' HD21 ' A' ' 49' ' ' LEU . 18.4 mm-40 -150.69 176.94 10.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.593 HG22 ' HG ' ' A' ' 49' ' ' LEU . 11.7 tt -110.35 157.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.484 ' HA ' HD21 ' A' ' 6' ' ' LEU . 6.5 t60 -71.53 71.9 0.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.472 1.13 . . . . 0.0 108.987 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.4 mmt -138.68 -167.41 2.19 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.089 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.72 113.28 22.44 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -100.75 130.31 46.76 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.029 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -124.08 85.17 2.37 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.513 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -99.58 75.92 0.48 Allowed Glycine 0 C--N 1.282 -2.442 0 C-N-CA 119.399 -1.382 . . . . 0.0 111.013 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.85 -79.87 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 121.35 0.595 . . . . 0.0 110.629 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.511 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 5.6 mpt_? -75.7 -35.83 60.19 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.006 0.432 . . . . 0.0 111.688 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 18.0 tp10 -66.28 -11.37 50.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.002 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 36.3 t -51.01 -41.75 59.99 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.477 0.656 . . . . 0.0 110.274 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.03 -43.1 75.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.075 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.695 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.28 -45.64 79.77 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.1 ptp -56.64 -33.11 66.0 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.519 0.512 . . . . 0.0 111.726 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 28' ' ' CYS . 51.2 mm -62.97 -36.34 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.434 0.635 . . . . 0.0 110.023 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -78.35 -33.63 48.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HE2' ' O ' ' A' ' 39' ' ' VAL . 60.7 mttt -67.42 -9.49 42.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.719 1.208 . . . . 0.0 113.391 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -69.49 -22.93 63.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.35 -65.01 0.75 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -152.45 -67.7 0.16 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.1 ttp180 -165.82 115.43 1.0 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.468 0.707 . . . . 0.0 109.413 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.554 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 44.3 t -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -112.68 149.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.695 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 32.5 t-80 -138.28 119.5 14.62 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.4 tt -83.31 147.44 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 94.3 mttt 68.61 51.59 0.49 Allowed Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.699 0.799 . . . . 0.0 112.039 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 96.4 Cg_endo -90.18 159.58 4.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.418 2.079 . . . . 0.0 110.608 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.511 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -151.66 44.9 0.64 Allowed Glycine 0 CA--C 1.467 -2.951 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 4.2 pm0 -97.76 156.86 16.37 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-O 122.627 1.204 . . . . 0.0 113.304 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 0.5 OUTLIER -145.19 86.85 1.79 Allowed 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.363 175.176 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 48' ' ' ILE . 2.6 pt -87.24 99.9 9.18 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 113.471 -1.695 . . . . 0.0 112.313 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.593 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 66.88 4.5 3.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.976 2.11 . . . . 0.0 114.098 175.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.56 -21.42 5.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.142 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.74 30.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' CZ ' HD12 ' A' ' 48' ' ' ILE . 21.8 tpt180 -86.58 105.93 17.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.63 136.91 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.471 HG23 ' HA ' ' A' ' 16' ' ' TYR . 45.4 mm -99.1 -40.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.531 0.681 . . . . 0.0 109.588 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.83 -26.37 22.61 Favored Glycine 0 C--N 1.312 -0.756 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 15' ' ' GLU . 36.6 mm -111.69 109.79 55.35 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.89 109.25 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.995 2.463 . . . . 0.0 111.723 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -101.95 -163.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.415 2.743 . . . . 0.0 109.919 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 75' ' ' THR . 86.6 t -73.47 118.95 73.15 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.13 40.86 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.118 2.545 . . . . 0.0 114.541 -172.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 65.1 mt -116.31 149.52 18.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . 166.5 138.35 2.42 Favored Glycine 0 C--N 1.305 -1.186 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.894 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.51 114.14 41.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 122.706 0.402 . . . . 0.0 110.661 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.43 106.2 18.24 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.73 -64.24 1.04 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 68' ' ' SER . 3.7 tm-20 -166.94 179.94 5.0 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -176.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.445 HH22 ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.04 -40.09 14.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 119.045 0.839 . . . . 0.0 109.437 -176.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.677 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.6 t -89.39 26.76 1.59 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.695 1.236 . . . . 0.0 109.511 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.9 m -144.28 160.93 40.16 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 85' ' ' GLU . 17.3 m -77.72 144.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 122.676 0.39 . . . . 0.0 110.335 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.617 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 27.1 ptt? -99.93 136.7 39.45 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.9 mm -109.05 89.19 6.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 71' ' ' MET . 2.5 Cg_endo -88.1 146.9 6.59 Favored 'Trans proline' 0 N--CA 1.427 -2.439 0 C-N-CA 122.126 1.884 . . . . 0.0 111.737 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 67.7 m-85 -123.25 44.27 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.579 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 41.4 p -100.86 111.41 23.62 Favored 'General case' 0 N--CA 1.4 -2.961 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.103 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -100.74 97.2 6.37 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 75' ' ' THR . 97.2 Cg_endo -103.98 -165.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.04 2.493 . . . . 0.0 111.593 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.6 t -74.04 -21.57 59.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.504 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -95.84 -84.7 0.34 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.734 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.97 -179.67 45.7 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 9.8 m -106.4 145.58 31.56 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -119.34 121.88 40.56 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -175.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 56.3 t -110.02 120.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 27' ' ' GLU . 35.4 m -113.49 143.77 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.9 tt0 -148.65 115.78 6.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.216 0.462 . . . . 0.0 110.224 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 68' ' ' SER . 29.5 tp -94.84 143.33 25.98 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -93.39 -2.55 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.621 1.547 . . . . 0.0 110.971 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.606 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 23.7 t -91.49 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.19 149.3 75.96 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 124.166 0.916 . . . . 0.0 112.792 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.69 -6.17 4.21 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.838 3.025 . . . . 0.0 113.351 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.56 -27.3 66.11 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.274 0.559 . . . . 0.0 109.504 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -60.07 -26.82 66.47 Favored 'General case' 0 C--O 1.204 -1.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.163 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.3 mt -56.87 -40.12 69.45 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.809 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.633 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.46 -47.67 85.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.645 0.736 . . . . 0.0 109.795 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -64.95 -44.13 90.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.451 HG22 ' HE2' ' A' ' 47' ' ' LYS . 73.7 mt -69.6 -28.29 37.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.613 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.1 tp -70.77 -29.6 65.86 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 123.313 0.645 . . . . 0.0 110.173 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -32.25 51.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.7 15.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.355 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.69 -47.89 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.747 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -135.6 87.93 25.28 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 C--O 1.257 1.432 0 C-N-CA 123.262 2.641 . . . . 0.0 112.347 -178.318 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 65.7 mtm -156.11 124.7 5.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -102.04 113.59 26.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 64.9 m-85 -127.96 12.5 6.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.799 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 74.0 m -140.66 102.68 4.36 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -77.23 -36.45 54.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 111.419 -175.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.424 ' H ' HD13 ' A' ' 6' ' ' LEU . 10.1 tp10 -71.09 -25.56 62.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.691 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -77.99 -24.34 48.03 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -24.17 60.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 110.232 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.51 -43.63 98.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -69.42 -35.76 76.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.226 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.31 -35.42 66.08 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.435 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -161.81 -54.92 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.243 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.7 173.47 37.22 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.3 141.22 38.64 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.489 0.662 . . . . 0.0 111.73 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' HG23 ' A' ' 54' ' ' ILE . 88.5 t80 -137.66 4.86 2.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 44.7 mt-10 -149.79 146.33 27.11 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.572 HG22 ' HG ' ' A' ' 49' ' ' LEU . 15.3 tt -85.1 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.561 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -68.59 77.17 0.28 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 122.724 1.25 . . . . 0.0 110.483 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.418 ' HA ' ' CE ' ' A' ' 20' ' ' MET . 2.0 mmt -146.15 -174.39 4.42 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.39 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 10.5 mtmp? -88.5 114.72 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.164 0.893 . . . . 0.0 110.874 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.605 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -102.98 152.53 21.21 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.124 -175.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.08 77.75 1.32 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.616 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -97.68 82.35 0.68 Allowed Glycine 0 C--N 1.294 -1.789 0 C-N-CA 121.02 -0.609 . . . . 0.0 114.052 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -70.18 -82.52 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 117.352 0.576 . . . . 0.0 111.652 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.559 ' HB2' ' H ' ' A' ' 45' ' ' GLY . 2.5 mmp_? -70.39 -36.72 74.25 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 2.7 tp10 -69.35 -12.64 61.83 Favored 'General case' 0 C--O 1.217 -0.647 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.219 -177.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 44.4 t -60.9 -34.19 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-O 121.218 0.532 . . . . 0.0 110.009 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.53 -41.64 72.27 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.788 0.804 . . . . 0.0 109.398 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -64.23 -47.73 78.56 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.106 -1.407 . . . . 0.0 113.077 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.509 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 ptp -56.12 -31.64 63.47 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.577 0.548 . . . . 0.0 112.272 -176.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 28' ' ' CYS . 48.6 mm -59.65 -42.84 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 122.08 0.943 . . . . 0.0 109.078 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.87 -34.34 30.12 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.547 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 31' ' ' MET . 72.2 mttt -65.92 -12.91 58.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.702 0.801 . . . . 0.0 111.927 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.11 -24.83 62.37 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.816 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.67 -53.14 36.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.107 0.48 . . . . 0.0 110.718 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -166.9 -69.97 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' THR . 58.3 ttp180 -162.12 123.63 2.71 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 84.4 t -134.66 159.95 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.7 p -105.96 143.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.488 0.715 . . . . 0.0 109.596 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.562 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 57.4 t-80 -135.01 123.34 23.14 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 2.6 mp -89.7 142.42 12.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 99.2 mttt 71.62 43.35 0.2 Allowed Pre-proline 0 C--O 1.21 -1.019 0 C-N-CA 124.11 0.964 . . . . 0.0 112.545 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 9.8 Cg_endo -75.42 143.04 27.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 CA-C-N 120.786 1.316 . . . . 0.0 110.783 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 26' ' ' ARG . . . -144.03 54.29 0.58 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 10.0 pm0 -101.1 129.48 46.99 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.19 0.995 . . . . 0.0 110.125 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 43.1 mtmt -118.84 69.99 0.82 Allowed 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.407 ' C ' HD22 ' A' ' 49' ' ' LEU . 39.1 pt -86.57 109.7 19.25 Favored 'Isoleucine or valine' 1 C--N 1.222 -4.936 0 CA-C-N 111.317 -2.674 . . . . 0.0 112.329 -175.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.572 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 65.7 -3.1 0.76 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.936 2.095 . . . . 0.0 113.863 175.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.04 -25.66 13.53 Favored Glycine 0 C--N 1.293 -1.82 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.23 19.33 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 52' ' ' ARG . 2.2 ptm180 -71.39 103.05 2.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.735 0.779 . . . . 0.0 111.646 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 55' ' ' GLY . 55.9 mt -128.0 132.17 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 16' ' ' TYR . 49.4 mm -73.45 -27.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.99 0.9 . . . . 0.0 108.888 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 53' ' ' ILE . . . 97.23 -28.1 15.51 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 78' ' ' CYS . 62.4 mt -105.54 114.99 62.56 Favored Pre-proline 0 N--CA 1.416 -2.159 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.85 107.27 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.605 2.203 . . . . 0.0 110.518 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -95.96 -174.99 0.29 Allowed 'Trans proline' 0 N--CA 1.426 -2.441 0 C-N-CA 122.671 2.247 . . . . 0.0 111.663 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.7 t -68.86 116.48 41.65 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.81 70.52 7.38 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.002 1.801 . . . . 0.0 113.293 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -130.71 145.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 156.94 153.67 6.75 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 118.98 -1.581 . . . . 0.0 113.67 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.75 103.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.65 108.97 20.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.2 -69.8 0.53 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.418 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.514 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -153.21 164.92 37.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -80.76 -31.69 35.81 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.022 0.915 . . . . 0.0 108.602 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.514 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 11.1 p -94.86 38.48 1.12 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.4 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -161.75 171.22 18.21 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.44 161.21 4.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.69 0.757 . . . . 0.0 109.714 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.644 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 16.1 ptp -140.09 118.0 11.78 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -106.65 94.59 10.46 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-O 121.137 0.494 . . . . 0.0 109.913 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 71' ' ' MET . 9.6 Cg_endo -92.2 164.99 3.08 Favored 'Trans proline' 0 N--CA 1.412 -3.296 0 C-N-CA 122.103 1.869 . . . . 0.0 110.8 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -129.1 58.81 1.59 Allowed 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.558 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 27.2 p -100.42 110.11 22.29 Favored 'General case' 0 N--CA 1.386 -3.644 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.149 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -105.19 100.65 26.27 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.8 Cg_endo -104.74 -159.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 123.092 2.528 . . . . 0.0 108.41 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.439 ' HB3' HD13 ' A' ' 56' ' ' ILE . 50.3 t -83.02 -9.04 59.47 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.062 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.34 -79.59 0.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.796 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 176.45 -172.23 45.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.8 m -112.7 149.18 33.27 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 117.452 0.626 . . . . 0.0 109.422 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.84 47.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 59.0 t -109.82 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG12 ' OE2' ' A' ' 27' ' ' GLU . 2.6 m -102.2 155.27 4.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -155.0 108.83 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.072 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.1 tp -97.61 128.97 32.7 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.15 22.55 0.94 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.542 2.161 . . . . 0.0 111.412 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 68' ' ' SER . 14.6 t -130.5 151.7 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.84 152.55 82.39 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 38.4 Cg_endo -65.41 -4.19 8.97 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.736 2.957 . . . . 0.0 112.656 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.64 -29.91 70.37 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -66.1 -25.16 66.88 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.056 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.37 -35.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 O-C-N 123.074 0.234 . . . . 0.0 110.681 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.81 -43.77 97.93 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -43.5 83.55 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.629 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.88 -21.88 24.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 123.397 0.679 . . . . 0.0 111.099 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -74.06 -27.29 60.85 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.259 0.552 . . . . 0.0 109.808 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.5 -41.61 14.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.989 0.9 . . . . 0.0 108.63 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.6 t -82.45 7.86 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.987 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -52.91 -60.59 3.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.497 1.119 . . . . 0.0 113.813 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.01 -47.91 0.33 Allowed Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.426 -2.451 0 C-N-CA 121.583 1.522 . . . . 0.0 112.507 177.802 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 p80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -174.01 135.6 0.49 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.3 m -134.14 124.16 25.6 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . 74.0 m-85 -121.55 3.32 10.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.83 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.2 m -95.75 101.74 13.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.306 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 7' ' ' GLU . 1.6 pp -92.3 -29.71 16.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.797 0.808 . . . . 0.0 112.263 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' HD12 ' A' ' 6' ' ' LEU . 35.2 tt0 -68.97 -24.51 64.26 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.158 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.8 m -66.44 -32.48 73.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.022 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.74 -28.95 60.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.889 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tt -69.52 -35.13 75.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -66.8 -38.06 85.76 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.624 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 8' ' ' THR . 89.0 mt-30 -73.72 -3.12 26.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.056 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m 67.48 13.5 9.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.107 1.363 . . . . 0.0 111.783 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.84 59.74 0.36 Allowed Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.67 127.49 31.53 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.244 -0.978 . . . . 0.0 110.613 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -145.77 10.73 1.22 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 27.8 mt-10 -148.0 176.65 10.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.809 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.494 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.6 tt -127.33 161.02 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -67.31 73.36 0.13 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.359 1.076 . . . . 0.0 111.111 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.43 ' HB2' HD12 ' A' ' 49' ' ' LEU . 81.9 mtp -130.1 -121.79 0.22 Allowed 'General case' 0 C--N 1.266 -3.055 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.169 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 11.0 tmtt? -147.18 122.89 10.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HD2' ' OE1' ' A' ' 17' ' ' GLU . 14.1 ptm180 -104.11 167.33 9.83 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -152.58 79.25 1.22 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 46' ' ' GLU . . . -109.32 82.84 0.31 Allowed Glycine 0 CA--C 1.471 -2.714 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -72.22 -63.45 1.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.939 0.876 . . . . 0.0 109.251 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.619 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 29.2 mmt180 -84.12 -38.81 20.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.906 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 29.2 mt-10 -74.84 -1.86 24.14 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 31' ' ' MET . 41.5 t -51.21 -45.15 61.78 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.08 -41.22 74.39 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.59 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.4 -47.19 87.15 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 124.165 0.986 . . . . 0.0 113.152 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -56.83 -38.67 72.95 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.414 0.446 . . . . 0.0 111.345 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.65 -39.05 80.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.747 0.784 . . . . 0.0 109.604 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' HG11 ' A' ' 39' ' ' VAL . 13.7 mm-40 -75.11 -42.74 55.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.63 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.5 mttt -63.58 -20.03 65.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.543 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -67.28 -26.52 66.58 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.552 0.533 . . . . 0.0 110.306 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -53.15 32.34 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.866 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -162.43 -70.84 0.05 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.559 0.695 . . . . 0.0 110.052 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.3 ttt180 -163.28 117.67 1.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 33' ' ' GLU . 55.4 t -137.15 144.03 33.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.593 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -97.22 145.81 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.482 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 74.0 t60 -138.93 121.45 16.19 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 61.6 mt -79.42 138.06 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 64.6 mttm 74.68 65.88 0.27 Allowed Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.692 1.245 . . . . 0.0 109.22 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 48.6 Cg_endo -88.38 166.17 6.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.224 1.949 . . . . 0.0 111.767 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 27' ' ' GLU . . . -179.79 55.61 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.794 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 7.1 tp10 -122.12 145.22 48.38 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.66 0.784 . . . . 0.0 109.958 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 4.5 mmpt? -140.46 80.98 1.78 Allowed 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 50' ' ' GLY . 23.8 pt -71.75 105.14 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.323 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 68.52 -23.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.756 2.022 . . . . 0.0 113.996 175.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.16 -30.43 10.4 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -176.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.01 142.98 50.25 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.25 97.7 9.72 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.389 -1.325 . . . . 0.0 113.386 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.02 117.83 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.28 -37.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 120.968 0.413 . . . . 0.0 111.344 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.98 -0.97 70.01 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.28 130.45 16.04 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -53.89 107.46 0.21 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.366 2.711 . . . . 0.0 112.903 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -114.33 -169.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 123.324 2.682 . . . . 0.0 112.63 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.11 107.95 51.23 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.648 ' HA ' HG22 ' A' ' 75' ' ' THR . 32.5 Cg_exo -61.26 118.42 5.29 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.23 2.62 . . . . 0.0 111.964 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.6 mm -128.54 100.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . -118.18 81.1 0.32 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.51 112.97 38.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 4.8 p-10 -126.03 127.28 45.61 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.12 -48.21 10.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.8 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.5 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 21.7 tt0 -170.16 167.17 8.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 6.7 tpt85 -76.58 -29.66 56.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.801 0.334 . . . . 0.0 111.059 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.5 ' HB3' ' OE1' ' A' ' 66' ' ' GLU . 33.1 t -99.24 33.74 2.34 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.897 1.332 . . . . 0.0 108.558 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -148.75 162.53 39.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.93 124.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 122.137 0.97 . . . . 0.0 112.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.54 ' HE3' ' HA ' ' A' ' 67' ' ' ARG . 16.7 ptp -134.72 152.05 51.46 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.407 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.412 HG12 HG22 ' A' ' 83' ' ' VAL . 59.9 mt -121.65 90.47 48.15 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 42.2 Cg_endo -105.02 44.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.052 2.501 . . . . 0.0 113.437 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.74 -103.4 0.14 Allowed 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 121.526 0.679 . . . . 0.0 112.012 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 60' ' ' PRO . 3.0 p -162.18 179.66 7.75 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.973 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.71 85.02 43.87 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -103.59 -167.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 123.086 2.524 . . . . 0.0 113.896 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.67 -22.12 60.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.008 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -75.59 -68.79 0.53 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.578 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 170.4 163.72 24.91 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 38' ' ' ARG . 6.5 m -91.73 151.18 20.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -127.23 126.08 42.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 t -118.21 129.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.478 HG12 ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -122.72 142.37 39.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.7 tt0 -142.83 122.17 13.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 25.0 tp -99.78 137.06 20.12 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.54 -5.74 7.16 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.153 1.902 . . . . 0.0 111.53 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.643 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.0 t -99.01 163.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.9 t70 -65.32 144.91 99.11 Favored Pre-proline 0 C--N 1.304 -1.396 0 C-N-CA 123.153 0.581 . . . . 0.0 110.214 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.72 -9.58 0.15 Allowed 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 124.034 3.156 . . . . 0.0 115.404 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 9.9 pt-20 -59.43 -18.7 41.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.12 0.568 . . . . 0.0 111.411 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 96' ' ' ILE . 13.3 mm-40 -61.27 -19.91 62.26 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.24 -36.96 77.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.564 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.89 -39.22 88.46 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 109.609 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -69.37 -47.01 65.57 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.445 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 92' ' ' GLU . 44.3 mm -73.34 -10.13 13.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.824 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.65 -31.4 32.36 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.45 -34.28 54.49 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 99' ' ' VAL . 41.3 t -100.72 29.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.574 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.61 -20.71 64.51 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.659 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.497 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.6 mt-10 -139.89 -59.47 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 52.5 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 C-N-CA 121.415 1.41 . . . . 0.0 113.858 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.421 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.8 ptp -171.44 130.8 0.72 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.315 0.646 . . . . 0.0 110.016 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -120.96 126.54 50.21 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.597 0.713 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CE1' ' HA ' ' A' ' 23' ' ' ALA . 91.7 m-85 -133.25 22.05 4.06 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.63 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 7.7 p -103.44 78.46 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.089 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 22' ' ' ARG . 5.2 tt -70.68 -54.28 12.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.085 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -75.96 3.95 9.23 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.7 1.238 . . . . 0.0 111.802 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 5' ' ' CYS . 9.0 m -87.44 -2.24 58.48 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.541 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -64.68 -17.92 64.52 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.111 176.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.541 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 4.8 tt -76.12 -35.55 59.24 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.45 -30.47 68.39 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 108.073 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 9' ' ' TYR . 45.5 mt-30 -78.39 -14.63 59.31 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.575 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.7 t 67.03 30.75 7.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.22 1.008 . . . . 0.0 109.833 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.79 88.66 0.11 Allowed Glycine 0 N--CA 1.417 -2.608 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.186 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.47 132.67 54.63 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.645 ' HA ' HG23 ' A' ' 54' ' ' ILE . 48.2 t80 -139.44 12.06 2.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.509 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 6' ' ' LEU . 41.4 mt-10 -146.46 176.21 9.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.705 HG22 ' HG ' ' A' ' 49' ' ' LEU . 11.2 tp -118.9 154.5 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -69.71 74.55 0.42 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.968 1.366 . . . . 0.0 111.387 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.3 mmm -132.51 -145.8 0.27 Allowed 'General case' 0 C--N 1.269 -2.897 0 C-N-CA 127.235 2.214 . . . . 0.0 107.371 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HE3' ' HG2' ' A' ' 101' ' ' GLU . 56.7 mtmt -119.45 129.54 54.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 119.202 0.91 . . . . 0.0 110.471 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.591 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.8 175.18 5.58 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB2' ' CG ' ' A' ' 102' ' ' PRO . . . -163.59 76.89 0.39 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.822 0.701 . . . . 0.0 111.901 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 46' ' ' GLU . . . -90.9 74.46 1.69 Allowed Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.674 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.1 -68.19 0.58 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.559 0.695 . . . . 0.0 110.357 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.627 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 32.3 mmt180 -75.33 -44.18 46.68 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.896 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 24.8 mt-10 -77.62 2.59 16.11 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.2 t -50.41 -44.34 55.06 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.89 -34.07 57.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.464 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' C ' ' HD3' ' A' ' 34' ' ' LYS . . . -61.4 -48.79 79.62 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.456 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.9 ptp -59.89 -33.85 72.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.907 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.747 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 81.3 mt -62.94 -34.24 65.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.51 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.04 -31.78 21.79 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.042 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.7 mtpt -59.09 -16.8 21.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.893 0.877 . . . . 0.0 111.877 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 22.3 ptmt -77.4 -16.0 59.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.455 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.4 72.31 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.347 -0.221 . . . . 0.0 111.524 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 177.17 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' THR . 41.5 ttp180 -156.78 116.87 3.55 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -133.1 146.06 33.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.664 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -93.4 137.81 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 124.119 0.887 . . . . 0.0 109.017 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.417 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 27.7 t60 -139.1 125.79 20.74 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.82 140.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 62.5 mttp 69.23 65.67 0.5 Allowed Pre-proline 0 C--O 1.22 -0.467 0 C-N-CA 124.24 1.016 . . . . 0.0 110.2 -175.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 44.3 Cg_endo -88.35 161.48 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.802 2.335 . . . . 0.0 112.91 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.594 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 177.69 62.64 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 16.1 tt0 -118.21 101.29 8.1 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 124.147 0.979 . . . . 0.0 108.667 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -95.43 91.39 6.18 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.002 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 22' ' ' ARG . 42.1 pt -92.13 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.246 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.705 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 68.32 -1.99 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.139 1.776 . . . . 0.0 112.818 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.95 -33.16 4.32 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.27 122.41 37.68 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HD3' HD11 ' A' ' 48' ' ' ILE . 19.1 tpp180 -64.65 100.2 0.37 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.795 0.684 . . . . 0.0 110.409 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.509 HD12 HG21 ' A' ' 18' ' ' ILE . 60.2 mt -121.47 131.1 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.645 HG23 ' HA ' ' A' ' 16' ' ' TYR . 57.9 mt -99.15 -31.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.666 0.746 . . . . 0.0 109.822 -177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.48 15.48 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.34 117.04 43.66 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.19 112.11 3.24 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.806 2.338 . . . . 0.0 113.514 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 3.1 Cg_endo -91.92 -171.35 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.924 2.416 . . . . 0.0 108.838 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.587 ' HB ' ' CB ' ' A' ' 75' ' ' THR . 80.9 t -82.2 132.85 52.05 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.1 Cg_endo -81.6 70.59 7.23 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.557 1.504 . . . . 0.0 113.827 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.14 91.67 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.94 103.25 3.02 Favored Glycine 0 N--CA 1.414 -2.827 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.815 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.8 mt -102.35 76.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -110.94 118.83 37.17 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.164 0.507 . . . . 0.0 110.081 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -90.18 -57.15 2.95 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.373 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.639 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -162.54 167.61 23.11 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.409 HH11 HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.63 -27.41 34.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.106 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.639 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 20.8 t -94.09 30.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 123.058 1.409 . . . . 0.0 108.952 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.7 m -153.85 162.93 40.82 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -63.64 131.25 29.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.765 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.4 ptp -126.99 124.33 39.17 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 83' ' ' VAL . 23.7 mt -114.1 96.79 43.32 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.24 148.89 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.851 1.7 . . . . 0.0 113.04 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 58' ' ' PRO . 73.4 m-85 75.57 -155.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 125.088 1.355 . . . . 0.0 110.681 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.587 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 97.4 m -145.61 -75.51 0.22 Allowed 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HG2' HG22 ' A' ' 75' ' ' THR . 73.1 mmtt -129.53 90.87 42.68 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.433 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HB3' HD13 ' A' ' 54' ' ' ILE . 4.7 Cg_exo -85.85 -171.03 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.671 2.247 . . . . 0.0 110.837 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 41.2 t -81.53 -34.45 31.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.473 0.654 . . . . 0.0 110.465 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -89.3 -68.55 0.77 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -177.1 169.93 42.41 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.9 m -98.42 152.52 19.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.94 149.9 42.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.8 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.5 t -134.43 98.67 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 19.9 m -113.48 135.96 51.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.32 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -135.82 124.94 24.42 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.979 0.418 . . . . 0.0 110.184 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.0 tp -101.34 125.83 36.52 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.93 13.41 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.484 2.122 . . . . 0.0 111.05 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.556 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 18.3 t -113.71 151.91 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 25.7 m-20 -61.95 154.85 66.32 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 124.08 0.952 . . . . 0.0 111.309 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.29 -17.09 24.85 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.723 2.949 . . . . 0.0 113.367 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.8 pt-20 -63.41 -16.79 61.56 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.516 0.726 . . . . 0.0 111.222 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.14 -19.78 63.2 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 93' ' ' ILE . 26.3 mm -66.42 -28.31 43.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.308 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.48 -42.66 92.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.326 0.584 . . . . 0.0 109.749 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.51 -50.24 70.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.654 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -68.14 -20.06 25.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.452 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 tp -70.91 -28.67 64.7 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.285 0.634 . . . . 0.0 110.0 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.95 -32.25 61.69 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.3 t -83.58 -3.07 7.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.67 -35.17 60.76 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.272 0.629 . . . . 0.0 112.534 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.412 ' HG2' ' HE3' ' A' ' 21' ' ' LYS . 32.7 tt0 -149.39 93.94 4.0 Favored Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.548 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 23.1 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 123.25 2.634 . . . . 0.0 112.422 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 m80 . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.764 0.316 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.578 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 72.0 mtm -147.53 123.18 10.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.9 m -98.77 114.43 26.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.794 0.33 . . . . 0.0 111.04 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.9 m-85 -129.28 14.41 6.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.455 0.645 . . . . 0.0 109.306 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.5 m -135.53 102.85 5.25 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -78.56 -33.95 47.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.079 0.942 . . . . 0.0 111.956 -175.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.84 -20.99 60.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.88 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 14.6 m -70.68 -35.15 72.67 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -70.29 -27.3 64.3 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.454 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.14 -51.12 70.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.85 -27.85 66.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.01 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 8' ' ' THR . 53.2 mt-30 -77.35 -44.74 28.37 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.662 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -148.37 -50.76 0.17 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.289 0.566 . . . . 0.0 110.904 -176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.43 163.28 19.8 Favored Glycine 0 N--CA 1.422 -2.26 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.24 139.2 58.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.389 0.614 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -132.22 2.94 3.95 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 55.5 mt-10 -149.95 143.68 25.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.666 HG22 ' HG ' ' A' ' 49' ' ' LEU . 13.8 tt -81.63 163.74 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.0 72.32 1.63 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.635 1.207 . . . . 0.0 109.646 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.9 mmt -140.51 -176.06 4.5 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.246 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -81.11 116.67 21.14 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 119.284 0.947 . . . . 0.0 111.243 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -106.94 134.75 49.62 Favored 'General case' 0 N--CA 1.4 -2.95 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.39 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.41 79.88 1.79 Allowed 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.62 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.24 80.81 0.49 Allowed Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.859 -175.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -68.94 -79.44 0.06 Allowed 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 117.045 0.422 . . . . 0.0 111.585 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 19.9 mtp-105 -75.33 -31.24 60.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.917 -1.113 . . . . 0.0 113.435 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 9.0 tp10 -70.9 -12.64 61.66 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 109.665 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.3 t -60.73 -32.24 71.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -69.04 -45.49 70.3 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.435 0.635 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -67.55 -42.53 82.52 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.872 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -57.26 -32.34 66.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.584 0.23 . . . . 0.0 111.38 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 28' ' ' CYS . 50.0 mm -62.31 -40.3 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.52 -36.77 52.15 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.733 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HE2' ' H ' ' A' ' 83' ' ' VAL . 72.4 mttt -65.04 -15.22 62.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.755 0.822 . . . . 0.0 112.533 -178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -67.95 -23.98 65.12 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.636 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.15 -39.76 68.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.334 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 178.35 -68.76 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.761 0.824 . . . . 0.0 109.413 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.0 ttp180 -163.51 124.01 2.25 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 86.5 t -138.29 157.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -107.76 149.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.472 0.709 . . . . 0.0 109.991 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 51.6 t60 -135.62 128.02 30.37 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.413 HG22 ' HG3' ' A' ' 43' ' ' LYS . 3.2 mp -96.8 136.54 27.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 98.9 mttt 70.48 53.89 0.42 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.58 1.152 . . . . 0.0 111.294 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 65.3 Cg_endo -70.58 144.55 49.96 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 121.161 1.241 . . . . 0.0 109.981 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.29 47.7 0.97 Allowed Glycine 0 CA--C 1.474 -2.489 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 10.2 pm0 -105.98 148.47 27.66 Favored 'General case' 0 N--CA 1.396 -3.159 0 CA-C-O 121.945 0.879 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 51.4 mtmt -134.75 80.85 1.87 Allowed 'General case' 0 CA--C 1.454 -2.742 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.433 ' C ' HD22 ' A' ' 49' ' ' LEU . 34.6 pt -95.89 104.35 15.74 Favored 'Isoleucine or valine' 1 C--N 1.221 -4.98 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.148 -175.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 59.03 6.01 0.61 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 126.733 2.013 . . . . 0.0 113.728 175.398 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.5 -3.46 67.89 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.84 131.83 4.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -76.86 86.33 3.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.443 HD12 HG21 ' A' ' 18' ' ' ILE . 57.3 mt -108.39 127.17 64.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.24 -39.28 64.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.82 9.57 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.431 HD13 ' HB3' ' A' ' 78' ' ' CYS . 58.8 mt -102.96 120.83 51.19 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.85 107.39 0.17 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 123.257 2.638 . . . . 0.0 112.74 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -97.26 137.02 0.44 Allowed 'Trans proline' 0 N--CA 1.424 -2.587 0 C-N-CA 122.573 2.182 . . . . 0.0 111.693 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -67.63 114.03 17.5 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.24 88.01 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.397 2.065 . . . . 0.0 114.418 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 74' ' ' TYR . 73.0 mt -122.89 146.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 142.47 -174.84 23.21 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.829 -2.129 . . . . 0.0 114.547 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.16 102.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.17 105.38 17.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.82 -69.91 0.55 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.523 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.74 167.78 12.93 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -34.23 77.36 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 124.785 1.234 . . . . 0.0 107.844 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -99.46 32.16 2.89 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.385 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -151.72 160.46 43.59 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.435 HG13 ' OE2' ' A' ' 85' ' ' GLU . 5.3 m -77.8 119.79 27.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.893 0.854 . . . . 0.0 110.735 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.669 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.0 ptp -98.49 111.59 23.9 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.72 92.55 7.46 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 71' ' ' MET . 30.4 Cg_endo -100.9 178.04 0.23 Allowed 'Trans proline' 0 N--CA 1.406 -3.63 0 C-N-CA 121.799 1.666 . . . . 0.0 112.489 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 43.0 t80 -135.42 81.7 1.91 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.581 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 22.5 p -97.24 139.24 33.51 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.871 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -111.56 88.1 8.86 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.448 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 75' ' ' THR . 58.0 Cg_endo -107.68 -153.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 123.914 3.076 . . . . 0.0 108.454 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.431 ' HB3' HD13 ' A' ' 56' ' ' ILE . 21.7 t -110.65 11.01 22.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -118.1 -82.26 0.63 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.951 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.87 -174.55 45.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 37.1 m -109.78 148.26 31.78 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.77 135.53 55.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.9 t -121.43 108.65 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 20.2 m -108.24 129.65 62.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' HG13 ' A' ' 70' ' ' VAL . 39.8 tt0 -132.6 117.67 18.23 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.598 0.636 . . . . 0.0 110.821 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 19.8 tp -99.75 134.76 20.81 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.18 -3.1 9.53 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.328 2.019 . . . . 0.0 111.734 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -94.76 157.95 3.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 18.0 t70 -65.07 146.29 98.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 122.476 0.31 . . . . 0.0 111.512 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -50.98 -10.93 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.215 3.277 . . . . 0.0 114.788 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 7.9 pt-20 -57.29 -23.13 46.45 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 120.964 0.411 . . . . 0.0 110.438 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -59.74 -26.85 66.0 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.494 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 93' ' ' ILE . 20.0 mm -67.89 -33.71 63.03 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 C-N-CA 121.398 -0.121 . . . . 0.0 110.796 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.33 -43.16 99.47 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -64.74 -51.02 64.58 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.719 -1.582 . . . . 0.0 109.01 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.8 mt -64.59 -25.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 124.003 0.921 . . . . 0.0 112.453 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.67 -39.89 94.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.174 0.511 . . . . 0.0 109.797 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -86.63 -41.31 14.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.942 0.877 . . . . 0.0 110.09 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.42 2.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.458 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -47.74 -48.67 29.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -176.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.65 -47.15 0.48 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 N--CA 1.434 -2.025 0 CA-C-N 120.224 1.116 . . . . 0.0 112.019 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.496 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.3 mpp? -151.77 132.57 14.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -127.77 115.39 18.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 84.2 m-85 -125.39 -5.0 7.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 48.0 m -77.69 90.07 3.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.212 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 20' ' ' MET 0.251 0.0 OUTLIER -79.17 -50.35 11.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.685 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' HD22 ' A' ' 6' ' ' LEU . 1.2 tt0 -76.75 -8.5 57.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.755 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 65.6 m -69.61 -26.36 64.4 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 54.2 m-85 -75.38 -23.21 57.07 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 4.4 tt -70.11 -40.05 75.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -68.3 -23.72 64.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.966 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -99.58 5.62 45.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.012 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m 60.9 31.4 19.99 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.523 0.729 . . . . 0.0 111.937 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . -145.72 67.61 0.41 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.67 145.47 53.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.255 0.55 . . . . 0.0 111.337 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -145.66 27.79 1.2 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' HD11 ' A' ' 49' ' ' LEU . 1.6 pm0 -155.99 171.77 19.53 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.406 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.556 HG22 ' HG ' ' A' ' 49' ' ' LEU . 8.7 tt -105.5 16.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.758 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 71.7 m80 65.31 69.09 0.48 Allowed 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 122.522 1.153 . . . . 0.0 110.471 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.719 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.7 tmm? -148.97 -168.69 3.17 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 63.5 tttp -75.76 112.36 12.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 119.66 1.118 . . . . 0.0 110.986 -177.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -106.8 161.07 15.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . . . -160.24 91.09 0.92 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.23 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.41 89.59 0.59 Allowed Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.94 -67.36 0.71 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.155 0.979 . . . . 0.0 109.279 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.8 mmt180 -81.42 -34.76 31.34 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.023 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 21.1 tt0 -80.31 -5.01 55.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.097 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 12.4 t -49.42 -46.28 47.43 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.274 0.559 . . . . 0.0 109.553 174.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.16 75.72 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.556 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.7 -47.32 86.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.02 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.518 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.0 ptm -61.02 -35.25 76.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.23 -42.87 91.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.338 0.589 . . . . 0.0 109.923 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -77.73 -35.13 52.26 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.898 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 31' ' ' MET . 82.1 mttt -57.9 -24.8 59.33 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 0.0 112.39 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.34 -21.78 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.331 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.59 77.77 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.644 0.259 . . . . 0.0 110.596 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -175.36 -69.44 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.336 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.539 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.4 ptt180 -151.15 123.58 8.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.0 t -138.07 141.43 38.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.78 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.6 p -108.82 143.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 56.0 t-80 -133.81 130.49 38.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 15.7 tt -83.87 141.49 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.5 mttt 68.14 64.62 0.63 Allowed Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 0.0 110.781 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.47 171.1 16.37 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.927 1.751 . . . . 0.0 111.483 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.489 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -174.5 50.35 0.14 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.957 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.8 tp10 -119.09 144.47 46.59 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HZ2' ' HB2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -139.68 81.6 1.83 Allowed 'General case' 0 CA--C 1.444 -3.118 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.571 ' HB ' HD22 ' A' ' 49' ' ' LEU . 9.6 pt -72.72 110.05 5.48 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.444 0 CA-C-N 111.677 -2.511 . . . . 0.0 109.903 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER 62.11 14.74 6.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 125.84 1.656 . . . . 0.0 112.398 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 -41.07 2.6 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.53 121.41 41.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HA ' HG13 ' A' ' 48' ' ' ILE . 56.7 ttp180 -62.52 92.48 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 124.506 1.122 . . . . 0.0 113.011 -177.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.5 mm -124.26 132.73 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.3 mt -79.99 -29.36 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.504 0.668 . . . . 0.0 109.851 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 17' ' ' GLU . . . 82.6 5.72 89.22 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.943 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.462 HD13 ' H ' ' A' ' 78' ' ' CYS . 70.6 mt -126.72 122.14 23.44 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -65.18 107.87 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.192 1.928 . . . . 0.0 109.783 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -110.26 -172.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.132 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.0 t -73.67 116.85 55.77 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.26 39.19 0.52 Allowed 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 123.583 2.855 . . . . 0.0 115.6 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.73 141.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 165.09 129.65 1.06 Allowed Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 117.979 -2.058 . . . . 0.0 113.635 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 146.96 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -121.76 93.58 4.04 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.69 -64.34 0.88 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.265 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 1.5 tm-20 -159.78 169.92 22.6 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.53 ' HB2' HD11 ' A' ' 93' ' ' ILE . 5.0 tpp180 -87.1 -38.6 16.33 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.279 0.561 . . . . 0.0 112.351 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 18.5 t -91.23 29.9 1.35 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 122.994 1.378 . . . . 0.0 107.924 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 67' ' ' ARG . 16.9 m -145.65 170.02 17.3 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.58 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.468 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.3 ptt? -115.78 142.96 46.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.4 tp -114.34 80.44 5.89 Favored Pre-proline 0 C--N 1.292 -1.905 0 C-N-CA 119.655 -0.818 . . . . 0.0 113.12 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 3.0 Cg_exo -84.82 98.64 0.7 Allowed 'Trans proline' 0 N--CA 1.425 -2.503 0 C-N-CA 121.932 1.754 . . . . 0.0 107.72 176.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -88.92 67.65 8.24 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 123.046 1.403 . . . . 0.0 108.865 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.525 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 18.8 p -104.59 138.94 40.19 Favored 'General case' 1 N--CA 1.366 -4.665 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.618 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.17 92.52 9.61 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.564 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.3 Cg_endo -101.76 -165.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 122.93 2.42 . . . . 0.0 110.828 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.462 ' H ' HD13 ' A' ' 56' ' ' ILE . 44.1 t -93.24 0.74 57.16 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -108.29 -78.48 0.59 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.256 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.21 178.35 46.83 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 71.3 m -93.1 131.61 37.98 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.54 116.85 32.74 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.871 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 39.0 t -120.85 133.31 67.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.49 144.29 35.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 38.7 tt0 -137.73 125.82 22.91 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.549 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 26.3 tp -101.16 138.24 19.91 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.76 -3.95 11.32 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 121.82 1.68 . . . . 0.0 111.568 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.549 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 40.1 t -103.63 159.06 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.422 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 7.5 m-20 -63.59 158.68 57.67 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 123.637 0.585 . . . . 0.0 110.909 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.33 -9.87 7.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.895 3.063 . . . . 0.0 113.636 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.7 pt-20 -56.57 -25.64 52.94 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 110.487 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.2 tp10 -63.82 -31.51 72.72 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 67' ' ' ARG . 65.5 mt -60.12 -42.58 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.44 0.296 . . . . 0.0 110.8 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.17 -36.9 85.68 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.313 0.578 . . . . 0.0 110.397 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.455 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 43.2 ttt180 -71.71 -42.3 67.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.256 1.027 . . . . 0.0 108.257 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.2 mm -65.46 -17.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 125.347 1.459 . . . . 0.0 110.908 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -78.38 -28.39 47.01 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -82.14 -43.92 17.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 59.1 t -79.35 11.61 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.98 -50.94 67.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.779 0.832 . . . . 0.0 110.23 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.52 92.51 47.75 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.861 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 123.753 2.969 . . . . 0.0 110.849 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.572 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HD11 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.527 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.632 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 20' ' ' MET . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' ILE . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.528 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.825 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 96' ' ' ILE . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG22 ' HB2' ' A' ' 22' ' ' ARG . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' HB2' ' A' ' 20' ' ' MET . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.61 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.657 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 67' ' ' ARG . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.491 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.693 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.697 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.683 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HB ' HD22 ' A' ' 49' ' ' LEU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.616 HD22 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 75' ' ' THR . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.534 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 73' ' ' PRO . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -170.92 130.4 0.79 Allowed 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 125.712 1.605 . . . . 0.0 107.77 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.433 HG21 ' SD ' ' A' ' 31' ' ' MET . 9.9 t -114.57 129.01 56.63 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.94 0.876 . . . . 0.0 112.124 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -130.87 25.39 4.99 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.669 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 82.4 m -129.89 99.99 5.3 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -80.63 -45.17 17.7 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' N ' HD22 ' A' ' 6' ' ' LEU . 41.8 tt0 -74.55 -2.84 27.65 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.155 0.979 . . . . 0.0 111.863 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 49.9 m -76.84 -26.64 54.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.85 -24.15 58.54 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.26 -20.12 62.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.102 0.953 . . . . 0.0 108.924 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -91.14 9.53 30.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.857 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -128.97 -46.45 1.25 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.597 0.713 . . . . 0.0 109.349 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 m -153.67 -155.66 0.61 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.56 166.01 53.24 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -81.35 147.25 29.94 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.541 ' HA ' HG23 ' A' ' 54' ' ' ILE . 61.1 t80 -126.88 22.63 6.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 122.652 1.215 . . . . 0.0 108.348 -176.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HB3' HD21 ' A' ' 49' ' ' LEU . 7.5 mp0 -142.36 167.9 21.0 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.337 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.679 HG22 HD22 ' A' ' 49' ' ' LEU . 3.1 tt -100.59 -1.54 9.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 -176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' HA ' HD21 ' A' ' 6' ' ' LEU . 60.9 t-80 79.98 79.25 0.05 OUTLIER 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 126.716 2.007 . . . . 0.0 106.581 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.7 -179.08 7.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -176.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.71 101.99 3.22 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.918 1.342 . . . . 0.0 111.292 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.684 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -93.8 121.68 35.5 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.697 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.88 79.06 1.68 Allowed 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.602 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -95.85 88.39 1.05 Allowed Glycine 0 CA--C 1.472 -2.645 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.529 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.34 -64.6 1.13 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.543 0.687 . . . . 0.0 110.13 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.666 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 6.1 mmp_? -84.38 -40.96 17.21 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 34' ' ' LYS . 33.5 tt0 -67.34 -11.98 59.02 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.952 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 48.8 t -55.48 -41.92 73.67 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.88 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -70.81 -32.11 69.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.027 0.442 . . . . 0.0 110.625 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -75.49 -41.36 55.64 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.45 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.3 ptp -61.62 -33.06 73.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.993 0.425 . . . . 0.0 111.672 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.19 -28.41 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.798 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' ALA . 15.4 mm-40 -92.73 -37.24 12.48 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.571 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 73.2 mttt -58.8 -24.94 62.64 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 124.772 1.229 . . . . 0.0 111.246 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -60.47 -26.83 67.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 O-C-N 124.331 1.019 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.26 -62.7 1.3 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.198 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -152.11 -70.01 0.16 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.862 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 28.2 ptt180 -158.48 123.76 4.36 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.0 t -140.74 154.73 21.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.901 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.7 p -115.03 144.15 23.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.169 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.831 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 4.0 t-80 -113.45 126.34 55.22 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.3 tt -86.33 134.57 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 86' ' ' LEU . 65.3 mttp 66.7 60.1 0.94 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.861 0.865 . . . . 0.0 109.906 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 86' ' ' LEU . 57.5 Cg_endo -69.25 168.24 21.45 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.771 1.647 . . . . 0.0 110.639 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.666 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 179.47 56.8 0.08 OUTLIER Glycine 1 CA--C 1.448 -4.103 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -177.148 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . 2.6 pm0 -116.35 147.27 41.76 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 114.163 -1.019 . . . . 0.0 109.857 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.592 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 7.8 mmtm -136.64 76.56 1.6 Allowed 'General case' 0 C--N 1.263 -3.193 0 CA-C-O 123.801 1.762 . . . . 0.0 107.907 174.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 79.9 mt -88.39 107.55 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.698 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.364 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.679 HD22 HG22 ' A' ' 18' ' ' ILE . 2.4 mt 70.57 -3.77 1.82 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.492 1.117 . . . . 0.0 111.251 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.8 -37.73 3.66 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.27 131.12 27.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -71.93 103.84 3.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.904 0.859 . . . . 0.0 109.216 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 49' ' ' LEU . 50.8 mm -120.01 134.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 16' ' ' TYR . 69.5 mt -84.61 -41.38 15.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.752 0.787 . . . . 0.0 109.229 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.69 -18.51 34.03 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 mm -101.02 108.78 56.07 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.5 Cg_exo -53.05 109.32 0.34 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.477 2.785 . . . . 0.0 112.577 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 59.0 Cg_endo -97.37 -179.66 0.38 Allowed 'Trans proline' 0 N--CA 1.432 -2.12 0 C-N-CA 122.713 2.275 . . . . 0.0 111.487 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 75' ' ' THR . 77.6 t -67.37 112.33 9.82 Favored Pre-proline 0 C--O 1.213 -0.835 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.27 75.09 5.14 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.86 1.707 . . . . 0.0 115.455 -170.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 75.0 mt -136.64 142.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.658 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 138.11 156.74 7.24 Favored Glycine 0 N--CA 1.403 -3.535 0 C-N-CA 118.981 -1.58 . . . . 0.0 114.13 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.1 pt -150.87 160.84 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 123.423 0.689 . . . . 0.0 111.3 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.93 136.48 42.68 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.44 -61.87 1.66 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.737 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -155.83 166.22 34.16 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 67' ' ' ARG . 3.0 tpp180 -77.09 -33.62 56.96 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.793 0.806 . . . . 0.0 110.468 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.49 31.54 1.02 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 122.782 1.277 . . . . 0.0 110.288 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.483 ' CA ' ' HG3' ' A' ' 85' ' ' GLU . 64.4 m -154.61 173.49 16.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 85' ' ' GLU . 29.1 m -79.19 166.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-O 122.473 1.13 . . . . 0.0 110.228 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.526 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.4 ptt? -120.77 122.25 39.96 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 174.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.8 90.29 15.01 Favored Pre-proline 0 C--N 1.293 -1.867 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.174 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.658 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 71.7 Cg_endo -103.21 171.09 0.21 Allowed 'Trans proline' 1 N--CA 1.385 -4.898 0 C-N-CA 120.8 1.0 . . . . 0.0 111.449 176.022 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m-85 -126.05 32.53 5.23 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 122.213 1.006 . . . . 0.0 110.304 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 37.0 p -80.6 104.38 11.09 Favored 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.511 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -103.88 102.23 29.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.688 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 75' ' ' THR . 64.3 Cg_endo -98.46 -156.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.736 2.957 . . . . 0.0 112.072 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.2 t -95.95 28.56 3.08 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.369 1.08 . . . . 0.0 108.092 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -136.81 -85.28 0.33 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.68 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -172.77 173.81 45.59 Favored Glycine 0 C--N 1.315 -0.589 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.551 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 25.1 m -89.28 135.7 33.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.418 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . . . -109.91 126.93 54.39 Favored 'General case' 0 N--CA 1.397 -3.119 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 54.2 t -133.02 138.85 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 30.7 m -140.06 140.52 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.483 ' HG3' ' CA ' ' A' ' 69' ' ' THR . 42.5 tt0 -138.71 118.67 13.34 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' SER . 13.2 tp -97.17 143.9 26.94 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.27 12.67 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.907 1.738 . . . . 0.0 112.34 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 68' ' ' SER . 26.1 t -117.79 156.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.474 ' CB ' ' HG2' ' A' ' 91' ' ' GLU . 1.8 m-20 -51.81 157.51 1.97 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 124.201 0.938 . . . . 0.0 111.871 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.28 -11.37 31.11 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.586 2.191 . . . . 0.0 110.539 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 89' ' ' ASP . 12.8 pt-20 -66.61 -16.87 64.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.226 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 96' ' ' ILE . 7.3 tp10 -59.52 -26.49 65.36 Favored 'General case' 0 C--N 1.375 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -56.38 -36.16 45.98 Favored 'Isoleucine or valine' 0 C--O 1.167 -3.242 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -56.04 -40.94 74.23 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.93 0.871 . . . . 0.0 110.796 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -39.03 42.29 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.208 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 92' ' ' GLU . 43.2 mm -75.29 -18.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.317 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.9 tp -82.14 -27.89 32.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.731 0.777 . . . . 0.0 109.018 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -100.74 7.88 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.669 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.592 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -55.13 -61.8 2.08 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -177.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.54 -43.93 0.22 Allowed Pre-proline 0 C--N 1.258 -3.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.911 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.423 -2.638 0 C-N-CA 121.163 1.242 . . . . 0.0 112.347 179.129 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' HIS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.693 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.697 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.683 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HB ' HD22 ' A' ' 49' ' ' LEU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.616 HD22 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 75' ' ' THR . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.534 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 73' ' ' PRO . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.5 t60 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -176.96 148.86 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.23 0.612 . . . . 0.0 110.966 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -148.93 130.67 15.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 55.9 m-85 -114.68 7.57 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.985 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.4 m -84.53 115.0 22.36 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 7' ' ' GLU . 0.6 OUTLIER -102.92 -53.07 2.92 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.759 ' H ' HD12 ' A' ' 6' ' ' LEU . 33.1 tt0 -70.22 -13.82 62.35 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 125.155 1.382 . . . . 0.0 110.91 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -73.12 -25.05 60.71 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.237 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -32.3 63.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.68 -42.13 98.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -67.0 -17.32 64.87 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.95 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -95.19 -45.2 7.29 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.9 m -149.59 -67.34 0.21 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.933 0.396 . . . . 0.0 111.127 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.33 163.54 32.04 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.7 152.93 22.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 124.222 0.601 . . . . 0.0 109.831 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.518 ' HA ' HG23 ' A' ' 54' ' ' ILE . 41.9 t80 -151.44 13.58 0.66 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.401 0.619 . . . . 0.0 110.452 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -144.59 171.06 14.91 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.699 HG22 ' HG ' ' A' ' 49' ' ' LEU . 15.5 tt -105.2 150.46 7.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -69.53 67.68 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.305 1.05 . . . . 0.0 110.973 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mmm -122.07 -101.03 0.41 Allowed 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.979 1.712 . . . . 0.0 110.242 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 37.6 ttmt -159.45 124.22 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.413 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -108.06 141.45 39.73 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . . . -118.06 90.47 3.34 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.56 76.07 0.22 Allowed Glycine 0 CA--C 1.479 -2.199 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.358 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 97.3 m-85 -70.37 -74.96 0.13 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.072 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.601 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.7 mmt180 -80.73 -33.02 35.52 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.375 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -66.29 -13.07 59.89 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' MET . 25.0 t -49.44 -37.38 25.54 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 121.501 0.667 . . . . 0.0 110.987 175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.68 -42.97 63.69 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 121.82 -0.55 . . . . 0.0 110.456 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -60.28 -47.07 87.6 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.122 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -53.39 -39.53 64.33 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.383 0.427 . . . . 0.0 112.023 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.7 mm -62.17 -43.36 97.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.128 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.608 ' HB3' HG21 ' A' ' 39' ' ' VAL . 18.5 mm-40 -79.58 -28.86 41.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.805 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -64.47 -22.95 67.12 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 123.952 0.901 . . . . 0.0 111.973 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.06 -26.61 66.83 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -59.54 2.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.07 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -141.67 -79.12 0.25 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.487 1.137 . . . . 0.0 110.01 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.499 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 14.2 ptp180 -170.49 123.19 0.65 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 33' ' ' GLU . 74.2 t -132.93 143.19 40.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.639 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.7 p -97.75 139.41 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.901 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.633 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 57.6 t-80 -123.27 124.9 44.03 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.8 tt -85.65 136.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 96.4 mttt 68.1 58.32 0.73 Allowed Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 123.64 0.776 . . . . 0.0 110.93 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 Cg_endo -78.24 155.91 29.3 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 121.647 1.565 . . . . 0.0 110.29 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -152.99 39.16 0.73 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.3 pm0 -105.6 175.6 5.44 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.925 0.869 . . . . 0.0 111.565 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.609 ' HG2' HG23 ' A' ' 96' ' ' ILE . 4.7 tmtt? -157.44 102.67 1.92 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.38 105.95 17.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.699 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.26 -1.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 127.349 2.26 . . . . 0.0 114.47 175.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.75 -38.89 2.93 Favored Glycine 0 C--N 1.291 -1.946 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.79 39.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -75.79 104.07 6.17 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.466 HD12 HG21 ' A' ' 18' ' ' ILE . 48.5 mt -124.31 119.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 16' ' ' TYR . 62.9 mt -77.9 -33.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.932 0.77 . . . . 0.0 110.18 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.63 14.99 Favored Glycine 0 C--N 1.309 -0.933 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.58 131.25 23.19 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 48.2 Cg_exo -58.79 110.43 0.67 Allowed 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.811 2.341 . . . . 0.0 111.324 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 30.0 Cg_endo -110.58 -177.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 122.878 2.385 . . . . 0.0 112.905 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 75' ' ' THR . 59.1 t -87.23 121.17 71.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 40.22 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.042 2.495 . . . . 0.0 114.792 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.09 145.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.34 145.39 6.0 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.352 -1.404 . . . . 0.0 112.356 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.13 86.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 123.404 0.681 . . . . 0.0 109.428 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -95.07 114.96 26.82 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.29 -69.53 0.72 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -148.07 168.25 22.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -32.82 42.44 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.27 28.47 1.43 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.426 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -152.3 167.91 27.1 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 85' ' ' GLU . 29.9 m -78.83 156.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.9 0.857 . . . . 0.0 111.383 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.614 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 ptt? -119.37 124.85 47.59 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.1 mt -107.95 87.48 3.81 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.2 Cg_exo -82.24 142.01 11.84 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.998 1.799 . . . . 0.0 112.332 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.8 49.88 1.07 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.997 1.38 . . . . 0.0 107.819 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.5 p -98.51 119.97 38.13 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 112.746 -2.024 . . . . 0.0 107.313 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -100.51 102.19 17.94 Favored Pre-proline 0 C--N 1.305 -1.345 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.002 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.3 Cg_endo -104.17 -164.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.708 0 C-N-CA 123.069 2.513 . . . . 0.0 111.18 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 74.3 m -109.8 35.39 3.38 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -141.86 -71.76 0.34 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.577 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.16 40.54 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 22.7 m -115.31 149.36 37.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 118.304 1.052 . . . . 0.0 111.214 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.07 124.68 52.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.4 t -122.33 124.83 71.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.517 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 21.8 m -125.17 145.79 31.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.432 ' HB2' HG12 ' A' ' 70' ' ' VAL . 44.2 tt0 -147.6 118.58 7.67 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.209 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.1 tp -95.85 125.66 47.92 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 1.13 8.97 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.254 1.969 . . . . 0.0 111.164 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.55 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 19.5 t -100.25 164.42 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 91' ' ' GLU . 6.2 m-20 -70.23 162.21 71.01 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 118.074 0.397 . . . . 0.0 110.132 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.73 16.42 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.137 2.558 . . . . 0.0 112.207 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -70.41 -20.01 62.95 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.014 0.911 . . . . 0.0 109.115 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.504 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 7.3 tp10 -65.74 -24.29 66.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.033 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.559 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 66.5 mt -59.23 -26.96 35.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.83 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -63.59 -41.09 98.37 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HD2' ' H ' ' A' ' 95' ' ' ARG . 2.8 mpt_? -74.82 -38.9 61.92 Favored 'General case' 0 C--O 1.193 -1.921 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.609 HG23 ' HG2' ' A' ' 47' ' ' LYS . 62.2 mt -58.66 -33.97 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 124.37 1.068 . . . . 0.0 111.316 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.45 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.558 0.694 . . . . 0.0 109.797 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.57 -42.55 24.77 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.011 0.91 . . . . 0.0 109.518 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.19 3.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 125.119 1.367 . . . . 0.0 111.674 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -42.19 -44.13 3.62 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 124.518 1.127 . . . . 0.0 110.751 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -160.18 98.18 1.46 Allowed Pre-proline 0 N--CA 1.401 -2.882 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.243 0.734 0 C-N-CA 123.543 2.828 . . . . 0.0 112.739 -178.022 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.572 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HD11 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.527 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.632 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 20' ' ' MET . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' ILE . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.528 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.825 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 96' ' ' ILE . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG22 ' HB2' ' A' ' 22' ' ' ARG . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' HB2' ' A' ' 20' ' ' MET . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.61 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.657 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 67' ' ' ARG . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.491 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 79.9 m-70 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtt -152.49 122.26 6.94 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.649 HG21 ' SD ' ' A' ' 31' ' ' MET . 8.6 t -111.25 125.3 53.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.445 0.641 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.54 7.44 6.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.875 0.845 . . . . 0.0 109.43 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 62.5 m -94.89 96.56 9.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.769 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 7' ' ' GLU . 4.1 pp -100.29 -39.48 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.984 0.897 . . . . 0.0 110.358 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.625 ' N ' HD12 ' A' ' 6' ' ' LEU . 35.2 tt0 -77.74 -13.77 59.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.165 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.7 m -68.5 -33.56 74.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -80.33 -26.4 38.76 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.641 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HG ' ' OE2' ' A' ' 15' ' ' GLU . 7.8 tt -73.55 -26.79 61.01 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.295 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 7' ' ' GLU . 79.5 mt-30 -68.89 -29.96 68.35 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -93.34 -7.0 46.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.059 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.9 m 63.85 37.85 9.39 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 122.318 1.056 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.27 55.71 0.57 Allowed Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.475 ' OE2' ' HG ' ' A' ' 10' ' ' LEU . 6.1 pm0 -100.07 174.25 6.25 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.146 0.578 . . . . 0.0 111.423 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.431 ' CD1' HG13 ' A' ' 54' ' ' ILE . 70.9 t80 -144.87 25.44 1.44 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -138.13 163.96 30.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.75 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.477 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.1 tt -115.83 165.23 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.404 ' N ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-70 -65.84 71.87 0.06 Allowed 'General case' 0 C--N 1.362 1.15 0 CA-C-O 122.213 1.006 . . . . 0.0 109.989 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.641 ' SD ' ' HB3' ' A' ' 49' ' ' LEU . 47.7 mtt -135.82 -148.4 0.3 Allowed 'General case' 0 C--N 1.259 -3.326 0 C-N-CA 126.209 1.804 . . . . 0.0 106.872 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 20' ' ' MET . 11.9 tmtt? -124.03 123.28 40.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HB3' HD23 ' A' ' 6' ' ' LEU . 8.9 ptm180 -98.89 165.8 11.59 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.78 80.68 0.94 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.492 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -96.9 82.3 0.74 Allowed Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.4 -65.9 0.87 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.3 mpt_? -85.62 -34.66 21.33 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.984 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 29.8 tt0 -79.21 -3.01 43.68 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.648 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -53.54 -41.91 66.92 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.11 94.98 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.19 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.32 -45.73 91.91 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.293 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.649 ' SD ' HG21 ' A' ' 3' ' ' THR . 18.4 ptm -55.98 -35.73 67.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.9 mm -59.9 -46.44 93.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 123.93 0.769 . . . . 0.0 109.927 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.4 -28.51 31.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.193 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 34.7 mtpt -57.01 -26.86 60.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.692 0.797 . . . . 0.0 110.924 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 7.0 tmtm? -62.67 -21.25 65.57 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.316 1.047 . . . . 0.0 111.26 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.86 -39.24 69.81 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 121.86 -0.525 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -176.12 -65.46 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 7.2 ptp180 -169.6 132.41 1.2 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.67 145.79 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -98.26 139.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 O-C-N 124.343 1.027 . . . . 0.0 109.996 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 37.6 t-80 -137.7 123.29 19.75 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.0 137.85 20.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.8 mttt 66.6 64.24 0.82 Allowed Pre-proline 0 C--O 1.216 -0.667 0 C-N-CA 123.133 0.573 . . . . 0.0 111.097 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.635 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 44.9 Cg_endo -95.28 148.82 1.53 Allowed 'Trans proline' 0 N--CA 1.427 -2.395 0 C-N-CA 122.126 1.884 . . . . 0.0 111.046 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.457 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -154.21 64.76 0.34 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.265 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.658 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.0 tp10 -114.38 123.24 48.98 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 124.072 0.949 . . . . 0.0 109.11 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 44.4 mtmt -106.96 72.5 0.89 Allowed 'General case' 0 CA--C 1.464 -2.339 0 CA-C-O 123.287 1.518 . . . . 0.0 107.786 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.658 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -75.43 94.73 0.98 Allowed 'Isoleucine or valine' 1 C--N 1.239 -4.229 0 CA-C-N 111.683 -2.508 . . . . 0.0 111.828 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.641 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER 64.27 -8.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.646 1.578 . . . . 0.0 113.362 175.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.29 -6.26 78.23 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.31 152.19 18.27 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -88.83 99.87 12.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.816 0.341 . . . . 0.0 111.77 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.34 118.02 57.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 77' ' ' PRO . 3.5 mp -75.51 -43.54 41.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.403 0.62 . . . . 0.0 110.736 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.6 -9.47 77.0 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.3 mt -124.64 131.21 24.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.9 107.33 1.86 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.563 1.509 . . . . 0.0 109.252 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -103.4 -164.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 122.721 2.281 . . . . 0.0 111.485 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 75' ' ' THR . 55.7 t -75.75 116.96 60.07 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -84.1 43.93 1.46 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 122.502 2.135 . . . . 0.0 113.964 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 51.1 mt -114.98 164.88 10.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.21 155.93 9.14 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.157 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.2 pt -126.22 84.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.096 0.95 . . . . 0.0 111.32 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.78 95.96 7.44 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -76.95 -56.92 4.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.769 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.13 169.88 12.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 0.1 OUTLIER -88.77 -31.7 18.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.23 1.014 . . . . 0.0 108.464 -176.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 14.9 m -93.71 34.63 1.18 Allowed 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.909 1.338 . . . . 0.0 109.203 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.2 m -154.66 166.74 32.45 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.42 105.87 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 121.861 0.839 . . . . 0.0 110.968 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.47 ' HE3' ' HA ' ' A' ' 67' ' ' ARG . 21.4 ptp -86.29 123.54 31.66 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.9 mt -118.93 86.35 30.92 Favored Pre-proline 0 C--N 1.295 -1.792 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.857 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.555 ' O ' HG21 ' A' ' 81' ' ' THR . 4.3 Cg_exo -75.14 149.96 36.89 Favored 'Trans proline' 0 N--CA 1.422 -2.689 0 N-CA-C 108.353 -1.441 . . . . 0.0 108.353 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 72.4 m-85 -113.08 41.4 2.11 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 44.5 p -95.07 102.85 14.68 Favored 'General case' 0 N--CA 1.398 -3.054 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -102.05 102.38 23.75 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.743 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.8 Cg_endo -102.45 -159.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.311 0 C-N-CA 123.253 2.635 . . . . 0.0 110.136 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -93.86 25.46 3.62 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.121 0.962 . . . . 0.0 110.172 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -128.09 -74.91 0.57 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.829 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 157.66 -174.78 35.07 Favored Glycine 0 N--CA 1.416 -2.655 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 73' ' ' PRO . 5.0 m -121.48 152.12 39.5 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 117.406 0.603 . . . . 0.0 109.627 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -105.15 111.83 24.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.7 t -102.24 90.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.635 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 26.9 m -104.64 135.47 42.42 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 O-C-N 121.457 -0.777 . . . . 0.0 111.473 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.17 115.88 16.95 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.529 0.68 . . . . 0.0 109.277 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 68' ' ' SER . 26.8 tp -99.49 125.03 42.39 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.2 8.45 4.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.348 2.032 . . . . 0.0 111.785 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.509 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.8 t -104.15 157.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.42 152.71 94.23 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.89 -7.51 18.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.625 2.883 . . . . 0.0 112.398 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.64 -24.56 63.97 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.61 -27.71 69.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.573 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 67' ' ' ARG . 78.2 mt -59.17 -41.0 82.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 C-N-CA 122.168 0.187 . . . . 0.0 110.988 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.92 -47.33 86.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.973 0.892 . . . . 0.0 109.66 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -68.32 -41.78 80.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.174 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.455 HG23 ' HG2' ' A' ' 47' ' ' LYS . 4.1 mt -65.92 -28.56 44.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 C-N-CA 124.128 0.971 . . . . 0.0 113.188 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.36 -37.09 84.5 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.212 0.53 . . . . 0.0 110.343 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.22 -37.06 46.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.219 1.009 . . . . 0.0 108.996 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 99' ' ' VAL . 57.8 t -91.07 17.25 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.287 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.524 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.65 -48.33 69.5 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.23 -48.31 0.6 Allowed Pre-proline 0 C--N 1.293 -1.887 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.392 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 C--N 1.389 2.675 0 C-N-CA 123.687 2.925 . . . . 0.0 115.25 177.804 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 64.6 t60 . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -130.07 139.56 50.95 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 t -107.6 123.53 48.6 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.525 0.679 . . . . 0.0 111.706 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -129.99 -0.48 4.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.419 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p -87.22 101.36 13.44 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.652 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.554 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -97.34 -44.85 6.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' N ' HD22 ' A' ' 6' ' ' LEU . 34.9 tt0 -81.42 -4.8 56.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.316 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -71.04 -24.77 62.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.883 0.849 . . . . 0.0 109.559 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 79' ' ' TYR . 38.5 t80 -78.39 -21.84 48.74 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.828 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.06 -35.29 79.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.89 -14.01 62.31 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -91.95 -46.24 7.93 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.7 m -163.39 -67.69 0.04 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.47 0.653 . . . . 0.0 109.428 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.11 -179.87 20.11 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 16' ' ' TYR . 29.8 tt0 -97.1 177.51 5.57 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 118.243 1.022 . . . . 0.0 108.777 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.563 ' HA ' HG23 ' A' ' 54' ' ' ILE . 18.1 t80 -129.15 14.41 6.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.655 1.217 . . . . 0.0 108.549 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HA ' HD21 ' A' ' 49' ' ' LEU . 5.0 mp0 -132.3 -168.01 1.98 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.489 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.625 HG22 ' HG ' ' A' ' 49' ' ' LEU . 10.9 tt -122.39 45.59 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.375 1.084 . . . . 0.0 110.793 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 56.73 31.07 18.73 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.793 1.237 . . . . 0.0 111.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.505 ' HB2' HD12 ' A' ' 49' ' ' LEU . 91.1 mmm -121.86 -168.37 1.69 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 45.1 mmtm -89.25 138.16 31.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.782 1.628 . . . . 0.0 111.478 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.73 ' HB2' HG22 ' A' ' 48' ' ' ILE . 11.9 ptm180 -107.45 140.63 40.1 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.55 88.79 2.57 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.397 0.618 . . . . 0.0 111.146 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -108.88 78.87 0.24 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.678 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -71.19 -56.83 5.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.781 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 3.2 mmp_? -94.39 -33.17 13.26 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.63 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 25.9 tt0 -82.32 -0.43 45.63 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.975 -177.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 31' ' ' MET . 50.7 t -57.36 -38.15 73.73 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.73 -41.78 82.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.427 0.632 . . . . 0.0 109.335 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -62.5 -41.37 98.78 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.272 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 9.9 ptt? -54.52 -35.11 62.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.257 0.348 . . . . 0.0 111.749 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.697 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 44.9 mm -62.72 -39.44 84.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.421 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.77 -27.27 21.25 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.586 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 38.0 mtpt -59.6 -18.24 39.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.048 0.939 . . . . 0.0 112.126 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -68.6 -14.31 62.93 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.14 -55.55 5.34 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 111.213 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -167.62 -64.38 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 40.5 ptt180 -163.16 124.68 2.47 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.0 t -133.52 151.89 34.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.738 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.4 p -102.06 148.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 123.873 0.733 . . . . 0.0 110.215 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.458 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 78.5 t60 -144.47 143.98 31.14 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.21 146.16 9.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.594 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 49.1 mtmt 65.22 48.51 0.66 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 110.723 -176.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 6.0 Cg_exo -89.1 161.77 5.81 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.62 2.214 . . . . 0.0 111.096 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.519 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -171.75 75.19 0.1 OUTLIER Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.171 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 26.7 tt0 -120.94 123.83 43.43 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.709 0.766 . . . . 0.0 110.244 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 50' ' ' GLY . 2.4 tmtm? -124.03 104.13 8.71 Favored 'General case' 0 N--CA 1.394 -3.273 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.73 HG22 ' HB2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -106.6 130.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.795 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 55.32 15.95 1.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.038 2.135 . . . . 0.0 112.843 176.181 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.564 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . 81.68 -25.08 4.08 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.043 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.415 ' O ' HD12 ' A' ' 53' ' ' ILE . . . -143.44 145.1 32.34 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -74.57 89.14 2.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 117.754 0.252 . . . . 0.0 111.141 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 55' ' ' GLY . 4.7 mp -116.72 127.92 74.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 16' ' ' TYR . 55.2 mt -91.84 -17.23 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 122.096 0.95 . . . . 0.0 108.653 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 87.43 -17.68 42.22 Favored Glycine 0 CA--C 1.499 -0.923 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.1 mt -119.74 105.27 43.51 Favored Pre-proline 0 N--CA 1.413 -2.32 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 51.7 Cg_exo -53.16 110.31 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.667 2.912 . . . . 0.0 112.462 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 52.7 Cg_endo -95.85 175.29 0.9 Allowed 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.747 2.298 . . . . 0.0 111.741 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.9 t -85.12 106.5 9.05 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.3 100.76 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.373 2.049 . . . . 0.0 113.651 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.8 mt -134.54 86.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.6 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . -136.32 151.33 20.76 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.48 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.05 104.07 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 123.645 0.778 . . . . 0.0 108.931 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.13 99.06 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -76.36 -69.82 0.48 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.522 0.677 . . . . 0.0 109.821 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -163.91 168.4 19.47 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG3' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -81.69 -31.09 32.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.189 0.995 . . . . 0.0 108.432 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' HD3' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -92.17 28.41 1.9 Allowed 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.408 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 m -152.46 166.6 31.45 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 85' ' ' GLU . 18.6 m -76.95 103.59 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 118.979 0.809 . . . . 0.0 110.958 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.65 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 23.5 ptt? -83.43 119.26 24.44 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -108.58 88.48 5.2 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 71' ' ' MET . 12.6 Cg_endo -96.07 167.5 1.24 Allowed 'Trans proline' 0 N--CA 1.403 -3.807 0 C-N-CA 121.973 1.782 . . . . 0.0 111.097 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 73.4 t80 -140.34 113.01 8.05 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.7 p -128.06 139.79 52.33 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -112.31 88.88 11.34 Favored Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.636 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 75' ' ' THR . 73.5 Cg_endo -106.1 -151.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 123.923 3.082 . . . . 0.0 109.808 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.0 t -100.74 13.35 35.2 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.55 ' HD2' ' CE2' ' A' ' 9' ' ' TYR . 48.3 t80 -124.84 -81.55 0.63 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.562 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -174.0 40.63 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 10.2 m -118.75 158.06 26.31 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.33 0.565 . . . . 0.0 110.218 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -114.91 125.43 53.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.4 t -107.34 108.0 24.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 44' ' ' PRO . 29.3 m -114.32 141.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.446 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.484 ' HB2' HG12 ' A' ' 70' ' ' VAL . 38.7 tt0 -134.56 108.57 8.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.0 tp -95.23 129.09 36.29 Favored Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.5 13.51 2.63 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.429 2.086 . . . . 0.0 110.839 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.514 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 21.4 t -115.88 159.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 9.7 t70 -65.66 146.12 99.0 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.542 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 11.3 Cg_endo -54.34 -13.74 5.68 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.84 3.027 . . . . 0.0 113.879 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.4 pt-20 -61.4 -20.69 63.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 4.4 tp10 -64.3 -30.53 71.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HG3' ' A' ' 67' ' ' ARG . 48.8 mm -70.04 -31.58 48.21 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.954 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.96 -39.47 94.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -64.97 -48.67 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.463 1.125 . . . . 0.0 108.172 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.1 mt -68.96 -19.58 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.088 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 65.5 tp -77.18 -26.58 53.07 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.019 0.928 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.69 -37.53 59.46 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 56.5 t -62.36 -65.56 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . 59.2 -57.67 0.05 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.732 2.013 . . . . 0.0 114.969 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 32.5 mt-10 -128.06 -69.66 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.134 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.558 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 73.1 Cg_endo . . . . . 0 N--CA 1.437 -1.829 0 CA-C-N 120.681 1.279 . . . . 0.0 112.565 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.622 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 67.1 mtm -152.79 128.54 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m -106.74 111.45 23.98 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.2 m-85 -128.69 10.43 6.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.169 0.509 . . . . 0.0 111.141 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.4 m -131.69 106.93 8.46 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -80.92 -37.47 29.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.121 0.962 . . . . 0.0 111.419 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' H ' HD13 ' A' ' 6' ' ' LEU . 8.3 tp10 -71.38 -19.24 62.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.278 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.535 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.3 m -73.01 -31.96 64.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -70.47 -30.13 66.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.126 0.489 . . . . 0.0 110.092 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.6 -43.64 98.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.81 -11.7 59.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.388 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 8' ' ' THR . 52.5 mt-30 -89.67 -32.83 16.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.6 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -164.5 -67.07 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.47 166.01 38.66 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.85 141.29 56.49 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.716 0.769 . . . . 0.0 111.732 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -139.7 8.38 2.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 54.7 mt-10 -152.86 148.98 27.8 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.34 -1.754 . . . . 0.0 106.741 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.54 HG22 ' HG ' ' A' ' 49' ' ' LEU . 12.4 tt -89.31 159.93 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -72.11 70.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.794 1.283 . . . . 0.0 109.972 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 mmt -136.69 -175.5 4.04 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.901 -1.954 . . . . 0.0 106.139 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 51.4 mttp -84.52 118.19 24.16 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 119.485 1.039 . . . . 0.0 110.997 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -108.37 136.62 47.69 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.411 -177.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . . . -143.36 96.18 2.87 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -114.48 85.12 0.38 Allowed Glycine 0 N--CA 1.423 -2.176 0 C-N-CA 120.302 -0.951 . . . . 0.0 114.476 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -69.28 -81.03 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 117.105 0.452 . . . . 0.0 112.108 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 20.9 mtp-105 -73.13 -32.95 65.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 13.1 tp10 -70.05 -13.85 62.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.743 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 43.4 t -60.63 -31.9 71.07 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.13 68.5 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.455 0.645 . . . . 0.0 110.204 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.63 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.51 -44.87 81.38 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.379 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.465 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 22.4 ptp -56.32 -31.14 63.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 28' ' ' CYS . 46.7 mm -60.96 -40.74 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.663 0.744 . . . . 0.0 109.531 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HB3' HG21 ' A' ' 39' ' ' VAL . 8.5 mm-40 -80.45 -34.25 36.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.281 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.503 ' HE2' ' O ' ' A' ' 39' ' ' VAL . 74.3 mttt -68.26 -13.54 62.33 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -64.23 -30.55 71.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.484 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.71 -47.06 27.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.626 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.58 -74.3 0.06 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 120.756 0.313 . . . . 0.0 110.595 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 ttp180 -165.82 124.63 1.61 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 58.8 t -136.39 165.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.6 p -112.51 149.35 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.437 0.695 . . . . 0.0 109.901 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.63 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 46.2 t60 -140.74 128.84 22.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.4 mp -98.09 136.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 97.0 mttt 71.78 55.97 0.38 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.868 1.267 . . . . 0.0 110.432 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 85.4 Cg_endo -74.16 135.38 20.71 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.997 1.131 . . . . 0.0 109.716 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.94 46.58 1.08 Allowed Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 4.4 pm0 -112.99 153.21 28.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-O 121.643 0.735 . . . . 0.0 110.696 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -140.97 61.76 1.49 Allowed 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.446 ' C ' HD22 ' A' ' 49' ' ' LEU . 33.7 pt -64.29 105.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.576 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.54 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 70.49 -10.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.965 2.106 . . . . 0.0 113.792 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.84 -1.16 88.03 Favored Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.59 120.79 3.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.721 1.608 . . . . 0.0 107.069 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.93 87.5 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.321 0.582 . . . . 0.0 112.275 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.493 HD12 HG21 ' A' ' 18' ' ' ILE . 61.5 mt -116.54 130.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.1 mm -71.88 -40.87 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.498 0.666 . . . . 0.0 109.597 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.0 0.24 63.87 Favored Glycine 0 C--N 1.308 -0.996 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mt -130.52 129.38 22.75 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.64 107.08 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.333 2.022 . . . . 0.0 110.07 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 36.0 Cg_endo -103.97 -167.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.272 0 C-N-CA 122.566 2.177 . . . . 0.0 111.319 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 75' ' ' THR . 41.3 t -99.16 100.67 10.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 10.3 Cg_endo -87.66 102.59 0.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.721 2.28 . . . . 0.0 113.541 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.53 164.52 34.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 133.13 -175.09 20.3 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.556 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.72 107.04 4.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -99.51 108.62 21.1 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -85.34 -55.93 3.78 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.597 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -171.94 166.8 6.29 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -35.48 74.58 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.597 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 16.0 m -96.37 31.4 2.24 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.608 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -151.43 161.65 42.33 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG13 ' OE2' ' A' ' 85' ' ' GLU . 9.5 m -77.35 112.77 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.979 0.895 . . . . 0.0 109.865 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.603 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -90.84 123.05 34.08 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.72 89.27 12.85 Favored Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.138 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 71' ' ' MET . 4.9 Cg_exo -85.04 155.94 11.29 Favored 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 121.872 1.714 . . . . 0.0 110.029 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -125.22 75.73 1.48 Allowed 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.553 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 p -106.51 134.62 49.36 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.455 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -110.79 88.81 8.42 Favored Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.875 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 75' ' ' THR . 44.3 Cg_endo -103.38 -159.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.658 2.905 . . . . 0.0 109.797 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 10.1 t -94.58 5.31 52.21 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.448 0.642 . . . . 0.0 109.302 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -120.68 -84.42 0.66 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.152 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -168.8 39.63 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 27.7 m -116.96 147.76 41.99 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.313 0.578 . . . . 0.0 110.08 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.471 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -120.12 121.59 39.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 82.9 t -104.38 104.91 17.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -103.22 133.78 46.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.448 ' OE2' HG13 ' A' ' 70' ' ' VAL . 36.2 tt0 -132.69 115.21 15.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.324 0.583 . . . . 0.0 109.696 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 21.9 tp -99.37 132.99 22.33 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.38 -3.4 10.8 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.311 2.007 . . . . 0.0 111.834 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.602 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.5 t -96.0 164.32 2.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.0 t70 -68.61 146.89 97.93 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 123.208 0.603 . . . . 0.0 110.755 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.04 -10.92 1.24 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 124.134 3.223 . . . . 0.0 114.749 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.1 pt-20 -55.63 -22.61 23.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.279 0.632 . . . . 0.0 110.814 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -58.88 -23.19 60.65 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.864 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 27.2 mm -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -65.15 -37.55 87.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.09 -51.01 66.07 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' A' ' 47' ' ' LYS . 3.0 mt -58.42 -29.58 38.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.451 0 C-N-CA 125.74 1.616 . . . . 0.0 113.028 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.48 -36.68 79.3 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.237 0.542 . . . . 0.0 110.685 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.43 -45.1 10.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.215 1.007 . . . . 0.0 109.878 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.67 13.81 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 125.771 1.628 . . . . 0.0 111.095 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.713 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . . . -63.84 -36.31 83.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 29.2 mt-10 -88.73 -52.54 0.37 Allowed Pre-proline 0 N--CA 1.412 -2.361 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.657 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 32.5 Cg_endo . . . . . 0 N--CA 1.426 -2.491 0 C-N-CA 122.079 1.853 . . . . 0.0 112.353 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 CA--C 1.499 -0.987 0 CA-C-O 120.995 0.426 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.474 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 70.9 mtm -152.0 123.83 7.99 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.3 m -100.61 118.53 36.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 120.4 0.143 . . . . 0.0 111.085 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.8 m-85 -134.74 14.48 3.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.411 0.624 . . . . 0.0 109.535 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.0 m -135.05 102.43 5.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -76.04 -33.3 59.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.387 1.089 . . . . 0.0 111.542 -175.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' OE1' HD13 ' A' ' 10' ' ' LEU . 10.6 tp10 -73.7 -22.16 60.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.77 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -68.61 -30.87 69.69 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.14 -29.18 61.69 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.102 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD13 ' OE1' ' A' ' 7' ' ' GLU . 8.4 tt -61.9 -45.24 94.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' A' ' 7' ' ' GLU . 67.8 mt-30 -68.34 -35.34 77.63 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.162 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.27 -46.58 76.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.661 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 m -155.33 -67.82 0.12 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.244 0.545 . . . . 0.0 110.647 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.25 166.84 37.27 Favored Glycine 0 N--CA 1.413 -2.865 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.52 143.57 56.09 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-O 121.499 0.666 . . . . 0.0 111.767 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.13 3.85 3.44 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 48.6 mt-10 -151.49 155.54 38.75 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.643 HG22 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -94.88 166.89 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -75.66 72.43 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.406 1.098 . . . . 0.0 109.787 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 mmt -137.89 -176.37 4.41 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.899 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -78.04 111.31 13.8 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 118.784 0.72 . . . . 0.0 109.997 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HB2' ' OE2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -103.72 132.19 50.21 Favored 'General case' 0 N--CA 1.406 -2.632 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.64 98.56 3.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -120.89 86.9 0.4 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.207 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' CE1' ' HZ ' ' A' ' 4' ' ' PHE . 98.2 m-85 -71.78 -75.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.249 0.547 . . . . 0.0 110.51 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.632 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.2 mmp_? -70.08 -38.24 75.65 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -74.91 -8.74 57.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.987 -176.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.8 t -58.21 -35.14 71.22 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.132 0.491 . . . . 0.0 109.686 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.19 -42.66 79.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.512 0.673 . . . . 0.0 110.219 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -63.67 -49.1 74.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.122 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.5 ptp -57.14 -33.12 67.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 28' ' ' CYS . 47.5 mm -65.15 -39.25 84.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.715 0.769 . . . . 0.0 109.63 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.35 -31.78 43.1 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.62 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.0 mttt -66.4 -21.29 66.22 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -60.98 -25.61 66.97 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.66 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.71 -49.68 24.5 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -166.38 -71.38 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.911 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' THR . 52.2 ttp180 -164.15 111.56 1.11 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.89 150.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.168 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -103.23 148.0 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.625 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 49.3 t-80 -133.43 111.96 11.17 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.5 mp -82.77 138.32 19.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.431 ' HA ' HD12 ' A' ' 86' ' ' LEU . 96.1 mttt 69.99 59.23 0.53 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.522 1.129 . . . . 0.0 110.782 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 96.6 Cg_endo -78.95 166.0 23.66 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.059 1.839 . . . . 0.0 111.051 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -162.06 52.41 0.32 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 4.9 pm0 -116.32 151.98 34.78 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.053 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -138.34 60.43 1.61 Allowed 'General case' 0 CA--C 1.468 -2.203 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 175.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.406 ' C ' HD22 ' A' ' 49' ' ' LEU . 40.1 pt -69.27 112.2 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.129 0 CA-C-N 112.187 -2.278 . . . . 0.0 110.407 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 75.64 -19.33 0.41 Allowed 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.723 2.009 . . . . 0.0 113.139 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.71 -9.9 60.56 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.15 115.82 2.07 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -67.74 123.3 20.14 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -136.8 128.35 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.84 -37.15 60.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.22 -35.65 4.65 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 78' ' ' CYS . 59.0 mt -93.24 120.71 66.53 Favored Pre-proline 0 N--CA 1.417 -2.093 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.49 111.42 2.32 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.176 1.917 . . . . 0.0 110.004 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -101.76 -176.04 0.12 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.556 2.17 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 75' ' ' THR . 52.2 t -79.86 113.96 42.24 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 8.1 Cg_exo -72.96 52.93 2.3 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.13 2.553 . . . . 0.0 115.272 -173.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.4 mt -111.93 154.35 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 150.35 173.6 20.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 119.238 -1.458 . . . . 0.0 113.436 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -122.32 90.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.53 101.22 13.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.52 -70.43 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.626 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -162.62 170.98 17.63 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.1 -29.7 64.35 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.524 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 17.6 m -99.35 27.63 5.08 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.179 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 m -149.02 159.03 44.59 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.3 114.79 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 122.026 0.917 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.615 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -92.88 96.69 10.28 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.64 98.51 9.68 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 71' ' ' MET . 25.0 Cg_endo -92.19 171.19 2.6 Favored 'Trans proline' 1 N--CA 1.398 -4.104 0 C-N-CA 121.671 1.581 . . . . 0.0 112.08 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -124.18 48.05 1.98 Allowed 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.6 p -97.94 111.29 23.65 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-N 113.078 -1.873 . . . . 0.0 108.122 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -103.53 103.64 37.1 Favored Pre-proline 0 C--N 1.29 -2.0 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.858 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 75' ' ' THR . 19.6 Cg_endo -97.31 -164.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.768 0 C-N-CA 122.202 1.934 . . . . 0.0 108.249 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.483 ' H ' HG21 ' A' ' 56' ' ' ILE . 42.6 t -98.6 13.84 30.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.191 0.996 . . . . 0.0 109.065 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -115.02 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.962 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -179.2 164.14 32.14 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 8.4 m -91.29 152.48 20.46 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.07 135.52 53.62 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 t -127.65 131.79 69.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.42 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.3 m -131.45 147.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 40.6 tt0 -149.88 116.82 5.93 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.367 0.417 . . . . 0.0 110.24 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.3 tp -96.45 129.88 32.15 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.35 -8.27 17.28 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.748 1.632 . . . . 0.0 111.588 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.51 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 11.6 t -100.46 156.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.54 151.72 87.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 O-C-N 123.197 0.31 . . . . 0.0 111.699 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.16 -14.35 33.27 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.726 2.951 . . . . 0.0 113.263 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.65 -25.61 62.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.318 0.647 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' ARG . 49.8 mm-40 -75.04 -28.87 60.6 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.257 0.551 . . . . 0.0 110.017 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 48.9 mm -77.42 -27.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.931 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -65.91 -37.01 84.96 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 38.2 ttt180 -65.48 -47.25 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.992 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.66 -21.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.1 -27.08 60.71 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -27.16 61.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 99' ' ' VAL . 43.2 t -102.79 22.46 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.136 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . . . -58.21 -49.58 76.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.46 -42.13 0.41 Allowed Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 C--N 1.386 2.521 0 C-N-CA 123.752 2.968 . . . . 0.0 115.722 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -172.85 136.18 0.68 Allowed 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.977 0.911 . . . . 0.0 109.675 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.5 m -148.62 129.48 14.28 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 61.2 m-85 -116.22 0.73 12.98 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.82 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.2 m -82.31 111.8 18.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.857 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 22' ' ' ARG . 4.5 pp -106.37 -44.73 4.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.766 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.665 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 42.5 tt0 -68.42 -10.77 57.47 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.048 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 p -70.96 -28.36 64.42 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -75.89 -30.33 58.79 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 15' ' ' GLU . 36.5 tp -57.67 -43.39 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.974 0.893 . . . . 0.0 109.325 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -74.04 -12.76 60.71 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.381 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.39 -32.82 10.97 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.055 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -155.43 -66.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 109.844 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.02 162.89 36.68 Favored Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.665 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 9.5 tp10 -83.62 147.99 27.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 117.709 0.755 . . . . 0.0 109.318 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' HG23 ' A' ' 54' ' ' ILE . 66.9 t80 -131.27 18.12 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.055 0.931 . . . . 0.0 109.586 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 19.4 mm-40 -147.26 170.52 17.11 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.606 HG22 ' HG ' ' A' ' 49' ' ' LEU . 16.9 tt -102.69 158.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -75.06 69.87 2.0 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 123.34 1.543 . . . . 0.0 112.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.426 ' O ' HD21 ' A' ' 6' ' ' LEU . 29.9 mmm -128.62 -155.86 0.72 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.55 2.74 . . . . 0.0 106.037 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.24 123.19 47.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.886 0.766 . . . . 0.0 109.314 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -93.92 135.14 35.56 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.16 92.68 3.83 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -111.78 79.01 0.25 Allowed Glycine 0 C--N 1.291 -1.957 0 C-N-CA 118.818 -1.658 . . . . 0.0 112.47 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 95.3 m-85 -73.12 -69.6 0.41 Allowed 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 117.459 0.629 . . . . 0.0 109.311 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.698 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 25.9 mmt180 -80.5 -36.78 32.82 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.288 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 3.5 tm-20 -66.0 -13.05 59.18 Favored 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 31' ' ' MET . 27.2 t -48.68 -40.13 26.98 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.82 0.819 . . . . 0.0 110.287 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.71 -42.43 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.728 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.236 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.566 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 27.3 ptt? -51.58 -40.38 59.67 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.799 0.687 . . . . 0.0 111.863 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.3 mm -60.25 -45.02 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 39' ' ' VAL . 19.8 mm-40 -80.8 -30.45 35.91 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.175 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 81' ' ' THR . 28.6 mtpt -61.29 -26.97 68.14 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.348 1.059 . . . . 0.0 112.288 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -66.27 -22.56 66.31 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 123.837 0.71 . . . . 0.0 110.694 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.97 -60.12 2.41 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -144.37 -76.85 0.22 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.106 0.955 . . . . 0.0 109.974 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.2 ptp180 -168.7 124.79 0.96 Allowed 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 33' ' ' GLU . 73.4 t -134.43 145.66 32.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.291 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.4 p -98.5 142.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 O-C-N 124.398 1.061 . . . . 0.0 108.566 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.51 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 51.9 t-80 -133.49 120.29 20.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.1 tt -81.33 147.73 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 62.07 56.52 2.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.528 0.731 . . . . 0.0 111.473 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 84.4 Cg_endo -77.37 156.37 32.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.033 1.822 . . . . 0.0 111.152 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.698 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -160.75 56.49 0.32 Allowed Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 2.3 pm0 -115.98 174.38 6.07 Favored 'General case' 0 C--N 1.26 -3.314 0 CA-C-N 113.919 -1.14 . . . . 0.0 110.555 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.514 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.1 mmtt -154.85 89.45 1.24 Allowed 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 126.309 1.844 . . . . 0.0 106.09 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.418 ' C ' HD22 ' A' ' 49' ' ' LEU . 28.8 pt -85.34 100.39 8.45 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.269 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.606 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 58.52 16.59 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.063 1.745 . . . . 0.0 111.967 176.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 -51.74 4.04 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.23 142.68 50.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -70.21 103.4 2.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 18' ' ' ILE . 61.5 mt -123.06 114.59 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.444 HG23 ' CD1' ' A' ' 16' ' ' TYR . 69.3 mt -77.43 -44.45 30.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 122.229 1.014 . . . . 0.0 109.057 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.91 -29.96 9.75 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' H ' HG22 ' A' ' 54' ' ' ILE . 31.9 mm -86.59 125.64 66.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.58 106.82 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.478 2.119 . . . . 0.0 110.521 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -107.79 -161.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.234 0 C-N-CA 123.002 2.468 . . . . 0.0 111.396 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 75' ' ' THR . 46.8 t -96.35 113.05 61.74 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.34 50.12 1.86 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.524 2.816 . . . . 0.0 114.63 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.58 149.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.37 167.66 36.55 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.747 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -135.4 82.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.22 94.53 9.23 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 8.2 mm-40 -72.19 -62.49 1.41 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.548 -177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.8 179.13 9.5 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -90.98 -33.37 15.58 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.12 40.08 1.01 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.679 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.4 t -165.19 -178.74 5.24 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.58 105.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.555 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 22.8 ptm -89.53 100.87 13.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.9 mt -101.29 100.81 14.49 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.709 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.7 Cg_exo -82.09 148.62 15.21 Favored 'Trans proline' 0 N--CA 1.436 -1.907 0 C-N-CA 122.071 1.847 . . . . 0.0 110.405 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.49 60.39 0.73 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.604 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.1 p -106.39 119.81 40.23 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.145 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.13 101.64 13.19 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 75' ' ' THR . 87.1 Cg_endo -105.07 -156.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 123.198 2.599 . . . . 0.0 111.191 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -109.24 29.13 7.81 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.061 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -144.07 -80.36 0.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.195 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.81 -176.54 46.75 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 51.0 m -118.31 146.95 43.96 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.052 0.926 . . . . 0.0 110.873 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.26 38.5 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 123.372 0.669 . . . . 0.0 111.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 42.6 t -117.97 112.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.1 m -115.01 142.53 27.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 O-C-N 121.486 -0.759 . . . . 0.0 109.247 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 tt0 -139.12 113.79 9.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.284 0.564 . . . . 0.0 110.421 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.3 tp -93.44 130.09 36.62 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.06 19.63 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.624 2.216 . . . . 0.0 111.277 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' SER . 36.5 t -122.34 156.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.01 162.14 41.22 Favored Pre-proline 0 C--N 1.307 -1.255 0 O-C-N 123.487 0.492 . . . . 0.0 111.258 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.2 2.41 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.406 2.737 . . . . 0.0 113.219 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.95 -30.62 70.34 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.834 0.854 . . . . 0.0 109.708 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -66.66 -23.49 66.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.252 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.67 -30.17 41.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.66 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.84 -39.73 94.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.635 ' HD2' ' H ' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -76.93 -37.77 54.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.76 -29.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.0 -33.69 76.11 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.6 0.76 . . . . 0.0 109.851 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.61 -24.9 38.78 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.429 1.109 . . . . 0.0 109.049 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -92.61 15.25 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.075 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.514 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.96 -49.8 8.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.542 1.137 . . . . 0.0 113.198 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.05 93.38 3.42 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.355 2.704 . . . . 0.0 112.405 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 . . . . . 0 C--O 1.219 -0.519 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.7 mtt 69.95 112.26 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.075 0.95 . . . . 0.0 109.853 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.42 HG21 ' SD ' ' A' ' 31' ' ' MET . 90.4 m -113.37 128.17 56.37 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.533 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -129.85 21.45 5.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 30.9 m -89.16 87.42 7.16 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.6 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.621 HD13 ' H ' ' A' ' 6' ' ' LEU 0.295 0.0 OUTLIER -84.28 -43.7 14.58 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.43 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 28.3 tt0 -69.75 -4.83 21.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 123.031 1.396 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 29.6 m -76.62 -19.96 57.25 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.617 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.686 ' CD1' ' HA ' ' A' ' 15' ' ' GLU . 2.7 p90 -64.8 -33.11 75.22 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' CE1' ' A' ' 9' ' ' TYR . 10.0 mt -71.41 -35.63 71.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.891 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -76.57 -26.66 55.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.271 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 8' ' ' THR . 45.8 mt-30 -83.38 -14.0 53.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 m 71.25 33.96 1.87 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.495 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.27 90.57 0.2 Allowed Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.879 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.686 ' HA ' ' CD1' ' A' ' 9' ' ' TYR . 3.0 pm0 -59.55 124.35 19.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.984 0.897 . . . . 0.0 111.781 177.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -147.15 9.76 0.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.488 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 44.9 mt-10 -147.34 179.76 7.42 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.485 -175.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.655 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.288 13.0 tt -109.49 18.43 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-O 121.91 0.862 . . . . 0.0 111.376 178.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.37 36.33 25.41 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.769 1.271 . . . . 0.0 109.701 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.2 mmt -98.46 -96.54 0.22 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.684 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.76 126.9 9.12 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.575 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . 10.7 ptm180 -113.7 154.07 27.92 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -134.98 89.39 2.52 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . -106.72 82.0 0.31 Allowed Glycine 0 CA--C 1.486 -1.76 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.335 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -70.95 -70.14 0.33 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.651 0.263 . . . . 0.0 111.339 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 51.1 mtt180 -87.61 -30.54 20.39 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.322 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 10.5 mt-10 -75.22 -3.75 34.93 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 28.0 p -53.14 -37.15 61.55 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 121.419 0.628 . . . . 0.0 110.455 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.59 -41.09 63.33 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.149 0.5 . . . . 0.0 110.443 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.65 68.6 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.063 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.42 ' SD ' HG21 ' A' ' 3' ' ' THR . 26.2 ptm -51.8 -38.49 55.88 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.763 0.664 . . . . 0.0 112.619 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 28' ' ' CYS . 76.7 mt -57.51 -49.52 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 123.923 0.764 . . . . 0.0 110.567 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 39' ' ' VAL . 38.7 mt-10 -82.79 -26.96 31.3 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.888 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 81' ' ' THR . 14.2 mtpp -58.58 -21.64 53.67 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 123.965 0.906 . . . . 0.0 112.29 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -58.44 -22.76 55.5 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.858 0.724 . . . . 0.0 111.398 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.62 1.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -166.24 -59.64 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -155.31 121.03 5.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 33' ' ' GLU . 77.5 t -128.61 145.13 36.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 2.7 p -96.73 137.59 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 O-C-N 123.858 0.723 . . . . 0.0 110.053 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -139.84 129.43 24.36 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.1 tt -90.26 145.04 7.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 53.0 mtmt 67.54 61.97 0.77 Allowed Pre-proline 0 C--O 1.217 -0.636 0 C-N-CA 123.351 0.66 . . . . 0.0 110.992 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 69.6 Cg_endo -81.14 173.03 12.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.584 2.189 . . . . 0.0 112.19 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.8 55.86 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.134 -1.031 . . . . 0.0 112.258 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 29.5 tt0 -121.98 137.56 54.75 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.626 0.727 . . . . 0.0 111.856 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 6.1 mmtt -126.51 111.03 13.92 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.604 ' HB ' HD22 ' A' ' 49' ' ' LEU . 29.2 pt -100.2 122.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.553 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.655 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 54.51 16.42 1.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.014 2.126 . . . . 0.0 113.74 175.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 100' ' ' ALA . . . 83.81 -44.89 3.38 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.006 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.84 125.2 42.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG3' HD11 ' A' ' 48' ' ' ILE . 55.8 ttp180 -67.56 98.82 0.7 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 123.639 0.587 . . . . 0.0 111.173 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.69 123.5 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mm -83.35 -37.68 13.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.894 0.854 . . . . 0.0 109.207 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.43 -7.96 66.41 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.562 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.2 mm -135.3 132.47 20.03 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 51.5 Cg_exo -55.78 109.45 0.42 Allowed 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 123.204 2.603 . . . . 0.0 112.175 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 6.9 Cg_endo -87.67 161.27 7.82 Favored 'Trans proline' 0 N--CA 1.427 -2.404 0 C-N-CA 122.388 2.059 . . . . 0.0 110.938 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.71 139.17 95.38 Favored Pre-proline 0 C--N 1.301 -1.505 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.095 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.79 34.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.523 3.262 1 C-N-CA 127.349 5.366 . . . . 0.0 119.656 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' HA ' HG23 ' A' ' 75' ' ' THR 0.27 2.8 pt 67.78 -171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 127.676 2.39 . . . . 0.0 112.602 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' H ' ' A' ' 74' ' ' TYR . . . -143.63 -113.2 0.9 Allowed Glycine 1 N--CA 1.388 -4.525 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.296 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.38 122.94 64.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 71' ' ' MET . 4.0 p-10 -130.27 125.43 34.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -100.54 -63.72 1.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.1 tp10 -165.33 168.58 16.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -31.7 67.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 8.5 p -93.34 30.88 1.59 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.323 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.416 ' CA ' ' HG3' ' A' ' 85' ' ' GLU . 31.4 m -156.99 161.0 39.57 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 m -71.08 145.02 12.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.29 0.567 . . . . 0.0 110.216 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 83' ' ' VAL . 25.2 ptt? -134.73 139.2 45.01 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.87 80.32 25.26 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.464 ' O ' HG21 ' A' ' 81' ' ' THR . 1.3 Cg_endo -81.86 132.06 7.35 Favored 'Trans proline' 0 N--CA 1.414 -3.198 0 C-N-CA 121.587 1.525 . . . . 0.0 109.981 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' H ' ' N ' ' A' ' 62' ' ' GLY . 79.2 m-85 -91.9 57.89 3.27 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-O 122.268 1.033 . . . . 0.0 108.705 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 61' ' ' ILE . 36.7 p -103.92 102.66 12.46 Favored 'General case' 1 N--CA 1.376 -4.157 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -95.29 106.9 28.97 Favored Pre-proline 0 C--N 1.277 -2.587 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.249 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 75' ' ' THR . 22.6 Cg_endo -95.26 -165.53 0.11 Allowed 'Trans proline' 0 N--CA 1.431 -2.167 0 C-N-CA 122.704 2.27 . . . . 0.0 110.471 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.3 t -95.77 15.7 19.48 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.637 0.732 . . . . 0.0 109.131 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -135.56 -62.95 0.68 Allowed 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 166.28 148.27 5.5 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.186 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.634 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -84.61 158.3 20.92 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 124.879 1.272 . . . . 0.0 108.678 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . . . -122.36 120.68 34.72 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.879 -0.513 . . . . 0.0 111.063 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 95.4 t -103.31 84.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 44' ' ' PRO . 12.4 m -108.45 124.71 65.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' HG3' ' CA ' ' A' ' 69' ' ' THR . 43.4 tt0 -118.43 120.75 38.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.126 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.4 tp -96.65 130.77 29.58 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.09 -4.13 11.81 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.214 1.943 . . . . 0.0 111.142 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.537 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 12.0 t -97.64 161.66 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 91' ' ' GLU . 11.7 m-20 -72.44 163.66 65.88 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 118.096 0.407 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.79 6.2 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 89' ' ' ASP . 11.2 pt-20 -67.38 -27.17 66.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.813 0.845 . . . . 0.0 109.016 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.4 mm-40 -64.2 -29.27 70.39 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.083 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 mt -64.35 -28.45 44.91 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.661 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.62 -47.29 70.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.365 0.602 . . . . 0.0 109.602 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -66.78 -32.04 73.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.411 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 92' ' ' GLU . 69.1 mt -86.28 -5.63 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-O 121.879 0.847 . . . . 0.0 110.107 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.78 -33.49 30.85 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.03 -32.79 71.11 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.785 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' VAL . 18.9 t -107.03 28.35 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.448 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.581 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.588 ' HB1' ' HA2' ' A' ' 50' ' ' GLY . . . -59.67 -31.29 69.41 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 37.0 tt0 -157.27 -57.78 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.58 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 92.8 Cg_endo . . . . . 0 N--CA 1.442 -1.557 0 C-N-CA 120.942 1.095 . . . . 0.0 113.228 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.402 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 63.6 m-70 . . . . . 0 CA--C 1.505 -0.788 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -174.95 126.74 0.28 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.875 1.27 . . . . 0.0 109.146 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.534 HG21 ' SD ' ' A' ' 31' ' ' MET . 11.9 t -124.47 134.45 53.05 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.73 0.776 . . . . 0.0 110.855 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.08 26.11 4.57 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.916 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.477 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 65.3 m -126.51 101.1 6.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.689 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.567 ' CD2' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -84.96 -46.03 11.63 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.969 0.89 . . . . 0.0 113.031 -176.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' H ' HD13 ' A' ' 6' ' ' LEU . 42.0 tt0 -73.18 -12.29 60.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.118 0.961 . . . . 0.0 110.95 -175.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 24.2 m -73.58 -26.2 60.71 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.986 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -72.64 -32.96 66.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.99 -41.7 99.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 11' ' ' GLN . 11.3 mm-40 -67.78 -27.7 66.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.13 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 8' ' ' THR . 28.1 mt-30 -78.41 -45.86 21.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.659 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.431 ' OG ' ' HD2' ' A' ' 35' ' ' LYS . 45.1 m -158.68 -68.29 0.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.899 0.38 . . . . 0.0 111.367 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.04 174.33 31.06 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.358 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.02 146.16 24.56 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 124.295 0.644 . . . . 0.0 109.725 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.425 ' HA ' HG23 ' A' ' 54' ' ' ILE . 40.8 t80 -139.59 21.48 2.53 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.635 ' HB3' HD21 ' A' ' 49' ' ' LEU . 38.7 mp0 -140.97 175.84 9.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.091 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.702 HG22 HD22 ' A' ' 49' ' ' LEU . 7.0 tt -109.47 7.04 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.047 -1.033 . . . . 0.0 109.079 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 65.2 t-80 74.7 73.97 0.11 Allowed 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.829 1.651 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.522 ' HB3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.0 179.49 9.17 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' N ' ' SD ' ' A' ' 20' ' ' MET . 86.2 mttt -61.46 111.06 1.64 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.967 0.889 . . . . 0.0 109.883 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.762 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.2 119.24 38.58 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.389 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.3 85.99 2.49 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.676 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.76 81.66 0.48 Allowed Glycine 0 CA--C 1.469 -2.803 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.289 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -69.89 -78.73 0.07 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 117.119 0.459 . . . . 0.0 110.314 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -84.04 -21.04 31.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.958 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.619 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -81.51 -10.72 59.41 Favored 'General case' 0 C--O 1.205 -1.263 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.48 -177.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 53.7 t -51.97 -38.15 55.59 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.569 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.01 -44.59 69.0 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.179 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -58.85 -52.44 65.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.965 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 3' ' ' THR . 21.6 ptp -54.07 -38.2 65.04 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.864 0.728 . . . . 0.0 112.779 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 28' ' ' CYS . 80.3 mt -58.96 -45.02 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.682 0.753 . . . . 0.0 109.524 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 39' ' ' VAL . 61.7 mm-40 -79.85 -32.2 40.49 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.617 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 84.1 mttt -58.42 -28.5 65.31 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 122.924 0.49 . . . . 0.0 111.165 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 8.1 ttpp -64.66 -13.39 53.82 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.049 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -65.52 0.92 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -142.85 -75.22 0.27 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.721 0.772 . . . . 0.0 109.687 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.48 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 36.3 ptt180 -156.3 128.15 7.35 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 33' ' ' GLU . 69.6 t -140.08 141.64 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.526 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.5 p -106.94 147.06 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 19.8 t-80 -135.56 134.21 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 20.7 tt -90.48 143.65 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 86' ' ' LEU . 61.7 mttp 67.41 64.01 0.72 Allowed Pre-proline 0 C--N 1.32 -0.714 0 C-N-CA 123.822 0.849 . . . . 0.0 110.642 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.38 172.12 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.205 1.27 . . . . 0.0 110.233 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.21 54.43 0.13 Allowed Glycine 0 CA--C 1.464 -3.152 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.619 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 1.6 pm0 -112.35 157.84 20.52 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 122.366 1.079 . . . . 0.0 112.414 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -143.86 72.4 1.35 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 113.479 -1.692 . . . . 0.0 107.577 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.618 HG22 ' HG ' ' A' ' 49' ' ' LEU . 72.0 mt -91.58 108.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.702 HD22 HG22 ' A' ' 18' ' ' ILE . 0.9 OUTLIER 66.01 16.93 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.96 1.304 . . . . 0.0 109.381 177.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.19 4.5 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -175.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.18 118.3 25.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -64.32 104.39 0.76 Allowed 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.131 0.894 . . . . 0.0 112.716 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 49' ' ' LEU . 49.6 mm -114.66 135.13 55.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.425 HG23 ' HA ' ' A' ' 16' ' ' TYR . 60.2 mt -75.49 -35.36 32.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-O 121.233 0.539 . . . . 0.0 110.0 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.51 -21.73 20.34 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.25 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.62 120.26 56.42 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.42 112.55 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.968 2.445 . . . . 0.0 111.327 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -101.39 -176.61 0.13 Allowed 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 122.615 2.21 . . . . 0.0 111.081 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.3 t -67.57 121.02 77.35 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.05 56.02 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 114.745 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.4 147.66 32.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 155.5 148.15 4.94 Favored Glycine 0 CA--C 1.483 -1.933 0 C-N-CA 118.539 -1.791 . . . . 0.0 113.52 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.3 pt -129.12 153.19 38.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.02 115.29 20.31 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.99 -71.97 0.44 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.242 0.544 . . . . 0.0 111.902 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 31.0 tt0 -148.36 166.12 29.02 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 5.7 tpp180 -83.22 -35.43 25.41 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.058 0.933 . . . . 0.0 110.551 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.7 p -88.66 29.96 0.96 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.775 1.274 . . . . 0.0 111.514 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 66' ' ' GLU . 87.5 m -154.72 170.72 20.91 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 85' ' ' GLU . 27.1 m -78.93 161.01 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.202 1.001 . . . . 0.0 111.117 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.547 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 26.8 ptt? -118.4 131.38 56.29 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.11 88.35 14.71 Favored Pre-proline 0 C--N 1.291 -1.961 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.343 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 71' ' ' MET . 6.4 Cg_endo -90.53 144.28 3.81 Favored 'Trans proline' 0 N--CA 1.408 -3.534 0 C-N-CA 121.545 1.496 . . . . 0.0 109.966 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -110.87 46.32 1.07 Allowed 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 123.298 1.523 . . . . 0.0 107.405 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 39.6 p -93.26 105.57 17.63 Favored 'General case' 0 N--CA 1.389 -3.498 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.163 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -105.78 96.61 12.85 Favored Pre-proline 0 C--N 1.275 -2.634 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 75' ' ' THR . 23.7 Cg_endo -99.0 -164.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.365 2.71 . . . . 0.0 111.166 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.5 t -88.72 -6.16 57.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.362 0.601 . . . . 0.0 110.058 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -96.32 -74.22 0.57 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 171.26 172.08 37.07 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 28.0 m -94.5 141.73 28.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.63 125.58 52.74 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.29 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 41.7 t -126.47 124.69 65.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.2 m -126.71 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.442 ' HB2' HG12 ' A' ' 70' ' ' VAL . 52.5 tt0 -134.31 123.12 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' SER . 28.4 tp -103.05 128.18 28.22 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.84 1.78 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.69 1.593 . . . . 0.0 110.698 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.548 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -103.59 158.27 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.98 151.13 81.22 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 123.203 0.314 . . . . 0.0 110.671 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 11.6 Cg_endo -56.13 -22.03 37.92 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.686 2.924 . . . . 0.0 112.997 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.84 -23.11 60.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.681 0.792 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 96' ' ' ILE . 8.4 tp10 -69.18 -43.59 73.91 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.42 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 58.4 mt -71.17 -27.0 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.73 -37.64 76.59 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -67.98 -36.36 79.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.631 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 92' ' ' GLU . 37.3 mm -72.65 -17.82 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.961 177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.72 -20.86 58.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.106 0.955 . . . . 0.0 108.715 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.19 -25.96 42.68 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.02 14.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.406 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.21 49.77 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.74 -50.65 0.15 Allowed Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.432 -2.114 0 C-N-CA 121.087 1.191 . . . . 0.0 112.664 -178.648 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 85.2 m-70 . . . . . 0 C--O 1.215 -0.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -139.59 129.63 25.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -121.61 117.09 25.85 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -126.08 2.26 7.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.571 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.428 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 61.0 m -86.48 92.19 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.571 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.661 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -85.6 -34.65 21.37 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -81.12 -16.92 51.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.942 0.877 . . . . 0.0 110.931 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.3 m -69.79 -22.29 63.34 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -78.33 -20.12 52.09 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.661 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.1 tt -72.91 -37.87 67.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.79 -30.43 69.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.366 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -94.18 -5.49 46.94 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.926 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m 60.33 43.29 13.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.125 0.964 . . . . 0.0 110.305 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.48 49.97 0.65 Allowed Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.532 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.26 138.83 54.26 Favored 'General case' 0 C--O 1.248 1.007 0 O-C-N 124.61 0.829 . . . . 0.0 110.783 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -143.55 20.35 1.86 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -154.97 179.75 8.83 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.806 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.622 ' H ' HD21 ' A' ' 49' ' ' LEU 0.329 13.5 tt -107.31 29.48 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.973 178.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.661 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 43.5 m80 61.99 17.84 9.36 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.423 ' HB2' HD12 ' A' ' 49' ' ' LEU . 60.6 mmm -85.57 -110.79 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.015 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.6 tttp -129.09 115.0 17.06 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -109.15 162.32 14.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.377 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -156.71 87.69 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -103.82 81.01 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 115.154 0.821 . . . . 0.0 115.154 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -77.47 -39.35 46.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.562 0.696 . . . . 0.0 111.177 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.518 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 38.2 mmt180 -107.78 -41.05 5.1 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.712 0.768 . . . . 0.0 111.241 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 26.3 tt0 -78.88 -0.04 29.17 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.103 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 39.4 t -52.58 -47.16 67.05 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 109.728 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -68.88 -38.8 79.9 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.754 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -58.78 -44.74 90.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.701 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.7 ptm -65.02 -33.26 75.61 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.554 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.1 -38.61 82.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 34.8 mt-10 -77.7 -38.25 47.77 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.667 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 31' ' ' MET . 78.7 mttt -63.51 -20.01 65.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.462 0.705 . . . . 0.0 111.771 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -67.4 -20.42 65.53 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.504 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.57 -62.17 1.67 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.62 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 2.2 mmp_? -159.82 -67.14 0.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.577 1.151 . . . . 0.0 109.824 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.591 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 19.0 ptt180 -155.12 122.19 5.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.75 145.11 28.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.5 p -108.89 142.38 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 19.4 t60 -135.06 130.8 36.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.6 tt -82.82 144.17 10.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 94.8 mttt 63.82 63.11 1.48 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.148 0.579 . . . . 0.0 110.717 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 63.4 Cg_endo -80.32 170.7 15.82 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.969 1.78 . . . . 0.0 111.767 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -175.06 54.0 0.13 Allowed Glycine 0 N--CA 1.409 -3.102 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.441 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 7.6 tp10 -110.44 118.39 36.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.507 1.146 . . . . 0.0 108.841 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 34.0 mtmt -110.17 71.44 0.76 Allowed 'General case' 0 N--CA 1.393 -3.309 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.136 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.541 ' HB ' HD22 ' A' ' 49' ' ' LEU . 5.0 pt -70.92 102.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.25 -3.74 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.923 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.622 HD21 ' H ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 69.72 -26.12 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 126.823 2.049 . . . . 0.0 113.621 175.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.91 -3.36 48.62 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.71 116.18 11.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -69.73 88.17 0.52 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 mm -123.73 127.38 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -76.39 -28.86 18.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.548 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.43 17.59 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.3 mt -99.88 121.67 53.45 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.65 107.65 0.91 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.773 2.315 . . . . 0.0 110.92 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -104.8 179.92 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 122.68 2.253 . . . . 0.0 111.752 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' THR . 51.3 t -84.87 106.73 9.35 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 75' ' ' THR . 89.9 Cg_endo -84.41 98.78 0.74 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.234 1.956 . . . . 0.0 114.554 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.49 158.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 130.12 167.18 11.99 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 118.577 -1.773 . . . . 0.0 113.769 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.2 mp -142.63 124.35 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.43 101.76 12.27 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.74 -55.65 16.16 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.55 171.41 7.61 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HA ' HH11 ' A' ' 67' ' ' ARG . 3.4 tpp180 -85.68 -35.99 20.54 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 118.881 0.764 . . . . 0.0 112.113 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 9.4 t -91.03 28.32 1.62 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 122.96 1.362 . . . . 0.0 108.569 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' ARG . 24.8 m -143.21 163.93 31.59 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 17.1 m -72.88 124.01 28.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.332 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.509 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.9 ptt? -85.32 132.19 34.29 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.4 tp -116.02 80.92 9.53 Favored Pre-proline 0 C--N 1.293 -1.884 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.667 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 9.5 Cg_endo -89.58 104.8 0.37 Allowed 'Trans proline' 0 N--CA 1.409 -3.456 0 C-N-CA 121.971 1.781 . . . . 0.0 108.707 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.26 57.28 4.39 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.114 1.435 . . . . 0.0 107.374 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.634 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.2 p -91.17 127.86 36.77 Favored 'General case' 1 N--CA 1.378 -4.064 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.58 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -99.49 95.97 4.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.4 Cg_endo -105.29 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.787 0 C-N-CA 122.974 2.449 . . . . 0.0 111.281 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.6 t -95.87 12.08 31.47 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -117.74 -80.83 0.61 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.068 -0.395 . . . . 0.0 110.339 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.72 176.35 47.99 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.591 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 29.2 m -94.7 135.14 36.53 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.447 0.641 . . . . 0.0 109.401 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.52 112.38 23.89 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.949 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 33.9 t -115.34 134.61 57.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 15.8 m -136.26 151.08 28.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -142.13 122.12 13.67 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.4 tp -104.13 139.05 19.73 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 5.7 Cg_exo -86.14 2.1 7.56 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 122.616 2.211 . . . . 0.0 111.69 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.59 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 9.9 t -103.14 150.84 6.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.44 144.32 92.28 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 124.14 0.9 . . . . 0.0 110.163 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.4 -18.67 3.84 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.61 3.54 . . . . 0.0 114.385 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.51 -18.38 51.52 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.642 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 25.6 tp10 -60.24 -28.03 67.7 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 124.187 0.995 . . . . 0.0 109.575 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.75 -38.37 75.65 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.121 0 C-N-CA 122.155 0.182 . . . . 0.0 111.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.46 -33.64 75.54 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.406 0.622 . . . . 0.0 110.768 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 63.4 ttt180 -71.49 -45.58 62.1 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 ' HG2' ' A' ' 47' ' ' LYS . 14.8 mm -65.64 -22.5 30.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.189 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.0 tp -74.21 -30.07 62.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.154 0.502 . . . . 0.0 109.792 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.21 -41.74 27.62 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.65 15.66 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.996 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -67.14 -33.53 75.63 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.25 98.06 21.56 Favored Pre-proline 0 N--CA 1.416 -2.136 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.555 2.837 . . . . 0.0 111.269 177.716 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 CA--C 1.498 -1.04 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.41 ' SD ' ' HE2' ' A' ' 4' ' ' PHE . 26.0 ptt? -179.97 133.22 0.1 Allowed 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.238 1.415 . . . . 0.0 108.762 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.4 m -132.16 122.82 25.93 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HE2' ' SD ' ' A' ' 2' ' ' MET . 88.6 m-85 -116.85 -8.99 11.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.976 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 76.5 m -80.0 100.8 8.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.807 0.813 . . . . 0.0 110.793 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.668 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -88.32 -38.13 15.41 Favored 'General case' 0 C--O 1.182 -2.461 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 30.3 tt0 -68.82 -9.45 51.24 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.817 0.818 . . . . 0.0 111.871 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.487 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.4 m -75.38 -15.17 60.49 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.104 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.661 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.71 -28.4 67.29 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.409 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.661 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 6.1 tt -70.23 -39.05 75.31 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.055 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -76.36 -1.79 28.58 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.714 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.97 -28.71 5.47 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -163.58 -54.13 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.442 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.32 -153.91 24.71 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HB2' HG12 ' A' ' 56' ' ' ILE . 2.2 mp0 -80.63 137.33 36.34 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 118.994 1.397 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' HA ' HG23 ' A' ' 54' ' ' ILE . 34.9 t80 -142.31 3.28 1.52 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.591 0.71 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB3' HD21 ' A' ' 49' ' ' LEU . 18.4 mm-40 -150.69 176.94 10.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.593 HG22 ' HG ' ' A' ' 49' ' ' LEU . 11.7 tt -110.35 157.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.484 ' HA ' HD21 ' A' ' 6' ' ' LEU . 6.5 t60 -71.53 71.9 0.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.472 1.13 . . . . 0.0 108.987 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.4 mmt -138.68 -167.41 2.19 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.089 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.72 113.28 22.44 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -100.75 130.31 46.76 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -124.08 85.17 2.37 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.513 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -99.58 75.92 0.48 Allowed Glycine 0 C--N 1.282 -2.442 0 C-N-CA 119.399 -1.382 . . . . 0.0 111.013 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.85 -79.87 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 121.35 0.595 . . . . 0.0 110.629 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.511 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 5.6 mpt_? -75.7 -35.83 60.19 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.006 0.432 . . . . 0.0 111.688 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 18.0 tp10 -66.28 -11.37 50.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.002 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 36.3 t -51.01 -41.75 59.99 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.477 0.656 . . . . 0.0 110.274 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.03 -43.1 75.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.075 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.695 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.28 -45.64 79.77 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.1 ptp -56.64 -33.11 66.0 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.519 0.512 . . . . 0.0 111.726 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 28' ' ' CYS . 51.2 mm -62.97 -36.34 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.434 0.635 . . . . 0.0 110.023 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -78.35 -33.63 48.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HE2' ' O ' ' A' ' 39' ' ' VAL . 60.7 mttt -67.42 -9.49 42.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.719 1.208 . . . . 0.0 113.391 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -69.49 -22.93 63.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.35 -65.01 0.75 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -152.45 -67.7 0.16 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.1 ttp180 -165.82 115.43 1.0 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.468 0.707 . . . . 0.0 109.413 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.554 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 44.3 t -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -112.68 149.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.695 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 32.5 t-80 -138.28 119.5 14.62 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.4 tt -83.31 147.44 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 94.3 mttt 68.61 51.59 0.49 Allowed Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.699 0.799 . . . . 0.0 112.039 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 96.4 Cg_endo -90.18 159.58 4.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.418 2.079 . . . . 0.0 110.608 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.511 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -151.66 44.9 0.64 Allowed Glycine 0 CA--C 1.467 -2.951 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 4.2 pm0 -97.76 156.86 16.37 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-O 122.627 1.204 . . . . 0.0 113.304 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 0.5 OUTLIER -145.19 86.85 1.79 Allowed 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.363 175.176 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 48' ' ' ILE . 2.6 pt -87.24 99.9 9.18 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 113.471 -1.695 . . . . 0.0 112.313 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.593 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 66.88 4.5 3.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.976 2.11 . . . . 0.0 114.098 175.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.56 -21.42 5.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.142 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.74 30.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' CZ ' HD12 ' A' ' 48' ' ' ILE . 21.8 tpt180 -86.58 105.93 17.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.63 136.91 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.471 HG23 ' HA ' ' A' ' 16' ' ' TYR . 45.4 mm -99.1 -40.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.531 0.681 . . . . 0.0 109.588 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.83 -26.37 22.61 Favored Glycine 0 C--N 1.312 -0.756 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 15' ' ' GLU . 36.6 mm -111.69 109.79 55.35 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.89 109.25 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.995 2.463 . . . . 0.0 111.723 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -101.95 -163.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.415 2.743 . . . . 0.0 109.919 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 75' ' ' THR . 86.6 t -73.47 118.95 73.15 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.13 40.86 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.118 2.545 . . . . 0.0 114.541 -172.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 65.1 mt -116.31 149.52 18.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . 166.5 138.35 2.42 Favored Glycine 0 C--N 1.305 -1.186 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.894 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.51 114.14 41.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 122.706 0.402 . . . . 0.0 110.661 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.43 106.2 18.24 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.73 -64.24 1.04 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 68' ' ' SER . 3.7 tm-20 -166.94 179.94 5.0 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -176.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.445 HH22 ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.04 -40.09 14.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 119.045 0.839 . . . . 0.0 109.437 -176.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.677 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.6 t -89.39 26.76 1.59 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.695 1.236 . . . . 0.0 109.511 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.9 m -144.28 160.93 40.16 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 85' ' ' GLU . 17.3 m -77.72 144.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 122.676 0.39 . . . . 0.0 110.335 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.617 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 27.1 ptt? -99.93 136.7 39.45 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.9 mm -109.05 89.19 6.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 71' ' ' MET . 2.5 Cg_endo -88.1 146.9 6.59 Favored 'Trans proline' 0 N--CA 1.427 -2.439 0 C-N-CA 122.126 1.884 . . . . 0.0 111.737 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 67.7 m-85 -123.25 44.27 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.579 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 41.4 p -100.86 111.41 23.62 Favored 'General case' 0 N--CA 1.4 -2.961 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.103 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -100.74 97.2 6.37 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 75' ' ' THR . 97.2 Cg_endo -103.98 -165.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.04 2.493 . . . . 0.0 111.593 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.6 t -74.04 -21.57 59.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.504 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -95.84 -84.7 0.34 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.734 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.97 -179.67 45.7 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 9.8 m -106.4 145.58 31.56 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -119.34 121.88 40.56 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -175.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 56.3 t -110.02 120.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 27' ' ' GLU . 35.4 m -113.49 143.77 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.9 tt0 -148.65 115.78 6.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.216 0.462 . . . . 0.0 110.224 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 68' ' ' SER . 29.5 tp -94.84 143.33 25.98 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -93.39 -2.55 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.621 1.547 . . . . 0.0 110.971 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.606 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 23.7 t -91.49 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.19 149.3 75.96 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 124.166 0.916 . . . . 0.0 112.792 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.69 -6.17 4.21 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.838 3.025 . . . . 0.0 113.351 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.56 -27.3 66.11 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.274 0.559 . . . . 0.0 109.504 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -60.07 -26.82 66.47 Favored 'General case' 0 C--O 1.204 -1.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.163 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.3 mt -56.87 -40.12 69.45 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.809 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.633 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.46 -47.67 85.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.645 0.736 . . . . 0.0 109.795 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -64.95 -44.13 90.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.451 HG22 ' HE2' ' A' ' 47' ' ' LYS . 73.7 mt -69.6 -28.29 37.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.613 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.1 tp -70.77 -29.6 65.86 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 123.313 0.645 . . . . 0.0 110.173 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -32.25 51.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.7 15.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.355 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.69 -47.89 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.747 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -135.6 87.93 25.28 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 C--O 1.257 1.432 0 C-N-CA 123.262 2.641 . . . . 0.0 112.347 -178.318 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 65.7 mtm -156.11 124.7 5.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -102.04 113.59 26.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 64.9 m-85 -127.96 12.5 6.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.799 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 74.0 m -140.66 102.68 4.36 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -77.23 -36.45 54.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 111.419 -175.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' H ' HD13 ' A' ' 6' ' ' LEU . 10.1 tp10 -71.09 -25.56 62.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.691 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -77.99 -24.34 48.03 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -24.17 60.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 110.232 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.51 -43.63 98.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -69.42 -35.76 76.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.226 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.31 -35.42 66.08 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.435 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -161.81 -54.92 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.243 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.7 173.47 37.22 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.3 141.22 38.64 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.489 0.662 . . . . 0.0 111.73 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' HG23 ' A' ' 54' ' ' ILE . 88.5 t80 -137.66 4.86 2.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 44.7 mt-10 -149.79 146.33 27.11 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.572 HG22 ' HG ' ' A' ' 49' ' ' LEU . 15.3 tt -85.1 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.561 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -68.59 77.17 0.28 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 122.724 1.25 . . . . 0.0 110.483 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.418 ' HA ' ' CE ' ' A' ' 20' ' ' MET . 2.0 mmt -146.15 -174.39 4.42 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.39 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 10.5 mtmp? -88.5 114.72 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.164 0.893 . . . . 0.0 110.874 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.605 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -102.98 152.53 21.21 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.124 -175.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.08 77.75 1.32 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.616 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -97.68 82.35 0.68 Allowed Glycine 0 C--N 1.294 -1.789 0 C-N-CA 121.02 -0.609 . . . . 0.0 114.052 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -70.18 -82.52 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 117.352 0.576 . . . . 0.0 111.652 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.559 ' HB2' ' H ' ' A' ' 45' ' ' GLY . 2.5 mmp_? -70.39 -36.72 74.25 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 2.7 tp10 -69.35 -12.64 61.83 Favored 'General case' 0 C--O 1.217 -0.647 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.219 -177.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 44.4 t -60.9 -34.19 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-O 121.218 0.532 . . . . 0.0 110.009 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.53 -41.64 72.27 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.788 0.804 . . . . 0.0 109.398 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -64.23 -47.73 78.56 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.106 -1.407 . . . . 0.0 113.077 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.509 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 ptp -56.12 -31.64 63.47 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.577 0.548 . . . . 0.0 112.272 -176.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 28' ' ' CYS . 48.6 mm -59.65 -42.84 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 122.08 0.943 . . . . 0.0 109.078 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.87 -34.34 30.12 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.547 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 31' ' ' MET . 72.2 mttt -65.92 -12.91 58.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.702 0.801 . . . . 0.0 111.927 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.11 -24.83 62.37 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.816 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.67 -53.14 36.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.107 0.48 . . . . 0.0 110.718 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -166.9 -69.97 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' THR . 58.3 ttp180 -162.12 123.63 2.71 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 84.4 t -134.66 159.95 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.7 p -105.96 143.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.488 0.715 . . . . 0.0 109.596 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.562 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 57.4 t-80 -135.01 123.34 23.14 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 2.6 mp -89.7 142.42 12.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 99.2 mttt 71.62 43.35 0.2 Allowed Pre-proline 0 C--O 1.21 -1.019 0 C-N-CA 124.11 0.964 . . . . 0.0 112.545 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 9.8 Cg_endo -75.42 143.04 27.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 CA-C-N 120.786 1.316 . . . . 0.0 110.783 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 26' ' ' ARG . . . -144.03 54.29 0.58 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 10.0 pm0 -101.1 129.48 46.99 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.19 0.995 . . . . 0.0 110.125 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 43.1 mtmt -118.84 69.99 0.82 Allowed 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.407 ' C ' HD22 ' A' ' 49' ' ' LEU . 39.1 pt -86.57 109.7 19.25 Favored 'Isoleucine or valine' 1 C--N 1.222 -4.936 0 CA-C-N 111.317 -2.674 . . . . 0.0 112.329 -175.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.572 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 65.7 -3.1 0.76 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.936 2.095 . . . . 0.0 113.863 175.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.04 -25.66 13.53 Favored Glycine 0 C--N 1.293 -1.82 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.23 19.33 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 52' ' ' ARG . 2.2 ptm180 -71.39 103.05 2.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.735 0.779 . . . . 0.0 111.646 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 55' ' ' GLY . 55.9 mt -128.0 132.17 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 16' ' ' TYR . 49.4 mm -73.45 -27.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.99 0.9 . . . . 0.0 108.888 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 53' ' ' ILE . . . 97.23 -28.1 15.51 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 78' ' ' CYS . 62.4 mt -105.54 114.99 62.56 Favored Pre-proline 0 N--CA 1.416 -2.159 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.85 107.27 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.605 2.203 . . . . 0.0 110.518 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -95.96 -174.99 0.29 Allowed 'Trans proline' 0 N--CA 1.426 -2.441 0 C-N-CA 122.671 2.247 . . . . 0.0 111.663 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.7 t -68.86 116.48 41.65 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.81 70.52 7.38 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.002 1.801 . . . . 0.0 113.293 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -130.71 145.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 156.94 153.67 6.75 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 118.98 -1.581 . . . . 0.0 113.67 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.75 103.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.65 108.97 20.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.2 -69.8 0.53 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.418 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.514 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -153.21 164.92 37.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -80.76 -31.69 35.81 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.022 0.915 . . . . 0.0 108.602 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.514 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 11.1 p -94.86 38.48 1.12 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.4 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -161.75 171.22 18.21 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.44 161.21 4.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.69 0.757 . . . . 0.0 109.714 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.644 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 16.1 ptp -140.09 118.0 11.78 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -106.65 94.59 10.46 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-O 121.137 0.494 . . . . 0.0 109.913 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 71' ' ' MET . 9.6 Cg_endo -92.2 164.99 3.08 Favored 'Trans proline' 0 N--CA 1.412 -3.296 0 C-N-CA 122.103 1.869 . . . . 0.0 110.8 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -129.1 58.81 1.59 Allowed 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.558 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 27.2 p -100.42 110.11 22.29 Favored 'General case' 0 N--CA 1.386 -3.644 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.149 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -105.19 100.65 26.27 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.8 Cg_endo -104.74 -159.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 123.092 2.528 . . . . 0.0 108.41 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.439 ' HB3' HD13 ' A' ' 56' ' ' ILE . 50.3 t -83.02 -9.04 59.47 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.062 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.34 -79.59 0.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.796 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 176.45 -172.23 45.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.8 m -112.7 149.18 33.27 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 117.452 0.626 . . . . 0.0 109.422 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.84 47.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 59.0 t -109.82 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG12 ' OE2' ' A' ' 27' ' ' GLU . 2.6 m -102.2 155.27 4.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -155.0 108.83 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.072 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.1 tp -97.61 128.97 32.7 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.15 22.55 0.94 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.542 2.161 . . . . 0.0 111.412 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 68' ' ' SER . 14.6 t -130.5 151.7 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.84 152.55 82.39 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 38.4 Cg_endo -65.41 -4.19 8.97 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.736 2.957 . . . . 0.0 112.656 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.64 -29.91 70.37 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -66.1 -25.16 66.88 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.056 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.37 -35.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 O-C-N 123.074 0.234 . . . . 0.0 110.681 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.81 -43.77 97.93 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -43.5 83.55 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.629 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.88 -21.88 24.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 123.397 0.679 . . . . 0.0 111.099 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -74.06 -27.29 60.85 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.259 0.552 . . . . 0.0 109.808 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.5 -41.61 14.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.989 0.9 . . . . 0.0 108.63 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.6 t -82.45 7.86 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.987 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -52.91 -60.59 3.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.497 1.119 . . . . 0.0 113.813 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.01 -47.91 0.33 Allowed Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.426 -2.451 0 C-N-CA 121.583 1.522 . . . . 0.0 112.507 177.802 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 p80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -174.01 135.6 0.49 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.3 m -134.14 124.16 25.6 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . 74.0 m-85 -121.55 3.32 10.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.83 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.2 m -95.75 101.74 13.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.306 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 7' ' ' GLU . 1.6 pp -92.3 -29.71 16.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.797 0.808 . . . . 0.0 112.263 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' HD12 ' A' ' 6' ' ' LEU . 35.2 tt0 -68.97 -24.51 64.26 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.158 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.8 m -66.44 -32.48 73.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.022 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.74 -28.95 60.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.889 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tt -69.52 -35.13 75.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -66.8 -38.06 85.76 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.624 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 8' ' ' THR . 89.0 mt-30 -73.72 -3.12 26.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.056 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m 67.48 13.5 9.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.107 1.363 . . . . 0.0 111.783 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.84 59.74 0.36 Allowed Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.67 127.49 31.53 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.244 -0.978 . . . . 0.0 110.613 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -145.77 10.73 1.22 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 27.8 mt-10 -148.0 176.65 10.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.809 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.494 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.6 tt -127.33 161.02 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -67.31 73.36 0.13 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.359 1.076 . . . . 0.0 111.111 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.43 ' HB2' HD12 ' A' ' 49' ' ' LEU . 81.9 mtp -130.1 -121.79 0.22 Allowed 'General case' 0 C--N 1.266 -3.055 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.169 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 11.0 tmtt? -147.18 122.89 10.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HD2' ' OE1' ' A' ' 17' ' ' GLU . 14.1 ptm180 -104.11 167.33 9.83 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -152.58 79.25 1.22 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 46' ' ' GLU . . . -109.32 82.84 0.31 Allowed Glycine 0 CA--C 1.471 -2.714 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -72.22 -63.45 1.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.939 0.876 . . . . 0.0 109.251 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.619 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 29.2 mmt180 -84.12 -38.81 20.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.906 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 29.2 mt-10 -74.84 -1.86 24.14 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 31' ' ' MET . 41.5 t -51.21 -45.15 61.78 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.08 -41.22 74.39 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.59 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.4 -47.19 87.15 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 124.165 0.986 . . . . 0.0 113.152 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -56.83 -38.67 72.95 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.414 0.446 . . . . 0.0 111.345 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.65 -39.05 80.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.747 0.784 . . . . 0.0 109.604 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' HG11 ' A' ' 39' ' ' VAL . 13.7 mm-40 -75.11 -42.74 55.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.63 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.5 mttt -63.58 -20.03 65.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.543 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -67.28 -26.52 66.58 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.552 0.533 . . . . 0.0 110.306 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -53.15 32.34 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.866 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -162.43 -70.84 0.05 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.559 0.695 . . . . 0.0 110.052 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.3 ttt180 -163.28 117.67 1.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 33' ' ' GLU . 55.4 t -137.15 144.03 33.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.593 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -97.22 145.81 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.482 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 74.0 t60 -138.93 121.45 16.19 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 61.6 mt -79.42 138.06 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 64.6 mttm 74.68 65.88 0.27 Allowed Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.692 1.245 . . . . 0.0 109.22 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 48.6 Cg_endo -88.38 166.17 6.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.224 1.949 . . . . 0.0 111.767 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 27' ' ' GLU . . . -179.79 55.61 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.794 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 7.1 tp10 -122.12 145.22 48.38 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.66 0.784 . . . . 0.0 109.958 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 4.5 mmpt? -140.46 80.98 1.78 Allowed 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 50' ' ' GLY . 23.8 pt -71.75 105.14 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.323 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 68.52 -23.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.756 2.022 . . . . 0.0 113.996 175.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.16 -30.43 10.4 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -176.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.01 142.98 50.25 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.25 97.7 9.72 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.389 -1.325 . . . . 0.0 113.386 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.02 117.83 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.28 -37.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 120.968 0.413 . . . . 0.0 111.344 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.98 -0.97 70.01 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.28 130.45 16.04 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -53.89 107.46 0.21 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.366 2.711 . . . . 0.0 112.903 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -114.33 -169.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 123.324 2.682 . . . . 0.0 112.63 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.11 107.95 51.23 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.648 ' HA ' HG22 ' A' ' 75' ' ' THR . 32.5 Cg_exo -61.26 118.42 5.29 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.23 2.62 . . . . 0.0 111.964 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.6 mm -128.54 100.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . -118.18 81.1 0.32 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.51 112.97 38.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 4.8 p-10 -126.03 127.28 45.61 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.12 -48.21 10.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.8 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.5 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 21.7 tt0 -170.16 167.17 8.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 6.7 tpt85 -76.58 -29.66 56.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.801 0.334 . . . . 0.0 111.059 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.5 ' HB3' ' OE1' ' A' ' 66' ' ' GLU . 33.1 t -99.24 33.74 2.34 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.897 1.332 . . . . 0.0 108.558 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -148.75 162.53 39.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.93 124.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 122.137 0.97 . . . . 0.0 112.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.54 ' HE3' ' HA ' ' A' ' 67' ' ' ARG . 16.7 ptp -134.72 152.05 51.46 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.407 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.412 HG12 HG22 ' A' ' 83' ' ' VAL . 59.9 mt -121.65 90.47 48.15 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 42.2 Cg_endo -105.02 44.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.052 2.501 . . . . 0.0 113.437 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.74 -103.4 0.14 Allowed 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 121.526 0.679 . . . . 0.0 112.012 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 60' ' ' PRO . 3.0 p -162.18 179.66 7.75 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.973 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.71 85.02 43.87 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -103.59 -167.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 123.086 2.524 . . . . 0.0 113.896 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.67 -22.12 60.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.008 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -75.59 -68.79 0.53 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.578 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 170.4 163.72 24.91 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 38' ' ' ARG . 6.5 m -91.73 151.18 20.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -127.23 126.08 42.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 t -118.21 129.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.478 HG12 ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -122.72 142.37 39.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.7 tt0 -142.83 122.17 13.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 25.0 tp -99.78 137.06 20.12 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.54 -5.74 7.16 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.153 1.902 . . . . 0.0 111.53 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.643 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.0 t -99.01 163.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.9 t70 -65.32 144.91 99.11 Favored Pre-proline 0 C--N 1.304 -1.396 0 C-N-CA 123.153 0.581 . . . . 0.0 110.214 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.72 -9.58 0.15 Allowed 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 124.034 3.156 . . . . 0.0 115.404 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 9.9 pt-20 -59.43 -18.7 41.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.12 0.568 . . . . 0.0 111.411 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 96' ' ' ILE . 13.3 mm-40 -61.27 -19.91 62.26 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.24 -36.96 77.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.564 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.89 -39.22 88.46 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 109.609 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -69.37 -47.01 65.57 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.445 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 92' ' ' GLU . 44.3 mm -73.34 -10.13 13.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.824 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.65 -31.4 32.36 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.45 -34.28 54.49 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 99' ' ' VAL . 41.3 t -100.72 29.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.574 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.61 -20.71 64.51 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.659 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.497 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.6 mt-10 -139.89 -59.47 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 52.5 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 C-N-CA 121.415 1.41 . . . . 0.0 113.858 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.421 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.8 ptp -171.44 130.8 0.72 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.315 0.646 . . . . 0.0 110.016 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -120.96 126.54 50.21 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.597 0.713 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CE1' ' HA ' ' A' ' 23' ' ' ALA . 91.7 m-85 -133.25 22.05 4.06 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.63 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 7.7 p -103.44 78.46 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.089 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 22' ' ' ARG . 5.2 tt -70.68 -54.28 12.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.085 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -75.96 3.95 9.23 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.7 1.238 . . . . 0.0 111.802 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 5' ' ' CYS . 9.0 m -87.44 -2.24 58.48 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.541 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -64.68 -17.92 64.52 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.111 176.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.541 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 4.8 tt -76.12 -35.55 59.24 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.45 -30.47 68.39 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 108.073 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 9' ' ' TYR . 45.5 mt-30 -78.39 -14.63 59.31 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.575 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.7 t 67.03 30.75 7.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.22 1.008 . . . . 0.0 109.833 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.79 88.66 0.11 Allowed Glycine 0 N--CA 1.417 -2.608 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.186 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.47 132.67 54.63 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.645 ' HA ' HG23 ' A' ' 54' ' ' ILE . 48.2 t80 -139.44 12.06 2.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.509 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 6' ' ' LEU . 41.4 mt-10 -146.46 176.21 9.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.705 HG22 ' HG ' ' A' ' 49' ' ' LEU . 11.2 tp -118.9 154.5 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -69.71 74.55 0.42 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.968 1.366 . . . . 0.0 111.387 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.3 mmm -132.51 -145.8 0.27 Allowed 'General case' 0 C--N 1.269 -2.897 0 C-N-CA 127.235 2.214 . . . . 0.0 107.371 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HE3' ' HG2' ' A' ' 101' ' ' GLU . 56.7 mtmt -119.45 129.54 54.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 119.202 0.91 . . . . 0.0 110.471 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.591 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.8 175.18 5.58 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB2' ' CG ' ' A' ' 102' ' ' PRO . . . -163.59 76.89 0.39 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.822 0.701 . . . . 0.0 111.901 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 46' ' ' GLU . . . -90.9 74.46 1.69 Allowed Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.674 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.1 -68.19 0.58 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.559 0.695 . . . . 0.0 110.357 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.627 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 32.3 mmt180 -75.33 -44.18 46.68 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.896 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 24.8 mt-10 -77.62 2.59 16.11 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.2 t -50.41 -44.34 55.06 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.89 -34.07 57.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.464 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' C ' ' HD3' ' A' ' 34' ' ' LYS . . . -61.4 -48.79 79.62 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.456 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.9 ptp -59.89 -33.85 72.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.907 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.747 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 81.3 mt -62.94 -34.24 65.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.51 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.04 -31.78 21.79 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.042 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.7 mtpt -59.09 -16.8 21.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.893 0.877 . . . . 0.0 111.877 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 22.3 ptmt -77.4 -16.0 59.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.455 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.4 72.31 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.347 -0.221 . . . . 0.0 111.524 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 177.17 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' THR . 41.5 ttp180 -156.78 116.87 3.55 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -133.1 146.06 33.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.664 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -93.4 137.81 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 124.119 0.887 . . . . 0.0 109.017 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.417 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 27.7 t60 -139.1 125.79 20.74 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.82 140.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 62.5 mttp 69.23 65.67 0.5 Allowed Pre-proline 0 C--O 1.22 -0.467 0 C-N-CA 124.24 1.016 . . . . 0.0 110.2 -175.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 44.3 Cg_endo -88.35 161.48 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.802 2.335 . . . . 0.0 112.91 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.594 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 177.69 62.64 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 16.1 tt0 -118.21 101.29 8.1 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 124.147 0.979 . . . . 0.0 108.667 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -95.43 91.39 6.18 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.002 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 22' ' ' ARG . 42.1 pt -92.13 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.246 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.705 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 68.32 -1.99 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.139 1.776 . . . . 0.0 112.818 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.95 -33.16 4.32 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.27 122.41 37.68 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HD3' HD11 ' A' ' 48' ' ' ILE . 19.1 tpp180 -64.65 100.2 0.37 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.795 0.684 . . . . 0.0 110.409 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.509 HD12 HG21 ' A' ' 18' ' ' ILE . 60.2 mt -121.47 131.1 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.645 HG23 ' HA ' ' A' ' 16' ' ' TYR . 57.9 mt -99.15 -31.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.666 0.746 . . . . 0.0 109.822 -177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.48 15.48 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.34 117.04 43.66 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.19 112.11 3.24 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.806 2.338 . . . . 0.0 113.514 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 3.1 Cg_endo -91.92 -171.35 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.924 2.416 . . . . 0.0 108.838 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.587 ' HB ' ' CB ' ' A' ' 75' ' ' THR . 80.9 t -82.2 132.85 52.05 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.1 Cg_endo -81.6 70.59 7.23 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.557 1.504 . . . . 0.0 113.827 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.14 91.67 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.94 103.25 3.02 Favored Glycine 0 N--CA 1.414 -2.827 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.815 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.8 mt -102.35 76.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -110.94 118.83 37.17 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.164 0.507 . . . . 0.0 110.081 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -90.18 -57.15 2.95 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.373 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.639 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -162.54 167.61 23.11 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.409 HH11 HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.63 -27.41 34.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.106 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.639 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 20.8 t -94.09 30.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 123.058 1.409 . . . . 0.0 108.952 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.7 m -153.85 162.93 40.82 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -63.64 131.25 29.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.765 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.4 ptp -126.99 124.33 39.17 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 83' ' ' VAL . 23.7 mt -114.1 96.79 43.32 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.24 148.89 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.851 1.7 . . . . 0.0 113.04 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 58' ' ' PRO . 73.4 m-85 75.57 -155.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 125.088 1.355 . . . . 0.0 110.681 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.587 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 97.4 m -145.61 -75.51 0.22 Allowed 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HG2' HG22 ' A' ' 75' ' ' THR . 73.1 mmtt -129.53 90.87 42.68 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.433 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HB3' HD13 ' A' ' 54' ' ' ILE . 4.7 Cg_exo -85.85 -171.03 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.671 2.247 . . . . 0.0 110.837 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 41.2 t -81.53 -34.45 31.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.473 0.654 . . . . 0.0 110.465 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -89.3 -68.55 0.77 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -177.1 169.93 42.41 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.9 m -98.42 152.52 19.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.94 149.9 42.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.8 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.5 t -134.43 98.67 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 19.9 m -113.48 135.96 51.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.32 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -135.82 124.94 24.42 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.979 0.418 . . . . 0.0 110.184 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.0 tp -101.34 125.83 36.52 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.93 13.41 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.484 2.122 . . . . 0.0 111.05 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.556 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 18.3 t -113.71 151.91 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 25.7 m-20 -61.95 154.85 66.32 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 124.08 0.952 . . . . 0.0 111.309 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.29 -17.09 24.85 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.723 2.949 . . . . 0.0 113.367 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.8 pt-20 -63.41 -16.79 61.56 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.516 0.726 . . . . 0.0 111.222 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.14 -19.78 63.2 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 93' ' ' ILE . 26.3 mm -66.42 -28.31 43.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.308 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.48 -42.66 92.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.326 0.584 . . . . 0.0 109.749 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.51 -50.24 70.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.654 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -68.14 -20.06 25.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.452 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 tp -70.91 -28.67 64.7 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.285 0.634 . . . . 0.0 110.0 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.95 -32.25 61.69 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.3 t -83.58 -3.07 7.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.67 -35.17 60.76 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.272 0.629 . . . . 0.0 112.534 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.412 ' HG2' ' HE3' ' A' ' 21' ' ' LYS . 32.7 tt0 -149.39 93.94 4.0 Favored Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.548 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 23.1 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 123.25 2.634 . . . . 0.0 112.422 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 m80 . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.764 0.316 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.578 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 72.0 mtm -147.53 123.18 10.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.9 m -98.77 114.43 26.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.794 0.33 . . . . 0.0 111.04 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.9 m-85 -129.28 14.41 6.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.455 0.645 . . . . 0.0 109.306 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.5 m -135.53 102.85 5.25 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -78.56 -33.95 47.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.079 0.942 . . . . 0.0 111.956 -175.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.84 -20.99 60.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.88 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 14.6 m -70.68 -35.15 72.67 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -70.29 -27.3 64.3 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.454 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.14 -51.12 70.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.85 -27.85 66.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.01 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 8' ' ' THR . 53.2 mt-30 -77.35 -44.74 28.37 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.662 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -148.37 -50.76 0.17 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.289 0.566 . . . . 0.0 110.904 -176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.43 163.28 19.8 Favored Glycine 0 N--CA 1.422 -2.26 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.24 139.2 58.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.389 0.614 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -132.22 2.94 3.95 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 55.5 mt-10 -149.95 143.68 25.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.666 HG22 ' HG ' ' A' ' 49' ' ' LEU . 13.8 tt -81.63 163.74 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.0 72.32 1.63 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.635 1.207 . . . . 0.0 109.646 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.9 mmt -140.51 -176.06 4.5 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.246 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -81.11 116.67 21.14 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 119.284 0.947 . . . . 0.0 111.243 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -106.94 134.75 49.62 Favored 'General case' 0 N--CA 1.4 -2.95 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.39 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.41 79.88 1.79 Allowed 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.62 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.24 80.81 0.49 Allowed Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.859 -175.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -68.94 -79.44 0.06 Allowed 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 117.045 0.422 . . . . 0.0 111.585 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 19.9 mtp-105 -75.33 -31.24 60.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.917 -1.113 . . . . 0.0 113.435 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 9.0 tp10 -70.9 -12.64 61.66 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 109.665 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.3 t -60.73 -32.24 71.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -69.04 -45.49 70.3 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.435 0.635 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -67.55 -42.53 82.52 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.872 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -57.26 -32.34 66.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.584 0.23 . . . . 0.0 111.38 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 28' ' ' CYS . 50.0 mm -62.31 -40.3 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.52 -36.77 52.15 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.733 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HE2' ' H ' ' A' ' 83' ' ' VAL . 72.4 mttt -65.04 -15.22 62.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.755 0.822 . . . . 0.0 112.533 -178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -67.95 -23.98 65.12 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.636 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.15 -39.76 68.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.334 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 178.35 -68.76 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.761 0.824 . . . . 0.0 109.413 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.0 ttp180 -163.51 124.01 2.25 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 86.5 t -138.29 157.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -107.76 149.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.472 0.709 . . . . 0.0 109.991 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 51.6 t60 -135.62 128.02 30.37 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.413 HG22 ' HG3' ' A' ' 43' ' ' LYS . 3.2 mp -96.8 136.54 27.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 98.9 mttt 70.48 53.89 0.42 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.58 1.152 . . . . 0.0 111.294 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 65.3 Cg_endo -70.58 144.55 49.96 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 121.161 1.241 . . . . 0.0 109.981 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.29 47.7 0.97 Allowed Glycine 0 CA--C 1.474 -2.489 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 10.2 pm0 -105.98 148.47 27.66 Favored 'General case' 0 N--CA 1.396 -3.159 0 CA-C-O 121.945 0.879 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 51.4 mtmt -134.75 80.85 1.87 Allowed 'General case' 0 CA--C 1.454 -2.742 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.433 ' C ' HD22 ' A' ' 49' ' ' LEU . 34.6 pt -95.89 104.35 15.74 Favored 'Isoleucine or valine' 1 C--N 1.221 -4.98 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.148 -175.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 59.03 6.01 0.61 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 126.733 2.013 . . . . 0.0 113.728 175.398 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.5 -3.46 67.89 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.84 131.83 4.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -76.86 86.33 3.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.443 HD12 HG21 ' A' ' 18' ' ' ILE . 57.3 mt -108.39 127.17 64.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.24 -39.28 64.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.82 9.57 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.431 HD13 ' HB3' ' A' ' 78' ' ' CYS . 58.8 mt -102.96 120.83 51.19 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.85 107.39 0.17 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 123.257 2.638 . . . . 0.0 112.74 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -97.26 137.02 0.44 Allowed 'Trans proline' 0 N--CA 1.424 -2.587 0 C-N-CA 122.573 2.182 . . . . 0.0 111.693 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -67.63 114.03 17.5 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.24 88.01 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.397 2.065 . . . . 0.0 114.418 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 74' ' ' TYR . 73.0 mt -122.89 146.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 142.47 -174.84 23.21 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.829 -2.129 . . . . 0.0 114.547 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.16 102.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.17 105.38 17.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.82 -69.91 0.55 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.523 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.74 167.78 12.93 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -34.23 77.36 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 124.785 1.234 . . . . 0.0 107.844 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -99.46 32.16 2.89 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.385 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -151.72 160.46 43.59 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.435 HG13 ' OE2' ' A' ' 85' ' ' GLU . 5.3 m -77.8 119.79 27.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.893 0.854 . . . . 0.0 110.735 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.669 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.0 ptp -98.49 111.59 23.9 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.72 92.55 7.46 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 71' ' ' MET . 30.4 Cg_endo -100.9 178.04 0.23 Allowed 'Trans proline' 0 N--CA 1.406 -3.63 0 C-N-CA 121.799 1.666 . . . . 0.0 112.489 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 43.0 t80 -135.42 81.7 1.91 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.581 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 22.5 p -97.24 139.24 33.51 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.871 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -111.56 88.1 8.86 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.448 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 75' ' ' THR . 58.0 Cg_endo -107.68 -153.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 123.914 3.076 . . . . 0.0 108.454 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.431 ' HB3' HD13 ' A' ' 56' ' ' ILE . 21.7 t -110.65 11.01 22.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -118.1 -82.26 0.63 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.951 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.87 -174.55 45.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 37.1 m -109.78 148.26 31.78 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.77 135.53 55.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.9 t -121.43 108.65 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 20.2 m -108.24 129.65 62.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' HG13 ' A' ' 70' ' ' VAL . 39.8 tt0 -132.6 117.67 18.23 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.598 0.636 . . . . 0.0 110.821 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 19.8 tp -99.75 134.76 20.81 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.18 -3.1 9.53 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.328 2.019 . . . . 0.0 111.734 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -94.76 157.95 3.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 18.0 t70 -65.07 146.29 98.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 122.476 0.31 . . . . 0.0 111.512 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -50.98 -10.93 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.215 3.277 . . . . 0.0 114.788 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 7.9 pt-20 -57.29 -23.13 46.45 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 120.964 0.411 . . . . 0.0 110.438 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -59.74 -26.85 66.0 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.494 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 93' ' ' ILE . 20.0 mm -67.89 -33.71 63.03 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 C-N-CA 121.398 -0.121 . . . . 0.0 110.796 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.33 -43.16 99.47 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -64.74 -51.02 64.58 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.719 -1.582 . . . . 0.0 109.01 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.8 mt -64.59 -25.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 124.003 0.921 . . . . 0.0 112.453 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.67 -39.89 94.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.174 0.511 . . . . 0.0 109.797 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -86.63 -41.31 14.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.942 0.877 . . . . 0.0 110.09 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.42 2.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.458 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -47.74 -48.67 29.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -176.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.65 -47.15 0.48 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 N--CA 1.434 -2.025 0 CA-C-N 120.224 1.116 . . . . 0.0 112.019 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.496 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.3 mpp? -151.77 132.57 14.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -127.77 115.39 18.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 84.2 m-85 -125.39 -5.0 7.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 48.0 m -77.69 90.07 3.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.212 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 20' ' ' MET 0.251 0.0 OUTLIER -79.17 -50.35 11.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.685 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' HD22 ' A' ' 6' ' ' LEU . 1.2 tt0 -76.75 -8.5 57.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.755 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 65.6 m -69.61 -26.36 64.4 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 54.2 m-85 -75.38 -23.21 57.07 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 4.4 tt -70.11 -40.05 75.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -68.3 -23.72 64.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.966 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -99.58 5.62 45.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.012 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m 60.9 31.4 19.99 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.523 0.729 . . . . 0.0 111.937 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . -145.72 67.61 0.41 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.67 145.47 53.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.255 0.55 . . . . 0.0 111.337 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -145.66 27.79 1.2 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' HD11 ' A' ' 49' ' ' LEU . 1.6 pm0 -155.99 171.77 19.53 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.406 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.556 HG22 ' HG ' ' A' ' 49' ' ' LEU . 8.7 tt -105.5 16.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.758 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 71.7 m80 65.31 69.09 0.48 Allowed 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 122.522 1.153 . . . . 0.0 110.471 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.719 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.7 tmm? -148.97 -168.69 3.17 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 63.5 tttp -75.76 112.36 12.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 119.66 1.118 . . . . 0.0 110.986 -177.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -106.8 161.07 15.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . . . -160.24 91.09 0.92 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.23 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.41 89.59 0.59 Allowed Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.94 -67.36 0.71 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.155 0.979 . . . . 0.0 109.279 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.8 mmt180 -81.42 -34.76 31.34 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.023 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 21.1 tt0 -80.31 -5.01 55.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.097 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 12.4 t -49.42 -46.28 47.43 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.274 0.559 . . . . 0.0 109.553 174.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.16 75.72 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.556 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.7 -47.32 86.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.02 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.518 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.0 ptm -61.02 -35.25 76.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.23 -42.87 91.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.338 0.589 . . . . 0.0 109.923 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -77.73 -35.13 52.26 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.898 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 31' ' ' MET . 82.1 mttt -57.9 -24.8 59.33 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 0.0 112.39 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.34 -21.78 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.331 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.59 77.77 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.644 0.259 . . . . 0.0 110.596 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -175.36 -69.44 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.336 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.539 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.4 ptt180 -151.15 123.58 8.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.0 t -138.07 141.43 38.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.78 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.6 p -108.82 143.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 56.0 t-80 -133.81 130.49 38.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 15.7 tt -83.87 141.49 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.5 mttt 68.14 64.62 0.63 Allowed Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 0.0 110.781 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.47 171.1 16.37 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.927 1.751 . . . . 0.0 111.483 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.489 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -174.5 50.35 0.14 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.957 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.8 tp10 -119.09 144.47 46.59 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HZ2' ' HB2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -139.68 81.6 1.83 Allowed 'General case' 0 CA--C 1.444 -3.118 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.571 ' HB ' HD22 ' A' ' 49' ' ' LEU . 9.6 pt -72.72 110.05 5.48 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.444 0 CA-C-N 111.677 -2.511 . . . . 0.0 109.903 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER 62.11 14.74 6.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 125.84 1.656 . . . . 0.0 112.398 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 -41.07 2.6 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.53 121.41 41.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HA ' HG13 ' A' ' 48' ' ' ILE . 56.7 ttp180 -62.52 92.48 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 124.506 1.122 . . . . 0.0 113.011 -177.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.5 mm -124.26 132.73 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.3 mt -79.99 -29.36 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.504 0.668 . . . . 0.0 109.851 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 17' ' ' GLU . . . 82.6 5.72 89.22 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.943 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.462 HD13 ' H ' ' A' ' 78' ' ' CYS . 70.6 mt -126.72 122.14 23.44 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -65.18 107.87 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.192 1.928 . . . . 0.0 109.783 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -110.26 -172.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.132 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.0 t -73.67 116.85 55.77 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.26 39.19 0.52 Allowed 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 123.583 2.855 . . . . 0.0 115.6 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.73 141.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 165.09 129.65 1.06 Allowed Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 117.979 -2.058 . . . . 0.0 113.635 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 146.96 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -121.76 93.58 4.04 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.69 -64.34 0.88 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.265 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 1.5 tm-20 -159.78 169.92 22.6 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.53 ' HB2' HD11 ' A' ' 93' ' ' ILE . 5.0 tpp180 -87.1 -38.6 16.33 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.279 0.561 . . . . 0.0 112.351 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 18.5 t -91.23 29.9 1.35 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 122.994 1.378 . . . . 0.0 107.924 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 67' ' ' ARG . 16.9 m -145.65 170.02 17.3 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.58 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.468 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.3 ptt? -115.78 142.96 46.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.4 tp -114.34 80.44 5.89 Favored Pre-proline 0 C--N 1.292 -1.905 0 C-N-CA 119.655 -0.818 . . . . 0.0 113.12 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 3.0 Cg_exo -84.82 98.64 0.7 Allowed 'Trans proline' 0 N--CA 1.425 -2.503 0 C-N-CA 121.932 1.754 . . . . 0.0 107.72 176.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -88.92 67.65 8.24 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 123.046 1.403 . . . . 0.0 108.865 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.525 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 18.8 p -104.59 138.94 40.19 Favored 'General case' 1 N--CA 1.366 -4.665 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.618 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.17 92.52 9.61 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.564 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.3 Cg_endo -101.76 -165.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 122.93 2.42 . . . . 0.0 110.828 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.462 ' H ' HD13 ' A' ' 56' ' ' ILE . 44.1 t -93.24 0.74 57.16 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -108.29 -78.48 0.59 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.256 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.21 178.35 46.83 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 71.3 m -93.1 131.61 37.98 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.54 116.85 32.74 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.871 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 39.0 t -120.85 133.31 67.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.49 144.29 35.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 38.7 tt0 -137.73 125.82 22.91 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.549 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 26.3 tp -101.16 138.24 19.91 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.76 -3.95 11.32 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 121.82 1.68 . . . . 0.0 111.568 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.549 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 40.1 t -103.63 159.06 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.422 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 7.5 m-20 -63.59 158.68 57.67 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 123.637 0.585 . . . . 0.0 110.909 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.33 -9.87 7.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.895 3.063 . . . . 0.0 113.636 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.7 pt-20 -56.57 -25.64 52.94 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 110.487 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.2 tp10 -63.82 -31.51 72.72 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 67' ' ' ARG . 65.5 mt -60.12 -42.58 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.44 0.296 . . . . 0.0 110.8 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.17 -36.9 85.68 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.313 0.578 . . . . 0.0 110.397 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.455 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 43.2 ttt180 -71.71 -42.3 67.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.256 1.027 . . . . 0.0 108.257 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.2 mm -65.46 -17.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 125.347 1.459 . . . . 0.0 110.908 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -78.38 -28.39 47.01 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -82.14 -43.92 17.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 59.1 t -79.35 11.61 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.98 -50.94 67.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.779 0.832 . . . . 0.0 110.23 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.52 92.51 47.75 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.861 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 123.753 2.969 . . . . 0.0 110.849 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.572 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HD11 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.527 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.632 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 20' ' ' MET . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' ILE . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.528 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.825 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 96' ' ' ILE . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG22 ' HB2' ' A' ' 22' ' ' ARG . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' HB2' ' A' ' 20' ' ' MET . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.61 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.657 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 67' ' ' ARG . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.491 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.693 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.697 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.683 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HB ' HD22 ' A' ' 49' ' ' LEU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.616 HD22 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 75' ' ' THR . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 73' ' ' PRO . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -170.92 130.4 0.79 Allowed 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 125.712 1.605 . . . . 0.0 107.77 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.433 HG21 ' SD ' ' A' ' 31' ' ' MET . 9.9 t -114.57 129.01 56.63 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.94 0.876 . . . . 0.0 112.124 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -130.87 25.39 4.99 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.669 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 82.4 m -129.89 99.99 5.3 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -80.63 -45.17 17.7 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' N ' HD22 ' A' ' 6' ' ' LEU . 41.8 tt0 -74.55 -2.84 27.65 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.155 0.979 . . . . 0.0 111.863 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 49.9 m -76.84 -26.64 54.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.85 -24.15 58.54 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.26 -20.12 62.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.102 0.953 . . . . 0.0 108.924 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -91.14 9.53 30.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.857 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -128.97 -46.45 1.25 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.597 0.713 . . . . 0.0 109.349 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 m -153.67 -155.66 0.61 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.56 166.01 53.24 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -81.35 147.25 29.94 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.541 ' HA ' HG23 ' A' ' 54' ' ' ILE . 61.1 t80 -126.88 22.63 6.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 122.652 1.215 . . . . 0.0 108.348 -176.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HB3' HD21 ' A' ' 49' ' ' LEU . 7.5 mp0 -142.36 167.9 21.0 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.337 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.679 HG22 HD22 ' A' ' 49' ' ' LEU . 3.1 tt -100.59 -1.54 9.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 -176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' HA ' HD21 ' A' ' 6' ' ' LEU . 60.9 t-80 79.98 79.25 0.05 OUTLIER 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 126.716 2.007 . . . . 0.0 106.581 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.7 -179.08 7.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -176.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.71 101.99 3.22 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.918 1.342 . . . . 0.0 111.292 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.684 ' H ' ' NE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -93.8 121.68 35.5 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.697 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.88 79.06 1.68 Allowed 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.602 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -95.85 88.39 1.05 Allowed Glycine 0 CA--C 1.472 -2.645 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.529 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.34 -64.6 1.13 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.543 0.687 . . . . 0.0 110.13 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.666 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 6.1 mmp_? -84.38 -40.96 17.21 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 34' ' ' LYS . 33.5 tt0 -67.34 -11.98 59.02 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.952 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 48.8 t -55.48 -41.92 73.67 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.88 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -70.81 -32.11 69.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.027 0.442 . . . . 0.0 110.625 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -75.49 -41.36 55.64 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.45 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.3 ptp -61.62 -33.06 73.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.993 0.425 . . . . 0.0 111.672 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.19 -28.41 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.798 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' ALA . 15.4 mm-40 -92.73 -37.24 12.48 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.571 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 73.2 mttt -58.8 -24.94 62.64 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 124.772 1.229 . . . . 0.0 111.246 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -60.47 -26.83 67.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 O-C-N 124.331 1.019 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.26 -62.7 1.3 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.198 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -152.11 -70.01 0.16 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.862 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 28.2 ptt180 -158.48 123.76 4.36 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.0 t -140.74 154.73 21.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.901 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.7 p -115.03 144.15 23.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.169 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.831 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 4.0 t-80 -113.45 126.34 55.22 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.3 tt -86.33 134.57 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 86' ' ' LEU . 65.3 mttp 66.7 60.1 0.94 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.861 0.865 . . . . 0.0 109.906 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 86' ' ' LEU . 57.5 Cg_endo -69.25 168.24 21.45 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.771 1.647 . . . . 0.0 110.639 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.666 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 179.47 56.8 0.08 OUTLIER Glycine 1 CA--C 1.448 -4.103 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -177.148 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . 2.6 pm0 -116.35 147.27 41.76 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 114.163 -1.019 . . . . 0.0 109.857 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.592 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 7.8 mmtm -136.64 76.56 1.6 Allowed 'General case' 0 C--N 1.263 -3.193 0 CA-C-O 123.801 1.762 . . . . 0.0 107.907 174.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 79.9 mt -88.39 107.55 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.698 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.364 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.679 HD22 HG22 ' A' ' 18' ' ' ILE . 2.4 mt 70.57 -3.77 1.82 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.492 1.117 . . . . 0.0 111.251 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.8 -37.73 3.66 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.27 131.12 27.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -71.93 103.84 3.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.904 0.859 . . . . 0.0 109.216 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 49' ' ' LEU . 50.8 mm -120.01 134.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 16' ' ' TYR . 69.5 mt -84.61 -41.38 15.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.752 0.787 . . . . 0.0 109.229 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.69 -18.51 34.03 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 mm -101.02 108.78 56.07 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.5 Cg_exo -53.05 109.32 0.34 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.477 2.785 . . . . 0.0 112.577 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 59.0 Cg_endo -97.37 -179.66 0.38 Allowed 'Trans proline' 0 N--CA 1.432 -2.12 0 C-N-CA 122.713 2.275 . . . . 0.0 111.487 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 75' ' ' THR . 77.6 t -67.37 112.33 9.82 Favored Pre-proline 0 C--O 1.213 -0.835 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.27 75.09 5.14 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.86 1.707 . . . . 0.0 115.455 -170.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 75.0 mt -136.64 142.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.658 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 138.11 156.74 7.24 Favored Glycine 0 N--CA 1.403 -3.535 0 C-N-CA 118.981 -1.58 . . . . 0.0 114.13 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.1 pt -150.87 160.84 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 123.423 0.689 . . . . 0.0 111.3 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.93 136.48 42.68 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.44 -61.87 1.66 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.737 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -155.83 166.22 34.16 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 67' ' ' ARG . 3.0 tpp180 -77.09 -33.62 56.96 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.793 0.806 . . . . 0.0 110.468 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.49 31.54 1.02 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 122.782 1.277 . . . . 0.0 110.288 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.483 ' CA ' ' HG3' ' A' ' 85' ' ' GLU . 64.4 m -154.61 173.49 16.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 85' ' ' GLU . 29.1 m -79.19 166.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-O 122.473 1.13 . . . . 0.0 110.228 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.526 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.4 ptt? -120.77 122.25 39.96 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 174.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.8 90.29 15.01 Favored Pre-proline 0 C--N 1.293 -1.867 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.174 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.658 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 71.7 Cg_endo -103.21 171.09 0.21 Allowed 'Trans proline' 1 N--CA 1.385 -4.898 0 C-N-CA 120.8 1.0 . . . . 0.0 111.449 176.022 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m-85 -126.05 32.53 5.23 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 122.213 1.006 . . . . 0.0 110.304 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 37.0 p -80.6 104.38 11.09 Favored 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.511 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -103.88 102.23 29.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.688 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 75' ' ' THR . 64.3 Cg_endo -98.46 -156.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.736 2.957 . . . . 0.0 112.072 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.2 t -95.95 28.56 3.08 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.369 1.08 . . . . 0.0 108.092 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -136.81 -85.28 0.33 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.68 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -172.77 173.81 45.59 Favored Glycine 0 C--N 1.315 -0.589 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.551 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 25.1 m -89.28 135.7 33.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.418 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . . . -109.91 126.93 54.39 Favored 'General case' 0 N--CA 1.397 -3.119 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 54.2 t -133.02 138.85 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 30.7 m -140.06 140.52 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.483 ' HG3' ' CA ' ' A' ' 69' ' ' THR . 42.5 tt0 -138.71 118.67 13.34 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' SER . 13.2 tp -97.17 143.9 26.94 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.27 12.67 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.907 1.738 . . . . 0.0 112.34 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 68' ' ' SER . 26.1 t -117.79 156.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.474 ' CB ' ' HG2' ' A' ' 91' ' ' GLU . 1.8 m-20 -51.81 157.51 1.97 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 124.201 0.938 . . . . 0.0 111.871 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.28 -11.37 31.11 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.586 2.191 . . . . 0.0 110.539 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 89' ' ' ASP . 12.8 pt-20 -66.61 -16.87 64.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.226 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 96' ' ' ILE . 7.3 tp10 -59.52 -26.49 65.36 Favored 'General case' 0 C--N 1.375 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -56.38 -36.16 45.98 Favored 'Isoleucine or valine' 0 C--O 1.167 -3.242 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -56.04 -40.94 74.23 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.93 0.871 . . . . 0.0 110.796 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -39.03 42.29 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.208 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 92' ' ' GLU . 43.2 mm -75.29 -18.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.317 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.9 tp -82.14 -27.89 32.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.731 0.777 . . . . 0.0 109.018 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -100.74 7.88 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.669 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.592 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -55.13 -61.8 2.08 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -177.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.54 -43.93 0.22 Allowed Pre-proline 0 C--N 1.258 -3.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.911 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.423 -2.638 0 C-N-CA 121.163 1.242 . . . . 0.0 112.347 179.129 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.693 HD13 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.697 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.683 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HB ' HD22 ' A' ' 49' ' ' LEU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.616 HD22 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 75' ' ' THR . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 73' ' ' PRO . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.5 t60 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -176.96 148.86 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.23 0.612 . . . . 0.0 110.966 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -148.93 130.67 15.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 55.9 m-85 -114.68 7.57 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.985 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.4 m -84.53 115.0 22.36 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 7' ' ' GLU . 0.6 OUTLIER -102.92 -53.07 2.92 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.759 ' H ' HD12 ' A' ' 6' ' ' LEU . 33.1 tt0 -70.22 -13.82 62.35 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 125.155 1.382 . . . . 0.0 110.91 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -73.12 -25.05 60.71 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.237 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -32.3 63.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.68 -42.13 98.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -67.0 -17.32 64.87 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.95 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -95.19 -45.2 7.29 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.9 m -149.59 -67.34 0.21 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.933 0.396 . . . . 0.0 111.127 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.33 163.54 32.04 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.7 152.93 22.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 124.222 0.601 . . . . 0.0 109.831 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.518 ' HA ' HG23 ' A' ' 54' ' ' ILE . 41.9 t80 -151.44 13.58 0.66 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.401 0.619 . . . . 0.0 110.452 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -144.59 171.06 14.91 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.699 HG22 ' HG ' ' A' ' 49' ' ' LEU . 15.5 tt -105.2 150.46 7.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -69.53 67.68 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.305 1.05 . . . . 0.0 110.973 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mmm -122.07 -101.03 0.41 Allowed 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.979 1.712 . . . . 0.0 110.242 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 37.6 ttmt -159.45 124.22 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.413 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -108.06 141.45 39.73 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . . . -118.06 90.47 3.34 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.56 76.07 0.22 Allowed Glycine 0 CA--C 1.479 -2.199 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.358 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 97.3 m-85 -70.37 -74.96 0.13 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.072 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.601 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.7 mmt180 -80.73 -33.02 35.52 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.375 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -66.29 -13.07 59.89 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' MET . 25.0 t -49.44 -37.38 25.54 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 121.501 0.667 . . . . 0.0 110.987 175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.583 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -72.68 -42.97 63.69 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 121.82 -0.55 . . . . 0.0 110.456 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -60.28 -47.07 87.6 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.122 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -53.39 -39.53 64.33 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.383 0.427 . . . . 0.0 112.023 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.7 mm -62.17 -43.36 97.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.128 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.608 ' HB3' HG21 ' A' ' 39' ' ' VAL . 18.5 mm-40 -79.58 -28.86 41.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.805 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -64.47 -22.95 67.12 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 123.952 0.901 . . . . 0.0 111.973 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.06 -26.61 66.83 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -59.54 2.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.07 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -141.67 -79.12 0.25 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.487 1.137 . . . . 0.0 110.01 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.499 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 14.2 ptp180 -170.49 123.19 0.65 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 33' ' ' GLU . 74.2 t -132.93 143.19 40.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.639 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.7 p -97.75 139.41 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.901 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.633 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 66.6 t60 -123.27 124.9 44.03 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.8 tt -85.65 136.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 96.4 mttt 68.1 58.32 0.73 Allowed Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 123.64 0.776 . . . . 0.0 110.93 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 Cg_endo -78.24 155.91 29.3 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 121.647 1.565 . . . . 0.0 110.29 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -152.99 39.16 0.73 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.3 pm0 -105.6 175.6 5.44 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.925 0.869 . . . . 0.0 111.565 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.609 ' HG2' HG23 ' A' ' 96' ' ' ILE . 4.7 tmtt? -157.44 102.67 1.92 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.38 105.95 17.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.699 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.26 -1.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 127.349 2.26 . . . . 0.0 114.47 175.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.75 -38.89 2.93 Favored Glycine 0 C--N 1.291 -1.946 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.79 39.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -75.79 104.07 6.17 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.466 HD12 HG21 ' A' ' 18' ' ' ILE . 48.5 mt -124.31 119.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 16' ' ' TYR . 62.9 mt -77.9 -33.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.932 0.77 . . . . 0.0 110.18 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.63 14.99 Favored Glycine 0 C--N 1.309 -0.933 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.58 131.25 23.19 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 48.2 Cg_exo -58.79 110.43 0.67 Allowed 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.811 2.341 . . . . 0.0 111.324 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 30.0 Cg_endo -110.58 -177.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 122.878 2.385 . . . . 0.0 112.905 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 75' ' ' THR . 59.1 t -87.23 121.17 71.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 40.22 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.042 2.495 . . . . 0.0 114.792 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.09 145.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.34 145.39 6.0 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.352 -1.404 . . . . 0.0 112.356 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.13 86.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 123.404 0.681 . . . . 0.0 109.428 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -95.07 114.96 26.82 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.29 -69.53 0.72 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -148.07 168.25 22.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -32.82 42.44 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.27 28.47 1.43 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.426 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -152.3 167.91 27.1 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 85' ' ' GLU . 29.9 m -78.83 156.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.9 0.857 . . . . 0.0 111.383 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.614 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 ptt? -119.37 124.85 47.59 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.1 mt -107.95 87.48 3.81 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.2 Cg_exo -82.24 142.01 11.84 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.998 1.799 . . . . 0.0 112.332 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.8 49.88 1.07 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.997 1.38 . . . . 0.0 107.819 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.5 p -98.51 119.97 38.13 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 112.746 -2.024 . . . . 0.0 107.313 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -100.51 102.19 17.94 Favored Pre-proline 0 C--N 1.305 -1.345 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.002 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.3 Cg_endo -104.17 -164.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.708 0 C-N-CA 123.069 2.513 . . . . 0.0 111.18 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 74.3 m -109.8 35.39 3.38 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -141.86 -71.76 0.34 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.577 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.16 40.54 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 22.7 m -115.31 149.36 37.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 118.304 1.052 . . . . 0.0 111.214 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.07 124.68 52.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.4 t -122.33 124.83 71.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.517 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 21.8 m -125.17 145.79 31.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.432 ' HB2' HG12 ' A' ' 70' ' ' VAL . 44.2 tt0 -147.6 118.58 7.67 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.209 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.1 tp -95.85 125.66 47.92 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 1.13 8.97 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.254 1.969 . . . . 0.0 111.164 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.55 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 19.5 t -100.25 164.42 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 91' ' ' GLU . 6.2 m-20 -70.23 162.21 71.01 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 118.074 0.397 . . . . 0.0 110.132 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.73 16.42 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.137 2.558 . . . . 0.0 112.207 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -70.41 -20.01 62.95 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.014 0.911 . . . . 0.0 109.115 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.504 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 7.3 tp10 -65.74 -24.29 66.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.033 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.559 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 66.5 mt -59.23 -26.96 35.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.83 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -63.59 -41.09 98.37 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.573 ' H ' ' HD2' ' A' ' 95' ' ' ARG . 2.8 mpt_? -74.82 -38.9 61.92 Favored 'General case' 0 C--O 1.193 -1.921 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.609 HG23 ' HG2' ' A' ' 47' ' ' LYS . 62.2 mt -58.66 -33.97 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 124.37 1.068 . . . . 0.0 111.316 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.45 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.558 0.694 . . . . 0.0 109.797 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.57 -42.55 24.77 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.011 0.91 . . . . 0.0 109.518 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.19 3.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 125.119 1.367 . . . . 0.0 111.674 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -42.19 -44.13 3.62 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 124.518 1.127 . . . . 0.0 110.751 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -160.18 98.18 1.46 Allowed Pre-proline 0 N--CA 1.401 -2.882 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.243 0.734 0 C-N-CA 123.543 2.828 . . . . 0.0 112.739 -178.022 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.572 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HD11 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.527 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.632 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 20' ' ' MET . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' ILE . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.528 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.825 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 96' ' ' ILE . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG22 ' HB2' ' A' ' 22' ' ' ARG . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' HB2' ' A' ' 20' ' ' MET . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.467 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.61 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.657 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 67' ' ' ARG . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.491 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 79.9 m-70 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtt -152.49 122.26 6.94 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.649 HG21 ' SD ' ' A' ' 31' ' ' MET . 8.6 t -111.25 125.3 53.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.445 0.641 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.54 7.44 6.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.875 0.845 . . . . 0.0 109.43 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 62.5 m -94.89 96.56 9.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.769 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 7' ' ' GLU . 4.1 pp -100.29 -39.48 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.984 0.897 . . . . 0.0 110.358 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.625 ' N ' HD12 ' A' ' 6' ' ' LEU . 35.2 tt0 -77.74 -13.77 59.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.165 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.7 m -68.5 -33.56 74.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -80.33 -26.4 38.76 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.641 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HG ' ' OE2' ' A' ' 15' ' ' GLU . 7.8 tt -73.55 -26.79 61.01 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.295 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 7' ' ' GLU . 79.5 mt-30 -68.89 -29.96 68.35 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -93.34 -7.0 46.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.059 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.9 m 63.85 37.85 9.39 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 122.318 1.056 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.27 55.71 0.57 Allowed Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.475 ' OE2' ' HG ' ' A' ' 10' ' ' LEU . 6.1 pm0 -100.07 174.25 6.25 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.146 0.578 . . . . 0.0 111.423 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.431 ' CD1' HG13 ' A' ' 54' ' ' ILE . 70.9 t80 -144.87 25.44 1.44 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -138.13 163.96 30.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.75 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.477 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.1 tt -115.83 165.23 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.404 ' N ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-70 -65.84 71.87 0.06 Allowed 'General case' 0 C--N 1.362 1.15 0 CA-C-O 122.213 1.006 . . . . 0.0 109.989 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.641 ' SD ' ' HB3' ' A' ' 49' ' ' LEU . 47.7 mtt -135.82 -148.4 0.3 Allowed 'General case' 0 C--N 1.259 -3.326 0 C-N-CA 126.209 1.804 . . . . 0.0 106.872 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 20' ' ' MET . 11.9 tmtt? -124.03 123.28 40.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HB3' HD23 ' A' ' 6' ' ' LEU . 8.9 ptm180 -98.89 165.8 11.59 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.78 80.68 0.94 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.492 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -96.9 82.3 0.74 Allowed Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.4 -65.9 0.87 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.3 mpt_? -85.62 -34.66 21.33 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.984 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 29.8 tt0 -79.21 -3.01 43.68 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.648 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -53.54 -41.91 66.92 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.11 94.98 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.19 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.32 -45.73 91.91 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.293 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.649 ' SD ' HG21 ' A' ' 3' ' ' THR . 18.4 ptm -55.98 -35.73 67.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.9 mm -59.9 -46.44 93.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 123.93 0.769 . . . . 0.0 109.927 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.4 -28.51 31.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.193 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 34.7 mtpt -57.01 -26.86 60.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.692 0.797 . . . . 0.0 110.924 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 7.0 tmtm? -62.67 -21.25 65.57 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.316 1.047 . . . . 0.0 111.26 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.86 -39.24 69.81 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 121.86 -0.525 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -176.12 -65.46 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 7.2 ptp180 -169.6 132.41 1.2 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.67 145.79 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -98.26 139.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 O-C-N 124.343 1.027 . . . . 0.0 109.996 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 37.6 t-80 -137.7 123.29 19.75 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.0 137.85 20.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.8 mttt 66.6 64.24 0.82 Allowed Pre-proline 0 C--O 1.216 -0.667 0 C-N-CA 123.133 0.573 . . . . 0.0 111.097 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.635 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 44.9 Cg_endo -95.28 148.82 1.53 Allowed 'Trans proline' 0 N--CA 1.427 -2.395 0 C-N-CA 122.126 1.884 . . . . 0.0 111.046 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.457 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -154.21 64.76 0.34 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.265 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.658 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.0 tp10 -114.38 123.24 48.98 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 124.072 0.949 . . . . 0.0 109.11 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 44.4 mtmt -106.96 72.5 0.89 Allowed 'General case' 0 CA--C 1.464 -2.339 0 CA-C-O 123.287 1.518 . . . . 0.0 107.786 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.658 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -75.43 94.73 0.98 Allowed 'Isoleucine or valine' 1 C--N 1.239 -4.229 0 CA-C-N 111.683 -2.508 . . . . 0.0 111.828 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.641 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER 64.27 -8.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.646 1.578 . . . . 0.0 113.362 175.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.29 -6.26 78.23 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.31 152.19 18.27 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -88.83 99.87 12.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.816 0.341 . . . . 0.0 111.77 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.34 118.02 57.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 77' ' ' PRO . 3.5 mp -75.51 -43.54 41.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.403 0.62 . . . . 0.0 110.736 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.6 -9.47 77.0 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.3 mt -124.64 131.21 24.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.9 107.33 1.86 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.563 1.509 . . . . 0.0 109.252 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -103.4 -164.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 122.721 2.281 . . . . 0.0 111.485 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 75' ' ' THR . 55.7 t -75.75 116.96 60.07 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -84.1 43.93 1.46 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 122.502 2.135 . . . . 0.0 113.964 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 51.1 mt -114.98 164.88 10.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.21 155.93 9.14 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.157 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.2 pt -126.22 84.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.096 0.95 . . . . 0.0 111.32 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.78 95.96 7.44 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -76.95 -56.92 4.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.769 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.13 169.88 12.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 0.1 OUTLIER -88.77 -31.7 18.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.23 1.014 . . . . 0.0 108.464 -176.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 14.9 m -93.71 34.63 1.18 Allowed 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.909 1.338 . . . . 0.0 109.203 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.2 m -154.66 166.74 32.45 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.42 105.87 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 121.861 0.839 . . . . 0.0 110.968 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.47 ' HE3' ' HA ' ' A' ' 67' ' ' ARG . 21.4 ptp -86.29 123.54 31.66 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.9 mt -118.93 86.35 30.92 Favored Pre-proline 0 C--N 1.295 -1.792 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.857 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.555 ' O ' HG21 ' A' ' 81' ' ' THR . 4.3 Cg_exo -75.14 149.96 36.89 Favored 'Trans proline' 0 N--CA 1.422 -2.689 0 N-CA-C 108.353 -1.441 . . . . 0.0 108.353 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 72.4 m-85 -113.08 41.4 2.11 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 44.5 p -95.07 102.85 14.68 Favored 'General case' 0 N--CA 1.398 -3.054 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -102.05 102.38 23.75 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.743 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.8 Cg_endo -102.45 -159.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.311 0 C-N-CA 123.253 2.635 . . . . 0.0 110.136 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -93.86 25.46 3.62 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.121 0.962 . . . . 0.0 110.172 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -128.09 -74.91 0.57 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.829 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 157.66 -174.78 35.07 Favored Glycine 0 N--CA 1.416 -2.655 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 73' ' ' PRO . 5.0 m -121.48 152.12 39.5 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 117.406 0.603 . . . . 0.0 109.627 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -105.15 111.83 24.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.7 t -102.24 90.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.635 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 26.9 m -104.64 135.47 42.42 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 O-C-N 121.457 -0.777 . . . . 0.0 111.473 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.17 115.88 16.95 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.529 0.68 . . . . 0.0 109.277 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 68' ' ' SER . 26.8 tp -99.49 125.03 42.39 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.2 8.45 4.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.348 2.032 . . . . 0.0 111.785 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.509 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.8 t -104.15 157.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.42 152.71 94.23 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.89 -7.51 18.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.625 2.883 . . . . 0.0 112.398 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.64 -24.56 63.97 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.61 -27.71 69.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.573 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 67' ' ' ARG . 78.2 mt -59.17 -41.0 82.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 C-N-CA 122.168 0.187 . . . . 0.0 110.988 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.92 -47.33 86.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.973 0.892 . . . . 0.0 109.66 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -68.32 -41.78 80.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.174 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.455 HG23 ' HG2' ' A' ' 47' ' ' LYS . 4.1 mt -65.92 -28.56 44.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 C-N-CA 124.128 0.971 . . . . 0.0 113.188 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.36 -37.09 84.5 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.212 0.53 . . . . 0.0 110.343 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.22 -37.06 46.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.219 1.009 . . . . 0.0 108.996 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 99' ' ' VAL . 57.8 t -91.07 17.25 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.287 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.524 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.65 -48.33 69.5 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.23 -48.31 0.6 Allowed Pre-proline 0 C--N 1.293 -1.887 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.392 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 C--N 1.389 2.675 0 C-N-CA 123.687 2.925 . . . . 0.0 115.25 177.804 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 64.6 t60 . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -130.07 139.56 50.95 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 t -107.6 123.53 48.6 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.525 0.679 . . . . 0.0 111.706 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -129.99 -0.48 4.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.419 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p -87.22 101.36 13.44 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.652 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.554 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -97.34 -44.85 6.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' N ' HD22 ' A' ' 6' ' ' LEU . 34.9 tt0 -81.42 -4.8 56.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.316 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -71.04 -24.77 62.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.883 0.849 . . . . 0.0 109.559 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 79' ' ' TYR . 38.5 t80 -78.39 -21.84 48.74 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.828 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.06 -35.29 79.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.89 -14.01 62.31 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -91.95 -46.24 7.93 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.7 m -163.39 -67.69 0.04 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.47 0.653 . . . . 0.0 109.428 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.11 -179.87 20.11 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 16' ' ' TYR . 29.8 tt0 -97.1 177.51 5.57 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 118.243 1.022 . . . . 0.0 108.777 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.563 ' HA ' HG23 ' A' ' 54' ' ' ILE . 18.1 t80 -129.15 14.41 6.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.655 1.217 . . . . 0.0 108.549 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HA ' HD21 ' A' ' 49' ' ' LEU . 5.0 mp0 -132.3 -168.01 1.98 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.489 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.625 HG22 ' HG ' ' A' ' 49' ' ' LEU . 10.9 tt -122.39 45.59 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.375 1.084 . . . . 0.0 110.793 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 56.73 31.07 18.73 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.793 1.237 . . . . 0.0 111.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.505 ' HB2' HD12 ' A' ' 49' ' ' LEU . 91.1 mmm -121.86 -168.37 1.69 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 45.1 mmtm -89.25 138.16 31.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.782 1.628 . . . . 0.0 111.478 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.73 ' HB2' HG22 ' A' ' 48' ' ' ILE . 11.9 ptm180 -107.45 140.63 40.1 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.55 88.79 2.57 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.397 0.618 . . . . 0.0 111.146 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -108.88 78.87 0.24 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.678 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -71.19 -56.83 5.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.781 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 3.2 mmp_? -94.39 -33.17 13.26 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.63 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 25.9 tt0 -82.32 -0.43 45.63 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.975 -177.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 31' ' ' MET . 50.7 t -57.36 -38.15 73.73 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.73 -41.78 82.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.427 0.632 . . . . 0.0 109.335 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -62.5 -41.37 98.78 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.272 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 9.9 ptt? -54.52 -35.11 62.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.257 0.348 . . . . 0.0 111.749 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.697 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 44.9 mm -62.72 -39.44 84.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.421 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.77 -27.27 21.25 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.586 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 38.0 mtpt -59.6 -18.24 39.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.048 0.939 . . . . 0.0 112.126 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -68.6 -14.31 62.93 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.14 -55.55 5.34 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 111.213 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -167.62 -64.38 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 40.5 ptt180 -163.16 124.68 2.47 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.0 t -133.52 151.89 34.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.738 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.4 p -102.06 148.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 123.873 0.733 . . . . 0.0 110.215 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.458 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 78.5 t60 -144.47 143.98 31.14 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.21 146.16 9.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.594 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 49.1 mtmt 65.22 48.51 0.66 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 110.723 -176.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 6.0 Cg_exo -89.1 161.77 5.81 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.62 2.214 . . . . 0.0 111.096 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.519 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -171.75 75.19 0.1 OUTLIER Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.171 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 26.7 tt0 -120.94 123.83 43.43 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.709 0.766 . . . . 0.0 110.244 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 50' ' ' GLY . 2.4 tmtm? -124.03 104.13 8.71 Favored 'General case' 0 N--CA 1.394 -3.273 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.73 HG22 ' HB2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -106.6 130.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.795 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 55.32 15.95 1.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.038 2.135 . . . . 0.0 112.843 176.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.564 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . 81.68 -25.08 4.08 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.043 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.415 ' O ' HD12 ' A' ' 53' ' ' ILE . . . -143.44 145.1 32.34 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -74.57 89.14 2.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 117.754 0.252 . . . . 0.0 111.141 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 55' ' ' GLY . 4.7 mp -116.72 127.92 74.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 16' ' ' TYR . 55.2 mt -91.84 -17.23 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 122.096 0.95 . . . . 0.0 108.653 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 87.43 -17.68 42.22 Favored Glycine 0 CA--C 1.499 -0.923 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.1 mt -119.74 105.27 43.51 Favored Pre-proline 0 N--CA 1.413 -2.32 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 51.7 Cg_exo -53.16 110.31 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.667 2.912 . . . . 0.0 112.462 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 52.7 Cg_endo -95.85 175.29 0.9 Allowed 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.747 2.298 . . . . 0.0 111.741 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.9 t -85.12 106.5 9.05 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.3 100.76 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.373 2.049 . . . . 0.0 113.651 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.8 mt -134.54 86.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.6 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . -136.32 151.33 20.76 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.48 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.05 104.07 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 123.645 0.778 . . . . 0.0 108.931 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.13 99.06 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -76.36 -69.82 0.48 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.522 0.677 . . . . 0.0 109.821 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -163.91 168.4 19.47 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG3' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -81.69 -31.09 32.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.189 0.995 . . . . 0.0 108.432 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' HD3' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -92.17 28.41 1.9 Allowed 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.408 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 m -152.46 166.6 31.45 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 85' ' ' GLU . 18.6 m -76.95 103.59 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 118.979 0.809 . . . . 0.0 110.958 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.65 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 23.5 ptt? -83.43 119.26 24.44 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -108.58 88.48 5.2 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 71' ' ' MET . 12.6 Cg_endo -96.07 167.5 1.24 Allowed 'Trans proline' 0 N--CA 1.403 -3.807 0 C-N-CA 121.973 1.782 . . . . 0.0 111.097 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 73.4 t80 -140.34 113.01 8.05 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.7 p -128.06 139.79 52.33 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -112.31 88.88 11.34 Favored Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.636 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 75' ' ' THR . 73.5 Cg_endo -106.1 -151.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 123.923 3.082 . . . . 0.0 109.808 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.0 t -100.74 13.35 35.2 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.55 ' HD2' ' CE2' ' A' ' 9' ' ' TYR . 48.3 t80 -124.84 -81.55 0.63 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.562 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -174.0 40.63 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 10.2 m -118.75 158.06 26.31 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.33 0.565 . . . . 0.0 110.218 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -114.91 125.43 53.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.4 t -107.34 108.0 24.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 44' ' ' PRO . 29.3 m -114.32 141.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.446 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.484 ' HB2' HG12 ' A' ' 70' ' ' VAL . 38.7 tt0 -134.56 108.57 8.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.0 tp -95.23 129.09 36.29 Favored Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.5 13.51 2.63 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.429 2.086 . . . . 0.0 110.839 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.514 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 21.4 t -115.88 159.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 9.7 t70 -65.66 146.12 99.0 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.542 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 11.3 Cg_endo -54.34 -13.74 5.68 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.84 3.027 . . . . 0.0 113.879 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.4 pt-20 -61.4 -20.69 63.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 92' ' ' GLU . 4.4 tp10 -64.3 -30.53 71.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HG3' ' A' ' 67' ' ' ARG . 48.8 mm -70.04 -31.58 48.21 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.954 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.96 -39.47 94.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -64.97 -48.67 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.463 1.125 . . . . 0.0 108.172 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.1 mt -68.96 -19.58 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.088 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 65.5 tp -77.18 -26.58 53.07 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.019 0.928 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.69 -37.53 59.46 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 56.5 t -62.36 -65.56 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . 59.2 -57.67 0.05 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.732 2.013 . . . . 0.0 114.969 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 32.5 mt-10 -128.06 -69.66 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.134 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.558 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 73.1 Cg_endo . . . . . 0 N--CA 1.437 -1.829 0 CA-C-N 120.681 1.279 . . . . 0.0 112.565 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.622 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 67.1 mtm -152.79 128.54 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m -106.74 111.45 23.98 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.2 m-85 -128.69 10.43 6.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.169 0.509 . . . . 0.0 111.141 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.4 m -131.69 106.93 8.46 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -80.92 -37.47 29.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.121 0.962 . . . . 0.0 111.419 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' H ' HD13 ' A' ' 6' ' ' LEU . 8.3 tp10 -71.38 -19.24 62.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.278 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.535 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.3 m -73.01 -31.96 64.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -70.47 -30.13 66.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.126 0.489 . . . . 0.0 110.092 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.6 -43.64 98.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.81 -11.7 59.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.388 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 8' ' ' THR . 52.5 mt-30 -89.67 -32.83 16.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.6 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -164.5 -67.07 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.47 166.01 38.66 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.85 141.29 56.49 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.716 0.769 . . . . 0.0 111.732 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -139.7 8.38 2.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 54.7 mt-10 -152.86 148.98 27.8 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.34 -1.754 . . . . 0.0 106.741 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.54 HG22 ' HG ' ' A' ' 49' ' ' LEU . 12.4 tt -89.31 159.93 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -72.11 70.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.794 1.283 . . . . 0.0 109.972 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 mmt -136.69 -175.5 4.04 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.901 -1.954 . . . . 0.0 106.139 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 51.4 mttp -84.52 118.19 24.16 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 119.485 1.039 . . . . 0.0 110.997 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.502 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -108.37 136.62 47.69 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.411 -177.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . . . -143.36 96.18 2.87 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -114.48 85.12 0.38 Allowed Glycine 0 N--CA 1.423 -2.176 0 C-N-CA 120.302 -0.951 . . . . 0.0 114.476 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -69.28 -81.03 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 117.105 0.452 . . . . 0.0 112.108 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 20.9 mtp-105 -73.13 -32.95 65.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 13.1 tp10 -70.05 -13.85 62.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.743 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 43.4 t -60.63 -31.9 71.07 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.13 68.5 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.455 0.645 . . . . 0.0 110.204 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.63 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.51 -44.87 81.38 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.379 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.465 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 22.4 ptp -56.32 -31.14 63.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 28' ' ' CYS . 46.7 mm -60.96 -40.74 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.663 0.744 . . . . 0.0 109.531 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HB3' HG21 ' A' ' 39' ' ' VAL . 8.5 mm-40 -80.45 -34.25 36.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.281 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.503 ' HE2' ' O ' ' A' ' 39' ' ' VAL . 74.3 mttt -68.26 -13.54 62.33 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -64.23 -30.55 71.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.484 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.71 -47.06 27.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.626 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.58 -74.3 0.06 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 120.756 0.313 . . . . 0.0 110.595 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 ttp180 -165.82 124.63 1.61 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 58.8 t -136.39 165.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.6 p -112.51 149.35 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.437 0.695 . . . . 0.0 109.901 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.63 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 46.2 t60 -140.74 128.84 22.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.4 mp -98.09 136.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 97.0 mttt 71.78 55.97 0.38 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.868 1.267 . . . . 0.0 110.432 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 85.4 Cg_endo -74.16 135.38 20.71 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.997 1.131 . . . . 0.0 109.716 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.94 46.58 1.08 Allowed Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 4.4 pm0 -112.99 153.21 28.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-O 121.643 0.735 . . . . 0.0 110.696 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -140.97 61.76 1.49 Allowed 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.446 ' C ' HD22 ' A' ' 49' ' ' LEU . 33.7 pt -64.29 105.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.576 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.54 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 70.49 -10.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.965 2.106 . . . . 0.0 113.792 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.84 -1.16 88.03 Favored Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.59 120.79 3.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.721 1.608 . . . . 0.0 107.069 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.93 87.5 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.321 0.582 . . . . 0.0 112.275 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.493 HD12 HG21 ' A' ' 18' ' ' ILE . 61.5 mt -116.54 130.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.1 mm -71.88 -40.87 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.498 0.666 . . . . 0.0 109.597 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.0 0.24 63.87 Favored Glycine 0 C--N 1.308 -0.996 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mt -130.52 129.38 22.75 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.64 107.08 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.333 2.022 . . . . 0.0 110.07 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 36.0 Cg_endo -103.97 -167.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.272 0 C-N-CA 122.566 2.177 . . . . 0.0 111.319 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 75' ' ' THR . 41.3 t -99.16 100.67 10.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 10.3 Cg_endo -87.66 102.59 0.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.721 2.28 . . . . 0.0 113.541 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.53 164.52 34.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 133.13 -175.09 20.3 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.556 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.72 107.04 4.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -99.51 108.62 21.1 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -85.34 -55.93 3.78 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.597 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -171.94 166.8 6.29 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -35.48 74.58 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.597 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 16.0 m -96.37 31.4 2.24 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.608 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -151.43 161.65 42.33 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.448 HG13 ' OE2' ' A' ' 85' ' ' GLU . 9.5 m -77.35 112.77 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.979 0.895 . . . . 0.0 109.865 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.603 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -90.84 123.05 34.08 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.72 89.27 12.85 Favored Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.138 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 71' ' ' MET . 4.9 Cg_exo -85.04 155.94 11.29 Favored 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 121.872 1.714 . . . . 0.0 110.029 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -125.22 75.73 1.48 Allowed 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.553 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 p -106.51 134.62 49.36 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.455 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -110.79 88.81 8.42 Favored Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.875 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 75' ' ' THR . 44.3 Cg_endo -103.38 -159.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.658 2.905 . . . . 0.0 109.797 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 10.1 t -94.58 5.31 52.21 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.448 0.642 . . . . 0.0 109.302 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -120.68 -84.42 0.66 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.152 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -168.8 39.63 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 27.7 m -116.96 147.76 41.99 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.313 0.578 . . . . 0.0 110.08 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.471 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -120.12 121.59 39.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 82.9 t -104.38 104.91 17.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -103.22 133.78 46.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.448 ' OE2' HG13 ' A' ' 70' ' ' VAL . 36.2 tt0 -132.69 115.21 15.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.324 0.583 . . . . 0.0 109.696 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 21.9 tp -99.37 132.99 22.33 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.38 -3.4 10.8 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.311 2.007 . . . . 0.0 111.834 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.602 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.5 t -96.0 164.32 2.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.0 t70 -68.61 146.89 97.93 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 123.208 0.603 . . . . 0.0 110.755 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.04 -10.92 1.24 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 124.134 3.223 . . . . 0.0 114.749 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.1 pt-20 -55.63 -22.61 23.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.279 0.632 . . . . 0.0 110.814 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -58.88 -23.19 60.65 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.864 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 27.2 mm -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -65.15 -37.55 87.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.09 -51.01 66.07 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' A' ' 47' ' ' LYS . 3.0 mt -58.42 -29.58 38.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.451 0 C-N-CA 125.74 1.616 . . . . 0.0 113.028 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.48 -36.68 79.3 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.237 0.542 . . . . 0.0 110.685 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.43 -45.1 10.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.215 1.007 . . . . 0.0 109.878 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.67 13.81 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 125.771 1.628 . . . . 0.0 111.095 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.713 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . . . -63.84 -36.31 83.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 29.2 mt-10 -88.73 -52.54 0.37 Allowed Pre-proline 0 N--CA 1.412 -2.361 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.657 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 32.5 Cg_endo . . . . . 0 N--CA 1.426 -2.491 0 C-N-CA 122.079 1.853 . . . . 0.0 112.353 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 CA--C 1.499 -0.987 0 CA-C-O 120.995 0.426 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.474 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 70.9 mtm -152.0 123.83 7.99 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.3 m -100.61 118.53 36.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 120.4 0.143 . . . . 0.0 111.085 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.8 m-85 -134.74 14.48 3.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.411 0.624 . . . . 0.0 109.535 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.0 m -135.05 102.43 5.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -76.04 -33.3 59.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.387 1.089 . . . . 0.0 111.542 -175.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' OE1' HD13 ' A' ' 10' ' ' LEU . 10.6 tp10 -73.7 -22.16 60.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.77 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -68.61 -30.87 69.69 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.14 -29.18 61.69 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.102 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.49 HD13 ' OE1' ' A' ' 7' ' ' GLU . 8.4 tt -61.9 -45.24 94.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' A' ' 7' ' ' GLU . 67.8 mt-30 -68.34 -35.34 77.63 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.162 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.27 -46.58 76.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.661 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 m -155.33 -67.82 0.12 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.244 0.545 . . . . 0.0 110.647 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.25 166.84 37.27 Favored Glycine 0 N--CA 1.413 -2.865 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.52 143.57 56.09 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-O 121.499 0.666 . . . . 0.0 111.767 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.13 3.85 3.44 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 48.6 mt-10 -151.49 155.54 38.75 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.643 HG22 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -94.88 166.89 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -75.66 72.43 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.406 1.098 . . . . 0.0 109.787 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 mmt -137.89 -176.37 4.41 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.899 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -78.04 111.31 13.8 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 118.784 0.72 . . . . 0.0 109.997 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HB2' ' OE2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -103.72 132.19 50.21 Favored 'General case' 0 N--CA 1.406 -2.632 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.64 98.56 3.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -120.89 86.9 0.4 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.207 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.442 ' CE1' ' HZ ' ' A' ' 4' ' ' PHE . 98.2 m-85 -71.78 -75.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.249 0.547 . . . . 0.0 110.51 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.632 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.2 mmp_? -70.08 -38.24 75.65 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -74.91 -8.74 57.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.987 -176.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.8 t -58.21 -35.14 71.22 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.132 0.491 . . . . 0.0 109.686 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.488 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -68.19 -42.66 79.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.512 0.673 . . . . 0.0 110.219 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -63.67 -49.1 74.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.122 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.5 ptp -57.14 -33.12 67.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 28' ' ' CYS . 47.5 mm -65.15 -39.25 84.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.715 0.769 . . . . 0.0 109.63 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.35 -31.78 43.1 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.62 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.0 mttt -66.4 -21.29 66.22 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -60.98 -25.61 66.97 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.66 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.71 -49.68 24.5 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -166.38 -71.38 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.911 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' THR . 52.2 ttp180 -164.15 111.56 1.11 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.89 150.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.168 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -103.23 148.0 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.625 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 42.2 t60 -133.43 111.96 11.17 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.5 mp -82.77 138.32 19.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.431 ' HA ' HD12 ' A' ' 86' ' ' LEU . 96.1 mttt 69.99 59.23 0.53 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.522 1.129 . . . . 0.0 110.782 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 96.6 Cg_endo -78.95 166.0 23.66 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.059 1.839 . . . . 0.0 111.051 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -162.06 52.41 0.32 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 4.9 pm0 -116.32 151.98 34.78 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.053 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -138.34 60.43 1.61 Allowed 'General case' 0 CA--C 1.468 -2.203 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 175.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.406 ' C ' HD22 ' A' ' 49' ' ' LEU . 40.1 pt -69.27 112.2 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.129 0 CA-C-N 112.187 -2.278 . . . . 0.0 110.407 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.643 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 75.64 -19.33 0.41 Allowed 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.723 2.009 . . . . 0.0 113.139 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.71 -9.9 60.56 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.15 115.82 2.07 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -67.74 123.3 20.14 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -136.8 128.35 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.84 -37.15 60.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.22 -35.65 4.65 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 78' ' ' CYS . 59.0 mt -93.24 120.71 66.53 Favored Pre-proline 0 N--CA 1.417 -2.093 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.49 111.42 2.32 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.176 1.917 . . . . 0.0 110.004 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -101.76 -176.04 0.12 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.556 2.17 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 75' ' ' THR . 52.2 t -79.86 113.96 42.24 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 8.1 Cg_exo -72.96 52.93 2.3 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.13 2.553 . . . . 0.0 115.272 -173.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.4 mt -111.93 154.35 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 150.35 173.6 20.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 119.238 -1.458 . . . . 0.0 113.436 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -122.32 90.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.53 101.22 13.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.52 -70.43 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.626 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -162.62 170.98 17.63 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.1 -29.7 64.35 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.524 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 17.6 m -99.35 27.63 5.08 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.179 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 m -149.02 159.03 44.59 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.3 114.79 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 122.026 0.917 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.615 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -92.88 96.69 10.28 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.64 98.51 9.68 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 71' ' ' MET . 25.0 Cg_endo -92.19 171.19 2.6 Favored 'Trans proline' 1 N--CA 1.398 -4.104 0 C-N-CA 121.671 1.581 . . . . 0.0 112.08 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -124.18 48.05 1.98 Allowed 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.6 p -97.94 111.29 23.65 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-N 113.078 -1.873 . . . . 0.0 108.122 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -103.53 103.64 37.1 Favored Pre-proline 0 C--N 1.29 -2.0 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.858 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 75' ' ' THR . 19.6 Cg_endo -97.31 -164.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.768 0 C-N-CA 122.202 1.934 . . . . 0.0 108.249 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.483 ' H ' HG21 ' A' ' 56' ' ' ILE . 42.6 t -98.6 13.84 30.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.191 0.996 . . . . 0.0 109.065 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -115.02 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.962 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -179.2 164.14 32.14 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 8.4 m -91.29 152.48 20.46 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.07 135.52 53.62 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 t -127.65 131.79 69.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.42 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.3 m -131.45 147.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 40.6 tt0 -149.88 116.82 5.93 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.367 0.417 . . . . 0.0 110.24 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.3 tp -96.45 129.88 32.15 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.35 -8.27 17.28 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.748 1.632 . . . . 0.0 111.588 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.51 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 11.6 t -100.46 156.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.54 151.72 87.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 O-C-N 123.197 0.31 . . . . 0.0 111.699 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.16 -14.35 33.27 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.726 2.951 . . . . 0.0 113.263 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.65 -25.61 62.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.318 0.647 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' ARG . 49.8 mm-40 -75.04 -28.87 60.6 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.257 0.551 . . . . 0.0 110.017 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 48.9 mm -77.42 -27.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.931 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -65.91 -37.01 84.96 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 38.2 ttt180 -65.48 -47.25 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.992 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.66 -21.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.1 -27.08 60.71 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -27.16 61.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 99' ' ' VAL . 43.2 t -102.79 22.46 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.136 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . . . -58.21 -49.58 76.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.46 -42.13 0.41 Allowed Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 C--N 1.386 2.521 0 C-N-CA 123.752 2.968 . . . . 0.0 115.722 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -172.85 136.18 0.68 Allowed 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.977 0.911 . . . . 0.0 109.675 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.5 m -148.62 129.48 14.28 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 61.2 m-85 -116.22 0.73 12.98 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.82 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.2 m -82.31 111.8 18.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.857 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 22' ' ' ARG . 4.5 pp -106.37 -44.73 4.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.766 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.665 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 42.5 tt0 -68.42 -10.77 57.47 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.048 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 p -70.96 -28.36 64.42 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -75.89 -30.33 58.79 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 15' ' ' GLU . 36.5 tp -57.67 -43.39 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.974 0.893 . . . . 0.0 109.325 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -74.04 -12.76 60.71 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.381 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.39 -32.82 10.97 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.055 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -155.43 -66.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 109.844 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.02 162.89 36.68 Favored Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.665 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 9.5 tp10 -83.62 147.99 27.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 117.709 0.755 . . . . 0.0 109.318 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' HG23 ' A' ' 54' ' ' ILE . 66.9 t80 -131.27 18.12 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.055 0.931 . . . . 0.0 109.586 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 19.4 mm-40 -147.26 170.52 17.11 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.606 HG22 ' HG ' ' A' ' 49' ' ' LEU . 16.9 tt -102.69 158.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -75.06 69.87 2.0 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 123.34 1.543 . . . . 0.0 112.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.426 ' O ' HD21 ' A' ' 6' ' ' LEU . 29.9 mmm -128.62 -155.86 0.72 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.55 2.74 . . . . 0.0 106.037 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.24 123.19 47.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.886 0.766 . . . . 0.0 109.314 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -93.92 135.14 35.56 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.16 92.68 3.83 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -111.78 79.01 0.25 Allowed Glycine 0 C--N 1.291 -1.957 0 C-N-CA 118.818 -1.658 . . . . 0.0 112.47 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 95.3 m-85 -73.12 -69.6 0.41 Allowed 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 117.459 0.629 . . . . 0.0 109.311 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.698 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 25.9 mmt180 -80.5 -36.78 32.82 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.288 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 3.5 tm-20 -66.0 -13.05 59.18 Favored 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 31' ' ' MET . 27.2 t -48.68 -40.13 26.98 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.82 0.819 . . . . 0.0 110.287 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -71.71 -42.43 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.728 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.236 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.566 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 27.3 ptt? -51.58 -40.38 59.67 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.799 0.687 . . . . 0.0 111.863 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.3 mm -60.25 -45.02 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 39' ' ' VAL . 19.8 mm-40 -80.8 -30.45 35.91 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.175 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 81' ' ' THR . 28.6 mtpt -61.29 -26.97 68.14 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.348 1.059 . . . . 0.0 112.288 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -66.27 -22.56 66.31 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 123.837 0.71 . . . . 0.0 110.694 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.97 -60.12 2.41 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -144.37 -76.85 0.22 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.106 0.955 . . . . 0.0 109.974 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.2 ptp180 -168.7 124.79 0.96 Allowed 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 33' ' ' GLU . 73.4 t -134.43 145.66 32.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.291 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.4 p -98.5 142.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 O-C-N 124.398 1.061 . . . . 0.0 108.566 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.51 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 84.5 t60 -133.49 120.29 20.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.1 tt -81.33 147.73 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 62.07 56.52 2.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.528 0.731 . . . . 0.0 111.473 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 84.4 Cg_endo -77.37 156.37 32.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.033 1.822 . . . . 0.0 111.152 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.698 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -160.75 56.49 0.32 Allowed Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 2.3 pm0 -115.98 174.38 6.07 Favored 'General case' 0 C--N 1.26 -3.314 0 CA-C-N 113.919 -1.14 . . . . 0.0 110.555 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.514 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.1 mmtt -154.85 89.45 1.24 Allowed 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 126.309 1.844 . . . . 0.0 106.09 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.418 ' C ' HD22 ' A' ' 49' ' ' LEU . 28.8 pt -85.34 100.39 8.45 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.269 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.606 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 58.52 16.59 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.063 1.745 . . . . 0.0 111.967 176.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 -51.74 4.04 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.23 142.68 50.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -70.21 103.4 2.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 18' ' ' ILE . 61.5 mt -123.06 114.59 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.444 HG23 ' CD1' ' A' ' 16' ' ' TYR . 69.3 mt -77.43 -44.45 30.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 122.229 1.014 . . . . 0.0 109.057 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.91 -29.96 9.75 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.427 ' H ' HG22 ' A' ' 54' ' ' ILE . 31.9 mm -86.59 125.64 66.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.58 106.82 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.478 2.119 . . . . 0.0 110.521 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -107.79 -161.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.234 0 C-N-CA 123.002 2.468 . . . . 0.0 111.396 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 75' ' ' THR . 46.8 t -96.35 113.05 61.74 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.34 50.12 1.86 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.524 2.816 . . . . 0.0 114.63 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.58 149.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.37 167.66 36.55 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.747 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -135.4 82.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.22 94.53 9.23 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 8.2 mm-40 -72.19 -62.49 1.41 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.548 -177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.8 179.13 9.5 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -90.98 -33.37 15.58 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.12 40.08 1.01 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.679 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.4 t -165.19 -178.74 5.24 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.58 105.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.555 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 22.8 ptm -89.53 100.87 13.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.9 mt -101.29 100.81 14.49 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.709 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.7 Cg_exo -82.09 148.62 15.21 Favored 'Trans proline' 0 N--CA 1.436 -1.907 0 C-N-CA 122.071 1.847 . . . . 0.0 110.405 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.49 60.39 0.73 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.604 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.1 p -106.39 119.81 40.23 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.145 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.13 101.64 13.19 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 75' ' ' THR . 87.1 Cg_endo -105.07 -156.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 123.198 2.599 . . . . 0.0 111.191 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -109.24 29.13 7.81 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.061 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -144.07 -80.36 0.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.195 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.81 -176.54 46.75 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 51.0 m -118.31 146.95 43.96 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.052 0.926 . . . . 0.0 110.873 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.26 38.5 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 123.372 0.669 . . . . 0.0 111.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 42.6 t -117.97 112.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.1 m -115.01 142.53 27.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 O-C-N 121.486 -0.759 . . . . 0.0 109.247 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 tt0 -139.12 113.79 9.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.284 0.564 . . . . 0.0 110.421 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.3 tp -93.44 130.09 36.62 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.06 19.63 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.624 2.216 . . . . 0.0 111.277 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' SER . 36.5 t -122.34 156.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.01 162.14 41.22 Favored Pre-proline 0 C--N 1.307 -1.255 0 O-C-N 123.487 0.492 . . . . 0.0 111.258 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.2 2.41 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.406 2.737 . . . . 0.0 113.219 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.95 -30.62 70.34 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.834 0.854 . . . . 0.0 109.708 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -66.66 -23.49 66.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.252 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.67 -30.17 41.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.66 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.84 -39.73 94.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.635 ' H ' ' HD2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -76.93 -37.77 54.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.76 -29.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.0 -33.69 76.11 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.6 0.76 . . . . 0.0 109.851 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.61 -24.9 38.78 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.429 1.109 . . . . 0.0 109.049 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -92.61 15.25 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.075 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.514 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.96 -49.8 8.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.542 1.137 . . . . 0.0 113.198 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.05 93.38 3.42 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.355 2.704 . . . . 0.0 112.405 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 . . . . . 0 C--O 1.219 -0.519 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.7 mtt 69.95 112.26 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.075 0.95 . . . . 0.0 109.853 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.42 HG21 ' SD ' ' A' ' 31' ' ' MET . 90.4 m -113.37 128.17 56.37 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.533 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -129.85 21.45 5.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 30.9 m -89.16 87.42 7.16 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.6 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.621 ' H ' HD13 ' A' ' 6' ' ' LEU 0.295 0.0 OUTLIER -84.28 -43.7 14.58 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.43 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 28.3 tt0 -69.75 -4.83 21.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 123.031 1.396 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 29.6 m -76.62 -19.96 57.25 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.617 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.686 ' CD1' ' HA ' ' A' ' 15' ' ' GLU . 2.7 p90 -64.8 -33.11 75.22 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' CE1' ' A' ' 9' ' ' TYR . 10.0 mt -71.41 -35.63 71.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.891 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -76.57 -26.66 55.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.271 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 8' ' ' THR . 45.8 mt-30 -83.38 -14.0 53.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 m 71.25 33.96 1.87 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.495 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.27 90.57 0.2 Allowed Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.879 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.686 ' HA ' ' CD1' ' A' ' 9' ' ' TYR . 3.0 pm0 -59.55 124.35 19.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.984 0.897 . . . . 0.0 111.781 177.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -147.15 9.76 0.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.488 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.575 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 44.9 mt-10 -147.34 179.76 7.42 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.485 -175.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.655 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.288 13.0 tt -109.49 18.43 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-O 121.91 0.862 . . . . 0.0 111.376 178.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.37 36.33 25.41 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.769 1.271 . . . . 0.0 109.701 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.2 mmt -98.46 -96.54 0.22 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.684 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.76 126.9 9.12 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.575 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . 10.7 ptm180 -113.7 154.07 27.92 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -134.98 89.39 2.52 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . -106.72 82.0 0.31 Allowed Glycine 0 CA--C 1.486 -1.76 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.335 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -70.95 -70.14 0.33 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.651 0.263 . . . . 0.0 111.339 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 51.1 mtt180 -87.61 -30.54 20.39 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.322 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 10.5 mt-10 -75.22 -3.75 34.93 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 28.0 p -53.14 -37.15 61.55 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 121.419 0.628 . . . . 0.0 110.455 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.59 -41.09 63.33 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.149 0.5 . . . . 0.0 110.443 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.65 68.6 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.063 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.42 ' SD ' HG21 ' A' ' 3' ' ' THR . 26.2 ptm -51.8 -38.49 55.88 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.763 0.664 . . . . 0.0 112.619 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 28' ' ' CYS . 76.7 mt -57.51 -49.52 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 123.923 0.764 . . . . 0.0 110.567 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 39' ' ' VAL . 38.7 mt-10 -82.79 -26.96 31.3 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.888 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 81' ' ' THR . 14.2 mtpp -58.58 -21.64 53.67 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 123.965 0.906 . . . . 0.0 112.29 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -58.44 -22.76 55.5 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.858 0.724 . . . . 0.0 111.398 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.62 1.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -166.24 -59.64 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -155.31 121.03 5.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 33' ' ' GLU . 77.5 t -128.61 145.13 36.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 2.7 p -96.73 137.59 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 O-C-N 123.858 0.723 . . . . 0.0 110.053 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -139.84 129.43 24.36 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.1 tt -90.26 145.04 7.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 53.0 mtmt 67.54 61.97 0.77 Allowed Pre-proline 0 C--O 1.217 -0.636 0 C-N-CA 123.351 0.66 . . . . 0.0 110.992 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 69.6 Cg_endo -81.14 173.03 12.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.584 2.189 . . . . 0.0 112.19 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.8 55.86 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.134 -1.031 . . . . 0.0 112.258 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 29.5 tt0 -121.98 137.56 54.75 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.626 0.727 . . . . 0.0 111.856 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 6.1 mmtt -126.51 111.03 13.92 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.604 ' HB ' HD22 ' A' ' 49' ' ' LEU . 29.2 pt -100.2 122.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.553 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.655 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 54.51 16.42 1.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.014 2.126 . . . . 0.0 113.74 175.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 100' ' ' ALA . . . 83.81 -44.89 3.38 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.006 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.84 125.2 42.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG3' HD11 ' A' ' 48' ' ' ILE . 55.8 ttp180 -67.56 98.82 0.7 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 123.639 0.587 . . . . 0.0 111.173 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.69 123.5 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mm -83.35 -37.68 13.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.894 0.854 . . . . 0.0 109.207 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.43 -7.96 66.41 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.562 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.2 mm -135.3 132.47 20.03 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 51.5 Cg_exo -55.78 109.45 0.42 Allowed 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 123.204 2.603 . . . . 0.0 112.175 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 6.9 Cg_endo -87.67 161.27 7.82 Favored 'Trans proline' 0 N--CA 1.427 -2.404 0 C-N-CA 122.388 2.059 . . . . 0.0 110.938 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.71 139.17 95.38 Favored Pre-proline 0 C--N 1.301 -1.505 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.095 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.79 34.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.523 3.262 1 C-N-CA 127.349 5.366 . . . . 0.0 119.656 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' HA ' HG23 ' A' ' 75' ' ' THR 0.27 2.8 pt 67.78 -171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 127.676 2.39 . . . . 0.0 112.602 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' H ' ' A' ' 74' ' ' TYR . . . -143.63 -113.2 0.9 Allowed Glycine 1 N--CA 1.388 -4.525 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.296 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.38 122.94 64.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 71' ' ' MET . 4.0 p-10 -130.27 125.43 34.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -100.54 -63.72 1.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.1 tp10 -165.33 168.58 16.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -31.7 67.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 8.5 p -93.34 30.88 1.59 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.323 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.416 ' CA ' ' HG3' ' A' ' 85' ' ' GLU . 31.4 m -156.99 161.0 39.57 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 m -71.08 145.02 12.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.29 0.567 . . . . 0.0 110.216 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 83' ' ' VAL . 25.2 ptt? -134.73 139.2 45.01 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.87 80.32 25.26 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.464 ' O ' HG21 ' A' ' 81' ' ' THR . 1.3 Cg_endo -81.86 132.06 7.35 Favored 'Trans proline' 0 N--CA 1.414 -3.198 0 C-N-CA 121.587 1.525 . . . . 0.0 109.981 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.514 ' H ' ' N ' ' A' ' 62' ' ' GLY . 79.2 m-85 -91.9 57.89 3.27 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-O 122.268 1.033 . . . . 0.0 108.705 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 61' ' ' ILE . 36.7 p -103.92 102.66 12.46 Favored 'General case' 1 N--CA 1.376 -4.157 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -95.29 106.9 28.97 Favored Pre-proline 0 C--N 1.277 -2.587 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.249 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 75' ' ' THR . 22.6 Cg_endo -95.26 -165.53 0.11 Allowed 'Trans proline' 0 N--CA 1.431 -2.167 0 C-N-CA 122.704 2.27 . . . . 0.0 110.471 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.3 t -95.77 15.7 19.48 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.637 0.732 . . . . 0.0 109.131 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -135.56 -62.95 0.68 Allowed 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 166.28 148.27 5.5 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.186 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.634 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -84.61 158.3 20.92 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 124.879 1.272 . . . . 0.0 108.678 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . . . -122.36 120.68 34.72 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.879 -0.513 . . . . 0.0 111.063 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 95.4 t -103.31 84.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 44' ' ' PRO . 12.4 m -108.45 124.71 65.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.416 ' HG3' ' CA ' ' A' ' 69' ' ' THR . 43.4 tt0 -118.43 120.75 38.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.126 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.4 tp -96.65 130.77 29.58 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.09 -4.13 11.81 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.214 1.943 . . . . 0.0 111.142 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.537 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 12.0 t -97.64 161.66 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 91' ' ' GLU . 11.7 m-20 -72.44 163.66 65.88 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 118.096 0.407 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.79 6.2 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 89' ' ' ASP . 11.2 pt-20 -67.38 -27.17 66.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.813 0.845 . . . . 0.0 109.016 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.4 mm-40 -64.2 -29.27 70.39 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.083 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 mt -64.35 -28.45 44.91 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.661 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.62 -47.29 70.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.365 0.602 . . . . 0.0 109.602 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -66.78 -32.04 73.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.411 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 92' ' ' GLU . 69.1 mt -86.28 -5.63 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-O 121.879 0.847 . . . . 0.0 110.107 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.78 -33.49 30.85 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.03 -32.79 71.11 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.785 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' VAL . 18.9 t -107.03 28.35 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.448 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.581 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.588 ' HB1' ' HA2' ' A' ' 50' ' ' GLY . . . -59.67 -31.29 69.41 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.446 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 37.0 tt0 -157.27 -57.78 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.58 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 92.8 Cg_endo . . . . . 0 N--CA 1.442 -1.557 0 C-N-CA 120.942 1.095 . . . . 0.0 113.228 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.402 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 63.6 m-70 . . . . . 0 CA--C 1.505 -0.788 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -174.95 126.74 0.28 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.875 1.27 . . . . 0.0 109.146 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.534 HG21 ' SD ' ' A' ' 31' ' ' MET . 11.9 t -124.47 134.45 53.05 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.73 0.776 . . . . 0.0 110.855 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.08 26.11 4.57 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.916 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.477 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 65.3 m -126.51 101.1 6.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.689 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.567 ' CD2' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -84.96 -46.03 11.63 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.969 0.89 . . . . 0.0 113.031 -176.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' H ' HD13 ' A' ' 6' ' ' LEU . 42.0 tt0 -73.18 -12.29 60.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.118 0.961 . . . . 0.0 110.95 -175.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 24.2 m -73.58 -26.2 60.71 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.986 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -72.64 -32.96 66.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.99 -41.7 99.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 11.3 mm-40 -67.78 -27.7 66.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.13 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 8' ' ' THR . 28.1 mt-30 -78.41 -45.86 21.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.659 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.431 ' OG ' ' HD2' ' A' ' 35' ' ' LYS . 45.1 m -158.68 -68.29 0.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.899 0.38 . . . . 0.0 111.367 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.04 174.33 31.06 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.358 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.02 146.16 24.56 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 124.295 0.644 . . . . 0.0 109.725 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.425 ' HA ' HG23 ' A' ' 54' ' ' ILE . 40.8 t80 -139.59 21.48 2.53 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.635 ' HB3' HD21 ' A' ' 49' ' ' LEU . 38.7 mp0 -140.97 175.84 9.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.091 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.702 HG22 HD22 ' A' ' 49' ' ' LEU . 7.0 tt -109.47 7.04 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.047 -1.033 . . . . 0.0 109.079 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 65.2 t-80 74.7 73.97 0.11 Allowed 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.829 1.651 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.522 ' HB3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.0 179.49 9.17 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' N ' ' SD ' ' A' ' 20' ' ' MET . 86.2 mttt -61.46 111.06 1.64 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.967 0.889 . . . . 0.0 109.883 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.762 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.2 119.24 38.58 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.389 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.3 85.99 2.49 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.676 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.76 81.66 0.48 Allowed Glycine 0 CA--C 1.469 -2.803 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.289 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -69.89 -78.73 0.07 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 117.119 0.459 . . . . 0.0 110.314 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -84.04 -21.04 31.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.958 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.619 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -81.51 -10.72 59.41 Favored 'General case' 0 C--O 1.205 -1.263 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.48 -177.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 53.7 t -51.97 -38.15 55.59 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.569 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.01 -44.59 69.0 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.179 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -58.85 -52.44 65.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.965 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 3' ' ' THR . 21.6 ptp -54.07 -38.2 65.04 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.864 0.728 . . . . 0.0 112.779 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 28' ' ' CYS . 80.3 mt -58.96 -45.02 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.682 0.753 . . . . 0.0 109.524 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 39' ' ' VAL . 61.7 mm-40 -79.85 -32.2 40.49 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.617 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 84.1 mttt -58.42 -28.5 65.31 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 122.924 0.49 . . . . 0.0 111.165 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 8.1 ttpp -64.66 -13.39 53.82 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.049 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -65.52 0.92 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -142.85 -75.22 0.27 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.721 0.772 . . . . 0.0 109.687 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.48 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 36.3 ptt180 -156.3 128.15 7.35 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 33' ' ' GLU . 69.6 t -140.08 141.64 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.526 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.5 p -106.94 147.06 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 19.8 t-80 -135.56 134.21 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 20.7 tt -90.48 143.65 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 86' ' ' LEU . 61.7 mttp 67.41 64.01 0.72 Allowed Pre-proline 0 C--N 1.32 -0.714 0 C-N-CA 123.822 0.849 . . . . 0.0 110.642 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.38 172.12 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.205 1.27 . . . . 0.0 110.233 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.21 54.43 0.13 Allowed Glycine 0 CA--C 1.464 -3.152 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.619 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 1.6 pm0 -112.35 157.84 20.52 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 122.366 1.079 . . . . 0.0 112.414 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -143.86 72.4 1.35 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 113.479 -1.692 . . . . 0.0 107.577 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.618 HG22 ' HG ' ' A' ' 49' ' ' LEU . 72.0 mt -91.58 108.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.702 HD22 HG22 ' A' ' 18' ' ' ILE . 0.9 OUTLIER 66.01 16.93 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.96 1.304 . . . . 0.0 109.381 177.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.19 4.5 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -175.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.18 118.3 25.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -64.32 104.39 0.76 Allowed 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.131 0.894 . . . . 0.0 112.716 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 49' ' ' LEU . 49.6 mm -114.66 135.13 55.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.425 HG23 ' HA ' ' A' ' 16' ' ' TYR . 60.2 mt -75.49 -35.36 32.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-O 121.233 0.539 . . . . 0.0 110.0 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.51 -21.73 20.34 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.25 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.62 120.26 56.42 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.42 112.55 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.968 2.445 . . . . 0.0 111.327 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -101.39 -176.61 0.13 Allowed 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 122.615 2.21 . . . . 0.0 111.081 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.3 t -67.57 121.02 77.35 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.05 56.02 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 114.745 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.4 147.66 32.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 155.5 148.15 4.94 Favored Glycine 0 CA--C 1.483 -1.933 0 C-N-CA 118.539 -1.791 . . . . 0.0 113.52 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.3 pt -129.12 153.19 38.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.02 115.29 20.31 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.99 -71.97 0.44 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.242 0.544 . . . . 0.0 111.902 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 31.0 tt0 -148.36 166.12 29.02 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 5.7 tpp180 -83.22 -35.43 25.41 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.058 0.933 . . . . 0.0 110.551 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.7 p -88.66 29.96 0.96 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.775 1.274 . . . . 0.0 111.514 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 66' ' ' GLU . 87.5 m -154.72 170.72 20.91 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 85' ' ' GLU . 27.1 m -78.93 161.01 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.202 1.001 . . . . 0.0 111.117 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.547 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 26.8 ptt? -118.4 131.38 56.29 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.11 88.35 14.71 Favored Pre-proline 0 C--N 1.291 -1.961 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.343 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 71' ' ' MET . 6.4 Cg_endo -90.53 144.28 3.81 Favored 'Trans proline' 0 N--CA 1.408 -3.534 0 C-N-CA 121.545 1.496 . . . . 0.0 109.966 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -110.87 46.32 1.07 Allowed 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 123.298 1.523 . . . . 0.0 107.405 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 39.6 p -93.26 105.57 17.63 Favored 'General case' 0 N--CA 1.389 -3.498 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.163 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -105.78 96.61 12.85 Favored Pre-proline 0 C--N 1.275 -2.634 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 75' ' ' THR . 23.7 Cg_endo -99.0 -164.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.365 2.71 . . . . 0.0 111.166 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.5 t -88.72 -6.16 57.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.362 0.601 . . . . 0.0 110.058 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -96.32 -74.22 0.57 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 171.26 172.08 37.07 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 28.0 m -94.5 141.73 28.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.63 125.58 52.74 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.29 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 41.7 t -126.47 124.69 65.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.2 m -126.71 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.442 ' HB2' HG12 ' A' ' 70' ' ' VAL . 52.5 tt0 -134.31 123.12 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' SER . 28.4 tp -103.05 128.18 28.22 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.84 1.78 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.69 1.593 . . . . 0.0 110.698 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.548 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -103.59 158.27 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.98 151.13 81.22 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 123.203 0.314 . . . . 0.0 110.671 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 11.6 Cg_endo -56.13 -22.03 37.92 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.686 2.924 . . . . 0.0 112.997 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.84 -23.11 60.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.681 0.792 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 96' ' ' ILE . 8.4 tp10 -69.18 -43.59 73.91 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.42 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 58.4 mt -71.17 -27.0 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.73 -37.64 76.59 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -67.98 -36.36 79.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.631 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 92' ' ' GLU . 37.3 mm -72.65 -17.82 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.961 177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.72 -20.86 58.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.106 0.955 . . . . 0.0 108.715 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.19 -25.96 42.68 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.02 14.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.406 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.21 49.77 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.74 -50.65 0.15 Allowed Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.432 -2.114 0 C-N-CA 121.087 1.191 . . . . 0.0 112.664 -178.648 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 85.2 m-70 . . . . . 0 C--O 1.215 -0.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -139.59 129.63 25.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -121.61 117.09 25.85 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -126.08 2.26 7.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.571 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.428 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 61.0 m -86.48 92.19 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.571 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.661 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -85.6 -34.65 21.37 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -81.12 -16.92 51.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.942 0.877 . . . . 0.0 110.931 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.3 m -69.79 -22.29 63.34 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -78.33 -20.12 52.09 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.661 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.1 tt -72.91 -37.87 67.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.79 -30.43 69.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.366 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -94.18 -5.49 46.94 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.926 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m 60.33 43.29 13.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.125 0.964 . . . . 0.0 110.305 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.48 49.97 0.65 Allowed Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.532 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.26 138.83 54.26 Favored 'General case' 0 C--O 1.248 1.007 0 O-C-N 124.61 0.829 . . . . 0.0 110.783 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -143.55 20.35 1.86 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -154.97 179.75 8.83 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.806 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.622 ' H ' HD21 ' A' ' 49' ' ' LEU 0.329 13.5 tt -107.31 29.48 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.973 178.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.661 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 43.5 m80 61.99 17.84 9.36 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.423 ' HB2' HD12 ' A' ' 49' ' ' LEU . 60.6 mmm -85.57 -110.79 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.015 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.6 tttp -129.09 115.0 17.06 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -109.15 162.32 14.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.377 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -156.71 87.69 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -103.82 81.01 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 115.154 0.821 . . . . 0.0 115.154 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -77.47 -39.35 46.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.562 0.696 . . . . 0.0 111.177 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.518 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 38.2 mmt180 -107.78 -41.05 5.1 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.712 0.768 . . . . 0.0 111.241 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 26.3 tt0 -78.88 -0.04 29.17 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.103 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 39.4 t -52.58 -47.16 67.05 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 109.728 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -68.88 -38.8 79.9 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.754 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -58.78 -44.74 90.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.701 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.7 ptm -65.02 -33.26 75.61 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.554 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.1 -38.61 82.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 34.8 mt-10 -77.7 -38.25 47.77 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.667 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 31' ' ' MET . 78.7 mttt -63.51 -20.01 65.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.462 0.705 . . . . 0.0 111.771 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -67.4 -20.42 65.53 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.504 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.57 -62.17 1.67 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.62 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 2.2 mmp_? -159.82 -67.14 0.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.577 1.151 . . . . 0.0 109.824 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.591 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 19.0 ptt180 -155.12 122.19 5.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.75 145.11 28.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.5 p -108.89 142.38 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 19.4 t60 -135.06 130.8 36.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.6 tt -82.82 144.17 10.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 94.8 mttt 63.82 63.11 1.48 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.148 0.579 . . . . 0.0 110.717 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 63.4 Cg_endo -80.32 170.7 15.82 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.969 1.78 . . . . 0.0 111.767 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -175.06 54.0 0.13 Allowed Glycine 0 N--CA 1.409 -3.102 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.441 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 7.6 tp10 -110.44 118.39 36.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.507 1.146 . . . . 0.0 108.841 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 34.0 mtmt -110.17 71.44 0.76 Allowed 'General case' 0 N--CA 1.393 -3.309 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.136 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.541 ' HB ' HD22 ' A' ' 49' ' ' LEU . 5.0 pt -70.92 102.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.25 -3.74 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.923 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.622 HD21 ' H ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 69.72 -26.12 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 126.823 2.049 . . . . 0.0 113.621 175.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.91 -3.36 48.62 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.71 116.18 11.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -69.73 88.17 0.52 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 mm -123.73 127.38 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -76.39 -28.86 18.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.548 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.43 17.59 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.3 mt -99.88 121.67 53.45 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.65 107.65 0.91 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.773 2.315 . . . . 0.0 110.92 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -104.8 179.92 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 122.68 2.253 . . . . 0.0 111.752 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' THR . 51.3 t -84.87 106.73 9.35 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 75' ' ' THR . 89.9 Cg_endo -84.41 98.78 0.74 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.234 1.956 . . . . 0.0 114.554 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.49 158.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 130.12 167.18 11.99 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 118.577 -1.773 . . . . 0.0 113.769 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.2 mp -142.63 124.35 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.43 101.76 12.27 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.74 -55.65 16.16 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.55 171.41 7.61 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HA ' HH11 ' A' ' 67' ' ' ARG . 3.4 tpp180 -85.68 -35.99 20.54 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 118.881 0.764 . . . . 0.0 112.113 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 9.4 t -91.03 28.32 1.62 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 122.96 1.362 . . . . 0.0 108.569 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' ARG . 24.8 m -143.21 163.93 31.59 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 17.1 m -72.88 124.01 28.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.332 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.509 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.9 ptt? -85.32 132.19 34.29 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.4 tp -116.02 80.92 9.53 Favored Pre-proline 0 C--N 1.293 -1.884 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.667 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 9.5 Cg_endo -89.58 104.8 0.37 Allowed 'Trans proline' 0 N--CA 1.409 -3.456 0 C-N-CA 121.971 1.781 . . . . 0.0 108.707 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.26 57.28 4.39 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.114 1.435 . . . . 0.0 107.374 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.634 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.2 p -91.17 127.86 36.77 Favored 'General case' 1 N--CA 1.378 -4.064 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.58 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -99.49 95.97 4.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.4 Cg_endo -105.29 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.787 0 C-N-CA 122.974 2.449 . . . . 0.0 111.281 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.6 t -95.87 12.08 31.47 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -117.74 -80.83 0.61 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.068 -0.395 . . . . 0.0 110.339 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.72 176.35 47.99 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.591 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 29.2 m -94.7 135.14 36.53 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.447 0.641 . . . . 0.0 109.401 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.52 112.38 23.89 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.949 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 33.9 t -115.34 134.61 57.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.453 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 15.8 m -136.26 151.08 28.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -142.13 122.12 13.67 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.4 tp -104.13 139.05 19.73 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 5.7 Cg_exo -86.14 2.1 7.56 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 122.616 2.211 . . . . 0.0 111.69 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.59 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 9.9 t -103.14 150.84 6.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.44 144.32 92.28 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 124.14 0.9 . . . . 0.0 110.163 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.4 -18.67 3.84 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.61 3.54 . . . . 0.0 114.385 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.51 -18.38 51.52 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.642 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 25.6 tp10 -60.24 -28.03 67.7 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 124.187 0.995 . . . . 0.0 109.575 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.75 -38.37 75.65 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.121 0 C-N-CA 122.155 0.182 . . . . 0.0 111.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.46 -33.64 75.54 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.406 0.622 . . . . 0.0 110.768 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 63.4 ttt180 -71.49 -45.58 62.1 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 ' HG2' ' A' ' 47' ' ' LYS . 14.8 mm -65.64 -22.5 30.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.189 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.0 tp -74.21 -30.07 62.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.154 0.502 . . . . 0.0 109.792 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.21 -41.74 27.62 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.65 15.66 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.996 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -67.14 -33.53 75.63 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.25 98.06 21.56 Favored Pre-proline 0 N--CA 1.416 -2.136 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.555 2.837 . . . . 0.0 111.269 177.716 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 CA--C 1.498 -1.04 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.41 ' SD ' ' HE2' ' A' ' 4' ' ' PHE . 26.0 ptt? -179.97 133.22 0.1 Allowed 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.238 1.415 . . . . 0.0 108.762 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.4 m -132.16 122.82 25.93 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HE2' ' SD ' ' A' ' 2' ' ' MET . 88.6 m-85 -116.85 -8.99 11.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.976 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 76.5 m -80.0 100.8 8.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.807 0.813 . . . . 0.0 110.793 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.668 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -88.32 -38.13 15.41 Favored 'General case' 0 C--O 1.182 -2.461 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 30.3 tt0 -68.82 -9.45 51.24 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.817 0.818 . . . . 0.0 111.871 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.487 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.4 m -75.38 -15.17 60.49 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.104 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.661 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.71 -28.4 67.29 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.409 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.661 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 6.1 tt -70.23 -39.05 75.31 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.055 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -76.36 -1.79 28.58 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.714 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.97 -28.71 5.47 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -163.58 -54.13 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.442 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.32 -153.91 24.71 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HB2' HG12 ' A' ' 56' ' ' ILE . 2.2 mp0 -80.63 137.33 36.34 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 118.994 1.397 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.471 ' HA ' HG23 ' A' ' 54' ' ' ILE . 34.9 t80 -142.31 3.28 1.52 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.591 0.71 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB3' HD21 ' A' ' 49' ' ' LEU . 18.4 mm-40 -150.69 176.94 10.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.593 HG22 ' HG ' ' A' ' 49' ' ' LEU . 11.7 tt -110.35 157.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.484 ' HA ' HD21 ' A' ' 6' ' ' LEU . 6.5 t60 -71.53 71.9 0.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.472 1.13 . . . . 0.0 108.987 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.4 mmt -138.68 -167.41 2.19 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.089 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.72 113.28 22.44 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -100.75 130.31 46.76 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -124.08 85.17 2.37 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.513 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -99.58 75.92 0.48 Allowed Glycine 0 C--N 1.282 -2.442 0 C-N-CA 119.399 -1.382 . . . . 0.0 111.013 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.85 -79.87 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 121.35 0.595 . . . . 0.0 110.629 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.511 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 5.6 mpt_? -75.7 -35.83 60.19 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.006 0.432 . . . . 0.0 111.688 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 18.0 tp10 -66.28 -11.37 50.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.002 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 36.3 t -51.01 -41.75 59.99 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.477 0.656 . . . . 0.0 110.274 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.03 -43.1 75.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.075 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.695 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.28 -45.64 79.77 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.1 ptp -56.64 -33.11 66.0 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.519 0.512 . . . . 0.0 111.726 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 28' ' ' CYS . 51.2 mm -62.97 -36.34 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.434 0.635 . . . . 0.0 110.023 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -78.35 -33.63 48.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HE2' ' O ' ' A' ' 39' ' ' VAL . 60.7 mttt -67.42 -9.49 42.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.719 1.208 . . . . 0.0 113.391 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -69.49 -22.93 63.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.35 -65.01 0.75 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -152.45 -67.7 0.16 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.1 ttp180 -165.82 115.43 1.0 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.468 0.707 . . . . 0.0 109.413 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.554 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 44.3 t -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -112.68 149.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.695 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 32.5 t-80 -138.28 119.5 14.62 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.4 tt -83.31 147.44 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 94.3 mttt 68.61 51.59 0.49 Allowed Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.699 0.799 . . . . 0.0 112.039 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 96.4 Cg_endo -90.18 159.58 4.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.418 2.079 . . . . 0.0 110.608 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.511 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -151.66 44.9 0.64 Allowed Glycine 0 CA--C 1.467 -2.951 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 4.2 pm0 -97.76 156.86 16.37 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-O 122.627 1.204 . . . . 0.0 113.304 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 0.5 OUTLIER -145.19 86.85 1.79 Allowed 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.363 175.176 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 48' ' ' ILE . 2.6 pt -87.24 99.9 9.18 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 113.471 -1.695 . . . . 0.0 112.313 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.593 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 66.88 4.5 3.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.976 2.11 . . . . 0.0 114.098 175.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.56 -21.42 5.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.142 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.74 30.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' CZ ' HD12 ' A' ' 48' ' ' ILE . 21.8 tpt180 -86.58 105.93 17.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.63 136.91 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.471 HG23 ' HA ' ' A' ' 16' ' ' TYR . 45.4 mm -99.1 -40.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.531 0.681 . . . . 0.0 109.588 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.83 -26.37 22.61 Favored Glycine 0 C--N 1.312 -0.756 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 15' ' ' GLU . 36.6 mm -111.69 109.79 55.35 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.89 109.25 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.995 2.463 . . . . 0.0 111.723 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -101.95 -163.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.415 2.743 . . . . 0.0 109.919 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 75' ' ' THR . 86.6 t -73.47 118.95 73.15 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.13 40.86 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.118 2.545 . . . . 0.0 114.541 -172.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 65.1 mt -116.31 149.52 18.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . 166.5 138.35 2.42 Favored Glycine 0 C--N 1.305 -1.186 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.894 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.51 114.14 41.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 122.706 0.402 . . . . 0.0 110.661 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.43 106.2 18.24 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.73 -64.24 1.04 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 68' ' ' SER . 3.7 tm-20 -166.94 179.94 5.0 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -176.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.445 HH22 ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.04 -40.09 14.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 119.045 0.839 . . . . 0.0 109.437 -176.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.677 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.6 t -89.39 26.76 1.59 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.695 1.236 . . . . 0.0 109.511 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.9 m -144.28 160.93 40.16 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 85' ' ' GLU . 17.3 m -77.72 144.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 122.676 0.39 . . . . 0.0 110.335 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.617 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 27.1 ptt? -99.93 136.7 39.45 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.9 mm -109.05 89.19 6.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 71' ' ' MET . 2.5 Cg_endo -88.1 146.9 6.59 Favored 'Trans proline' 0 N--CA 1.427 -2.439 0 C-N-CA 122.126 1.884 . . . . 0.0 111.737 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 67.7 m-85 -123.25 44.27 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.579 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 41.4 p -100.86 111.41 23.62 Favored 'General case' 0 N--CA 1.4 -2.961 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.103 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -100.74 97.2 6.37 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 75' ' ' THR . 97.2 Cg_endo -103.98 -165.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.04 2.493 . . . . 0.0 111.593 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.6 t -74.04 -21.57 59.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.504 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -95.84 -84.7 0.34 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.734 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.97 -179.67 45.7 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 9.8 m -106.4 145.58 31.56 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -119.34 121.88 40.56 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -175.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 56.3 t -110.02 120.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 27' ' ' GLU . 35.4 m -113.49 143.77 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.9 tt0 -148.65 115.78 6.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.216 0.462 . . . . 0.0 110.224 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 68' ' ' SER . 29.5 tp -94.84 143.33 25.98 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -93.39 -2.55 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.621 1.547 . . . . 0.0 110.971 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.606 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 23.7 t -91.49 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.19 149.3 75.96 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 124.166 0.916 . . . . 0.0 112.792 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.69 -6.17 4.21 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.838 3.025 . . . . 0.0 113.351 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.56 -27.3 66.11 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.274 0.559 . . . . 0.0 109.504 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -60.07 -26.82 66.47 Favored 'General case' 0 C--O 1.204 -1.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.163 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.3 mt -56.87 -40.12 69.45 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.809 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.633 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.46 -47.67 85.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.645 0.736 . . . . 0.0 109.795 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -64.95 -44.13 90.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.451 HG22 ' HE2' ' A' ' 47' ' ' LYS . 73.7 mt -69.6 -28.29 37.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.613 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.1 tp -70.77 -29.6 65.86 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 123.313 0.645 . . . . 0.0 110.173 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -32.25 51.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.7 15.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.355 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.69 -47.89 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.747 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -135.6 87.93 25.28 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 C--O 1.257 1.432 0 C-N-CA 123.262 2.641 . . . . 0.0 112.347 -178.318 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 65.7 mtm -156.11 124.7 5.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -102.04 113.59 26.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 64.9 m-85 -127.96 12.5 6.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.799 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 74.0 m -140.66 102.68 4.36 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -77.23 -36.45 54.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 111.419 -175.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.424 ' H ' HD13 ' A' ' 6' ' ' LEU . 10.1 tp10 -71.09 -25.56 62.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.691 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -77.99 -24.34 48.03 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -24.17 60.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 110.232 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.51 -43.63 98.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -69.42 -35.76 76.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.226 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.31 -35.42 66.08 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.435 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -161.81 -54.92 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.243 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.7 173.47 37.22 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.3 141.22 38.64 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.489 0.662 . . . . 0.0 111.73 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' HG23 ' A' ' 54' ' ' ILE . 88.5 t80 -137.66 4.86 2.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 44.7 mt-10 -149.79 146.33 27.11 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.572 HG22 ' HG ' ' A' ' 49' ' ' LEU . 15.3 tt -85.1 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.561 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -68.59 77.17 0.28 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 122.724 1.25 . . . . 0.0 110.483 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.418 ' CE ' ' HA ' ' A' ' 20' ' ' MET . 2.0 mmt -146.15 -174.39 4.42 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.39 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 10.5 mtmp? -88.5 114.72 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.164 0.893 . . . . 0.0 110.874 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.605 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -102.98 152.53 21.21 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.124 -175.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.08 77.75 1.32 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.616 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -97.68 82.35 0.68 Allowed Glycine 0 C--N 1.294 -1.789 0 C-N-CA 121.02 -0.609 . . . . 0.0 114.052 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -70.18 -82.52 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 117.352 0.576 . . . . 0.0 111.652 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.559 ' HB2' ' H ' ' A' ' 45' ' ' GLY . 2.5 mmp_? -70.39 -36.72 74.25 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 2.7 tp10 -69.35 -12.64 61.83 Favored 'General case' 0 C--O 1.217 -0.647 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.219 -177.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 44.4 t -60.9 -34.19 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-O 121.218 0.532 . . . . 0.0 110.009 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -70.53 -41.64 72.27 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.788 0.804 . . . . 0.0 109.398 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -64.23 -47.73 78.56 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.106 -1.407 . . . . 0.0 113.077 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.509 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 ptp -56.12 -31.64 63.47 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.577 0.548 . . . . 0.0 112.272 -176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 28' ' ' CYS . 48.6 mm -59.65 -42.84 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 122.08 0.943 . . . . 0.0 109.078 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.87 -34.34 30.12 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.547 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 31' ' ' MET . 72.2 mttt -65.92 -12.91 58.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.702 0.801 . . . . 0.0 111.927 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.11 -24.83 62.37 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.816 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.67 -53.14 36.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.107 0.48 . . . . 0.0 110.718 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -166.9 -69.97 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' THR . 58.3 ttp180 -162.12 123.63 2.71 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 84.4 t -134.66 159.95 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.7 p -105.96 143.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.488 0.715 . . . . 0.0 109.596 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.562 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 62.3 t60 -135.01 123.34 23.14 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 2.6 mp -89.7 142.42 12.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 99.2 mttt 71.62 43.35 0.2 Allowed Pre-proline 0 C--O 1.21 -1.019 0 C-N-CA 124.11 0.964 . . . . 0.0 112.545 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 9.8 Cg_endo -75.42 143.04 27.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 CA-C-N 120.786 1.316 . . . . 0.0 110.783 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 26' ' ' ARG . . . -144.03 54.29 0.58 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 10.0 pm0 -101.1 129.48 46.99 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.19 0.995 . . . . 0.0 110.125 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 43.1 mtmt -118.84 69.99 0.82 Allowed 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.407 ' C ' HD22 ' A' ' 49' ' ' LEU . 39.1 pt -86.57 109.7 19.25 Favored 'Isoleucine or valine' 1 C--N 1.222 -4.936 0 CA-C-N 111.317 -2.674 . . . . 0.0 112.329 -175.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.572 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 65.7 -3.1 0.76 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.936 2.095 . . . . 0.0 113.863 175.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.04 -25.66 13.53 Favored Glycine 0 C--N 1.293 -1.82 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.23 19.33 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 52' ' ' ARG . 2.2 ptm180 -71.39 103.05 2.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.735 0.779 . . . . 0.0 111.646 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 55' ' ' GLY . 55.9 mt -128.0 132.17 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 16' ' ' TYR . 49.4 mm -73.45 -27.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.99 0.9 . . . . 0.0 108.888 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 53' ' ' ILE . . . 97.23 -28.1 15.51 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 78' ' ' CYS . 62.4 mt -105.54 114.99 62.56 Favored Pre-proline 0 N--CA 1.416 -2.159 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.85 107.27 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.605 2.203 . . . . 0.0 110.518 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -95.96 -174.99 0.29 Allowed 'Trans proline' 0 N--CA 1.426 -2.441 0 C-N-CA 122.671 2.247 . . . . 0.0 111.663 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.7 t -68.86 116.48 41.65 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.81 70.52 7.38 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.002 1.801 . . . . 0.0 113.293 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -130.71 145.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 156.94 153.67 6.75 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 118.98 -1.581 . . . . 0.0 113.67 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.75 103.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.65 108.97 20.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.2 -69.8 0.53 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.418 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.514 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -153.21 164.92 37.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -80.76 -31.69 35.81 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.022 0.915 . . . . 0.0 108.602 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.514 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 11.1 p -94.86 38.48 1.12 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.4 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -161.75 171.22 18.21 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.44 161.21 4.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.69 0.757 . . . . 0.0 109.714 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.644 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 16.1 ptp -140.09 118.0 11.78 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -106.65 94.59 10.46 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-O 121.137 0.494 . . . . 0.0 109.913 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 71' ' ' MET . 9.6 Cg_endo -92.2 164.99 3.08 Favored 'Trans proline' 0 N--CA 1.412 -3.296 0 C-N-CA 122.103 1.869 . . . . 0.0 110.8 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -129.1 58.81 1.59 Allowed 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.558 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 27.2 p -100.42 110.11 22.29 Favored 'General case' 0 N--CA 1.386 -3.644 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.149 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -105.19 100.65 26.27 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.8 Cg_endo -104.74 -159.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 123.092 2.528 . . . . 0.0 108.41 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.439 ' HB3' HD13 ' A' ' 56' ' ' ILE . 50.3 t -83.02 -9.04 59.47 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.062 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.34 -79.59 0.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.796 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 176.45 -172.23 45.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.8 m -112.7 149.18 33.27 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 117.452 0.626 . . . . 0.0 109.422 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.84 47.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 59.0 t -109.82 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG12 ' OE2' ' A' ' 27' ' ' GLU . 2.6 m -102.2 155.27 4.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -155.0 108.83 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.1 tp -97.61 128.97 32.7 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.15 22.55 0.94 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.542 2.161 . . . . 0.0 111.412 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 68' ' ' SER . 14.6 t -130.5 151.7 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.84 152.55 82.39 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 38.4 Cg_endo -65.41 -4.19 8.97 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.736 2.957 . . . . 0.0 112.656 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.64 -29.91 70.37 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -66.1 -25.16 66.88 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.056 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.37 -35.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 O-C-N 123.074 0.234 . . . . 0.0 110.681 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.81 -43.77 97.93 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -43.5 83.55 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.629 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.88 -21.88 24.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 123.397 0.679 . . . . 0.0 111.099 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -74.06 -27.29 60.85 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.259 0.552 . . . . 0.0 109.808 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.5 -41.61 14.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.989 0.9 . . . . 0.0 108.63 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.6 t -82.45 7.86 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.987 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -52.91 -60.59 3.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.497 1.119 . . . . 0.0 113.813 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.01 -47.91 0.33 Allowed Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.426 -2.451 0 C-N-CA 121.583 1.522 . . . . 0.0 112.507 177.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 p80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -174.01 135.6 0.49 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.3 m -134.14 124.16 25.6 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . 74.0 m-85 -121.55 3.32 10.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.83 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.2 m -95.75 101.74 13.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.306 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 7' ' ' GLU . 1.6 pp -92.3 -29.71 16.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.797 0.808 . . . . 0.0 112.263 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' HD12 ' A' ' 6' ' ' LEU . 35.2 tt0 -68.97 -24.51 64.26 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.158 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.8 m -66.44 -32.48 73.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.022 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.74 -28.95 60.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.889 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tt -69.52 -35.13 75.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -66.8 -38.06 85.76 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.624 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 8' ' ' THR . 89.0 mt-30 -73.72 -3.12 26.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.056 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m 67.48 13.5 9.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.107 1.363 . . . . 0.0 111.783 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.84 59.74 0.36 Allowed Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.67 127.49 31.53 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.244 -0.978 . . . . 0.0 110.613 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -145.77 10.73 1.22 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 27.8 mt-10 -148.0 176.65 10.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.809 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.494 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.6 tt -127.33 161.02 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -67.31 73.36 0.13 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.359 1.076 . . . . 0.0 111.111 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.43 ' HB2' HD12 ' A' ' 49' ' ' LEU . 81.9 mtp -130.1 -121.79 0.22 Allowed 'General case' 0 C--N 1.266 -3.055 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.169 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 11.0 tmtt? -147.18 122.89 10.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HD2' ' OE1' ' A' ' 17' ' ' GLU . 14.1 ptm180 -104.11 167.33 9.83 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -152.58 79.25 1.22 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 46' ' ' GLU . . . -109.32 82.84 0.31 Allowed Glycine 0 CA--C 1.471 -2.714 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -72.22 -63.45 1.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.939 0.876 . . . . 0.0 109.251 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.619 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 29.2 mmt180 -84.12 -38.81 20.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.906 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 29.2 mt-10 -74.84 -1.86 24.14 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 31' ' ' MET . 41.5 t -51.21 -45.15 61.78 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.08 -41.22 74.39 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.59 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.4 -47.19 87.15 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 124.165 0.986 . . . . 0.0 113.152 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -56.83 -38.67 72.95 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.414 0.446 . . . . 0.0 111.345 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.65 -39.05 80.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.747 0.784 . . . . 0.0 109.604 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' HG11 ' A' ' 39' ' ' VAL . 13.7 mm-40 -75.11 -42.74 55.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.63 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.5 mttt -63.58 -20.03 65.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.543 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -67.28 -26.52 66.58 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.552 0.533 . . . . 0.0 110.306 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -53.15 32.34 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.866 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -162.43 -70.84 0.05 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.559 0.695 . . . . 0.0 110.052 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.3 ttt180 -163.28 117.67 1.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 33' ' ' GLU . 55.4 t -137.15 144.03 33.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.593 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -97.22 145.81 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.482 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 74.0 t60 -138.93 121.45 16.19 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 61.6 mt -79.42 138.06 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 64.6 mttm 74.68 65.88 0.27 Allowed Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.692 1.245 . . . . 0.0 109.22 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 48.6 Cg_endo -88.38 166.17 6.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.224 1.949 . . . . 0.0 111.767 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 27' ' ' GLU . . . -179.79 55.61 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.794 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 7.1 tp10 -122.12 145.22 48.38 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.66 0.784 . . . . 0.0 109.958 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 4.5 mmpt? -140.46 80.98 1.78 Allowed 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 50' ' ' GLY . 23.8 pt -71.75 105.14 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.323 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 68.52 -23.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.756 2.022 . . . . 0.0 113.996 175.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.16 -30.43 10.4 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -176.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.01 142.98 50.25 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.25 97.7 9.72 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.389 -1.325 . . . . 0.0 113.386 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.02 117.83 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.28 -37.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 120.968 0.413 . . . . 0.0 111.344 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.98 -0.97 70.01 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.28 130.45 16.04 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -53.89 107.46 0.21 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.366 2.711 . . . . 0.0 112.903 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -114.33 -169.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 123.324 2.682 . . . . 0.0 112.63 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.11 107.95 51.23 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.648 ' HA ' HG22 ' A' ' 75' ' ' THR . 32.5 Cg_exo -61.26 118.42 5.29 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.23 2.62 . . . . 0.0 111.964 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.6 mm -128.54 100.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . -118.18 81.1 0.32 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.51 112.97 38.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 4.8 p-10 -126.03 127.28 45.61 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.12 -48.21 10.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.8 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.5 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 21.7 tt0 -170.16 167.17 8.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 6.7 tpt85 -76.58 -29.66 56.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.801 0.334 . . . . 0.0 111.059 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.5 ' HB3' ' OE1' ' A' ' 66' ' ' GLU . 33.1 t -99.24 33.74 2.34 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.897 1.332 . . . . 0.0 108.558 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -148.75 162.53 39.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.93 124.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 122.137 0.97 . . . . 0.0 112.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.54 ' HE3' ' HA ' ' A' ' 67' ' ' ARG . 16.7 ptp -134.72 152.05 51.46 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.407 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.412 HG12 HG22 ' A' ' 83' ' ' VAL . 59.9 mt -121.65 90.47 48.15 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 42.2 Cg_endo -105.02 44.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.052 2.501 . . . . 0.0 113.437 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.74 -103.4 0.14 Allowed 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 121.526 0.679 . . . . 0.0 112.012 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 60' ' ' PRO . 3.0 p -162.18 179.66 7.75 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.973 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.71 85.02 43.87 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -103.59 -167.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 123.086 2.524 . . . . 0.0 113.896 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.67 -22.12 60.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.008 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -75.59 -68.79 0.53 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.578 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 170.4 163.72 24.91 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 38' ' ' ARG . 6.5 m -91.73 151.18 20.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -127.23 126.08 42.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 t -118.21 129.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.478 HG12 ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -122.72 142.37 39.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.7 tt0 -142.83 122.17 13.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 25.0 tp -99.78 137.06 20.12 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.54 -5.74 7.16 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.153 1.902 . . . . 0.0 111.53 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.643 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.0 t -99.01 163.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.9 t70 -65.32 144.91 99.11 Favored Pre-proline 0 C--N 1.304 -1.396 0 C-N-CA 123.153 0.581 . . . . 0.0 110.214 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.72 -9.58 0.15 Allowed 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 124.034 3.156 . . . . 0.0 115.404 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 9.9 pt-20 -59.43 -18.7 41.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.12 0.568 . . . . 0.0 111.411 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 96' ' ' ILE . 13.3 mm-40 -61.27 -19.91 62.26 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.24 -36.96 77.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.564 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.89 -39.22 88.46 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 109.609 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -69.37 -47.01 65.57 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.445 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 92' ' ' GLU . 44.3 mm -73.34 -10.13 13.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.824 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.65 -31.4 32.36 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.45 -34.28 54.49 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 99' ' ' VAL . 41.3 t -100.72 29.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.574 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.61 -20.71 64.51 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.659 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.497 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.6 mt-10 -139.89 -59.47 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 52.5 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 C-N-CA 121.415 1.41 . . . . 0.0 113.858 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.421 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.8 ptp -171.44 130.8 0.72 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.315 0.646 . . . . 0.0 110.016 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -120.96 126.54 50.21 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.597 0.713 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CE1' ' HA ' ' A' ' 23' ' ' ALA . 91.7 m-85 -133.25 22.05 4.06 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.63 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 7.7 p -103.44 78.46 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.089 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 22' ' ' ARG . 5.2 tt -70.68 -54.28 12.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.085 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -75.96 3.95 9.23 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.7 1.238 . . . . 0.0 111.802 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 5' ' ' CYS . 9.0 m -87.44 -2.24 58.48 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.541 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -64.68 -17.92 64.52 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.111 176.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.541 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 4.8 tt -76.12 -35.55 59.24 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.45 -30.47 68.39 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 108.073 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 9' ' ' TYR . 45.5 mt-30 -78.39 -14.63 59.31 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.575 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.7 t 67.03 30.75 7.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.22 1.008 . . . . 0.0 109.833 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.79 88.66 0.11 Allowed Glycine 0 N--CA 1.417 -2.608 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.186 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.47 132.67 54.63 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.645 ' HA ' HG23 ' A' ' 54' ' ' ILE . 48.2 t80 -139.44 12.06 2.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.509 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 6' ' ' LEU . 41.4 mt-10 -146.46 176.21 9.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.705 HG22 ' HG ' ' A' ' 49' ' ' LEU . 11.2 tp -118.9 154.5 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -69.71 74.55 0.42 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.968 1.366 . . . . 0.0 111.387 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.3 mmm -132.51 -145.8 0.27 Allowed 'General case' 0 C--N 1.269 -2.897 0 C-N-CA 127.235 2.214 . . . . 0.0 107.371 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HE3' ' HG2' ' A' ' 101' ' ' GLU . 56.7 mtmt -119.45 129.54 54.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 119.202 0.91 . . . . 0.0 110.471 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.591 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -105.8 175.18 5.58 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB2' ' CG ' ' A' ' 102' ' ' PRO . . . -163.59 76.89 0.39 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.822 0.701 . . . . 0.0 111.901 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 46' ' ' GLU . . . -90.9 74.46 1.69 Allowed Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.674 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.1 -68.19 0.58 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.559 0.695 . . . . 0.0 110.357 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.627 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 32.3 mmt180 -75.33 -44.18 46.68 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.896 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 24.8 mt-10 -77.62 2.59 16.11 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.2 t -50.41 -44.34 55.06 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.89 -34.07 57.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.464 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' C ' ' HD3' ' A' ' 34' ' ' LYS . . . -61.4 -48.79 79.62 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.456 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.9 ptp -59.89 -33.85 72.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.907 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.747 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 81.3 mt -62.94 -34.24 65.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.51 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.04 -31.78 21.79 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.042 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.7 mtpt -59.09 -16.8 21.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.893 0.877 . . . . 0.0 111.877 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 22.3 ptmt -77.4 -16.0 59.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.455 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.4 72.31 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.347 -0.221 . . . . 0.0 111.524 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 177.17 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' THR . 41.5 ttp180 -156.78 116.87 3.55 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -133.1 146.06 33.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.664 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -93.4 137.81 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 124.119 0.887 . . . . 0.0 109.017 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.417 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 27.7 t60 -139.1 125.79 20.74 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.82 140.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 62.5 mttp 69.23 65.67 0.5 Allowed Pre-proline 0 C--O 1.22 -0.467 0 C-N-CA 124.24 1.016 . . . . 0.0 110.2 -175.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 44.3 Cg_endo -88.35 161.48 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.802 2.335 . . . . 0.0 112.91 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.594 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 177.69 62.64 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 16.1 tt0 -118.21 101.29 8.1 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 124.147 0.979 . . . . 0.0 108.667 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -95.43 91.39 6.18 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.002 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 22' ' ' ARG . 42.1 pt -92.13 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.246 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.705 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 68.32 -1.99 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.139 1.776 . . . . 0.0 112.818 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.95 -33.16 4.32 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.27 122.41 37.68 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HD3' HD11 ' A' ' 48' ' ' ILE . 19.1 tpp180 -64.65 100.2 0.37 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.795 0.684 . . . . 0.0 110.409 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.509 HD12 HG21 ' A' ' 18' ' ' ILE . 60.2 mt -121.47 131.1 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.645 HG23 ' HA ' ' A' ' 16' ' ' TYR . 57.9 mt -99.15 -31.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.666 0.746 . . . . 0.0 109.822 -177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.48 15.48 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.34 117.04 43.66 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.19 112.11 3.24 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.806 2.338 . . . . 0.0 113.514 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 3.1 Cg_endo -91.92 -171.35 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.924 2.416 . . . . 0.0 108.838 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.587 ' HB ' ' CB ' ' A' ' 75' ' ' THR . 80.9 t -82.2 132.85 52.05 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.1 Cg_endo -81.6 70.59 7.23 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.557 1.504 . . . . 0.0 113.827 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.14 91.67 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.94 103.25 3.02 Favored Glycine 0 N--CA 1.414 -2.827 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.815 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.8 mt -102.35 76.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -110.94 118.83 37.17 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.164 0.507 . . . . 0.0 110.081 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -90.18 -57.15 2.95 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.373 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.639 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -162.54 167.61 23.11 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.409 HH11 HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.63 -27.41 34.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.639 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 20.8 t -94.09 30.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 123.058 1.409 . . . . 0.0 108.952 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.7 m -153.85 162.93 40.82 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -63.64 131.25 29.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.765 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.4 ptp -126.99 124.33 39.17 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 83' ' ' VAL . 23.7 mt -114.1 96.79 43.32 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.24 148.89 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.851 1.7 . . . . 0.0 113.04 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 58' ' ' PRO . 73.4 m-85 75.57 -155.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 125.088 1.355 . . . . 0.0 110.681 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.587 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 97.4 m -145.61 -75.51 0.22 Allowed 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HG2' HG22 ' A' ' 75' ' ' THR . 73.1 mmtt -129.53 90.87 42.68 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.433 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HB3' HD13 ' A' ' 54' ' ' ILE . 4.7 Cg_exo -85.85 -171.03 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.671 2.247 . . . . 0.0 110.837 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 41.2 t -81.53 -34.45 31.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.473 0.654 . . . . 0.0 110.465 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -89.3 -68.55 0.77 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -177.1 169.93 42.41 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.9 m -98.42 152.52 19.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.94 149.9 42.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.8 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.5 t -134.43 98.67 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 19.9 m -113.48 135.96 51.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.32 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -135.82 124.94 24.42 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.979 0.418 . . . . 0.0 110.184 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.0 tp -101.34 125.83 36.52 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.93 13.41 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.484 2.122 . . . . 0.0 111.05 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.556 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 18.3 t -113.71 151.91 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 25.7 m-20 -61.95 154.85 66.32 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 124.08 0.952 . . . . 0.0 111.309 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.29 -17.09 24.85 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.723 2.949 . . . . 0.0 113.367 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.8 pt-20 -63.41 -16.79 61.56 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.516 0.726 . . . . 0.0 111.222 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.14 -19.78 63.2 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 93' ' ' ILE . 26.3 mm -66.42 -28.31 43.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.308 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.48 -42.66 92.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.326 0.584 . . . . 0.0 109.749 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.51 -50.24 70.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.654 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -68.14 -20.06 25.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.452 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 tp -70.91 -28.67 64.7 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.285 0.634 . . . . 0.0 110.0 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.95 -32.25 61.69 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.3 t -83.58 -3.07 7.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.67 -35.17 60.76 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.272 0.629 . . . . 0.0 112.534 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.412 ' HG2' ' HE3' ' A' ' 21' ' ' LYS . 32.7 tt0 -149.39 93.94 4.0 Favored Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.548 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 23.1 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 123.25 2.634 . . . . 0.0 112.422 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 m80 . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.764 0.316 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.578 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 72.0 mtm -147.53 123.18 10.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.9 m -98.77 114.43 26.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.794 0.33 . . . . 0.0 111.04 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.9 m-85 -129.28 14.41 6.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.455 0.645 . . . . 0.0 109.306 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.5 m -135.53 102.85 5.25 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -78.56 -33.95 47.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.079 0.942 . . . . 0.0 111.956 -175.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.84 -20.99 60.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.88 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 14.6 m -70.68 -35.15 72.67 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -70.29 -27.3 64.3 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.454 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.14 -51.12 70.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.85 -27.85 66.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.01 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 8' ' ' THR . 53.2 mt-30 -77.35 -44.74 28.37 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.662 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -148.37 -50.76 0.17 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.289 0.566 . . . . 0.0 110.904 -176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.43 163.28 19.8 Favored Glycine 0 N--CA 1.422 -2.26 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.24 139.2 58.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.389 0.614 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -132.22 2.94 3.95 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 55.5 mt-10 -149.95 143.68 25.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.666 HG22 ' HG ' ' A' ' 49' ' ' LEU . 13.8 tt -81.63 163.74 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.0 72.32 1.63 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.635 1.207 . . . . 0.0 109.646 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.9 mmt -140.51 -176.06 4.5 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.246 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -81.11 116.67 21.14 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 119.284 0.947 . . . . 0.0 111.243 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -106.94 134.75 49.62 Favored 'General case' 0 N--CA 1.4 -2.95 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.39 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.41 79.88 1.79 Allowed 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.62 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.24 80.81 0.49 Allowed Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.859 -175.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -68.94 -79.44 0.06 Allowed 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 117.045 0.422 . . . . 0.0 111.585 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 19.9 mtp-105 -75.33 -31.24 60.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.917 -1.113 . . . . 0.0 113.435 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 9.0 tp10 -70.9 -12.64 61.66 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 109.665 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.3 t -60.73 -32.24 71.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -69.04 -45.49 70.3 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.435 0.635 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -67.55 -42.53 82.52 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.872 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -57.26 -32.34 66.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.584 0.23 . . . . 0.0 111.38 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 28' ' ' CYS . 50.0 mm -62.31 -40.3 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.52 -36.77 52.15 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.733 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HE2' ' H ' ' A' ' 83' ' ' VAL . 72.4 mttt -65.04 -15.22 62.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.755 0.822 . . . . 0.0 112.533 -178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -67.95 -23.98 65.12 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.636 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.15 -39.76 68.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.334 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 178.35 -68.76 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.761 0.824 . . . . 0.0 109.413 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.0 ttp180 -163.51 124.01 2.25 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 86.5 t -138.29 157.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -107.76 149.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.472 0.709 . . . . 0.0 109.991 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 51.6 t60 -135.62 128.02 30.37 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.413 HG22 ' HG3' ' A' ' 43' ' ' LYS . 3.2 mp -96.8 136.54 27.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 98.9 mttt 70.48 53.89 0.42 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.58 1.152 . . . . 0.0 111.294 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 65.3 Cg_endo -70.58 144.55 49.96 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 121.161 1.241 . . . . 0.0 109.981 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.29 47.7 0.97 Allowed Glycine 0 CA--C 1.474 -2.489 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 10.2 pm0 -105.98 148.47 27.66 Favored 'General case' 0 N--CA 1.396 -3.159 0 CA-C-O 121.945 0.879 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 51.4 mtmt -134.75 80.85 1.87 Allowed 'General case' 0 CA--C 1.454 -2.742 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.433 ' C ' HD22 ' A' ' 49' ' ' LEU . 34.6 pt -95.89 104.35 15.74 Favored 'Isoleucine or valine' 1 C--N 1.221 -4.98 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.148 -175.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 59.03 6.01 0.61 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 126.733 2.013 . . . . 0.0 113.728 175.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.5 -3.46 67.89 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.84 131.83 4.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -76.86 86.33 3.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.443 HD12 HG21 ' A' ' 18' ' ' ILE . 57.3 mt -108.39 127.17 64.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.24 -39.28 64.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.82 9.57 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.431 HD13 ' HB3' ' A' ' 78' ' ' CYS . 58.8 mt -102.96 120.83 51.19 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.85 107.39 0.17 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 123.257 2.638 . . . . 0.0 112.74 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -97.26 137.02 0.44 Allowed 'Trans proline' 0 N--CA 1.424 -2.587 0 C-N-CA 122.573 2.182 . . . . 0.0 111.693 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -67.63 114.03 17.5 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.24 88.01 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.397 2.065 . . . . 0.0 114.418 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 74' ' ' TYR . 73.0 mt -122.89 146.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 142.47 -174.84 23.21 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.829 -2.129 . . . . 0.0 114.547 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.16 102.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.17 105.38 17.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.82 -69.91 0.55 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.523 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.74 167.78 12.93 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -34.23 77.36 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 124.785 1.234 . . . . 0.0 107.844 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -99.46 32.16 2.89 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.385 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -151.72 160.46 43.59 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.435 HG13 ' OE2' ' A' ' 85' ' ' GLU . 5.3 m -77.8 119.79 27.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.893 0.854 . . . . 0.0 110.735 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.669 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.0 ptp -98.49 111.59 23.9 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.72 92.55 7.46 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 71' ' ' MET . 30.4 Cg_endo -100.9 178.04 0.23 Allowed 'Trans proline' 0 N--CA 1.406 -3.63 0 C-N-CA 121.799 1.666 . . . . 0.0 112.489 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 43.0 t80 -135.42 81.7 1.91 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.581 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 22.5 p -97.24 139.24 33.51 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.871 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -111.56 88.1 8.86 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.448 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 75' ' ' THR . 58.0 Cg_endo -107.68 -153.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 123.914 3.076 . . . . 0.0 108.454 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.431 ' HB3' HD13 ' A' ' 56' ' ' ILE . 21.7 t -110.65 11.01 22.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -118.1 -82.26 0.63 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.951 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.87 -174.55 45.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 37.1 m -109.78 148.26 31.78 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.77 135.53 55.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.9 t -121.43 108.65 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 20.2 m -108.24 129.65 62.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' HG13 ' A' ' 70' ' ' VAL . 39.8 tt0 -132.6 117.67 18.23 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.598 0.636 . . . . 0.0 110.821 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 19.8 tp -99.75 134.76 20.81 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.18 -3.1 9.53 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.328 2.019 . . . . 0.0 111.734 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -94.76 157.95 3.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 18.0 t70 -65.07 146.29 98.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 122.476 0.31 . . . . 0.0 111.512 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -50.98 -10.93 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.215 3.277 . . . . 0.0 114.788 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 7.9 pt-20 -57.29 -23.13 46.45 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 120.964 0.411 . . . . 0.0 110.438 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -59.74 -26.85 66.0 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.494 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 93' ' ' ILE . 20.0 mm -67.89 -33.71 63.03 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 C-N-CA 121.398 -0.121 . . . . 0.0 110.796 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.33 -43.16 99.47 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -64.74 -51.02 64.58 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.719 -1.582 . . . . 0.0 109.01 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.8 mt -64.59 -25.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 124.003 0.921 . . . . 0.0 112.453 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.67 -39.89 94.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.174 0.511 . . . . 0.0 109.797 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -86.63 -41.31 14.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.942 0.877 . . . . 0.0 110.09 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.42 2.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.458 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -47.74 -48.67 29.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -176.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.65 -47.15 0.48 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 N--CA 1.434 -2.025 0 CA-C-N 120.224 1.116 . . . . 0.0 112.019 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.496 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.3 mpp? -151.77 132.57 14.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -127.77 115.39 18.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 84.2 m-85 -125.39 -5.0 7.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 48.0 m -77.69 90.07 3.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.212 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 20' ' ' MET 0.251 0.0 OUTLIER -79.17 -50.35 11.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.685 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' HD22 ' A' ' 6' ' ' LEU . 1.2 tt0 -76.75 -8.5 57.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.755 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 65.6 m -69.61 -26.36 64.4 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 54.2 m-85 -75.38 -23.21 57.07 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 4.4 tt -70.11 -40.05 75.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -68.3 -23.72 64.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.966 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.58 5.62 45.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.012 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m 60.9 31.4 19.99 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.523 0.729 . . . . 0.0 111.937 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . -145.72 67.61 0.41 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.67 145.47 53.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.255 0.55 . . . . 0.0 111.337 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -145.66 27.79 1.2 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' HD11 ' A' ' 49' ' ' LEU . 1.6 pm0 -155.99 171.77 19.53 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.406 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.556 HG22 ' HG ' ' A' ' 49' ' ' LEU . 8.7 tt -105.5 16.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.758 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 71.7 m80 65.31 69.09 0.48 Allowed 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 122.522 1.153 . . . . 0.0 110.471 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.719 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.7 tmm? -148.97 -168.69 3.17 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 63.5 tttp -75.76 112.36 12.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 119.66 1.118 . . . . 0.0 110.986 -177.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -106.8 161.07 15.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . . . -160.24 91.09 0.92 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.23 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.41 89.59 0.59 Allowed Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.94 -67.36 0.71 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.155 0.979 . . . . 0.0 109.279 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.8 mmt180 -81.42 -34.76 31.34 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.023 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 21.1 tt0 -80.31 -5.01 55.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.097 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 12.4 t -49.42 -46.28 47.43 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.274 0.559 . . . . 0.0 109.553 174.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.16 75.72 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.556 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.7 -47.32 86.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.02 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.518 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.0 ptm -61.02 -35.25 76.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.23 -42.87 91.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.338 0.589 . . . . 0.0 109.923 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -77.73 -35.13 52.26 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.898 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 31' ' ' MET . 82.1 mttt -57.9 -24.8 59.33 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 0.0 112.39 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.34 -21.78 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.331 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.59 77.77 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.644 0.259 . . . . 0.0 110.596 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -175.36 -69.44 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.336 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.539 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.4 ptt180 -151.15 123.58 8.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.0 t -138.07 141.43 38.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.78 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.6 p -108.82 143.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 52.0 t60 -133.81 130.49 38.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 15.7 tt -83.87 141.49 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.5 mttt 68.14 64.62 0.63 Allowed Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 0.0 110.781 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.47 171.1 16.37 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.927 1.751 . . . . 0.0 111.483 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.489 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -174.5 50.35 0.14 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.957 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.8 tp10 -119.09 144.47 46.59 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HB2' ' HZ2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -139.68 81.6 1.83 Allowed 'General case' 0 CA--C 1.444 -3.118 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.571 ' HB ' HD22 ' A' ' 49' ' ' LEU . 9.6 pt -72.72 110.05 5.48 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.444 0 CA-C-N 111.677 -2.511 . . . . 0.0 109.903 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER 62.11 14.74 6.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 125.84 1.656 . . . . 0.0 112.398 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 -41.07 2.6 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.53 121.41 41.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HA ' HG13 ' A' ' 48' ' ' ILE . 56.7 ttp180 -62.52 92.48 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 124.506 1.122 . . . . 0.0 113.011 -177.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.5 mm -124.26 132.73 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.3 mt -79.99 -29.36 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.504 0.668 . . . . 0.0 109.851 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 17' ' ' GLU . . . 82.6 5.72 89.22 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.943 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.462 HD13 ' H ' ' A' ' 78' ' ' CYS . 70.6 mt -126.72 122.14 23.44 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -65.18 107.87 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.192 1.928 . . . . 0.0 109.783 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -110.26 -172.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.132 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.0 t -73.67 116.85 55.77 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.26 39.19 0.52 Allowed 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 123.583 2.855 . . . . 0.0 115.6 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.73 141.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 165.09 129.65 1.06 Allowed Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 117.979 -2.058 . . . . 0.0 113.635 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 146.96 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -121.76 93.58 4.04 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.69 -64.34 0.88 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.265 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 1.5 tm-20 -159.78 169.92 22.6 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.53 ' HB2' HD11 ' A' ' 93' ' ' ILE . 5.0 tpp180 -87.1 -38.6 16.33 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.279 0.561 . . . . 0.0 112.351 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 18.5 t -91.23 29.9 1.35 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 122.994 1.378 . . . . 0.0 107.924 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 67' ' ' ARG . 16.9 m -145.65 170.02 17.3 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.58 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.468 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.3 ptt? -115.78 142.96 46.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.4 tp -114.34 80.44 5.89 Favored Pre-proline 0 C--N 1.292 -1.905 0 C-N-CA 119.655 -0.818 . . . . 0.0 113.12 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 3.0 Cg_exo -84.82 98.64 0.7 Allowed 'Trans proline' 0 N--CA 1.425 -2.503 0 C-N-CA 121.932 1.754 . . . . 0.0 107.72 176.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -88.92 67.65 8.24 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 123.046 1.403 . . . . 0.0 108.865 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.525 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 18.8 p -104.59 138.94 40.19 Favored 'General case' 1 N--CA 1.366 -4.665 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.618 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.17 92.52 9.61 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.564 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.3 Cg_endo -101.76 -165.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 122.93 2.42 . . . . 0.0 110.828 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.462 ' H ' HD13 ' A' ' 56' ' ' ILE . 44.1 t -93.24 0.74 57.16 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -108.29 -78.48 0.59 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.256 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.21 178.35 46.83 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 71.3 m -93.1 131.61 37.98 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.54 116.85 32.74 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.871 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 39.0 t -120.85 133.31 67.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.49 144.29 35.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 38.7 tt0 -137.73 125.82 22.91 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.549 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 26.3 tp -101.16 138.24 19.91 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.76 -3.95 11.32 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 121.82 1.68 . . . . 0.0 111.568 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.549 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 40.1 t -103.63 159.06 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.422 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 7.5 m-20 -63.59 158.68 57.67 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 123.637 0.585 . . . . 0.0 110.909 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.33 -9.87 7.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.895 3.063 . . . . 0.0 113.636 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.7 pt-20 -56.57 -25.64 52.94 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 110.487 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.2 tp10 -63.82 -31.51 72.72 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 67' ' ' ARG . 65.5 mt -60.12 -42.58 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.44 0.296 . . . . 0.0 110.8 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.17 -36.9 85.68 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.313 0.578 . . . . 0.0 110.397 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.455 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 43.2 ttt180 -71.71 -42.3 67.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.256 1.027 . . . . 0.0 108.257 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.2 mm -65.46 -17.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 125.347 1.459 . . . . 0.0 110.908 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -78.38 -28.39 47.01 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -82.14 -43.92 17.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 59.1 t -79.35 11.61 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.98 -50.94 67.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.779 0.832 . . . . 0.0 110.23 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.52 92.51 47.75 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.861 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 123.753 2.969 . . . . 0.0 110.849 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.572 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HD11 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.527 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.632 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 20' ' ' MET . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' ILE . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.528 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.825 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 96' ' ' ILE . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG22 ' HB2' ' A' ' 22' ' ' ARG . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' HB2' ' A' ' 20' ' ' MET . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.467 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.61 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.657 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 67' ' ' ARG . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.491 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.693 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.697 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.683 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HB ' HD22 ' A' ' 49' ' ' LEU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.616 HD22 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 75' ' ' THR . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.534 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 73' ' ' PRO . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -170.92 130.4 0.79 Allowed 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 125.712 1.605 . . . . 0.0 107.77 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.433 HG21 ' SD ' ' A' ' 31' ' ' MET . 9.9 t -114.57 129.01 56.63 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.94 0.876 . . . . 0.0 112.124 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -130.87 25.39 4.99 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.669 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 82.4 m -129.89 99.99 5.3 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -80.63 -45.17 17.7 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' N ' HD22 ' A' ' 6' ' ' LEU . 41.8 tt0 -74.55 -2.84 27.65 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.155 0.979 . . . . 0.0 111.863 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 49.9 m -76.84 -26.64 54.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.85 -24.15 58.54 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.26 -20.12 62.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.102 0.953 . . . . 0.0 108.924 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -91.14 9.53 30.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.857 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -128.97 -46.45 1.25 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.597 0.713 . . . . 0.0 109.349 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 m -153.67 -155.66 0.61 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.56 166.01 53.24 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -81.35 147.25 29.94 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.541 ' HA ' HG23 ' A' ' 54' ' ' ILE . 61.1 t80 -126.88 22.63 6.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 122.652 1.215 . . . . 0.0 108.348 -176.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HB3' HD21 ' A' ' 49' ' ' LEU . 7.5 mp0 -142.36 167.9 21.0 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.337 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.679 HG22 HD22 ' A' ' 49' ' ' LEU . 3.1 tt -100.59 -1.54 9.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 -176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' HA ' HD21 ' A' ' 6' ' ' LEU . 60.9 t-80 79.98 79.25 0.05 OUTLIER 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 126.716 2.007 . . . . 0.0 106.581 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.7 -179.08 7.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -176.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.71 101.99 3.22 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.918 1.342 . . . . 0.0 111.292 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.684 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -93.8 121.68 35.5 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.697 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.88 79.06 1.68 Allowed 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.602 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -95.85 88.39 1.05 Allowed Glycine 0 CA--C 1.472 -2.645 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.529 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.34 -64.6 1.13 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.543 0.687 . . . . 0.0 110.13 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.666 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 6.1 mmp_? -84.38 -40.96 17.21 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 34' ' ' LYS . 33.5 tt0 -67.34 -11.98 59.02 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.952 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 48.8 t -55.48 -41.92 73.67 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.88 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -70.81 -32.11 69.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.027 0.442 . . . . 0.0 110.625 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -75.49 -41.36 55.64 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.45 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.3 ptp -61.62 -33.06 73.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.993 0.425 . . . . 0.0 111.672 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.19 -28.41 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.798 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' ALA . 15.4 mm-40 -92.73 -37.24 12.48 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.571 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 73.2 mttt -58.8 -24.94 62.64 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 124.772 1.229 . . . . 0.0 111.246 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -60.47 -26.83 67.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 O-C-N 124.331 1.019 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.26 -62.7 1.3 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.198 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -152.11 -70.01 0.16 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.862 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 28.2 ptt180 -158.48 123.76 4.36 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.0 t -140.74 154.73 21.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.901 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.7 p -115.03 144.15 23.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.169 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.831 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 4.0 t-80 -113.45 126.34 55.22 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.3 tt -86.33 134.57 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 86' ' ' LEU . 65.3 mttp 66.7 60.1 0.94 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.861 0.865 . . . . 0.0 109.906 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 86' ' ' LEU . 57.5 Cg_endo -69.25 168.24 21.45 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.771 1.647 . . . . 0.0 110.639 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.666 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 179.47 56.8 0.08 OUTLIER Glycine 1 CA--C 1.448 -4.103 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -177.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . 2.6 pm0 -116.35 147.27 41.76 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 114.163 -1.019 . . . . 0.0 109.857 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.592 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 7.8 mmtm -136.64 76.56 1.6 Allowed 'General case' 0 C--N 1.263 -3.193 0 CA-C-O 123.801 1.762 . . . . 0.0 107.907 174.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 79.9 mt -88.39 107.55 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.698 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.364 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.679 HD22 HG22 ' A' ' 18' ' ' ILE . 2.4 mt 70.57 -3.77 1.82 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.492 1.117 . . . . 0.0 111.251 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.8 -37.73 3.66 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.27 131.12 27.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -71.93 103.84 3.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.904 0.859 . . . . 0.0 109.216 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 49' ' ' LEU . 50.8 mm -120.01 134.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 16' ' ' TYR . 69.5 mt -84.61 -41.38 15.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.752 0.787 . . . . 0.0 109.229 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.69 -18.51 34.03 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 mm -101.02 108.78 56.07 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.5 Cg_exo -53.05 109.32 0.34 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.477 2.785 . . . . 0.0 112.577 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 59.0 Cg_endo -97.37 -179.66 0.38 Allowed 'Trans proline' 0 N--CA 1.432 -2.12 0 C-N-CA 122.713 2.275 . . . . 0.0 111.487 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 75' ' ' THR . 77.6 t -67.37 112.33 9.82 Favored Pre-proline 0 C--O 1.213 -0.835 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.27 75.09 5.14 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.86 1.707 . . . . 0.0 115.455 -170.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 75.0 mt -136.64 142.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.658 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 138.11 156.74 7.24 Favored Glycine 0 N--CA 1.403 -3.535 0 C-N-CA 118.981 -1.58 . . . . 0.0 114.13 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.1 pt -150.87 160.84 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 123.423 0.689 . . . . 0.0 111.3 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.93 136.48 42.68 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.44 -61.87 1.66 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.737 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -155.83 166.22 34.16 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 67' ' ' ARG . 3.0 tpp180 -77.09 -33.62 56.96 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.793 0.806 . . . . 0.0 110.468 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.49 31.54 1.02 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 122.782 1.277 . . . . 0.0 110.288 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.483 ' CA ' ' HG3' ' A' ' 85' ' ' GLU . 64.4 m -154.61 173.49 16.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 85' ' ' GLU . 29.1 m -79.19 166.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-O 122.473 1.13 . . . . 0.0 110.228 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.526 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.4 ptt? -120.77 122.25 39.96 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 174.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.8 90.29 15.01 Favored Pre-proline 0 C--N 1.293 -1.867 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.174 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.658 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 71.7 Cg_endo -103.21 171.09 0.21 Allowed 'Trans proline' 1 N--CA 1.385 -4.898 0 C-N-CA 120.8 1.0 . . . . 0.0 111.449 176.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m-85 -126.05 32.53 5.23 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 122.213 1.006 . . . . 0.0 110.304 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 37.0 p -80.6 104.38 11.09 Favored 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.511 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -103.88 102.23 29.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.688 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 75' ' ' THR . 64.3 Cg_endo -98.46 -156.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.736 2.957 . . . . 0.0 112.072 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.2 t -95.95 28.56 3.08 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.369 1.08 . . . . 0.0 108.092 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -136.81 -85.28 0.33 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.68 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -172.77 173.81 45.59 Favored Glycine 0 C--N 1.315 -0.589 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.551 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 25.1 m -89.28 135.7 33.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.418 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . . . -109.91 126.93 54.39 Favored 'General case' 0 N--CA 1.397 -3.119 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 54.2 t -133.02 138.85 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 30.7 m -140.06 140.52 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.483 ' HG3' ' CA ' ' A' ' 69' ' ' THR . 42.5 tt0 -138.71 118.67 13.34 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' SER . 13.2 tp -97.17 143.9 26.94 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.27 12.67 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.907 1.738 . . . . 0.0 112.34 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 68' ' ' SER . 26.1 t -117.79 156.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.474 ' CB ' ' HG2' ' A' ' 91' ' ' GLU . 1.8 m-20 -51.81 157.51 1.97 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 124.201 0.938 . . . . 0.0 111.871 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.28 -11.37 31.11 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.586 2.191 . . . . 0.0 110.539 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 89' ' ' ASP . 12.8 pt-20 -66.61 -16.87 64.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.226 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 96' ' ' ILE . 7.3 tp10 -59.52 -26.49 65.36 Favored 'General case' 0 C--N 1.375 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -56.38 -36.16 45.98 Favored 'Isoleucine or valine' 0 C--O 1.167 -3.242 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -56.04 -40.94 74.23 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.93 0.871 . . . . 0.0 110.796 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -39.03 42.29 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.208 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 92' ' ' GLU . 43.2 mm -75.29 -18.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.317 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.9 tp -82.14 -27.89 32.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.731 0.777 . . . . 0.0 109.018 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -100.74 7.88 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.669 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.592 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -55.13 -61.8 2.08 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -177.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.54 -43.93 0.22 Allowed Pre-proline 0 C--N 1.258 -3.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.911 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.423 -2.638 0 C-N-CA 121.163 1.242 . . . . 0.0 112.347 179.129 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' HIS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.693 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.697 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.683 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HB ' HD22 ' A' ' 49' ' ' LEU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.616 HD22 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 75' ' ' THR . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.534 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 73' ' ' PRO . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.5 t60 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -176.96 148.86 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.23 0.612 . . . . 0.0 110.966 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -148.93 130.67 15.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 55.9 m-85 -114.68 7.57 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.985 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.4 m -84.53 115.0 22.36 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 7' ' ' GLU . 0.6 OUTLIER -102.92 -53.07 2.92 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.759 ' H ' HD12 ' A' ' 6' ' ' LEU . 33.1 tt0 -70.22 -13.82 62.35 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 125.155 1.382 . . . . 0.0 110.91 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -73.12 -25.05 60.71 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.237 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -32.3 63.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.68 -42.13 98.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -67.0 -17.32 64.87 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.95 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -95.19 -45.2 7.29 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.9 m -149.59 -67.34 0.21 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.933 0.396 . . . . 0.0 111.127 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.33 163.54 32.04 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -86.7 152.93 22.13 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 124.222 0.601 . . . . 0.0 109.831 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.518 ' HA ' HG23 ' A' ' 54' ' ' ILE . 41.9 t80 -151.44 13.58 0.66 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.401 0.619 . . . . 0.0 110.452 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -144.59 171.06 14.91 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.699 HG22 ' HG ' ' A' ' 49' ' ' LEU . 15.5 tt -105.2 150.46 7.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -69.53 67.68 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.305 1.05 . . . . 0.0 110.973 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.4 mmm -122.07 -101.03 0.41 Allowed 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.979 1.712 . . . . 0.0 110.242 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 37.6 ttmt -159.45 124.22 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.413 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -108.06 141.45 39.73 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . . . -118.06 90.47 3.34 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.56 76.07 0.22 Allowed Glycine 0 CA--C 1.479 -2.199 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.358 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 97.3 m-85 -70.37 -74.96 0.13 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.072 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.601 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.7 mmt180 -80.73 -33.02 35.52 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.375 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -66.29 -13.07 59.89 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 31' ' ' MET . 25.0 t -49.44 -37.38 25.54 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 121.501 0.667 . . . . 0.0 110.987 175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.583 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -72.68 -42.97 63.69 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 121.82 -0.55 . . . . 0.0 110.456 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -60.28 -47.07 87.6 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.122 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -53.39 -39.53 64.33 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.383 0.427 . . . . 0.0 112.023 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.7 mm -62.17 -43.36 97.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.128 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.608 ' HB3' HG21 ' A' ' 39' ' ' VAL . 18.5 mm-40 -79.58 -28.86 41.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.805 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -64.47 -22.95 67.12 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 123.952 0.901 . . . . 0.0 111.973 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.06 -26.61 66.83 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -59.54 2.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.07 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -141.67 -79.12 0.25 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.487 1.137 . . . . 0.0 110.01 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.499 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 14.2 ptp180 -170.49 123.19 0.65 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 33' ' ' GLU . 74.2 t -132.93 143.19 40.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.639 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.7 p -97.75 139.41 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.901 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.633 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 66.6 t60 -123.27 124.9 44.03 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.8 tt -85.65 136.73 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 96.4 mttt 68.1 58.32 0.73 Allowed Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 123.64 0.776 . . . . 0.0 110.93 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 Cg_endo -78.24 155.91 29.3 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 121.647 1.565 . . . . 0.0 110.29 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -152.99 39.16 0.73 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.3 pm0 -105.6 175.6 5.44 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.925 0.869 . . . . 0.0 111.565 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.609 ' HG2' HG23 ' A' ' 96' ' ' ILE . 4.7 tmtt? -157.44 102.67 1.92 Allowed 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.38 105.95 17.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.699 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 62.26 -1.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 127.349 2.26 . . . . 0.0 114.47 175.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.75 -38.89 2.93 Favored Glycine 0 C--N 1.291 -1.946 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.79 39.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -75.79 104.07 6.17 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.466 HD12 HG21 ' A' ' 18' ' ' ILE . 48.5 mt -124.31 119.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 16' ' ' TYR . 62.9 mt -77.9 -33.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.932 0.77 . . . . 0.0 110.18 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.63 14.99 Favored Glycine 0 C--N 1.309 -0.933 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.58 131.25 23.19 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 48.2 Cg_exo -58.79 110.43 0.67 Allowed 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.811 2.341 . . . . 0.0 111.324 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 30.0 Cg_endo -110.58 -177.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 122.878 2.385 . . . . 0.0 112.905 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 75' ' ' THR . 59.1 t -87.23 121.17 71.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 40.22 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.042 2.495 . . . . 0.0 114.792 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.09 145.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.34 145.39 6.0 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.352 -1.404 . . . . 0.0 112.356 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.13 86.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 123.404 0.681 . . . . 0.0 109.428 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -95.07 114.96 26.82 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.29 -69.53 0.72 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -148.07 168.25 22.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -32.82 42.44 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.27 28.47 1.43 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.426 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -152.3 167.91 27.1 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 85' ' ' GLU . 29.9 m -78.83 156.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.9 0.857 . . . . 0.0 111.383 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.614 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 ptt? -119.37 124.85 47.59 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.1 mt -107.95 87.48 3.81 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.2 Cg_exo -82.24 142.01 11.84 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.998 1.799 . . . . 0.0 112.332 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.8 49.88 1.07 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.997 1.38 . . . . 0.0 107.819 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.5 p -98.51 119.97 38.13 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 112.746 -2.024 . . . . 0.0 107.313 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -100.51 102.19 17.94 Favored Pre-proline 0 C--N 1.305 -1.345 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.002 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.3 Cg_endo -104.17 -164.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.708 0 C-N-CA 123.069 2.513 . . . . 0.0 111.18 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 74.3 m -109.8 35.39 3.38 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -141.86 -71.76 0.34 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.577 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.16 40.54 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 22.7 m -115.31 149.36 37.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 118.304 1.052 . . . . 0.0 111.214 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.07 124.68 52.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 44.4 t -122.33 124.83 71.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.517 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 21.8 m -125.17 145.79 31.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.432 ' HB2' HG12 ' A' ' 70' ' ' VAL . 44.2 tt0 -147.6 118.58 7.67 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.209 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.1 tp -95.85 125.66 47.92 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.03 1.13 8.97 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.254 1.969 . . . . 0.0 111.164 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.55 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 19.5 t -100.25 164.42 2.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 91' ' ' GLU . 6.2 m-20 -70.23 162.21 71.01 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 118.074 0.397 . . . . 0.0 110.132 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.73 16.42 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.137 2.558 . . . . 0.0 112.207 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -70.41 -20.01 62.95 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 122.014 0.911 . . . . 0.0 109.115 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.504 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 7.3 tp10 -65.74 -24.29 66.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.033 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.559 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 66.5 mt -59.23 -26.96 35.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.83 -177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -63.59 -41.09 98.37 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' H ' ' HD2' ' A' ' 95' ' ' ARG . 2.8 mpt_? -74.82 -38.9 61.92 Favored 'General case' 0 C--O 1.193 -1.921 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.609 HG23 ' HG2' ' A' ' 47' ' ' LYS . 62.2 mt -58.66 -33.97 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 124.37 1.068 . . . . 0.0 111.316 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.45 -38.17 90.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.558 0.694 . . . . 0.0 109.797 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.57 -42.55 24.77 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.011 0.91 . . . . 0.0 109.518 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.19 3.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 125.119 1.367 . . . . 0.0 111.674 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -42.19 -44.13 3.62 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 124.518 1.127 . . . . 0.0 110.751 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -160.18 98.18 1.46 Allowed Pre-proline 0 N--CA 1.401 -2.882 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--O 1.243 0.734 0 C-N-CA 123.543 2.828 . . . . 0.0 112.739 -178.022 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.572 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HD11 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.527 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.632 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 20' ' ' MET . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' ILE . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.528 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.825 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 96' ' ' ILE . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG22 ' HB2' ' A' ' 22' ' ' ARG . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' HB2' ' A' ' 20' ' ' MET . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.61 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.657 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 67' ' ' ARG . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.491 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 79.9 m-70 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtt -152.49 122.26 6.94 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.649 HG21 ' SD ' ' A' ' 31' ' ' MET . 8.6 t -111.25 125.3 53.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.445 0.641 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.54 7.44 6.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.875 0.845 . . . . 0.0 109.43 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 62.5 m -94.89 96.56 9.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.769 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 7' ' ' GLU . 4.1 pp -100.29 -39.48 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.984 0.897 . . . . 0.0 110.358 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.625 ' N ' HD12 ' A' ' 6' ' ' LEU . 35.2 tt0 -77.74 -13.77 59.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.165 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.7 m -68.5 -33.56 74.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -80.33 -26.4 38.76 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.641 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HG ' ' OE2' ' A' ' 15' ' ' GLU . 7.8 tt -73.55 -26.79 61.01 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.295 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 7' ' ' GLU . 79.5 mt-30 -68.89 -29.96 68.35 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -93.34 -7.0 46.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.059 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.9 m 63.85 37.85 9.39 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 122.318 1.056 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.27 55.71 0.57 Allowed Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.475 ' OE2' ' HG ' ' A' ' 10' ' ' LEU . 6.1 pm0 -100.07 174.25 6.25 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.146 0.578 . . . . 0.0 111.423 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.431 ' CD1' HG13 ' A' ' 54' ' ' ILE . 70.9 t80 -144.87 25.44 1.44 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -138.13 163.96 30.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.75 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.477 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.1 tt -115.83 165.23 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.404 ' N ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-70 -65.84 71.87 0.06 Allowed 'General case' 0 C--N 1.362 1.15 0 CA-C-O 122.213 1.006 . . . . 0.0 109.989 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.641 ' SD ' ' HB3' ' A' ' 49' ' ' LEU . 47.7 mtt -135.82 -148.4 0.3 Allowed 'General case' 0 C--N 1.259 -3.326 0 C-N-CA 126.209 1.804 . . . . 0.0 106.872 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 20' ' ' MET . 11.9 tmtt? -124.03 123.28 40.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HB3' HD23 ' A' ' 6' ' ' LEU . 8.9 ptm180 -98.89 165.8 11.59 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.78 80.68 0.94 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.492 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -96.9 82.3 0.74 Allowed Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 115.086 0.795 . . . . 0.0 115.086 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.4 -65.9 0.87 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.3 mpt_? -85.62 -34.66 21.33 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.984 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 29.8 tt0 -79.21 -3.01 43.68 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.648 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -53.54 -41.91 66.92 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.11 94.98 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.19 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.32 -45.73 91.91 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.293 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.649 ' SD ' HG21 ' A' ' 3' ' ' THR . 18.4 ptm -55.98 -35.73 67.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.9 mm -59.9 -46.44 93.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 123.93 0.769 . . . . 0.0 109.927 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.4 -28.51 31.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.193 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 34.7 mtpt -57.01 -26.86 60.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.692 0.797 . . . . 0.0 110.924 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 7.0 tmtm? -62.67 -21.25 65.57 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.316 1.047 . . . . 0.0 111.26 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.86 -39.24 69.81 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 121.86 -0.525 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -176.12 -65.46 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 7.2 ptp180 -169.6 132.41 1.2 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.67 145.79 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -98.26 139.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 O-C-N 124.343 1.027 . . . . 0.0 109.996 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 37.6 t-80 -137.7 123.29 19.75 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.0 137.85 20.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.8 mttt 66.6 64.24 0.82 Allowed Pre-proline 0 C--O 1.216 -0.667 0 C-N-CA 123.133 0.573 . . . . 0.0 111.097 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.635 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 44.9 Cg_endo -95.28 148.82 1.53 Allowed 'Trans proline' 0 N--CA 1.427 -2.395 0 C-N-CA 122.126 1.884 . . . . 0.0 111.046 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.457 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -154.21 64.76 0.34 Allowed Glycine 0 N--CA 1.424 -2.108 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.265 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.658 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.0 tp10 -114.38 123.24 48.98 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 124.072 0.949 . . . . 0.0 109.11 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 44.4 mtmt -106.96 72.5 0.89 Allowed 'General case' 0 CA--C 1.464 -2.339 0 CA-C-O 123.287 1.518 . . . . 0.0 107.786 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.658 HG23 ' CD ' ' A' ' 46' ' ' GLU . 2.2 pt -75.43 94.73 0.98 Allowed 'Isoleucine or valine' 1 C--N 1.239 -4.229 0 CA-C-N 111.683 -2.508 . . . . 0.0 111.828 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.641 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER 64.27 -8.29 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.646 1.578 . . . . 0.0 113.362 175.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.29 -6.26 78.23 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.31 152.19 18.27 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -88.83 99.87 12.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.816 0.341 . . . . 0.0 111.77 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.34 118.02 57.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 77' ' ' PRO . 3.5 mp -75.51 -43.54 41.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.403 0.62 . . . . 0.0 110.736 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.6 -9.47 77.0 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.3 mt -124.64 131.21 24.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.9 107.33 1.86 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.563 1.509 . . . . 0.0 109.252 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -103.4 -164.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 122.721 2.281 . . . . 0.0 111.485 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 75' ' ' THR . 55.7 t -75.75 116.96 60.07 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -84.1 43.93 1.46 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 122.502 2.135 . . . . 0.0 113.964 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 51.1 mt -114.98 164.88 10.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.21 155.93 9.14 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.408 -1.377 . . . . 0.0 114.157 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.2 pt -126.22 84.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.096 0.95 . . . . 0.0 111.32 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.78 95.96 7.44 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -76.95 -56.92 4.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.769 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.13 169.88 12.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 0.1 OUTLIER -88.77 -31.7 18.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.23 1.014 . . . . 0.0 108.464 -176.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 14.9 m -93.71 34.63 1.18 Allowed 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.909 1.338 . . . . 0.0 109.203 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.2 m -154.66 166.74 32.45 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.42 105.87 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 121.861 0.839 . . . . 0.0 110.968 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.47 ' HE3' ' HA ' ' A' ' 67' ' ' ARG . 21.4 ptp -86.29 123.54 31.66 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.9 mt -118.93 86.35 30.92 Favored Pre-proline 0 C--N 1.295 -1.792 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.857 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.555 ' O ' HG21 ' A' ' 81' ' ' THR . 4.3 Cg_exo -75.14 149.96 36.89 Favored 'Trans proline' 0 N--CA 1.422 -2.689 0 N-CA-C 108.353 -1.441 . . . . 0.0 108.353 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 72.4 m-85 -113.08 41.4 2.11 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 44.5 p -95.07 102.85 14.68 Favored 'General case' 0 N--CA 1.398 -3.054 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -102.05 102.38 23.75 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.743 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.8 Cg_endo -102.45 -159.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.311 0 C-N-CA 123.253 2.635 . . . . 0.0 110.136 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -93.86 25.46 3.62 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.121 0.962 . . . . 0.0 110.172 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -128.09 -74.91 0.57 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.829 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 157.66 -174.78 35.07 Favored Glycine 0 N--CA 1.416 -2.655 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 73' ' ' PRO . 5.0 m -121.48 152.12 39.5 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 117.406 0.603 . . . . 0.0 109.627 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -105.15 111.83 24.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.7 t -102.24 90.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.635 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 26.9 m -104.64 135.47 42.42 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 O-C-N 121.457 -0.777 . . . . 0.0 111.473 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.17 115.88 16.95 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.529 0.68 . . . . 0.0 109.277 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 68' ' ' SER . 26.8 tp -99.49 125.03 42.39 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.2 8.45 4.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.348 2.032 . . . . 0.0 111.785 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.509 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.8 t -104.15 157.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.42 152.71 94.23 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.89 -7.51 18.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.625 2.883 . . . . 0.0 112.398 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.64 -24.56 63.97 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.61 -27.71 69.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.573 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 67' ' ' ARG . 78.2 mt -59.17 -41.0 82.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 C-N-CA 122.168 0.187 . . . . 0.0 110.988 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.92 -47.33 86.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.973 0.892 . . . . 0.0 109.66 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -68.32 -41.78 80.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.174 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.455 HG23 ' HG2' ' A' ' 47' ' ' LYS . 4.1 mt -65.92 -28.56 44.25 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 C-N-CA 124.128 0.971 . . . . 0.0 113.188 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.36 -37.09 84.5 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.212 0.53 . . . . 0.0 110.343 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.22 -37.06 46.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.219 1.009 . . . . 0.0 108.996 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 99' ' ' VAL . 57.8 t -91.07 17.25 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.287 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.524 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.65 -48.33 69.5 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.23 -48.31 0.6 Allowed Pre-proline 0 C--N 1.293 -1.887 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.392 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 C--N 1.389 2.675 0 C-N-CA 123.687 2.925 . . . . 0.0 115.25 177.804 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 64.6 t60 . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -130.07 139.56 50.95 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 t -107.6 123.53 48.6 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.525 0.679 . . . . 0.0 111.706 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -129.99 -0.48 4.72 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.419 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p -87.22 101.36 13.44 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.652 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.554 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -97.34 -44.85 6.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' N ' HD22 ' A' ' 6' ' ' LEU . 34.9 tt0 -81.42 -4.8 56.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.316 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -71.04 -24.77 62.42 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.883 0.849 . . . . 0.0 109.559 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 79' ' ' TYR . 38.5 t80 -78.39 -21.84 48.74 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.828 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.06 -35.29 79.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.89 -14.01 62.31 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -91.95 -46.24 7.93 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.7 m -163.39 -67.69 0.04 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.47 0.653 . . . . 0.0 109.428 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.11 -179.87 20.11 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 16' ' ' TYR . 29.8 tt0 -97.1 177.51 5.57 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 118.243 1.022 . . . . 0.0 108.777 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.563 ' HA ' HG23 ' A' ' 54' ' ' ILE . 18.1 t80 -129.15 14.41 6.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.655 1.217 . . . . 0.0 108.549 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HA ' HD21 ' A' ' 49' ' ' LEU . 5.0 mp0 -132.3 -168.01 1.98 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.489 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.625 HG22 ' HG ' ' A' ' 49' ' ' LEU . 10.9 tt -122.39 45.59 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.375 1.084 . . . . 0.0 110.793 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 56.73 31.07 18.73 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.793 1.237 . . . . 0.0 111.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.505 ' HB2' HD12 ' A' ' 49' ' ' LEU . 91.1 mmm -121.86 -168.37 1.69 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 45.1 mmtm -89.25 138.16 31.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.782 1.628 . . . . 0.0 111.478 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.73 ' HB2' HG22 ' A' ' 48' ' ' ILE . 11.9 ptm180 -107.45 140.63 40.1 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.55 88.79 2.57 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.397 0.618 . . . . 0.0 111.146 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -108.88 78.87 0.24 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.678 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -71.19 -56.83 5.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.781 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 3.2 mmp_? -94.39 -33.17 13.26 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.63 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 25.9 tt0 -82.32 -0.43 45.63 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.975 -177.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 31' ' ' MET . 50.7 t -57.36 -38.15 73.73 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 121.19 0.519 . . . . 0.0 110.106 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.73 -41.78 82.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.427 0.632 . . . . 0.0 109.335 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -62.5 -41.37 98.78 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.272 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 9.9 ptt? -54.52 -35.11 62.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.257 0.348 . . . . 0.0 111.749 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.697 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 44.9 mm -62.72 -39.44 84.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.421 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.77 -27.27 21.25 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.586 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 38.0 mtpt -59.6 -18.24 39.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.048 0.939 . . . . 0.0 112.126 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -68.6 -14.31 62.93 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.14 -55.55 5.34 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 111.213 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -167.62 -64.38 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 40.5 ptt180 -163.16 124.68 2.47 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.0 t -133.52 151.89 34.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.738 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.4 p -102.06 148.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 123.873 0.733 . . . . 0.0 110.215 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.458 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 78.5 t60 -144.47 143.98 31.14 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.21 146.16 9.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.594 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 49.1 mtmt 65.22 48.51 0.66 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 110.723 -176.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 6.0 Cg_exo -89.1 161.77 5.81 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.62 2.214 . . . . 0.0 111.096 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.519 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -171.75 75.19 0.1 OUTLIER Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.171 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 26.7 tt0 -120.94 123.83 43.43 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.709 0.766 . . . . 0.0 110.244 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 50' ' ' GLY . 2.4 tmtm? -124.03 104.13 8.71 Favored 'General case' 0 N--CA 1.394 -3.273 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.73 HG22 ' HB2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -106.6 130.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.795 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 55.32 15.95 1.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.038 2.135 . . . . 0.0 112.843 176.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.564 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . 81.68 -25.08 4.08 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.043 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.415 ' O ' HD12 ' A' ' 53' ' ' ILE . . . -143.44 145.1 32.34 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -74.57 89.14 2.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 117.754 0.252 . . . . 0.0 111.141 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 55' ' ' GLY . 4.7 mp -116.72 127.92 74.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 16' ' ' TYR . 55.2 mt -91.84 -17.23 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 122.096 0.95 . . . . 0.0 108.653 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 87.43 -17.68 42.22 Favored Glycine 0 CA--C 1.499 -0.923 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.1 mt -119.74 105.27 43.51 Favored Pre-proline 0 N--CA 1.413 -2.32 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 51.7 Cg_exo -53.16 110.31 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.667 2.912 . . . . 0.0 112.462 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 52.7 Cg_endo -95.85 175.29 0.9 Allowed 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.747 2.298 . . . . 0.0 111.741 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.9 t -85.12 106.5 9.05 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.3 100.76 0.28 Allowed 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.373 2.049 . . . . 0.0 113.651 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.8 mt -134.54 86.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.6 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . -136.32 151.33 20.76 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.48 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.05 104.07 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 123.645 0.778 . . . . 0.0 108.931 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.13 99.06 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -76.36 -69.82 0.48 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.522 0.677 . . . . 0.0 109.821 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -163.91 168.4 19.47 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG3' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -81.69 -31.09 32.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.189 0.995 . . . . 0.0 108.432 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' HD3' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -92.17 28.41 1.9 Allowed 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.408 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 m -152.46 166.6 31.45 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 85' ' ' GLU . 18.6 m -76.95 103.59 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 118.979 0.809 . . . . 0.0 110.958 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.65 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 23.5 ptt? -83.43 119.26 24.44 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 175.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -108.58 88.48 5.2 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 71' ' ' MET . 12.6 Cg_endo -96.07 167.5 1.24 Allowed 'Trans proline' 0 N--CA 1.403 -3.807 0 C-N-CA 121.973 1.782 . . . . 0.0 111.097 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 73.4 t80 -140.34 113.01 8.05 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.7 p -128.06 139.79 52.33 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -112.31 88.88 11.34 Favored Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.636 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 75' ' ' THR . 73.5 Cg_endo -106.1 -151.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 123.923 3.082 . . . . 0.0 109.808 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.0 t -100.74 13.35 35.2 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.55 ' HD2' ' CE2' ' A' ' 9' ' ' TYR . 48.3 t80 -124.84 -81.55 0.63 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.562 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.66 -174.0 40.63 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 10.2 m -118.75 158.06 26.31 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 117.33 0.565 . . . . 0.0 110.218 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -114.91 125.43 53.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.4 t -107.34 108.0 24.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 44' ' ' PRO . 29.3 m -114.32 141.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.446 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.484 ' HB2' HG12 ' A' ' 70' ' ' VAL . 38.7 tt0 -134.56 108.57 8.15 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 27.0 tp -95.23 129.09 36.29 Favored Pre-proline 0 C--N 1.284 -2.244 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.5 13.51 2.63 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.429 2.086 . . . . 0.0 110.839 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.514 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 21.4 t -115.88 159.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 9.7 t70 -65.66 146.12 99.0 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.542 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 11.3 Cg_endo -54.34 -13.74 5.68 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.84 3.027 . . . . 0.0 113.879 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.4 pt-20 -61.4 -20.69 63.34 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 92' ' ' GLU . 4.4 tp10 -64.3 -30.53 71.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HG3' ' A' ' 67' ' ' ARG . 48.8 mm -70.04 -31.58 48.21 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.954 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.96 -39.47 94.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -64.97 -48.67 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.463 1.125 . . . . 0.0 108.172 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.1 mt -68.96 -19.58 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.088 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 65.5 tp -77.18 -26.58 53.07 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.019 0.928 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -75.69 -37.53 59.46 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 56.5 t -62.36 -65.56 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . 59.2 -57.67 0.05 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.732 2.013 . . . . 0.0 114.969 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 32.5 mt-10 -128.06 -69.66 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.134 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.558 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 73.1 Cg_endo . . . . . 0 N--CA 1.437 -1.829 0 CA-C-N 120.681 1.279 . . . . 0.0 112.565 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 CA--C 1.502 -0.904 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.622 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 67.1 mtm -152.79 128.54 10.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m -106.74 111.45 23.98 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.2 m-85 -128.69 10.43 6.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.169 0.509 . . . . 0.0 111.141 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.4 m -131.69 106.93 8.46 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -80.92 -37.47 29.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.121 0.962 . . . . 0.0 111.419 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' H ' HD13 ' A' ' 6' ' ' LEU . 8.3 tp10 -71.38 -19.24 62.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.278 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.535 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.3 m -73.01 -31.96 64.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -70.47 -30.13 66.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.126 0.489 . . . . 0.0 110.092 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.6 -43.64 98.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.81 -11.7 59.81 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.388 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 8' ' ' THR . 52.5 mt-30 -89.67 -32.83 16.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.6 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -164.5 -67.07 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.47 166.01 38.66 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.85 141.29 56.49 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.716 0.769 . . . . 0.0 111.732 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -139.7 8.38 2.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 54.7 mt-10 -152.86 148.98 27.8 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.34 -1.754 . . . . 0.0 106.741 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.54 HG22 ' HG ' ' A' ' 49' ' ' LEU . 12.4 tt -89.31 159.93 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -72.11 70.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.794 1.283 . . . . 0.0 109.972 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 mmt -136.69 -175.5 4.04 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.901 -1.954 . . . . 0.0 106.139 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 51.4 mttp -84.52 118.19 24.16 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 119.485 1.039 . . . . 0.0 110.997 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -108.37 136.62 47.69 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.411 -177.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . . . -143.36 96.18 2.87 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -114.48 85.12 0.38 Allowed Glycine 0 N--CA 1.423 -2.176 0 C-N-CA 120.302 -0.951 . . . . 0.0 114.476 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -69.28 -81.03 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 117.105 0.452 . . . . 0.0 112.108 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 20.9 mtp-105 -73.13 -32.95 65.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 13.1 tp10 -70.05 -13.85 62.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.743 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 43.4 t -60.63 -31.9 71.07 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.13 68.5 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.455 0.645 . . . . 0.0 110.204 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.63 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.51 -44.87 81.38 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.379 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.465 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 22.4 ptp -56.32 -31.14 63.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 28' ' ' CYS . 46.7 mm -60.96 -40.74 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.663 0.744 . . . . 0.0 109.531 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HB3' HG21 ' A' ' 39' ' ' VAL . 8.5 mm-40 -80.45 -34.25 36.14 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.281 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.503 ' HE2' ' O ' ' A' ' 39' ' ' VAL . 74.3 mttt -68.26 -13.54 62.33 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -64.23 -30.55 71.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.484 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.71 -47.06 27.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.626 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.58 -74.3 0.06 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 120.756 0.313 . . . . 0.0 110.595 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 ttp180 -165.82 124.63 1.61 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 58.8 t -136.39 165.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.6 p -112.51 149.35 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.437 0.695 . . . . 0.0 109.901 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.63 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 46.2 t60 -140.74 128.84 22.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.4 mp -98.09 136.61 28.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 97.0 mttt 71.78 55.97 0.38 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.868 1.267 . . . . 0.0 110.432 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 85.4 Cg_endo -74.16 135.38 20.71 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.997 1.131 . . . . 0.0 109.716 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.94 46.58 1.08 Allowed Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 4.4 pm0 -112.99 153.21 28.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-O 121.643 0.735 . . . . 0.0 110.696 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -140.97 61.76 1.49 Allowed 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.446 ' C ' HD22 ' A' ' 49' ' ' LEU . 33.7 pt -64.29 105.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.576 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.54 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER 70.49 -10.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.965 2.106 . . . . 0.0 113.792 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.84 -1.16 88.03 Favored Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.59 120.79 3.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.721 1.608 . . . . 0.0 107.069 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.93 87.5 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.321 0.582 . . . . 0.0 112.275 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.493 HD12 HG21 ' A' ' 18' ' ' ILE . 61.5 mt -116.54 130.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.1 mm -71.88 -40.87 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.498 0.666 . . . . 0.0 109.597 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.0 0.24 63.87 Favored Glycine 0 C--N 1.308 -0.996 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mt -130.52 129.38 22.75 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.64 107.08 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.333 2.022 . . . . 0.0 110.07 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 36.0 Cg_endo -103.97 -167.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.272 0 C-N-CA 122.566 2.177 . . . . 0.0 111.319 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 75' ' ' THR . 41.3 t -99.16 100.67 10.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 10.3 Cg_endo -87.66 102.59 0.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.721 2.28 . . . . 0.0 113.541 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.53 164.52 34.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 133.13 -175.09 20.3 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.556 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -137.72 107.04 4.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -99.51 108.62 21.1 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -85.34 -55.93 3.78 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.597 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -171.94 166.8 6.29 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -35.48 74.58 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.597 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 16.0 m -96.37 31.4 2.24 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.608 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -151.43 161.65 42.33 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG13 ' OE2' ' A' ' 85' ' ' GLU . 9.5 m -77.35 112.77 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.979 0.895 . . . . 0.0 109.865 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.603 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -90.84 123.05 34.08 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.72 89.27 12.85 Favored Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.138 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 71' ' ' MET . 4.9 Cg_exo -85.04 155.94 11.29 Favored 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 121.872 1.714 . . . . 0.0 110.029 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -125.22 75.73 1.48 Allowed 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.553 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 p -106.51 134.62 49.36 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.455 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -110.79 88.81 8.42 Favored Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.875 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 75' ' ' THR . 44.3 Cg_endo -103.38 -159.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.658 2.905 . . . . 0.0 109.797 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 10.1 t -94.58 5.31 52.21 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.448 0.642 . . . . 0.0 109.302 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -120.68 -84.42 0.66 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.152 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -168.8 39.63 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 27.7 m -116.96 147.76 41.99 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.313 0.578 . . . . 0.0 110.08 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.471 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -120.12 121.59 39.17 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 82.9 t -104.38 104.91 17.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -103.22 133.78 46.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.448 ' OE2' HG13 ' A' ' 70' ' ' VAL . 36.2 tt0 -132.69 115.21 15.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.324 0.583 . . . . 0.0 109.696 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 21.9 tp -99.37 132.99 22.33 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.38 -3.4 10.8 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.311 2.007 . . . . 0.0 111.834 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.602 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.5 t -96.0 164.32 2.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.0 t70 -68.61 146.89 97.93 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 123.208 0.603 . . . . 0.0 110.755 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.04 -10.92 1.24 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 124.134 3.223 . . . . 0.0 114.749 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 11.1 pt-20 -55.63 -22.61 23.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.279 0.632 . . . . 0.0 110.814 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -58.88 -23.19 60.65 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.864 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 27.2 mm -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -65.15 -37.55 87.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.09 -51.01 66.07 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' A' ' 47' ' ' LYS . 3.0 mt -58.42 -29.58 38.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.451 0 C-N-CA 125.74 1.616 . . . . 0.0 113.028 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.48 -36.68 79.3 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.237 0.542 . . . . 0.0 110.685 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -87.43 -45.1 10.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.215 1.007 . . . . 0.0 109.878 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.67 13.81 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 125.771 1.628 . . . . 0.0 111.095 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.713 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . . . -63.84 -36.31 83.49 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 29.2 mt-10 -88.73 -52.54 0.37 Allowed Pre-proline 0 N--CA 1.412 -2.361 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.657 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 32.5 Cg_endo . . . . . 0 N--CA 1.426 -2.491 0 C-N-CA 122.079 1.853 . . . . 0.0 112.353 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 CA--C 1.499 -0.987 0 CA-C-O 120.995 0.426 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.474 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 70.9 mtm -152.0 123.83 7.99 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.3 m -100.61 118.53 36.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 120.4 0.143 . . . . 0.0 111.085 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.8 m-85 -134.74 14.48 3.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.411 0.624 . . . . 0.0 109.535 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.0 m -135.05 102.43 5.2 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -76.04 -33.3 59.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.387 1.089 . . . . 0.0 111.542 -175.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' OE1' HD13 ' A' ' 10' ' ' LEU . 10.6 tp10 -73.7 -22.16 60.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.77 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -68.61 -30.87 69.69 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.14 -29.18 61.69 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.102 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD13 ' OE1' ' A' ' 7' ' ' GLU . 8.4 tt -61.9 -45.24 94.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' A' ' 7' ' ' GLU . 67.8 mt-30 -68.34 -35.34 77.63 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.162 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.27 -46.58 76.54 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.661 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 m -155.33 -67.82 0.12 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.244 0.545 . . . . 0.0 110.647 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.25 166.84 37.27 Favored Glycine 0 N--CA 1.413 -2.865 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.52 143.57 56.09 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-O 121.499 0.666 . . . . 0.0 111.767 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.13 3.85 3.44 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 48.6 mt-10 -151.49 155.54 38.75 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.643 HG22 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -94.88 166.89 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -75.66 72.43 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.406 1.098 . . . . 0.0 109.787 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 mmt -137.89 -176.37 4.41 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.899 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -78.04 111.31 13.8 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 118.784 0.72 . . . . 0.0 109.997 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HB2' ' OE2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -103.72 132.19 50.21 Favored 'General case' 0 N--CA 1.406 -2.632 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.64 98.56 3.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -120.89 86.9 0.4 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.207 -176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' CE1' ' HZ ' ' A' ' 4' ' ' PHE . 98.2 m-85 -71.78 -75.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.249 0.547 . . . . 0.0 110.51 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.632 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.2 mmp_? -70.08 -38.24 75.65 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -74.91 -8.74 57.36 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.987 -176.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.8 t -58.21 -35.14 71.22 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.132 0.491 . . . . 0.0 109.686 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.488 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -68.19 -42.66 79.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.512 0.673 . . . . 0.0 110.219 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -63.67 -49.1 74.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.122 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.5 ptp -57.14 -33.12 67.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 28' ' ' CYS . 47.5 mm -65.15 -39.25 84.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.715 0.769 . . . . 0.0 109.63 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.35 -31.78 43.1 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.62 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.0 mttt -66.4 -21.29 66.22 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -60.98 -25.61 66.97 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.66 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.71 -49.68 24.5 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -166.38 -71.38 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.911 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' THR . 52.2 ttp180 -164.15 111.56 1.11 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.89 150.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.168 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -103.23 148.0 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.625 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 42.2 t60 -133.43 111.96 11.17 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 3.5 mp -82.77 138.32 19.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.431 ' HA ' HD12 ' A' ' 86' ' ' LEU . 96.1 mttt 69.99 59.23 0.53 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.522 1.129 . . . . 0.0 110.782 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 96.6 Cg_endo -78.95 166.0 23.66 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 122.059 1.839 . . . . 0.0 111.051 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.632 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -162.06 52.41 0.32 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 4.9 pm0 -116.32 151.98 34.78 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.053 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -138.34 60.43 1.61 Allowed 'General case' 0 CA--C 1.468 -2.203 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 175.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.406 ' C ' HD22 ' A' ' 49' ' ' LEU . 40.1 pt -69.27 112.2 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.129 0 CA-C-N 112.187 -2.278 . . . . 0.0 110.407 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 75.64 -19.33 0.41 Allowed 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.723 2.009 . . . . 0.0 113.139 176.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.71 -9.9 60.56 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.15 115.82 2.07 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -67.74 123.3 20.14 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.5 mt -136.8 128.35 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.84 -37.15 60.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.22 -35.65 4.65 Favored Glycine 0 CA--C 1.486 -1.779 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 78' ' ' CYS . 59.0 mt -93.24 120.71 66.53 Favored Pre-proline 0 N--CA 1.417 -2.093 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.49 111.42 2.32 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.176 1.917 . . . . 0.0 110.004 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -101.76 -176.04 0.12 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.556 2.17 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 75' ' ' THR . 52.2 t -79.86 113.96 42.24 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 8.1 Cg_exo -72.96 52.93 2.3 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.13 2.553 . . . . 0.0 115.272 -173.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.4 mt -111.93 154.35 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 150.35 173.6 20.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 119.238 -1.458 . . . . 0.0 113.436 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -122.32 90.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.53 101.22 13.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.52 -70.43 0.54 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.626 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.4 tp10 -162.62 170.98 17.63 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.1 -29.7 64.35 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.524 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 17.6 m -99.35 27.63 5.08 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.179 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 m -149.02 159.03 44.59 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.3 114.79 14.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 122.026 0.917 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.615 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.4 ptp -92.88 96.69 10.28 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.64 98.51 9.68 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 71' ' ' MET . 25.0 Cg_endo -92.19 171.19 2.6 Favored 'Trans proline' 1 N--CA 1.398 -4.104 0 C-N-CA 121.671 1.581 . . . . 0.0 112.08 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -124.18 48.05 1.98 Allowed 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.6 p -97.94 111.29 23.65 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-N 113.078 -1.873 . . . . 0.0 108.122 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -103.53 103.64 37.1 Favored Pre-proline 0 C--N 1.29 -2.0 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.858 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 75' ' ' THR . 19.6 Cg_endo -97.31 -164.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.768 0 C-N-CA 122.202 1.934 . . . . 0.0 108.249 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.483 ' H ' HG21 ' A' ' 56' ' ' ILE . 42.6 t -98.6 13.84 30.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.191 0.996 . . . . 0.0 109.065 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -115.02 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.962 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -179.2 164.14 32.14 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 8.4 m -91.29 152.48 20.46 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.07 135.52 53.62 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 t -127.65 131.79 69.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.42 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.3 m -131.45 147.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 40.6 tt0 -149.88 116.82 5.93 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.367 0.417 . . . . 0.0 110.24 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.3 tp -96.45 129.88 32.15 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.35 -8.27 17.28 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.748 1.632 . . . . 0.0 111.588 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.51 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 11.6 t -100.46 156.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.54 151.72 87.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 O-C-N 123.197 0.31 . . . . 0.0 111.699 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.16 -14.35 33.27 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.726 2.951 . . . . 0.0 113.263 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.65 -25.61 62.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.318 0.647 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' ARG . 49.8 mm-40 -75.04 -28.87 60.6 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.257 0.551 . . . . 0.0 110.017 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 48.9 mm -77.42 -27.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.931 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -65.91 -37.01 84.96 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 38.2 ttt180 -65.48 -47.25 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.992 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.66 -21.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.1 -27.08 60.71 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.6 -27.16 61.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 99' ' ' VAL . 43.2 t -102.79 22.46 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.791 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.136 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . . . -58.21 -49.58 76.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.46 -42.13 0.41 Allowed Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 C--N 1.386 2.521 0 C-N-CA 123.752 2.968 . . . . 0.0 115.722 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -172.85 136.18 0.68 Allowed 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.977 0.911 . . . . 0.0 109.675 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.5 m -148.62 129.48 14.28 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 61.2 m-85 -116.22 0.73 12.98 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.82 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.2 m -82.31 111.8 18.71 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.857 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 22' ' ' ARG . 4.5 pp -106.37 -44.73 4.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.766 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.665 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 42.5 tt0 -68.42 -10.77 57.47 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.048 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 p -70.96 -28.36 64.42 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -75.89 -30.33 58.79 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.336 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 15' ' ' GLU . 36.5 tp -57.67 -43.39 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.974 0.893 . . . . 0.0 109.325 176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -74.04 -12.76 60.71 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.381 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -99.39 -32.82 10.97 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.055 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -155.43 -66.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 109.844 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.02 162.89 36.68 Favored Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.665 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 9.5 tp10 -83.62 147.99 27.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 117.709 0.755 . . . . 0.0 109.318 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' HG23 ' A' ' 54' ' ' ILE . 66.9 t80 -131.27 18.12 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.055 0.931 . . . . 0.0 109.586 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 19.4 mm-40 -147.26 170.52 17.11 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.606 HG22 ' HG ' ' A' ' 49' ' ' LEU . 16.9 tt -102.69 158.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 175.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -75.06 69.87 2.0 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 123.34 1.543 . . . . 0.0 112.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.426 ' O ' HD21 ' A' ' 6' ' ' LEU . 29.9 mmm -128.62 -155.86 0.72 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.55 2.74 . . . . 0.0 106.037 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.24 123.19 47.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.886 0.766 . . . . 0.0 109.314 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -93.92 135.14 35.56 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.16 92.68 3.83 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -111.78 79.01 0.25 Allowed Glycine 0 C--N 1.291 -1.957 0 C-N-CA 118.818 -1.658 . . . . 0.0 112.47 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 95.3 m-85 -73.12 -69.6 0.41 Allowed 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 117.459 0.629 . . . . 0.0 109.311 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.698 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 25.9 mmt180 -80.5 -36.78 32.82 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.288 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 3.5 tm-20 -66.0 -13.05 59.18 Favored 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 31' ' ' MET . 27.2 t -48.68 -40.13 26.98 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.82 0.819 . . . . 0.0 110.287 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -71.71 -42.43 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.728 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.236 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.566 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 27.3 ptt? -51.58 -40.38 59.67 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.799 0.687 . . . . 0.0 111.863 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.3 mm -60.25 -45.02 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 39' ' ' VAL . 19.8 mm-40 -80.8 -30.45 35.91 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.175 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 81' ' ' THR . 28.6 mtpt -61.29 -26.97 68.14 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 124.348 1.059 . . . . 0.0 112.288 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -66.27 -22.56 66.31 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 123.837 0.71 . . . . 0.0 110.694 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.97 -60.12 2.41 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -144.37 -76.85 0.22 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.106 0.955 . . . . 0.0 109.974 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.2 ptp180 -168.7 124.79 0.96 Allowed 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 33' ' ' GLU . 73.4 t -134.43 145.66 32.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.291 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.4 p -98.5 142.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 O-C-N 124.398 1.061 . . . . 0.0 108.566 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.51 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 84.5 t60 -133.49 120.29 20.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.1 tt -81.33 147.73 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 62.07 56.52 2.77 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.528 0.731 . . . . 0.0 111.473 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 84.4 Cg_endo -77.37 156.37 32.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.033 1.822 . . . . 0.0 111.152 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.698 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -160.75 56.49 0.32 Allowed Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 44' ' ' PRO . 2.3 pm0 -115.98 174.38 6.07 Favored 'General case' 0 C--N 1.26 -3.314 0 CA-C-N 113.919 -1.14 . . . . 0.0 110.555 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.514 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.1 mmtt -154.85 89.45 1.24 Allowed 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 126.309 1.844 . . . . 0.0 106.09 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.418 ' C ' HD22 ' A' ' 49' ' ' LEU . 28.8 pt -85.34 100.39 8.45 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.269 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.606 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 58.52 16.59 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 126.063 1.745 . . . . 0.0 111.967 176.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 -51.74 4.04 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.23 142.68 50.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -70.21 103.4 2.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 18' ' ' ILE . 61.5 mt -123.06 114.59 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.444 HG23 ' CD1' ' A' ' 16' ' ' TYR . 69.3 mt -77.43 -44.45 30.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 122.229 1.014 . . . . 0.0 109.057 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.91 -29.96 9.75 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' H ' HG22 ' A' ' 54' ' ' ILE . 31.9 mm -86.59 125.64 66.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.58 106.82 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.478 2.119 . . . . 0.0 110.521 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -107.79 -161.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.234 0 C-N-CA 123.002 2.468 . . . . 0.0 111.396 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 75' ' ' THR . 46.8 t -96.35 113.05 61.74 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.34 50.12 1.86 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.524 2.816 . . . . 0.0 114.63 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.58 149.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.37 167.66 36.55 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.747 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -135.4 82.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.22 94.53 9.23 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 8.2 mm-40 -72.19 -62.49 1.41 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.548 -177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.8 179.13 9.5 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -90.98 -33.37 15.58 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.12 40.08 1.01 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.679 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.4 t -165.19 -178.74 5.24 Favored 'General case' 0 N--CA 1.403 -2.8 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -82.58 105.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.555 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 22.8 ptm -89.53 100.87 13.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.9 mt -101.29 100.81 14.49 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.709 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 71' ' ' MET . 5.7 Cg_exo -82.09 148.62 15.21 Favored 'Trans proline' 0 N--CA 1.436 -1.907 0 C-N-CA 122.071 1.847 . . . . 0.0 110.405 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.49 60.39 0.73 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.604 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.1 p -106.39 119.81 40.23 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.145 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.13 101.64 13.19 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 75' ' ' THR . 87.1 Cg_endo -105.07 -156.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 123.198 2.599 . . . . 0.0 111.191 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.2 m -109.24 29.13 7.81 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.061 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -144.07 -80.36 0.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.195 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.81 -176.54 46.75 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 51.0 m -118.31 146.95 43.96 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.052 0.926 . . . . 0.0 110.873 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.26 38.5 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 123.372 0.669 . . . . 0.0 111.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 42.6 t -117.97 112.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 27.1 m -115.01 142.53 27.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 O-C-N 121.486 -0.759 . . . . 0.0 109.247 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 tt0 -139.12 113.79 9.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.284 0.564 . . . . 0.0 110.421 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.3 tp -93.44 130.09 36.62 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -89.06 19.63 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.624 2.216 . . . . 0.0 111.277 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' SER . 36.5 t -122.34 156.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.01 162.14 41.22 Favored Pre-proline 0 C--N 1.307 -1.255 0 O-C-N 123.487 0.492 . . . . 0.0 111.258 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.2 2.41 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.406 2.737 . . . . 0.0 113.219 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.95 -30.62 70.34 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.834 0.854 . . . . 0.0 109.708 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -66.66 -23.49 66.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.252 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.67 -30.17 41.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.66 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.84 -39.73 94.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.36 0.6 . . . . 0.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.635 ' H ' ' HD2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -76.93 -37.77 54.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.76 -29.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.0 -33.69 76.11 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.6 0.76 . . . . 0.0 109.851 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.61 -24.9 38.78 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.429 1.109 . . . . 0.0 109.049 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -92.61 15.25 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.075 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.514 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.96 -49.8 8.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.542 1.137 . . . . 0.0 113.198 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.05 93.38 3.42 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.446 -1.292 0 C-N-CA 123.355 2.704 . . . . 0.0 112.405 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 . . . . . 0 C--O 1.219 -0.519 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.7 mtt 69.95 112.26 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.075 0.95 . . . . 0.0 109.853 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.42 HG21 ' SD ' ' A' ' 31' ' ' MET . 90.4 m -113.37 128.17 56.37 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.533 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -129.85 21.45 5.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 30.9 m -89.16 87.42 7.16 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.6 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.621 ' H ' HD13 ' A' ' 6' ' ' LEU 0.295 0.0 OUTLIER -84.28 -43.7 14.58 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.43 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 28.3 tt0 -69.75 -4.83 21.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 123.031 1.396 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 29.6 m -76.62 -19.96 57.25 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.617 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.686 ' CD1' ' HA ' ' A' ' 15' ' ' GLU . 2.7 p90 -64.8 -33.11 75.22 Favored 'General case' 0 C--N 1.359 1.016 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' CE1' ' A' ' 9' ' ' TYR . 10.0 mt -71.41 -35.63 71.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.891 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -76.57 -26.66 55.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.271 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 8' ' ' THR . 45.8 mt-30 -83.38 -14.0 53.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 m 71.25 33.96 1.87 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.495 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.27 90.57 0.2 Allowed Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.879 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.686 ' HA ' ' CD1' ' A' ' 9' ' ' TYR . 3.0 pm0 -59.55 124.35 19.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.984 0.897 . . . . 0.0 111.781 177.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -147.15 9.76 0.98 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.488 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' OE1' ' HB3' ' A' ' 22' ' ' ARG . 44.9 mt-10 -147.34 179.76 7.42 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.485 -175.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.655 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.288 13.0 tt -109.49 18.43 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-O 121.91 0.862 . . . . 0.0 111.376 178.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.37 36.33 25.41 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.769 1.271 . . . . 0.0 109.701 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.2 mmt -98.46 -96.54 0.22 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.684 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -152.76 126.9 9.12 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.575 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . 10.7 ptm180 -113.7 154.07 27.92 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -134.98 89.39 2.52 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . -106.72 82.0 0.31 Allowed Glycine 0 CA--C 1.486 -1.76 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.335 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -70.95 -70.14 0.33 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.651 0.263 . . . . 0.0 111.339 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 51.1 mtt180 -87.61 -30.54 20.39 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.322 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 10.5 mt-10 -75.22 -3.75 34.93 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 28.0 p -53.14 -37.15 61.55 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 121.419 0.628 . . . . 0.0 110.455 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.59 -41.09 63.33 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.149 0.5 . . . . 0.0 110.443 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.65 68.6 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.063 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.42 ' SD ' HG21 ' A' ' 3' ' ' THR . 26.2 ptm -51.8 -38.49 55.88 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.763 0.664 . . . . 0.0 112.619 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 28' ' ' CYS . 76.7 mt -57.51 -49.52 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 123.923 0.764 . . . . 0.0 110.567 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 39' ' ' VAL . 38.7 mt-10 -82.79 -26.96 31.3 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.888 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 81' ' ' THR . 14.2 mtpp -58.58 -21.64 53.67 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 123.965 0.906 . . . . 0.0 112.29 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -58.44 -22.76 55.5 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.858 0.724 . . . . 0.0 111.398 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.62 1.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -166.24 -59.64 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -155.31 121.03 5.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 33' ' ' GLU . 77.5 t -128.61 145.13 36.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 2.7 p -96.73 137.59 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 O-C-N 123.858 0.723 . . . . 0.0 110.053 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -139.84 129.43 24.36 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.1 tt -90.26 145.04 7.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 53.0 mtmt 67.54 61.97 0.77 Allowed Pre-proline 0 C--O 1.217 -0.636 0 C-N-CA 123.351 0.66 . . . . 0.0 110.992 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 69.6 Cg_endo -81.14 173.03 12.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.584 2.189 . . . . 0.0 112.19 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.8 55.86 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.134 -1.031 . . . . 0.0 112.258 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 27' ' ' GLU . 29.5 tt0 -121.98 137.56 54.75 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.626 0.727 . . . . 0.0 111.856 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 6.1 mmtt -126.51 111.03 13.92 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.604 ' HB ' HD22 ' A' ' 49' ' ' LEU . 29.2 pt -100.2 122.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.553 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.655 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 54.51 16.42 1.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.014 2.126 . . . . 0.0 113.74 175.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 100' ' ' ALA . . . 83.81 -44.89 3.38 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.006 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.84 125.2 42.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG3' HD11 ' A' ' 48' ' ' ILE . 55.8 ttp180 -67.56 98.82 0.7 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 123.639 0.587 . . . . 0.0 111.173 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.69 123.5 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mm -83.35 -37.68 13.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.894 0.854 . . . . 0.0 109.207 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.43 -7.96 66.41 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.562 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.2 mm -135.3 132.47 20.03 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 51.5 Cg_exo -55.78 109.45 0.42 Allowed 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 123.204 2.603 . . . . 0.0 112.175 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 6.9 Cg_endo -87.67 161.27 7.82 Favored 'Trans proline' 0 N--CA 1.427 -2.404 0 C-N-CA 122.388 2.059 . . . . 0.0 110.938 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.71 139.17 95.38 Favored Pre-proline 0 C--N 1.301 -1.505 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.095 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -46.79 34.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.523 3.262 1 C-N-CA 127.349 5.366 . . . . 0.0 119.656 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' HA ' HG23 ' A' ' 75' ' ' THR 0.27 2.8 pt 67.78 -171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 127.676 2.39 . . . . 0.0 112.602 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' H ' ' A' ' 74' ' ' TYR . . . -143.63 -113.2 0.9 Allowed Glycine 1 N--CA 1.388 -4.525 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.296 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.4 mm -109.38 122.94 64.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 71' ' ' MET . 4.0 p-10 -130.27 125.43 34.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -100.54 -63.72 1.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.1 tp10 -165.33 168.58 16.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -31.7 67.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 8.5 p -93.34 30.88 1.59 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.323 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.416 ' CA ' ' HG3' ' A' ' 85' ' ' GLU . 31.4 m -156.99 161.0 39.57 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 m -71.08 145.02 12.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.29 0.567 . . . . 0.0 110.216 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 83' ' ' VAL . 25.2 ptt? -134.73 139.2 45.01 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.87 80.32 25.26 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.464 ' O ' HG21 ' A' ' 81' ' ' THR . 1.3 Cg_endo -81.86 132.06 7.35 Favored 'Trans proline' 0 N--CA 1.414 -3.198 0 C-N-CA 121.587 1.525 . . . . 0.0 109.981 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' H ' ' N ' ' A' ' 62' ' ' GLY . 79.2 m-85 -91.9 57.89 3.27 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-O 122.268 1.033 . . . . 0.0 108.705 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 61' ' ' ILE . 36.7 p -103.92 102.66 12.46 Favored 'General case' 1 N--CA 1.376 -4.157 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -95.29 106.9 28.97 Favored Pre-proline 0 C--N 1.277 -2.587 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.249 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 75' ' ' THR . 22.6 Cg_endo -95.26 -165.53 0.11 Allowed 'Trans proline' 0 N--CA 1.431 -2.167 0 C-N-CA 122.704 2.27 . . . . 0.0 110.471 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.3 t -95.77 15.7 19.48 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.637 0.732 . . . . 0.0 109.131 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -135.56 -62.95 0.68 Allowed 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 166.28 148.27 5.5 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.186 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.634 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 5.9 m -84.61 158.3 20.92 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 124.879 1.272 . . . . 0.0 108.678 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . . . -122.36 120.68 34.72 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.879 -0.513 . . . . 0.0 111.063 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 95.4 t -103.31 84.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 44' ' ' PRO . 12.4 m -108.45 124.71 65.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' HG3' ' CA ' ' A' ' 69' ' ' THR . 43.4 tt0 -118.43 120.75 38.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.126 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 22.4 tp -96.65 130.77 29.58 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.09 -4.13 11.81 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.214 1.943 . . . . 0.0 111.142 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.537 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 12.0 t -97.64 161.66 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 91' ' ' GLU . 11.7 m-20 -72.44 163.66 65.88 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 118.096 0.407 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.79 6.2 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 89' ' ' ASP . 11.2 pt-20 -67.38 -27.17 66.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.813 0.845 . . . . 0.0 109.016 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.4 mm-40 -64.2 -29.27 70.39 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.083 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 mt -64.35 -28.45 44.91 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.661 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.62 -47.29 70.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.365 0.602 . . . . 0.0 109.602 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -66.78 -32.04 73.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.411 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 92' ' ' GLU . 69.1 mt -86.28 -5.63 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-O 121.879 0.847 . . . . 0.0 110.107 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.78 -33.49 30.85 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.03 -32.79 71.11 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.785 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' VAL . 18.9 t -107.03 28.35 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.448 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.581 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.588 ' HB1' ' HA2' ' A' ' 50' ' ' GLY . . . -59.67 -31.29 69.41 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 37.0 tt0 -157.27 -57.78 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.58 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 92.8 Cg_endo . . . . . 0 N--CA 1.442 -1.557 0 C-N-CA 120.942 1.095 . . . . 0.0 113.228 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.402 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 63.6 m-70 . . . . . 0 CA--C 1.505 -0.788 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -174.95 126.74 0.28 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.875 1.27 . . . . 0.0 109.146 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.534 HG21 ' SD ' ' A' ' 31' ' ' MET . 11.9 t -124.47 134.45 53.05 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.73 0.776 . . . . 0.0 110.855 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -132.08 26.11 4.57 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.916 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.477 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 65.3 m -126.51 101.1 6.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.689 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.567 ' CD2' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -84.96 -46.03 11.63 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.969 0.89 . . . . 0.0 113.031 -176.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' H ' HD13 ' A' ' 6' ' ' LEU . 42.0 tt0 -73.18 -12.29 60.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.118 0.961 . . . . 0.0 110.95 -175.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 24.2 m -73.58 -26.2 60.71 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.986 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -72.64 -32.96 66.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.99 -41.7 99.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 11.3 mm-40 -67.78 -27.7 66.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.13 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 8' ' ' THR . 28.1 mt-30 -78.41 -45.86 21.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.659 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.431 ' OG ' ' HD2' ' A' ' 35' ' ' LYS . 45.1 m -158.68 -68.29 0.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.899 0.38 . . . . 0.0 111.367 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.04 174.33 31.06 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.358 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.02 146.16 24.56 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 124.295 0.644 . . . . 0.0 109.725 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.425 ' HA ' HG23 ' A' ' 54' ' ' ILE . 40.8 t80 -139.59 21.48 2.53 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.635 ' HB3' HD21 ' A' ' 49' ' ' LEU . 38.7 mp0 -140.97 175.84 9.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.091 -175.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.702 HG22 HD22 ' A' ' 49' ' ' LEU . 7.0 tt -109.47 7.04 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 O-C-N 121.047 -1.033 . . . . 0.0 109.079 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 65.2 t-80 74.7 73.97 0.11 Allowed 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 125.829 1.651 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.522 ' HB3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.0 179.49 9.17 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' N ' ' SD ' ' A' ' 20' ' ' MET . 86.2 mttt -61.46 111.06 1.64 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.967 0.889 . . . . 0.0 109.883 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.762 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -105.2 119.24 38.58 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.389 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.3 85.99 2.49 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.676 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.76 81.66 0.48 Allowed Glycine 0 CA--C 1.469 -2.803 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.289 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -69.89 -78.73 0.07 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 117.119 0.459 . . . . 0.0 110.314 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -84.04 -21.04 31.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.958 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.619 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -81.51 -10.72 59.41 Favored 'General case' 0 C--O 1.205 -1.263 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.48 -177.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 53.7 t -51.97 -38.15 55.59 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.569 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.01 -44.59 69.0 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.179 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 41' ' ' HIS . . . -58.85 -52.44 65.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.965 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 3' ' ' THR . 21.6 ptp -54.07 -38.2 65.04 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.864 0.728 . . . . 0.0 112.779 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 28' ' ' CYS . 80.3 mt -58.96 -45.02 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.682 0.753 . . . . 0.0 109.524 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 39' ' ' VAL . 61.7 mm-40 -79.85 -32.2 40.49 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.617 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 84.1 mttt -58.42 -28.5 65.31 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 122.924 0.49 . . . . 0.0 111.165 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 8.1 ttpp -64.66 -13.39 53.82 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.049 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -65.52 0.92 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -142.85 -75.22 0.27 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.721 0.772 . . . . 0.0 109.687 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.48 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 36.3 ptt180 -156.3 128.15 7.35 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 33' ' ' GLU . 69.6 t -140.08 141.64 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.526 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.5 p -106.94 147.06 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CB ' ' HB2' ' A' ' 30' ' ' ALA . 19.8 t-80 -135.56 134.21 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 20.7 tt -90.48 143.65 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 86' ' ' LEU . 61.7 mttp 67.41 64.01 0.72 Allowed Pre-proline 0 C--N 1.32 -0.714 0 C-N-CA 123.822 0.849 . . . . 0.0 110.642 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.38 172.12 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.205 1.27 . . . . 0.0 110.233 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.21 54.43 0.13 Allowed Glycine 0 CA--C 1.464 -3.152 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.619 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 1.6 pm0 -112.35 157.84 20.52 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 122.366 1.079 . . . . 0.0 112.414 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -143.86 72.4 1.35 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 113.479 -1.692 . . . . 0.0 107.577 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.618 HG22 ' HG ' ' A' ' 49' ' ' LEU . 72.0 mt -91.58 108.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.702 HD22 HG22 ' A' ' 18' ' ' ILE . 0.9 OUTLIER 66.01 16.93 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.96 1.304 . . . . 0.0 109.381 177.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.19 4.5 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -175.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.18 118.3 25.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -64.32 104.39 0.76 Allowed 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.131 0.894 . . . . 0.0 112.716 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 49' ' ' LEU . 49.6 mm -114.66 135.13 55.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.425 HG23 ' HA ' ' A' ' 16' ' ' TYR . 60.2 mt -75.49 -35.36 32.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-O 121.233 0.539 . . . . 0.0 110.0 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.51 -21.73 20.34 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.25 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.2 mm -100.62 120.26 56.42 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.42 112.55 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.968 2.445 . . . . 0.0 111.327 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -101.39 -176.61 0.13 Allowed 'Trans proline' 0 N--CA 1.425 -2.553 0 C-N-CA 122.615 2.21 . . . . 0.0 111.081 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.3 t -67.57 121.02 77.35 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.05 56.02 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.93 2.42 . . . . 0.0 114.745 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.6 mt -128.4 147.66 32.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 155.5 148.15 4.94 Favored Glycine 0 CA--C 1.483 -1.933 0 C-N-CA 118.539 -1.791 . . . . 0.0 113.52 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.3 pt -129.12 153.19 38.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.02 115.29 20.31 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.99 -71.97 0.44 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.242 0.544 . . . . 0.0 111.902 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 31.0 tt0 -148.36 166.12 29.02 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 5.7 tpp180 -83.22 -35.43 25.41 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.058 0.933 . . . . 0.0 110.551 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.7 p -88.66 29.96 0.96 Allowed 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.775 1.274 . . . . 0.0 111.514 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 66' ' ' GLU . 87.5 m -154.72 170.72 20.91 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 85' ' ' GLU . 27.1 m -78.93 161.01 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.202 1.001 . . . . 0.0 111.117 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.547 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 26.8 ptt? -118.4 131.38 56.29 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.11 88.35 14.71 Favored Pre-proline 0 C--N 1.291 -1.961 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.343 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 71' ' ' MET . 6.4 Cg_endo -90.53 144.28 3.81 Favored 'Trans proline' 0 N--CA 1.408 -3.534 0 C-N-CA 121.545 1.496 . . . . 0.0 109.966 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -110.87 46.32 1.07 Allowed 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 123.298 1.523 . . . . 0.0 107.405 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 39.6 p -93.26 105.57 17.63 Favored 'General case' 0 N--CA 1.389 -3.498 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.163 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -105.78 96.61 12.85 Favored Pre-proline 0 C--N 1.275 -2.634 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 75' ' ' THR . 23.7 Cg_endo -99.0 -164.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.365 2.71 . . . . 0.0 111.166 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 37.5 t -88.72 -6.16 57.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.362 0.601 . . . . 0.0 110.058 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -96.32 -74.22 0.57 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 171.26 172.08 37.07 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 28.0 m -94.5 141.73 28.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.63 125.58 52.74 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.29 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 41.7 t -126.47 124.69 65.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.2 m -126.71 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.442 ' HB2' HG12 ' A' ' 70' ' ' VAL . 52.5 tt0 -134.31 123.12 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' SER . 28.4 tp -103.05 128.18 28.22 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.84 1.78 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.69 1.593 . . . . 0.0 110.698 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.548 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -103.59 158.27 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.98 151.13 81.22 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 123.203 0.314 . . . . 0.0 110.671 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 11.6 Cg_endo -56.13 -22.03 37.92 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.686 2.924 . . . . 0.0 112.997 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.84 -23.11 60.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.681 0.792 . . . . 0.0 111.458 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 96' ' ' ILE . 8.4 tp10 -69.18 -43.59 73.91 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.42 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 58.4 mt -71.17 -27.0 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.73 -37.64 76.59 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' OE1' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -67.98 -36.36 79.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.631 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 92' ' ' GLU . 37.3 mm -72.65 -17.82 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.961 177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.72 -20.86 58.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.106 0.955 . . . . 0.0 108.715 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.19 -25.96 42.68 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.02 14.78 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.406 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.21 49.77 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.74 -50.65 0.15 Allowed Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.432 -2.114 0 C-N-CA 121.087 1.191 . . . . 0.0 112.664 -178.648 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 85.2 m-70 . . . . . 0 C--O 1.215 -0.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -139.59 129.63 25.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -121.61 117.09 25.85 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -126.08 2.26 7.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.571 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.428 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 61.0 m -86.48 92.19 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.571 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.661 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -85.6 -34.65 21.37 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -81.12 -16.92 51.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.942 0.877 . . . . 0.0 110.931 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 24.3 m -69.79 -22.29 63.34 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -78.33 -20.12 52.09 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.661 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.1 tt -72.91 -37.87 67.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.79 -30.43 69.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.366 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -94.18 -5.49 46.94 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.926 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m 60.33 43.29 13.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.125 0.964 . . . . 0.0 110.305 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.48 49.97 0.65 Allowed Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.532 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.26 138.83 54.26 Favored 'General case' 0 C--O 1.248 1.007 0 O-C-N 124.61 0.829 . . . . 0.0 110.783 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -143.55 20.35 1.86 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -154.97 179.75 8.83 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.806 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.622 ' H ' HD21 ' A' ' 49' ' ' LEU 0.329 13.5 tt -107.31 29.48 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.973 178.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.661 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 43.5 m80 61.99 17.84 9.36 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.423 ' HB2' HD12 ' A' ' 49' ' ' LEU . 60.6 mmm -85.57 -110.79 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.015 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.6 tttp -129.09 115.0 17.06 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -109.15 162.32 14.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.377 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -156.71 87.69 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -103.82 81.01 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 115.154 0.821 . . . . 0.0 115.154 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -77.47 -39.35 46.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.562 0.696 . . . . 0.0 111.177 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.518 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 38.2 mmt180 -107.78 -41.05 5.1 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.712 0.768 . . . . 0.0 111.241 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 26.3 tt0 -78.88 -0.04 29.17 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.103 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 39.4 t -52.58 -47.16 67.05 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 109.728 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -68.88 -38.8 79.9 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.754 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -58.78 -44.74 90.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.701 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.7 ptm -65.02 -33.26 75.61 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.554 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.1 -38.61 82.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 34.8 mt-10 -77.7 -38.25 47.77 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.667 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 31' ' ' MET . 78.7 mttt -63.51 -20.01 65.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.462 0.705 . . . . 0.0 111.771 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -67.4 -20.42 65.53 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.504 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.57 -62.17 1.67 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.62 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 2.2 mmp_? -159.82 -67.14 0.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.577 1.151 . . . . 0.0 109.824 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.591 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 19.0 ptt180 -155.12 122.19 5.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.75 145.11 28.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.985 0.421 . . . . 0.0 110.915 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 6.5 p -108.89 142.38 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 19.4 t60 -135.06 130.8 36.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.6 tt -82.82 144.17 10.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 94.8 mttt 63.82 63.11 1.48 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.148 0.579 . . . . 0.0 110.717 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 63.4 Cg_endo -80.32 170.7 15.82 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.969 1.78 . . . . 0.0 111.767 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 27' ' ' GLU . . . -175.06 54.0 0.13 Allowed Glycine 0 N--CA 1.409 -3.102 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.441 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 7.6 tp10 -110.44 118.39 36.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.507 1.146 . . . . 0.0 108.841 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 34.0 mtmt -110.17 71.44 0.76 Allowed 'General case' 0 N--CA 1.393 -3.309 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.136 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.541 ' HB ' HD22 ' A' ' 49' ' ' LEU . 5.0 pt -70.92 102.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.25 -3.74 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.923 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.622 HD21 ' H ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 69.72 -26.12 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 126.823 2.049 . . . . 0.0 113.621 175.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.91 -3.36 48.62 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.71 116.18 11.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -69.73 88.17 0.52 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 mm -123.73 127.38 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -76.39 -28.86 18.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.548 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.21 -25.43 17.59 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.3 mt -99.88 121.67 53.45 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.65 107.65 0.91 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.773 2.315 . . . . 0.0 110.92 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -104.8 179.92 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 122.68 2.253 . . . . 0.0 111.752 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' THR . 51.3 t -84.87 106.73 9.35 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 75' ' ' THR . 89.9 Cg_endo -84.41 98.78 0.74 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.234 1.956 . . . . 0.0 114.554 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -131.49 158.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 130.12 167.18 11.99 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 118.577 -1.773 . . . . 0.0 113.769 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.2 mp -142.63 124.35 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.43 101.76 12.27 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.74 -55.65 16.16 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.55 171.41 7.61 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HA ' HH11 ' A' ' 67' ' ' ARG . 3.4 tpp180 -85.68 -35.99 20.54 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 118.881 0.764 . . . . 0.0 112.113 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 9.4 t -91.03 28.32 1.62 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 122.96 1.362 . . . . 0.0 108.569 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' ARG . 24.8 m -143.21 163.93 31.59 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 17.1 m -72.88 124.01 28.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.332 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.509 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.9 ptt? -85.32 132.19 34.29 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.4 tp -116.02 80.92 9.53 Favored Pre-proline 0 C--N 1.293 -1.884 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.667 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 9.5 Cg_endo -89.58 104.8 0.37 Allowed 'Trans proline' 0 N--CA 1.409 -3.456 0 C-N-CA 121.971 1.781 . . . . 0.0 108.707 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.26 57.28 4.39 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.114 1.435 . . . . 0.0 107.374 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.634 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 38.2 p -91.17 127.86 36.77 Favored 'General case' 1 N--CA 1.378 -4.064 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.58 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -99.49 95.97 4.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.4 Cg_endo -105.29 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.787 0 C-N-CA 122.974 2.449 . . . . 0.0 111.281 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.6 t -95.87 12.08 31.47 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -117.74 -80.83 0.61 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.068 -0.395 . . . . 0.0 110.339 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.72 176.35 47.99 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.591 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 29.2 m -94.7 135.14 36.53 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.447 0.641 . . . . 0.0 109.401 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.52 112.38 23.89 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.949 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 33.9 t -115.34 134.61 57.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 15.8 m -136.26 151.08 28.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -142.13 122.12 13.67 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.4 tp -104.13 139.05 19.73 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 5.7 Cg_exo -86.14 2.1 7.56 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 122.616 2.211 . . . . 0.0 111.69 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.59 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 9.9 t -103.14 150.84 6.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.44 144.32 92.28 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 124.14 0.9 . . . . 0.0 110.163 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.4 -18.67 3.84 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.61 3.54 . . . . 0.0 114.385 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.51 -18.38 51.52 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.642 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 25.6 tp10 -60.24 -28.03 67.7 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 124.187 0.995 . . . . 0.0 109.575 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.75 -38.37 75.65 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.121 0 C-N-CA 122.155 0.182 . . . . 0.0 111.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.46 -33.64 75.54 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.406 0.622 . . . . 0.0 110.768 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 63.4 ttt180 -71.49 -45.58 62.1 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 ' HG2' ' A' ' 47' ' ' LYS . 14.8 mm -65.64 -22.5 30.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.189 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.0 tp -74.21 -30.07 62.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.154 0.502 . . . . 0.0 109.792 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.21 -41.74 27.62 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.65 15.66 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.996 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -67.14 -33.53 75.63 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.25 98.06 21.56 Favored Pre-proline 0 N--CA 1.416 -2.136 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.555 2.837 . . . . 0.0 111.269 177.716 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 CA--C 1.498 -1.04 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.41 ' SD ' ' HE2' ' A' ' 4' ' ' PHE . 26.0 ptt? -179.97 133.22 0.1 Allowed 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.238 1.415 . . . . 0.0 108.762 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.4 m -132.16 122.82 25.93 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HE2' ' SD ' ' A' ' 2' ' ' MET . 88.6 m-85 -116.85 -8.99 11.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.976 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 76.5 m -80.0 100.8 8.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.807 0.813 . . . . 0.0 110.793 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.668 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -88.32 -38.13 15.41 Favored 'General case' 0 C--O 1.182 -2.461 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 30.3 tt0 -68.82 -9.45 51.24 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.817 0.818 . . . . 0.0 111.871 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.487 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.4 m -75.38 -15.17 60.49 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.104 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.661 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.71 -28.4 67.29 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.409 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.661 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 6.1 tt -70.23 -39.05 75.31 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.055 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -76.36 -1.79 28.58 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.714 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.97 -28.71 5.47 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -163.58 -54.13 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.442 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.32 -153.91 24.71 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HB2' HG12 ' A' ' 56' ' ' ILE . 2.2 mp0 -80.63 137.33 36.34 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 118.994 1.397 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' HA ' HG23 ' A' ' 54' ' ' ILE . 34.9 t80 -142.31 3.28 1.52 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.591 0.71 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB3' HD21 ' A' ' 49' ' ' LEU . 18.4 mm-40 -150.69 176.94 10.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.593 HG22 ' HG ' ' A' ' 49' ' ' LEU . 11.7 tt -110.35 157.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.484 ' HA ' HD21 ' A' ' 6' ' ' LEU . 6.5 t60 -71.53 71.9 0.7 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.472 1.13 . . . . 0.0 108.987 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.4 mmt -138.68 -167.41 2.19 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.089 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.72 113.28 22.44 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -100.75 130.31 46.76 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -124.08 85.17 2.37 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.513 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -99.58 75.92 0.48 Allowed Glycine 0 C--N 1.282 -2.442 0 C-N-CA 119.399 -1.382 . . . . 0.0 111.013 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.85 -79.87 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 121.35 0.595 . . . . 0.0 110.629 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.511 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 5.6 mpt_? -75.7 -35.83 60.19 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.006 0.432 . . . . 0.0 111.688 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 18.0 tp10 -66.28 -11.37 50.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.002 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 36.3 t -51.01 -41.75 59.99 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.477 0.656 . . . . 0.0 110.274 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.03 -43.1 75.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.075 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.695 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -66.28 -45.64 79.77 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.1 ptp -56.64 -33.11 66.0 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.519 0.512 . . . . 0.0 111.726 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 28' ' ' CYS . 51.2 mm -62.97 -36.34 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.434 0.635 . . . . 0.0 110.023 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -78.35 -33.63 48.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.759 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HE2' ' O ' ' A' ' 39' ' ' VAL . 60.7 mttt -67.42 -9.49 42.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.719 1.208 . . . . 0.0 113.391 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -69.49 -22.93 63.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.35 -65.01 0.75 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -152.45 -67.7 0.16 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.1 ttp180 -165.82 115.43 1.0 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.468 0.707 . . . . 0.0 109.413 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.554 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 44.3 t -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -112.68 149.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.695 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 32.5 t-80 -138.28 119.5 14.62 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.4 tt -83.31 147.44 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 94.3 mttt 68.61 51.59 0.49 Allowed Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.699 0.799 . . . . 0.0 112.039 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 96.4 Cg_endo -90.18 159.58 4.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.418 2.079 . . . . 0.0 110.608 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.511 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -151.66 44.9 0.64 Allowed Glycine 0 CA--C 1.467 -2.951 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 4.2 pm0 -97.76 156.86 16.37 Favored 'General case' 0 C--N 1.262 -3.2 0 CA-C-O 122.627 1.204 . . . . 0.0 113.304 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 0.5 OUTLIER -145.19 86.85 1.79 Allowed 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.418 -1.719 . . . . 0.0 107.363 175.176 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 48' ' ' ILE . 2.6 pt -87.24 99.9 9.18 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 113.471 -1.695 . . . . 0.0 112.313 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.593 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 66.88 4.5 3.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.976 2.11 . . . . 0.0 114.098 175.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.56 -21.42 5.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.142 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.74 30.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' CZ ' HD12 ' A' ' 48' ' ' ILE . 21.8 tpt180 -86.58 105.93 17.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.63 136.91 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.471 HG23 ' HA ' ' A' ' 16' ' ' TYR . 45.4 mm -99.1 -40.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.531 0.681 . . . . 0.0 109.588 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.83 -26.37 22.61 Favored Glycine 0 C--N 1.312 -0.756 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 15' ' ' GLU . 36.6 mm -111.69 109.79 55.35 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.89 109.25 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.995 2.463 . . . . 0.0 111.723 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -101.95 -163.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.415 2.743 . . . . 0.0 109.919 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 75' ' ' THR . 86.6 t -73.47 118.95 73.15 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.13 40.86 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.118 2.545 . . . . 0.0 114.541 -172.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 65.1 mt -116.31 149.52 18.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . 166.5 138.35 2.42 Favored Glycine 0 C--N 1.305 -1.186 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.894 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.51 114.14 41.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 122.706 0.402 . . . . 0.0 110.661 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -92.43 106.2 18.24 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.73 -64.24 1.04 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 68' ' ' SER . 3.7 tm-20 -166.94 179.94 5.0 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -176.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.445 HH22 ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.04 -40.09 14.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 119.045 0.839 . . . . 0.0 109.437 -176.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.677 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 44.6 t -89.39 26.76 1.59 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.695 1.236 . . . . 0.0 109.511 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.9 m -144.28 160.93 40.16 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 85' ' ' GLU . 17.3 m -77.72 144.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 122.676 0.39 . . . . 0.0 110.335 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.617 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 27.1 ptt? -99.93 136.7 39.45 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.9 mm -109.05 89.19 6.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 71' ' ' MET . 2.5 Cg_endo -88.1 146.9 6.59 Favored 'Trans proline' 0 N--CA 1.427 -2.439 0 C-N-CA 122.126 1.884 . . . . 0.0 111.737 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 67.7 m-85 -123.25 44.27 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.579 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 41.4 p -100.86 111.41 23.62 Favored 'General case' 0 N--CA 1.4 -2.961 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.103 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -100.74 97.2 6.37 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 75' ' ' THR . 97.2 Cg_endo -103.98 -165.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.04 2.493 . . . . 0.0 111.593 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.6 t -74.04 -21.57 59.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.219 0.533 . . . . 0.0 110.504 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -95.84 -84.7 0.34 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.734 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.97 -179.67 45.7 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 9.8 m -106.4 145.58 31.56 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -119.34 121.88 40.56 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -175.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 56.3 t -110.02 120.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 27' ' ' GLU . 35.4 m -113.49 143.77 22.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.9 tt0 -148.65 115.78 6.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.216 0.462 . . . . 0.0 110.224 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 68' ' ' SER . 29.5 tp -94.84 143.33 25.98 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -93.39 -2.55 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.621 1.547 . . . . 0.0 110.971 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.606 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 23.7 t -91.49 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.19 149.3 75.96 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 124.166 0.916 . . . . 0.0 112.792 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.69 -6.17 4.21 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.838 3.025 . . . . 0.0 113.351 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.56 -27.3 66.11 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.274 0.559 . . . . 0.0 109.504 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -60.07 -26.82 66.47 Favored 'General case' 0 C--O 1.204 -1.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.163 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.3 mt -56.87 -40.12 69.45 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.809 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.633 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.46 -47.67 85.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.645 0.736 . . . . 0.0 109.795 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -64.95 -44.13 90.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.451 HG22 ' HE2' ' A' ' 47' ' ' LYS . 73.7 mt -69.6 -28.29 37.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.613 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.1 tp -70.77 -29.6 65.86 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 123.313 0.645 . . . . 0.0 110.173 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.93 -32.25 51.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.7 15.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.355 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -53.69 -47.89 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.747 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -135.6 87.93 25.28 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 C--O 1.257 1.432 0 C-N-CA 123.262 2.641 . . . . 0.0 112.347 -178.318 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 65.7 mtm -156.11 124.7 5.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -102.04 113.59 26.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 64.9 m-85 -127.96 12.5 6.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.799 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 74.0 m -140.66 102.68 4.36 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -77.23 -36.45 54.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.69 0.757 . . . . 0.0 111.419 -175.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' H ' HD13 ' A' ' 6' ' ' LEU . 10.1 tp10 -71.09 -25.56 62.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.691 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -77.99 -24.34 48.03 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -24.17 60.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 120.975 0.417 . . . . 0.0 110.232 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.51 -43.63 98.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -69.42 -35.76 76.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.226 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.31 -35.42 66.08 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.435 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -161.81 -54.92 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.243 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.7 173.47 37.22 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.3 141.22 38.64 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.489 0.662 . . . . 0.0 111.73 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' HG23 ' A' ' 54' ' ' ILE . 88.5 t80 -137.66 4.86 2.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 44.7 mt-10 -149.79 146.33 27.11 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.572 HG22 ' HG ' ' A' ' 49' ' ' LEU . 15.3 tt -85.1 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.561 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -68.59 77.17 0.28 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 122.724 1.25 . . . . 0.0 110.483 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.418 ' CE ' ' HA ' ' A' ' 20' ' ' MET . 2.0 mmt -146.15 -174.39 4.42 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.39 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 10.5 mtmp? -88.5 114.72 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.164 0.893 . . . . 0.0 110.874 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.605 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -102.98 152.53 21.21 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.124 -175.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.08 77.75 1.32 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.616 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -97.68 82.35 0.68 Allowed Glycine 0 C--N 1.294 -1.789 0 C-N-CA 121.02 -0.609 . . . . 0.0 114.052 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -70.18 -82.52 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 117.352 0.576 . . . . 0.0 111.652 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.559 ' HB2' ' H ' ' A' ' 45' ' ' GLY . 2.5 mmp_? -70.39 -36.72 74.25 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' CB ' ' HB3' ' A' ' 46' ' ' GLU . 2.7 tp10 -69.35 -12.64 61.83 Favored 'General case' 0 C--O 1.217 -0.647 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.219 -177.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 44.4 t -60.9 -34.19 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-O 121.218 0.532 . . . . 0.0 110.009 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -70.53 -41.64 72.27 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.788 0.804 . . . . 0.0 109.398 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -64.23 -47.73 78.56 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.106 -1.407 . . . . 0.0 113.077 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.509 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 ptp -56.12 -31.64 63.47 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.577 0.548 . . . . 0.0 112.272 -176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 28' ' ' CYS . 48.6 mm -59.65 -42.84 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 122.08 0.943 . . . . 0.0 109.078 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.87 -34.34 30.12 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.547 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 31' ' ' MET . 72.2 mttt -65.92 -12.91 58.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.702 0.801 . . . . 0.0 111.927 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -71.11 -24.83 62.37 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.816 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.67 -53.14 36.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.107 0.48 . . . . 0.0 110.718 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -166.9 -69.97 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' THR . 58.3 ttp180 -162.12 123.63 2.71 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 84.4 t -134.66 159.95 41.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.7 p -105.96 143.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 123.488 0.715 . . . . 0.0 109.596 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.562 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 62.3 t60 -135.01 123.34 23.14 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 2.6 mp -89.7 142.42 12.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 99.2 mttt 71.62 43.35 0.2 Allowed Pre-proline 0 C--O 1.21 -1.019 0 C-N-CA 124.11 0.964 . . . . 0.0 112.545 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 9.8 Cg_endo -75.42 143.04 27.33 Favored 'Trans proline' 0 C--N 1.373 1.838 0 CA-C-N 120.786 1.316 . . . . 0.0 110.783 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 26' ' ' ARG . . . -144.03 54.29 0.58 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 10.0 pm0 -101.1 129.48 46.99 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.19 0.995 . . . . 0.0 110.125 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 43.1 mtmt -118.84 69.99 0.82 Allowed 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.407 ' C ' HD22 ' A' ' 49' ' ' LEU . 39.1 pt -86.57 109.7 19.25 Favored 'Isoleucine or valine' 1 C--N 1.222 -4.936 0 CA-C-N 111.317 -2.674 . . . . 0.0 112.329 -175.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.572 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER 65.7 -3.1 0.76 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.936 2.095 . . . . 0.0 113.863 175.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.04 -25.66 13.53 Favored Glycine 0 C--N 1.293 -1.82 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.23 19.33 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 52' ' ' ARG . 2.2 ptm180 -71.39 103.05 2.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.735 0.779 . . . . 0.0 111.646 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 55' ' ' GLY . 55.9 mt -128.0 132.17 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 16' ' ' TYR . 49.4 mm -73.45 -27.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.99 0.9 . . . . 0.0 108.888 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 53' ' ' ILE . . . 97.23 -28.1 15.51 Favored Glycine 0 CA--C 1.492 -1.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 78' ' ' CYS . 62.4 mt -105.54 114.99 62.56 Favored Pre-proline 0 N--CA 1.416 -2.159 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.85 107.27 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.605 2.203 . . . . 0.0 110.518 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -95.96 -174.99 0.29 Allowed 'Trans proline' 0 N--CA 1.426 -2.441 0 C-N-CA 122.671 2.247 . . . . 0.0 111.663 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' THR . 42.7 t -68.86 116.48 41.65 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.81 70.52 7.38 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 122.002 1.801 . . . . 0.0 113.293 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.0 mt -130.71 145.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 156.94 153.67 6.75 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 118.98 -1.581 . . . . 0.0 113.67 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.75 103.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.65 108.97 20.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.2 -69.8 0.53 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.418 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.514 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -153.21 164.92 37.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -80.76 -31.69 35.81 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.022 0.915 . . . . 0.0 108.602 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.514 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 11.1 p -94.86 38.48 1.12 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.4 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -161.75 171.22 18.21 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.44 161.21 4.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.69 0.757 . . . . 0.0 109.714 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.644 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 16.1 ptp -140.09 118.0 11.78 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -106.65 94.59 10.46 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-O 121.137 0.494 . . . . 0.0 109.913 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 71' ' ' MET . 9.6 Cg_endo -92.2 164.99 3.08 Favored 'Trans proline' 0 N--CA 1.412 -3.296 0 C-N-CA 122.103 1.869 . . . . 0.0 110.8 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -129.1 58.81 1.59 Allowed 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.558 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 27.2 p -100.42 110.11 22.29 Favored 'General case' 0 N--CA 1.386 -3.644 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.149 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -105.19 100.65 26.27 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 75' ' ' THR . 55.8 Cg_endo -104.74 -159.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 123.092 2.528 . . . . 0.0 108.41 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.439 ' HB3' HD13 ' A' ' 56' ' ' ILE . 50.3 t -83.02 -9.04 59.47 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.062 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.34 -79.59 0.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.796 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 176.45 -172.23 45.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.8 m -112.7 149.18 33.27 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 117.452 0.626 . . . . 0.0 109.422 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.84 47.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 59.0 t -109.82 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG12 ' OE2' ' A' ' 27' ' ' GLU . 2.6 m -102.2 155.27 4.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -155.0 108.83 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 68' ' ' SER . 25.1 tp -97.61 128.97 32.7 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.15 22.55 0.94 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.542 2.161 . . . . 0.0 111.412 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 68' ' ' SER . 14.6 t -130.5 151.7 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.84 152.55 82.39 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HD3' ' OG ' ' A' ' 68' ' ' SER . 38.4 Cg_endo -65.41 -4.19 8.97 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.736 2.957 . . . . 0.0 112.656 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.64 -29.91 70.37 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -66.1 -25.16 66.88 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.056 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.37 -35.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 O-C-N 123.074 0.234 . . . . 0.0 110.681 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.81 -43.77 97.93 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -43.5 83.55 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.629 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.88 -21.88 24.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 123.397 0.679 . . . . 0.0 111.099 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -74.06 -27.29 60.85 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.259 0.552 . . . . 0.0 109.808 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.5 -41.61 14.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.989 0.9 . . . . 0.0 108.63 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.6 t -82.45 7.86 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.987 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -52.91 -60.59 3.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.497 1.119 . . . . 0.0 113.813 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.01 -47.91 0.33 Allowed Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.426 -2.451 0 C-N-CA 121.583 1.522 . . . . 0.0 112.507 177.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 p80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -174.01 135.6 0.49 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.3 m -134.14 124.16 25.6 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' HG3' ' A' ' 22' ' ' ARG . 74.0 m-85 -121.55 3.32 10.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.83 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.2 m -95.75 101.74 13.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.306 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 7' ' ' GLU . 1.6 pp -92.3 -29.71 16.23 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.797 0.808 . . . . 0.0 112.263 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' N ' HD12 ' A' ' 6' ' ' LEU . 35.2 tt0 -68.97 -24.51 64.26 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.158 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 34.8 m -66.44 -32.48 73.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.022 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.74 -28.95 60.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.889 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tt -69.52 -35.13 75.19 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -66.8 -38.06 85.76 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.624 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 8' ' ' THR . 89.0 mt-30 -73.72 -3.12 26.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.056 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m 67.48 13.5 9.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.107 1.363 . . . . 0.0 111.783 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.84 59.74 0.36 Allowed Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.67 127.49 31.53 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.244 -0.978 . . . . 0.0 110.613 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -145.77 10.73 1.22 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 27.8 mt-10 -148.0 176.65 10.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.809 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.494 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 9.6 tt -127.33 161.02 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -67.31 73.36 0.13 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.359 1.076 . . . . 0.0 111.111 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.43 ' HB2' HD12 ' A' ' 49' ' ' LEU . 81.9 mtp -130.1 -121.79 0.22 Allowed 'General case' 0 C--N 1.266 -3.055 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.169 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 11.0 tmtt? -147.18 122.89 10.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HD2' ' OE1' ' A' ' 17' ' ' GLU . 14.1 ptm180 -104.11 167.33 9.83 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -152.58 79.25 1.22 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 46' ' ' GLU . . . -109.32 82.84 0.31 Allowed Glycine 0 CA--C 1.471 -2.714 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 -176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -72.22 -63.45 1.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.939 0.876 . . . . 0.0 109.251 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.619 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 29.2 mmt180 -84.12 -38.81 20.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.906 -176.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 46' ' ' GLU . 29.2 mt-10 -74.84 -1.86 24.14 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 31' ' ' MET . 41.5 t -51.21 -45.15 61.78 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.08 -41.22 74.39 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.59 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.4 -47.19 87.15 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 124.165 0.986 . . . . 0.0 113.152 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 26.7 ptt? -56.83 -38.67 72.95 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.414 0.446 . . . . 0.0 111.345 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.65 -39.05 80.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.747 0.784 . . . . 0.0 109.604 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' HG11 ' A' ' 39' ' ' VAL . 13.7 mm-40 -75.11 -42.74 55.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.63 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 74.5 mttt -63.58 -20.03 65.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.543 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -67.28 -26.52 66.58 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.552 0.533 . . . . 0.0 110.306 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -53.15 32.34 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.866 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -162.43 -70.84 0.05 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.559 0.695 . . . . 0.0 110.052 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.3 ttt180 -163.28 117.67 1.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 33' ' ' GLU . 55.4 t -137.15 144.03 33.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.593 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.1 p -97.22 145.81 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.482 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 74.0 t60 -138.93 121.45 16.19 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 61.6 mt -79.42 138.06 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 64.6 mttm 74.68 65.88 0.27 Allowed Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.692 1.245 . . . . 0.0 109.22 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 48.6 Cg_endo -88.38 166.17 6.57 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.224 1.949 . . . . 0.0 111.767 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 27' ' ' GLU . . . -179.79 55.61 0.08 OUTLIER Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.794 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 7.1 tp10 -122.12 145.22 48.38 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.66 0.784 . . . . 0.0 109.958 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 47' ' ' LYS . 4.5 mmpt? -140.46 80.98 1.78 Allowed 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 50' ' ' GLY . 23.8 pt -71.75 105.14 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.323 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 0.1 OUTLIER 68.52 -23.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.756 2.022 . . . . 0.0 113.996 175.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 102.16 -30.43 10.4 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -176.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.01 142.98 50.25 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.25 97.7 9.72 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.389 -1.325 . . . . 0.0 113.386 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.02 117.83 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.28 -37.79 11.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 120.968 0.413 . . . . 0.0 111.344 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.98 -0.97 70.01 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.28 130.45 16.04 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -53.89 107.46 0.21 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.366 2.711 . . . . 0.0 112.903 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -114.33 -169.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 123.324 2.682 . . . . 0.0 112.63 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.11 107.95 51.23 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.648 ' HA ' HG22 ' A' ' 75' ' ' THR . 32.5 Cg_exo -61.26 118.42 5.29 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.23 2.62 . . . . 0.0 111.964 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.6 mm -128.54 100.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 73' ' ' PRO . . . -118.18 81.1 0.32 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.51 112.97 38.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 4.8 p-10 -126.03 127.28 45.61 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.12 -48.21 10.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.8 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.5 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 21.7 tt0 -170.16 167.17 8.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 6.7 tpt85 -76.58 -29.66 56.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 120.801 0.334 . . . . 0.0 111.059 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.5 ' HB3' ' OE1' ' A' ' 66' ' ' GLU . 33.1 t -99.24 33.74 2.34 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.897 1.332 . . . . 0.0 108.558 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -148.75 162.53 39.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.93 124.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 122.137 0.97 . . . . 0.0 112.582 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.54 ' HE3' ' HA ' ' A' ' 67' ' ' ARG . 16.7 ptp -134.72 152.05 51.46 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.407 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.412 HG12 HG22 ' A' ' 83' ' ' VAL . 59.9 mt -121.65 90.47 48.15 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 42.2 Cg_endo -105.02 44.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.052 2.501 . . . . 0.0 113.437 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.74 -103.4 0.14 Allowed 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 121.526 0.679 . . . . 0.0 112.012 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 60' ' ' PRO . 3.0 p -162.18 179.66 7.75 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.973 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.71 85.02 43.87 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -103.59 -167.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 123.086 2.524 . . . . 0.0 113.896 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.67 -22.12 60.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.008 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -75.59 -68.79 0.53 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.578 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 170.4 163.72 24.91 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 38' ' ' ARG . 6.5 m -91.73 151.18 20.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . . . -127.23 126.08 42.1 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.5 t -118.21 129.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.478 HG12 ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -122.72 142.37 39.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.7 tt0 -142.83 122.17 13.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 25.0 tp -99.78 137.06 20.12 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.54 -5.74 7.16 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.153 1.902 . . . . 0.0 111.53 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.643 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 16.0 t -99.01 163.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 13.9 t70 -65.32 144.91 99.11 Favored Pre-proline 0 C--N 1.304 -1.396 0 C-N-CA 123.153 0.581 . . . . 0.0 110.214 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.72 -9.58 0.15 Allowed 'Trans proline' 0 CA--C 1.557 1.645 0 C-N-CA 124.034 3.156 . . . . 0.0 115.404 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 9.9 pt-20 -59.43 -18.7 41.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.12 0.568 . . . . 0.0 111.411 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 96' ' ' ILE . 13.3 mm-40 -61.27 -19.91 62.26 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.24 -36.96 77.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.564 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.89 -39.22 88.46 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 109.609 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -69.37 -47.01 65.57 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.445 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 92' ' ' GLU . 44.3 mm -73.34 -10.13 13.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.824 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.65 -31.4 32.36 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.45 -34.28 54.49 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 99' ' ' VAL . 41.3 t -100.72 29.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.574 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.61 -20.71 64.51 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.659 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.497 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.6 mt-10 -139.89 -59.47 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 52.5 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 C-N-CA 121.415 1.41 . . . . 0.0 113.858 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.421 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 18.8 ptp -171.44 130.8 0.72 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.315 0.646 . . . . 0.0 110.016 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -120.96 126.54 50.21 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.597 0.713 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CE1' ' HA ' ' A' ' 23' ' ' ALA . 91.7 m-85 -133.25 22.05 4.06 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.63 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 7.7 p -103.44 78.46 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.089 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 22' ' ' ARG . 5.2 tt -70.68 -54.28 12.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.085 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -75.96 3.95 9.23 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.7 1.238 . . . . 0.0 111.802 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 5' ' ' CYS . 9.0 m -87.44 -2.24 58.48 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.541 ' HD1' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -64.68 -17.92 64.52 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.111 176.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.541 ' N ' ' HD1' ' A' ' 9' ' ' TYR . 4.8 tt -76.12 -35.55 59.24 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.45 -30.47 68.39 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 108.073 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 9' ' ' TYR . 45.5 mt-30 -78.39 -14.63 59.31 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.575 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.7 t 67.03 30.75 7.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.22 1.008 . . . . 0.0 109.833 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.79 88.66 0.11 Allowed Glycine 0 N--CA 1.417 -2.608 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.186 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.47 132.67 54.63 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.645 ' HA ' HG23 ' A' ' 54' ' ' ILE . 48.2 t80 -139.44 12.06 2.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.509 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 6' ' ' LEU . 41.4 mt-10 -146.46 176.21 9.97 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.705 HG22 ' HG ' ' A' ' 49' ' ' LEU . 11.2 tp -118.9 154.5 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -69.71 74.55 0.42 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.968 1.366 . . . . 0.0 111.387 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.3 mmm -132.51 -145.8 0.27 Allowed 'General case' 0 C--N 1.269 -2.897 0 C-N-CA 127.235 2.214 . . . . 0.0 107.371 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HE3' ' HG2' ' A' ' 101' ' ' GLU . 56.7 mtmt -119.45 129.54 54.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 119.202 0.91 . . . . 0.0 110.471 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.591 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -105.8 175.18 5.58 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB2' ' CG ' ' A' ' 102' ' ' PRO . . . -163.59 76.89 0.39 Allowed 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.822 0.701 . . . . 0.0 111.901 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 46' ' ' GLU . . . -90.9 74.46 1.69 Allowed Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.674 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.1 -68.19 0.58 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.559 0.695 . . . . 0.0 110.357 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.627 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 32.3 mmt180 -75.33 -44.18 46.68 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.896 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 24.8 mt-10 -77.62 2.59 16.11 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 41.2 t -50.41 -44.34 55.06 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.89 -34.07 57.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.464 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' C ' ' HD3' ' A' ' 34' ' ' LYS . . . -61.4 -48.79 79.62 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.456 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.9 ptp -59.89 -33.85 72.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.907 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.747 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 81.3 mt -62.94 -34.24 65.13 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.16 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.51 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.04 -31.78 21.79 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.042 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.7 mtpt -59.09 -16.8 21.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.893 0.877 . . . . 0.0 111.877 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 22.3 ptmt -77.4 -16.0 59.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.455 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.4 72.31 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.347 -0.221 . . . . 0.0 111.524 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 177.17 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' THR . 41.5 ttp180 -156.78 116.87 3.55 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -133.1 146.06 33.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.664 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.3 p -93.4 137.81 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 124.119 0.887 . . . . 0.0 109.017 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.417 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 27.7 t60 -139.1 125.79 20.74 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.82 140.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 62.5 mttp 69.23 65.67 0.5 Allowed Pre-proline 0 C--O 1.22 -0.467 0 C-N-CA 124.24 1.016 . . . . 0.0 110.2 -175.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 44.3 Cg_endo -88.35 161.48 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.802 2.335 . . . . 0.0 112.91 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.594 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 177.69 62.64 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 16.1 tt0 -118.21 101.29 8.1 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 124.147 0.979 . . . . 0.0 108.667 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -95.43 91.39 6.18 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.002 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 22' ' ' ARG . 42.1 pt -92.13 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.246 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.705 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 68.32 -1.99 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.139 1.776 . . . . 0.0 112.818 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.95 -33.16 4.32 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.27 122.41 37.68 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.524 ' HD3' HD11 ' A' ' 48' ' ' ILE . 19.1 tpp180 -64.65 100.2 0.37 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.795 0.684 . . . . 0.0 110.409 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.509 HD12 HG21 ' A' ' 18' ' ' ILE . 60.2 mt -121.47 131.1 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.645 HG23 ' HA ' ' A' ' 16' ' ' TYR . 57.9 mt -99.15 -31.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.666 0.746 . . . . 0.0 109.822 -177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -28.48 15.48 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.34 117.04 43.66 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.19 112.11 3.24 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.806 2.338 . . . . 0.0 113.514 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 74' ' ' TYR . 3.1 Cg_endo -91.92 -171.35 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.924 2.416 . . . . 0.0 108.838 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.587 ' HB ' ' CB ' ' A' ' 75' ' ' THR . 80.9 t -82.2 132.85 52.05 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.1 Cg_endo -81.6 70.59 7.23 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.557 1.504 . . . . 0.0 113.827 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.14 91.67 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.94 103.25 3.02 Favored Glycine 0 N--CA 1.414 -2.827 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.815 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.8 mt -102.35 76.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -110.94 118.83 37.17 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.164 0.507 . . . . 0.0 110.081 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -90.18 -57.15 2.95 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.373 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.639 ' HG3' ' H ' ' A' ' 68' ' ' SER . 9.3 tp10 -162.54 167.61 23.11 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.409 HH11 HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.63 -27.41 34.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.639 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 20.8 t -94.09 30.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 123.058 1.409 . . . . 0.0 108.952 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.7 m -153.85 162.93 40.82 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -63.64 131.25 29.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.765 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.4 ptp -126.99 124.33 39.17 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 83' ' ' VAL . 23.7 mt -114.1 96.79 43.32 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.24 148.89 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.851 1.7 . . . . 0.0 113.04 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 58' ' ' PRO . 73.4 m-85 75.57 -155.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 125.088 1.355 . . . . 0.0 110.681 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.587 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 97.4 m -145.61 -75.51 0.22 Allowed 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HG2' HG22 ' A' ' 75' ' ' THR . 73.1 mmtt -129.53 90.87 42.68 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.433 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HB3' HD13 ' A' ' 54' ' ' ILE . 4.7 Cg_exo -85.85 -171.03 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.671 2.247 . . . . 0.0 110.837 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 41.2 t -81.53 -34.45 31.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.473 0.654 . . . . 0.0 110.465 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -89.3 -68.55 0.77 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -177.1 169.93 42.41 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.9 m -98.42 152.52 19.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -121.94 149.9 42.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.8 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.5 t -134.43 98.67 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 19.9 m -113.48 135.96 51.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.32 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -135.82 124.94 24.42 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.979 0.418 . . . . 0.0 110.184 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 68' ' ' SER . 27.0 tp -101.34 125.83 36.52 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.93 13.41 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.484 2.122 . . . . 0.0 111.05 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.556 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 18.3 t -113.71 151.91 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 25.7 m-20 -61.95 154.85 66.32 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 124.08 0.952 . . . . 0.0 111.309 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.29 -17.09 24.85 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.723 2.949 . . . . 0.0 113.367 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.8 pt-20 -63.41 -16.79 61.56 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.516 0.726 . . . . 0.0 111.222 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.14 -19.78 63.2 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 93' ' ' ILE . 26.3 mm -66.42 -28.31 43.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.308 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.48 -42.66 92.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.326 0.584 . . . . 0.0 109.749 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.51 -50.24 70.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.654 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.4 mt -68.14 -20.06 25.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.452 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 tp -70.91 -28.67 64.7 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.285 0.634 . . . . 0.0 110.0 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.95 -32.25 61.69 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.3 t -83.58 -3.07 7.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.67 -35.17 60.76 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.272 0.629 . . . . 0.0 112.534 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.412 ' HG2' ' HE3' ' A' ' 21' ' ' LYS . 32.7 tt0 -149.39 93.94 4.0 Favored Pre-proline 0 N--CA 1.408 -2.564 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.548 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 23.1 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 123.25 2.634 . . . . 0.0 112.422 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 m80 . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.764 0.316 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.578 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 72.0 mtm -147.53 123.18 10.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.9 m -98.77 114.43 26.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.794 0.33 . . . . 0.0 111.04 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 66.9 m-85 -129.28 14.41 6.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.455 0.645 . . . . 0.0 109.306 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.5 m -135.53 102.85 5.25 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -78.56 -33.95 47.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.079 0.942 . . . . 0.0 111.956 -175.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.84 -20.99 60.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.88 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 14.6 m -70.68 -35.15 72.67 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -70.29 -27.3 64.3 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.454 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.14 -51.12 70.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.85 -27.85 66.2 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.01 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 8' ' ' THR . 53.2 mt-30 -77.35 -44.74 28.37 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.662 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -148.37 -50.76 0.17 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.289 0.566 . . . . 0.0 110.904 -176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.43 163.28 19.8 Favored Glycine 0 N--CA 1.422 -2.26 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.24 139.2 58.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.389 0.614 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -132.22 2.94 3.95 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 55.5 mt-10 -149.95 143.68 25.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.666 HG22 ' HG ' ' A' ' 49' ' ' LEU . 13.8 tt -81.63 163.74 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -74.0 72.32 1.63 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.635 1.207 . . . . 0.0 109.646 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.9 mmt -140.51 -176.06 4.5 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.246 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -81.11 116.67 21.14 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 119.284 0.947 . . . . 0.0 111.243 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -106.94 134.75 49.62 Favored 'General case' 0 N--CA 1.4 -2.95 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.39 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.41 79.88 1.79 Allowed 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.62 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -100.24 80.81 0.49 Allowed Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.859 -175.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -68.94 -79.44 0.06 Allowed 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 117.045 0.422 . . . . 0.0 111.585 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 19.9 mtp-105 -75.33 -31.24 60.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.917 -1.113 . . . . 0.0 113.435 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 9.0 tp10 -70.9 -12.64 61.66 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 109.665 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 42.3 t -60.73 -32.24 71.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . . . -69.04 -45.49 70.3 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.435 0.635 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -67.55 -42.53 82.52 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.872 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ptp -57.26 -32.34 66.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.584 0.23 . . . . 0.0 111.38 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 28' ' ' CYS . 50.0 mm -62.31 -40.3 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.52 -36.77 52.15 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.733 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HE2' ' H ' ' A' ' 83' ' ' VAL . 72.4 mttt -65.04 -15.22 62.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.755 0.822 . . . . 0.0 112.533 -178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -67.95 -23.98 65.12 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.636 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.15 -39.76 68.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.334 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 178.35 -68.76 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.761 0.824 . . . . 0.0 109.413 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 81' ' ' THR . 59.0 ttp180 -163.51 124.01 2.25 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 86.5 t -138.29 157.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.2 p -107.76 149.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.472 0.709 . . . . 0.0 109.991 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 51.6 t60 -135.62 128.02 30.37 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.413 HG22 ' HG3' ' A' ' 43' ' ' LYS . 3.2 mp -96.8 136.54 27.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 98.9 mttt 70.48 53.89 0.42 Allowed Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.58 1.152 . . . . 0.0 111.294 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 65.3 Cg_endo -70.58 144.55 49.96 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 121.161 1.241 . . . . 0.0 109.981 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.29 47.7 0.97 Allowed Glycine 0 CA--C 1.474 -2.489 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 10.2 pm0 -105.98 148.47 27.66 Favored 'General case' 0 N--CA 1.396 -3.159 0 CA-C-O 121.945 0.879 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 51.4 mtmt -134.75 80.85 1.87 Allowed 'General case' 0 CA--C 1.454 -2.742 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.433 ' C ' HD22 ' A' ' 49' ' ' LEU . 34.6 pt -95.89 104.35 15.74 Favored 'Isoleucine or valine' 1 C--N 1.221 -4.98 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.148 -175.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 59.03 6.01 0.61 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 126.733 2.013 . . . . 0.0 113.728 175.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.5 -3.46 67.89 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.84 131.83 4.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -76.86 86.33 3.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.443 HD12 HG21 ' A' ' 18' ' ' ILE . 57.3 mt -108.39 127.17 64.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.24 -39.28 64.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.82 9.57 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.431 HD13 ' HB3' ' A' ' 78' ' ' CYS . 58.8 mt -102.96 120.83 51.19 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.85 107.39 0.17 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 123.257 2.638 . . . . 0.0 112.74 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -97.26 137.02 0.44 Allowed 'Trans proline' 0 N--CA 1.424 -2.587 0 C-N-CA 122.573 2.182 . . . . 0.0 111.693 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -67.63 114.03 17.5 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.24 88.01 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.397 2.065 . . . . 0.0 114.418 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 74' ' ' TYR . 73.0 mt -122.89 146.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 142.47 -174.84 23.21 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.829 -2.129 . . . . 0.0 114.547 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.16 102.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.17 105.38 17.51 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.82 -69.91 0.55 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.523 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -167.74 167.78 12.93 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -34.23 77.36 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 124.785 1.234 . . . . 0.0 107.844 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -99.46 32.16 2.89 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.385 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -151.72 160.46 43.59 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.435 HG13 ' OE2' ' A' ' 85' ' ' GLU . 5.3 m -77.8 119.79 27.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.893 0.854 . . . . 0.0 110.735 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.669 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 20.0 ptp -98.49 111.59 23.9 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.72 92.55 7.46 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 71' ' ' MET . 30.4 Cg_endo -100.9 178.04 0.23 Allowed 'Trans proline' 0 N--CA 1.406 -3.63 0 C-N-CA 121.799 1.666 . . . . 0.0 112.489 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 43.0 t80 -135.42 81.7 1.91 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.581 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 22.5 p -97.24 139.24 33.51 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.871 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -111.56 88.1 8.86 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.448 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 75' ' ' THR . 58.0 Cg_endo -107.68 -153.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 123.914 3.076 . . . . 0.0 108.454 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.431 ' HB3' HD13 ' A' ' 56' ' ' ILE . 21.7 t -110.65 11.01 22.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -118.1 -82.26 0.63 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.951 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.87 -174.55 45.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 37.1 m -109.78 148.26 31.78 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.77 135.53 55.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.9 t -121.43 108.65 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 20.2 m -108.24 129.65 62.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' HG13 ' A' ' 70' ' ' VAL . 39.8 tt0 -132.6 117.67 18.23 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.598 0.636 . . . . 0.0 110.821 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 19.8 tp -99.75 134.76 20.81 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.18 -3.1 9.53 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.328 2.019 . . . . 0.0 111.734 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.2 t -94.76 157.95 3.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 91' ' ' GLU . 18.0 t70 -65.07 146.29 98.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 122.476 0.31 . . . . 0.0 111.512 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -50.98 -10.93 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.215 3.277 . . . . 0.0 114.788 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 89' ' ' ASP . 7.9 pt-20 -57.29 -23.13 46.45 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 120.964 0.411 . . . . 0.0 110.438 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -59.74 -26.85 66.0 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.494 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 93' ' ' ILE . 20.0 mm -67.89 -33.71 63.03 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 C-N-CA 121.398 -0.121 . . . . 0.0 110.796 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.33 -43.16 99.47 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -64.74 -51.02 64.58 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.719 -1.582 . . . . 0.0 109.01 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.8 mt -64.59 -25.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 124.003 0.921 . . . . 0.0 112.453 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.67 -39.89 94.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.174 0.511 . . . . 0.0 109.797 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -86.63 -41.31 14.35 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.942 0.877 . . . . 0.0 110.09 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.42 2.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 124.321 1.048 . . . . 0.0 112.115 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.458 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -47.74 -48.67 29.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -176.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.65 -47.15 0.48 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 N--CA 1.434 -2.025 0 CA-C-N 120.224 1.116 . . . . 0.0 112.019 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.496 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.3 mpp? -151.77 132.57 14.1 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -127.77 115.39 18.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 84.2 m-85 -125.39 -5.0 7.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 48.0 m -77.69 90.07 3.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.212 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 20' ' ' MET 0.251 0.0 OUTLIER -79.17 -50.35 11.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.685 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' N ' HD22 ' A' ' 6' ' ' LEU . 1.2 tt0 -76.75 -8.5 57.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.755 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 65.6 m -69.61 -26.36 64.4 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLY . 54.2 m-85 -75.38 -23.21 57.07 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 4.4 tt -70.11 -40.05 75.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -68.3 -23.72 64.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.966 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.58 5.62 45.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.012 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m 60.9 31.4 19.99 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.523 0.729 . . . . 0.0 111.937 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . -145.72 67.61 0.41 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -68.67 145.47 53.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.255 0.55 . . . . 0.0 111.337 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -145.66 27.79 1.2 Allowed 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' HD11 ' A' ' 49' ' ' LEU . 1.6 pm0 -155.99 171.77 19.53 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.406 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.556 HG22 ' HG ' ' A' ' 49' ' ' LEU . 8.7 tt -105.5 16.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.758 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 71.7 m80 65.31 69.09 0.48 Allowed 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 122.522 1.153 . . . . 0.0 110.471 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.719 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.7 tmm? -148.97 -168.69 3.17 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 63.5 tttp -75.76 112.36 12.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 119.66 1.118 . . . . 0.0 110.986 -177.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -106.8 161.07 15.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . . . -160.24 91.09 0.92 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.23 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -107.41 89.59 0.59 Allowed Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.94 -67.36 0.71 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.155 0.979 . . . . 0.0 109.279 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 26.8 mmt180 -81.42 -34.76 31.34 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.023 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 21.1 tt0 -80.31 -5.01 55.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.097 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 12.4 t -49.42 -46.28 47.43 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.274 0.559 . . . . 0.0 109.553 174.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.16 75.72 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.556 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -60.7 -47.32 86.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.02 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.518 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.0 ptm -61.02 -35.25 76.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.23 -42.87 91.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.338 0.589 . . . . 0.0 109.923 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -77.73 -35.13 52.26 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.898 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 31' ' ' MET . 82.1 mttt -57.9 -24.8 59.33 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 0.0 112.39 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.34 -21.78 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.331 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.59 77.77 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.644 0.259 . . . . 0.0 110.596 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -175.36 -69.44 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.336 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.539 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 17.4 ptt180 -151.15 123.58 8.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.0 t -138.07 141.43 38.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.78 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.6 p -108.82 143.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 52.0 t60 -133.81 130.49 38.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 15.7 tt -83.87 141.49 14.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 99.5 mttt 68.14 64.62 0.63 Allowed Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 0.0 110.781 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.47 171.1 16.37 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.927 1.751 . . . . 0.0 111.483 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.489 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -174.5 50.35 0.14 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.957 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' CD ' HG23 ' A' ' 48' ' ' ILE . 5.8 tp10 -119.09 144.47 46.59 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HB2' ' HZ2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -139.68 81.6 1.83 Allowed 'General case' 0 CA--C 1.444 -3.118 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.571 ' HB ' HD22 ' A' ' 49' ' ' LEU . 9.6 pt -72.72 110.05 5.48 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.444 0 CA-C-N 111.677 -2.511 . . . . 0.0 109.903 -179.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER 62.11 14.74 6.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 125.84 1.656 . . . . 0.0 112.398 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 -41.07 2.6 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.53 121.41 41.69 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HA ' HG13 ' A' ' 48' ' ' ILE . 56.7 ttp180 -62.52 92.48 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 124.506 1.122 . . . . 0.0 113.011 -177.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.5 mm -124.26 132.73 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.3 mt -79.99 -29.36 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.504 0.668 . . . . 0.0 109.851 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 17' ' ' GLU . . . 82.6 5.72 89.22 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.943 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.462 HD13 ' H ' ' A' ' 78' ' ' CYS . 70.6 mt -126.72 122.14 23.44 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -65.18 107.87 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.192 1.928 . . . . 0.0 109.783 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -110.26 -172.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.132 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.0 t -73.67 116.85 55.77 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.26 39.19 0.52 Allowed 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 123.583 2.855 . . . . 0.0 115.6 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.73 141.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 165.09 129.65 1.06 Allowed Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 117.979 -2.058 . . . . 0.0 113.635 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 146.96 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -121.76 93.58 4.04 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.69 -64.34 0.88 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.265 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 1.5 tm-20 -159.78 169.92 22.6 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.53 ' HB2' HD11 ' A' ' 93' ' ' ILE . 5.0 tpp180 -87.1 -38.6 16.33 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.279 0.561 . . . . 0.0 112.351 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 18.5 t -91.23 29.9 1.35 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 122.994 1.378 . . . . 0.0 107.924 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 67' ' ' ARG . 16.9 m -145.65 170.02 17.3 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.58 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.468 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 25.3 ptt? -115.78 142.96 46.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.4 tp -114.34 80.44 5.89 Favored Pre-proline 0 C--N 1.292 -1.905 0 C-N-CA 119.655 -0.818 . . . . 0.0 113.12 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 3.0 Cg_exo -84.82 98.64 0.7 Allowed 'Trans proline' 0 N--CA 1.425 -2.503 0 C-N-CA 121.932 1.754 . . . . 0.0 107.72 176.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -88.92 67.65 8.24 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 123.046 1.403 . . . . 0.0 108.865 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.525 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 18.8 p -104.59 138.94 40.19 Favored 'General case' 1 N--CA 1.366 -4.665 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.618 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.17 92.52 9.61 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.564 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 75' ' ' THR . 74.3 Cg_endo -101.76 -165.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 122.93 2.42 . . . . 0.0 110.828 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.462 ' H ' HD13 ' A' ' 56' ' ' ILE . 44.1 t -93.24 0.74 57.16 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -108.29 -78.48 0.59 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.256 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.21 178.35 46.83 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 71.3 m -93.1 131.61 37.98 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.54 116.85 32.74 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.871 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 39.0 t -120.85 133.31 67.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.49 144.29 35.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 38.7 tt0 -137.73 125.82 22.91 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.549 ' HG ' ' H ' ' A' ' 88' ' ' VAL . 26.3 tp -101.16 138.24 19.91 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.76 -3.95 11.32 Favored 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 121.82 1.68 . . . . 0.0 111.568 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.549 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 40.1 t -103.63 159.06 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.422 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 7.5 m-20 -63.59 158.68 57.67 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 123.637 0.585 . . . . 0.0 110.909 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.33 -9.87 7.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.895 3.063 . . . . 0.0 113.636 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 10.7 pt-20 -56.57 -25.64 52.94 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 110.487 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.2 tp10 -63.82 -31.51 72.72 Favored 'General case' 0 C--O 1.206 -1.232 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 67' ' ' ARG . 65.5 mt -60.12 -42.58 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.44 0.296 . . . . 0.0 110.8 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.17 -36.9 85.68 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.313 0.578 . . . . 0.0 110.397 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.455 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 43.2 ttt180 -71.71 -42.3 67.52 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.256 1.027 . . . . 0.0 108.257 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.2 mm -65.46 -17.66 22.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 125.347 1.459 . . . . 0.0 110.908 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.8 tp -78.38 -28.39 47.01 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -82.14 -43.92 17.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 59.1 t -79.35 11.61 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.98 -50.94 67.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.779 0.832 . . . . 0.0 110.23 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.52 92.51 47.75 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.861 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 123.753 2.969 . . . . 0.0 110.849 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 97.1 m-70 . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -145.01 128.89 17.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.572 HG21 ' SD ' ' A' ' 31' ' ' MET . 10.3 t -112.9 131.54 55.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.255 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -133.44 2.9 3.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.297 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 80.5 m -94.25 103.34 15.37 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.373 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -103.0 -36.74 8.07 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.392 177.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 6' ' ' LEU . 42.4 tt0 -75.52 -21.46 57.96 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.01 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 7.1 m -65.64 -40.0 92.03 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -73.34 -33.48 65.13 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.702 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.28 -38.27 89.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.639 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.76 -37.6 64.98 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.476 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -76.38 -15.56 59.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.49 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 m 74.26 107.32 0.07 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.621 1.168 . . . . 0.0 109.919 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.16 45.1 0.09 OUTLIER Glycine 0 C--N 1.288 -2.126 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 pm0 -100.86 158.95 15.6 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.483 1.113 . . . . 0.0 111.267 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 50.9 t80 -138.65 24.91 2.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HD11 ' A' ' 49' ' ' LEU . 10.5 mp0 -136.73 167.58 21.16 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.269 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 19' ' ' HIS . 7.0 tt -121.21 -175.02 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.527 ' H ' HG12 ' A' ' 18' ' ' ILE . 90.5 m-70 -73.03 43.23 0.12 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 119.489 1.041 . . . . 0.0 112.463 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.632 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 37.6 mtt -108.52 -145.7 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 124.935 1.294 . . . . 0.0 109.327 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 20' ' ' MET . 12.0 tmtt? -121.29 133.85 55.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' ILE . 5.5 ptm180 -110.18 147.78 33.08 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -140.74 84.15 1.93 Allowed 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -102.45 79.07 0.34 Allowed Glycine 0 CA--C 1.478 -2.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.265 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.43 -61.85 1.77 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.528 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 3.8 mpt_? -81.92 -41.3 21.08 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.693 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 14.7 mt-10 -75.91 1.14 15.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 54.1 t -56.72 -41.46 77.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.168 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -67.32 -40.0 85.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 109.787 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -61.82 -53.56 54.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.307 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 3' ' ' THR . 11.0 ptm -47.72 -36.46 11.37 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.395 1.06 . . . . 0.0 113.461 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.7 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.44 0.638 . . . . 0.0 110.714 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.61 ' HB3' HG21 ' A' ' 39' ' ' VAL . 31.6 mt-10 -89.13 -16.72 30.76 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.871 0.844 . . . . 0.0 109.929 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 11.6 ttpt -69.89 -27.96 65.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -86.19 -15.48 40.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.278 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.04 57.99 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.199 0.524 . . . . 0.0 109.604 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -162.35 -73.31 0.05 Allowed 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 81' ' ' THR . 12.1 ptp180 -159.85 119.3 2.87 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 33' ' ' GLU . 38.9 t -136.23 147.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.66 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.825 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 10.8 p -106.64 145.71 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 O-C-N 124.676 1.235 . . . . 0.0 108.886 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 29' ' ' ALA . 11.0 t-80 -132.1 127.23 35.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.5 tt -82.03 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 95.1 mttt 63.33 66.64 1.13 Allowed Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 98.7 Cg_endo -95.66 148.74 1.4 Allowed 'Trans proline' 0 N--CA 1.424 -2.601 0 C-N-CA 122.984 2.456 . . . . 0.0 111.448 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -161.8 65.05 0.26 Allowed Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.821 -1.18 . . . . 0.0 112.78 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 30.9 tt0 -114.18 112.03 22.51 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.115 0.959 . . . . 0.0 110.897 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 96' ' ' ILE . 37.6 mtmt -94.44 82.02 4.0 Favored 'General case' 0 CA--C 1.456 -2.644 0 CA-C-O 123.303 1.525 . . . . 0.0 107.324 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG22 ' HB2' ' A' ' 22' ' ' ARG . 2.5 pt -90.27 104.24 15.06 Favored 'Isoleucine or valine' 1 C--N 1.223 -4.899 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.02 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' HB2' ' A' ' 20' ' ' MET . 2.7 mp 67.25 -16.05 0.16 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.398 1.079 . . . . 0.0 113.089 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' ILE . . . 88.11 -5.93 84.18 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -174.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' LEU . . . -156.06 142.1 18.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.481 1.512 . . . . 0.0 107.684 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -84.6 101.55 12.21 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.3 mt -125.27 107.14 17.43 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.2 mp -70.73 -37.23 68.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.424 1.107 . . . . 0.0 108.871 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.85 6.55 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.98 137.95 21.72 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.12 109.08 2.75 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.43 2.086 . . . . 0.0 111.031 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -103.84 -164.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.896 0 C-N-CA 123.21 2.607 . . . . 0.0 111.163 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 75' ' ' THR . 90.5 t -79.02 114.31 43.24 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.72 49.55 3.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.516 2.811 . . . . 0.0 113.644 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.03 156.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA2' ' H ' ' A' ' 74' ' ' TYR . . . 167.16 156.7 9.99 Favored Glycine 0 CA--C 1.479 -2.175 0 C-N-CA 119.088 -1.53 . . . . 0.0 114.109 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.79 93.06 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.049 0.928 . . . . 0.0 111.593 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -86.99 96.06 10.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -75.19 -57.08 4.12 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.134 0.493 . . . . 0.0 111.664 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 0.6 OUTLIER -168.03 168.73 11.73 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -177.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.87 -32.69 20.09 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.98 0.895 . . . . 0.0 109.137 -177.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 15.3 m -93.41 32.04 1.42 Allowed 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.787 1.28 . . . . 0.0 109.867 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.8 m -151.39 168.14 25.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 m -76.11 106.46 5.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.552 0.692 . . . . 0.0 112.687 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 22.3 ptp -87.9 124.63 33.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.1 mt -121.53 87.85 45.88 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.741 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 81' ' ' THR . 2.4 Cg_endo -82.1 119.81 3.23 Favored 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 121.54 1.494 . . . . 0.0 109.079 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.61 ' H ' ' HA2' ' A' ' 62' ' ' GLY . 87.7 m-85 -86.64 59.99 5.96 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.427 1.108 . . . . 0.0 108.515 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 44.1 p -102.28 121.0 41.42 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 113.658 -1.61 . . . . 0.0 107.286 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -108.65 93.19 11.5 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 75' ' ' THR . 56.0 Cg_endo -106.16 -167.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 123.76 2.974 . . . . 0.0 110.485 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.9 m -74.05 -16.84 61.03 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.282 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.657 ' CG ' ' HB2' ' A' ' 16' ' ' TYR . 71.0 t80 -80.7 -82.39 0.12 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.75 -161.92 34.15 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 38' ' ' ARG . 85.4 m -110.93 135.63 51.16 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 123.038 0.535 . . . . 0.0 109.917 -177.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 34' ' ' LYS . . . -109.93 109.46 20.09 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.534 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 38.2 t -108.81 123.58 64.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 44' ' ' PRO . 18.5 m -134.34 142.03 41.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 O-C-N 121.146 -0.971 . . . . 0.0 108.675 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.51 117.66 16.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.42 130.03 31.82 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 63.1 Cg_endo -94.17 31.25 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.752 2.302 . . . . 0.0 110.593 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.89 154.83 37.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -68.76 152.45 96.72 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.28 -7.39 6.63 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 124.19 3.26 . . . . 0.0 113.341 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.64 -25.46 62.75 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.574 0.702 . . . . 0.0 109.465 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -59.18 -27.45 65.69 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.074 1.349 . . . . 0.0 109.661 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 67' ' ' ARG . 84.7 mt -64.93 -40.0 87.58 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 CA-C-O 119.383 -0.342 . . . . 0.0 110.924 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.89 -36.93 82.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.797 0.808 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -66.64 -52.0 49.97 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.491 HG23 ' HG2' ' A' ' 47' ' ' LYS . 8.7 mt -64.78 -21.65 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.14 -36.39 61.59 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.641 0.734 . . . . 0.0 109.043 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -82.82 -35.05 26.73 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 99' ' ' VAL . 46.9 t -97.52 26.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.402 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.965 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -61.33 -31.41 71.27 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.9 -45.07 0.33 Allowed Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.365 1.404 0 C-N-CA 121.877 1.718 . . . . 0.0 113.061 176.48 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.693 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.697 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.683 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HB ' HD22 ' A' ' 49' ' ' LEU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.616 HD22 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 75' ' ' THR . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 73' ' ' PRO . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -170.92 130.4 0.79 Allowed 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 125.712 1.605 . . . . 0.0 107.77 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.433 HG21 ' SD ' ' A' ' 31' ' ' MET . 9.9 t -114.57 129.01 56.63 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.94 0.876 . . . . 0.0 112.124 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -130.87 25.39 4.99 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.315 -1.312 . . . . 0.0 108.669 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 82.4 m -129.89 99.99 5.3 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -80.63 -45.17 17.7 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' N ' HD22 ' A' ' 6' ' ' LEU . 41.8 tt0 -74.55 -2.84 27.65 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.155 0.979 . . . . 0.0 111.863 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 49.9 m -76.84 -26.64 54.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -74.85 -24.15 58.54 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.69 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.26 -20.12 62.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.102 0.953 . . . . 0.0 108.924 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -91.14 9.53 30.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.857 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -128.97 -46.45 1.25 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.597 0.713 . . . . 0.0 109.349 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 m -153.67 -155.66 0.61 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.56 166.01 53.24 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -81.35 147.25 29.94 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.541 ' HA ' HG23 ' A' ' 54' ' ' ILE . 61.1 t80 -126.88 22.63 6.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 122.652 1.215 . . . . 0.0 108.348 -176.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HB3' HD21 ' A' ' 49' ' ' LEU . 7.5 mp0 -142.36 167.9 21.0 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.337 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.679 HG22 HD22 ' A' ' 49' ' ' LEU . 3.1 tt -100.59 -1.54 9.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 -176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' HA ' HD21 ' A' ' 6' ' ' LEU . 60.9 t-80 79.98 79.25 0.05 OUTLIER 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 126.716 2.007 . . . . 0.0 106.581 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.7 -179.08 7.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -176.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.71 101.99 3.22 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.918 1.342 . . . . 0.0 111.292 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.684 ' NE ' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -93.8 121.68 35.5 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.697 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.88 79.06 1.68 Allowed 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.602 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -95.85 88.39 1.05 Allowed Glycine 0 CA--C 1.472 -2.645 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.529 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.34 -64.6 1.13 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.543 0.687 . . . . 0.0 110.13 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.666 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 6.1 mmp_? -84.38 -40.96 17.21 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 34' ' ' LYS . 33.5 tt0 -67.34 -11.98 59.02 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.952 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 48.8 t -55.48 -41.92 73.67 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.88 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' NE2' ' A' ' 41' ' ' HIS . . . -70.81 -32.11 69.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.027 0.442 . . . . 0.0 110.625 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' A' ' 41' ' ' HIS . . . -75.49 -41.36 55.64 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.45 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 21.3 ptp -61.62 -33.06 73.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.993 0.425 . . . . 0.0 111.672 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.19 -28.41 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.798 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' ALA . 15.4 mm-40 -92.73 -37.24 12.48 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.571 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 73.2 mttt -58.8 -24.94 62.64 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 124.772 1.229 . . . . 0.0 111.246 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -60.47 -26.83 67.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 O-C-N 124.331 1.019 . . . . 0.0 110.801 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.26 -62.7 1.3 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.198 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -152.11 -70.01 0.16 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.862 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 28.2 ptt180 -158.48 123.76 4.36 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.0 t -140.74 154.73 21.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.901 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.7 p -115.03 144.15 23.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.169 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.831 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 4.0 t-80 -113.45 126.34 55.22 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.3 tt -86.33 134.57 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 86' ' ' LEU . 65.3 mttp 66.7 60.1 0.94 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.861 0.865 . . . . 0.0 109.906 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 86' ' ' LEU . 57.5 Cg_endo -69.25 168.24 21.45 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.771 1.647 . . . . 0.0 110.639 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.666 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . 179.47 56.8 0.08 OUTLIER Glycine 1 CA--C 1.448 -4.103 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -177.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . 2.6 pm0 -116.35 147.27 41.76 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 114.163 -1.019 . . . . 0.0 109.857 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.592 ' CG ' ' HA ' ' A' ' 100' ' ' ALA . 7.8 mmtm -136.64 76.56 1.6 Allowed 'General case' 0 C--N 1.263 -3.193 0 CA-C-O 123.801 1.762 . . . . 0.0 107.907 174.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 79.9 mt -88.39 107.55 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.698 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.364 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.679 HD22 HG22 ' A' ' 18' ' ' ILE . 2.4 mt 70.57 -3.77 1.82 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.492 1.117 . . . . 0.0 111.251 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.8 -37.73 3.66 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.27 131.12 27.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -71.93 103.84 3.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.904 0.859 . . . . 0.0 109.216 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 49' ' ' LEU . 50.8 mm -120.01 134.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 16' ' ' TYR . 69.5 mt -84.61 -41.38 15.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.752 0.787 . . . . 0.0 109.229 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.69 -18.51 34.03 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 mm -101.02 108.78 56.07 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.5 Cg_exo -53.05 109.32 0.34 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.477 2.785 . . . . 0.0 112.577 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 59.0 Cg_endo -97.37 -179.66 0.38 Allowed 'Trans proline' 0 N--CA 1.432 -2.12 0 C-N-CA 122.713 2.275 . . . . 0.0 111.487 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 75' ' ' THR . 77.6 t -67.37 112.33 9.82 Favored Pre-proline 0 C--O 1.213 -0.835 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.27 75.09 5.14 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.86 1.707 . . . . 0.0 115.455 -170.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 75.0 mt -136.64 142.21 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.658 ' CA ' ' HA ' ' A' ' 73' ' ' PRO . . . 138.11 156.74 7.24 Favored Glycine 0 N--CA 1.403 -3.535 0 C-N-CA 118.981 -1.58 . . . . 0.0 114.13 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.1 pt -150.87 160.84 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 123.423 0.689 . . . . 0.0 111.3 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -102.93 136.48 42.68 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.44 -61.87 1.66 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.737 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -155.83 166.22 34.16 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 67' ' ' ARG . 3.0 tpp180 -77.09 -33.62 56.96 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.793 0.806 . . . . 0.0 110.468 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -90.49 31.54 1.02 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 122.782 1.277 . . . . 0.0 110.288 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.483 ' CA ' ' HG3' ' A' ' 85' ' ' GLU . 64.4 m -154.61 173.49 16.28 Favored 'General case' 0 N--CA 1.393 -3.314 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 85' ' ' GLU . 29.1 m -79.19 166.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-O 122.473 1.13 . . . . 0.0 110.228 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.526 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.4 ptt? -120.77 122.25 39.96 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 174.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.8 90.29 15.01 Favored Pre-proline 0 C--N 1.293 -1.867 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.174 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.658 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 71.7 Cg_endo -103.21 171.09 0.21 Allowed 'Trans proline' 1 N--CA 1.385 -4.898 0 C-N-CA 120.8 1.0 . . . . 0.0 111.449 176.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m-85 -126.05 32.53 5.23 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 122.213 1.006 . . . . 0.0 110.304 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 37.0 p -80.6 104.38 11.09 Favored 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.511 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -103.88 102.23 29.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.688 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 75' ' ' THR . 64.3 Cg_endo -98.46 -156.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.736 2.957 . . . . 0.0 112.072 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 35.2 t -95.95 28.56 3.08 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.369 1.08 . . . . 0.0 108.092 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -136.81 -85.28 0.33 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.68 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -172.77 173.81 45.59 Favored Glycine 0 C--N 1.315 -0.589 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.551 ' HB ' ' CB ' ' A' ' 38' ' ' ARG . 25.1 m -89.28 135.7 33.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.418 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . . . -109.91 126.93 54.39 Favored 'General case' 0 N--CA 1.397 -3.119 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 54.2 t -133.02 138.85 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 30.7 m -140.06 140.52 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.483 ' HG3' ' CA ' ' A' ' 69' ' ' THR . 42.5 tt0 -138.71 118.67 13.34 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' SER . 13.2 tp -97.17 143.9 26.94 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -94.27 12.67 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.907 1.738 . . . . 0.0 112.34 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 68' ' ' SER . 26.1 t -117.79 156.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.474 ' CB ' ' HG2' ' A' ' 91' ' ' GLU . 1.8 m-20 -51.81 157.51 1.97 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 124.201 0.938 . . . . 0.0 111.871 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.28 -11.37 31.11 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.586 2.191 . . . . 0.0 110.539 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 89' ' ' ASP . 12.8 pt-20 -66.61 -16.87 64.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.226 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 96' ' ' ILE . 7.3 tp10 -59.52 -26.49 65.36 Favored 'General case' 0 C--N 1.375 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -56.38 -36.16 45.98 Favored 'Isoleucine or valine' 0 C--O 1.167 -3.242 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.464 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -56.04 -40.94 74.23 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.93 0.871 . . . . 0.0 110.796 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -39.03 42.29 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.208 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 92' ' ' GLU . 43.2 mm -75.29 -18.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.317 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.9 tp -82.14 -27.89 32.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.731 0.777 . . . . 0.0 109.018 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -100.74 7.88 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.669 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.592 ' HA ' ' CG ' ' A' ' 47' ' ' LYS . . . -55.13 -61.8 2.08 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -177.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.54 -43.93 0.22 Allowed Pre-proline 0 C--N 1.258 -3.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.911 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.423 -2.638 0 C-N-CA 121.163 1.242 . . . . 0.0 112.347 179.129 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 94.3 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 3.1 mpp? -150.44 141.78 23.3 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.6 m -125.38 112.05 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 2' ' ' MET . 76.3 m-85 -125.24 -10.94 7.0 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.237 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 73.9 m -81.38 92.17 6.38 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.001 0.429 . . . . 0.0 110.185 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.693 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.08 -41.79 20.07 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.977 0.894 . . . . 0.0 112.67 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' N ' HD22 ' A' ' 6' ' ' LEU . 26.9 tt0 -75.29 -12.22 60.23 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.174 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 5' ' ' CYS . 27.2 m -70.81 -25.79 63.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -76.39 -23.82 54.07 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 19' ' ' HIS . 6.6 tt -69.83 -40.53 75.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.47 -31.72 70.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.09 -0.7 57.09 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.141 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m 55.99 45.89 22.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.882 0.848 . . . . 0.0 110.021 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.66 53.4 0.52 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.89 134.59 57.05 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 124.86 0.977 . . . . 0.0 111.188 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -136.07 19.14 3.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 6' ' ' LEU . 1.6 pm0 -151.05 176.1 11.47 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.724 1.25 . . . . 0.0 114.006 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG22 ' HG ' ' A' ' 49' ' ' LEU 0.262 12.5 tt -106.82 18.67 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.154 176.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.697 ' NE2' ' HB2' ' A' ' 10' ' ' LEU . 77.8 m80 56.34 61.69 2.61 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-O 123.337 1.542 . . . . 0.0 111.084 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.683 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 90.4 mmm -135.98 -160.44 1.05 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.101 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 65.5 tttp -87.27 114.51 23.95 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 120.436 1.471 . . . . 0.0 111.154 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 6' ' ' LEU . 10.7 ptm180 -106.14 160.85 15.01 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' GLU . . . -156.52 88.35 1.06 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' CYS . . . -106.56 86.44 0.47 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -77.93 -62.51 1.65 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.81 0.814 . . . . 0.0 110.872 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' N ' ' A' ' 45' ' ' GLY . 36.0 mmt180 -82.49 -40.81 20.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.752 0.787 . . . . 0.0 111.437 -176.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 46' ' ' GLU . 24.6 tt0 -78.33 -4.68 49.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.717 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 1' ' ' HIS . 41.4 t -49.88 -46.68 51.88 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 121.345 0.593 . . . . 0.0 110.041 175.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -36.68 78.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.224 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 41' ' ' HIS . . . -62.85 -43.53 98.56 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.167 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.436 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 23.5 ptm -64.5 -31.56 72.82 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.036 -176.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.79 -36.66 77.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -77.14 -41.06 43.33 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.361 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 76.7 mttt -62.63 -17.7 60.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.631 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.62 -22.73 65.5 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.136 0.975 . . . . 0.0 110.974 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -57.31 5.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.717 0.294 . . . . 0.0 110.468 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -164.71 -63.08 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -158.36 131.83 7.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.7 t -145.17 145.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 7.4 p -103.42 146.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 30' ' ' ALA . 20.5 t60 -139.08 128.96 24.92 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' GLU . 13.2 tt -80.65 143.09 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 26' ' ' ARG . 97.1 mttt 67.04 65.61 0.7 Allowed Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.283 0.633 . . . . 0.0 111.225 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 75.4 Cg_endo -80.24 171.14 15.39 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.369 1.379 . . . . 0.0 111.835 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 26' ' ' ARG . . . -176.05 50.93 0.12 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' CD ' HG23 ' A' ' 48' ' ' ILE . 6.0 tp10 -117.95 129.2 55.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 100' ' ' ALA . 9.2 mtmt -121.86 72.52 1.03 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 123.304 1.526 . . . . 0.0 107.551 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.616 ' HB ' HD22 ' A' ' 49' ' ' LEU . 2.2 pt -71.02 105.79 1.68 Allowed 'Isoleucine or valine' 1 C--N 1.241 -4.151 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.963 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.616 HD22 ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER 60.68 4.97 0.82 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.043 2.137 . . . . 0.0 113.497 174.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.33 10.25 84.41 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.35 124.06 1.68 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -76.31 93.09 3.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.338 0.589 . . . . 0.0 112.527 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.9 113.74 41.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.44 -31.25 48.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.777 0.799 . . . . 0.0 109.787 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.47 21.52 Favored Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.77 120.08 62.49 Favored Pre-proline 0 N--CA 1.425 -1.687 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.21 109.83 1.64 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.018 2.479 . . . . 0.0 111.779 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -107.95 -172.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.335 0 C-N-CA 122.572 2.182 . . . . 0.0 112.539 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 75' ' ' THR . 61.9 t -81.3 113.53 42.25 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 1.4 Cg_endo -83.52 86.9 1.32 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.129 1.886 . . . . 0.0 113.626 -174.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -134.48 148.19 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 73' ' ' PRO . . . 160.79 154.88 7.57 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 119.466 -1.35 . . . . 0.0 112.189 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.01 135.58 45.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.12 107.23 18.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.51 -57.28 11.73 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.304 0.573 . . . . 0.0 110.014 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -162.3 172.57 15.47 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 7.3 tpp180 -86.48 -34.64 19.99 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-O 121.983 0.897 . . . . 0.0 109.636 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 26.5 t -90.3 29.92 1.19 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 122.964 1.364 . . . . 0.0 109.659 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.8 m -152.17 166.11 32.73 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 40' ' ' VAL . 32.6 m -71.3 156.47 7.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.294 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 83' ' ' VAL . 26.5 ptt? -121.66 146.25 47.19 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.5 tp -118.32 87.79 31.18 Favored Pre-proline 0 C--N 1.281 -2.386 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.592 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 Cg_endo -88.18 120.41 1.31 Allowed 'Trans proline' 0 N--CA 1.416 -3.072 0 C-N-CA 121.569 1.513 . . . . 0.0 109.089 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -99.6 86.28 3.31 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 35.1 p -119.52 154.24 34.13 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.702 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.63 85.31 43.77 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -92.09 -175.82 0.69 Allowed 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.502 2.135 . . . . 0.0 109.577 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 49.3 t -98.03 -8.53 27.68 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.472 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -100.46 -84.13 0.43 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.06 167.18 39.56 Favored Glycine 0 N--CA 1.42 -2.381 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 73' ' ' PRO . 41.2 m -98.33 147.06 25.05 Favored 'General case' 0 N--CA 1.414 -2.23 0 C-N-CA 123.869 0.868 . . . . 0.0 108.908 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.51 126.08 54.0 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.902 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 46.5 t -121.49 127.74 75.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' ' HG3' ' A' ' 44' ' ' PRO . 13.0 m -129.06 143.46 41.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 29.6 tt0 -131.68 113.35 13.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 68' ' ' SER . 24.9 tp -95.11 133.01 26.88 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.8 -9.25 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.588 1.526 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 86' ' ' LEU . 17.0 t -102.72 155.73 5.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 6.5 m-20 -59.34 157.11 25.8 Favored Pre-proline 0 C--N 1.311 -1.084 0 O-C-N 123.949 0.78 . . . . 0.0 111.251 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.34 -6.37 3.97 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 123.817 3.011 . . . . 0.0 113.783 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 89' ' ' ASP . 11.3 pt-20 -63.78 -22.42 66.9 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.655 0.782 . . . . 0.0 110.318 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' OE1' ' HD3' ' A' ' 95' ' ' ARG . 5.0 tp10 -62.11 -30.17 70.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.302 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 67' ' ' ARG . 82.2 mt -58.48 -38.74 72.04 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.653 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -45.06 92.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.264 0.554 . . . . 0.0 110.097 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 92' ' ' GLU . 67.1 ttt180 -65.23 -49.23 70.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.737 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mm -63.97 -26.67 41.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.463 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.7 tp -71.27 -31.15 67.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.042 0.449 . . . . 0.0 110.399 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -76.87 -39.95 49.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.531 1.158 . . . . 0.0 108.033 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.87 6.29 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.27 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.552 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -55.57 -45.82 77.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.68 96.75 29.12 Favored Pre-proline 0 N--CA 1.408 -2.542 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.933 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo . . . . . 0 C--N 1.317 -1.131 0 C-N-CA 122.954 2.436 . . . . 0.0 110.234 177.462 . . . . . . . . 0 0 . 1 stop_ save_